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Abstract 
 
Candida glabrata is a significant and increasingly common pathogen of humans 
yet its mechanism of virulence remains unclear. Comparative genomic studies 
revealed that C. glabrata is more closely related to the non-pathogenic yeast 
Saccharomyces cerevisiae and that both these genomes are distinct from C. 
albicans. In order to explore C. glabrata virulence attributes, C. glabrata ORFs 
with no orthologue in S. cerevisiae were studied since these ORFs may have 
accompanied the adaptation of C. glabrata to the human host. 
 
Reciprocal best hit searches identified C. glabrata ORFs with no S. cerevisiae 
orthologue. A barcoded deletion library targeting 65 C. glabrata-specific ORFs 
was constructed. To functionally characterise the deletion library, mutants were 
tested for fitness and phenotypically screened to identify gene products required 
for growth in response to biologically relevant stresses. As such, novel 
phenotypes associated with the deletion of previously uncharacterised ORFs 
were uncovered. Mutants were also tested for infection-related properties 
including biofilm formation, antifungal agent susceptibility and for virulence in a 
Drosophila melanogaster infection model, resulting in the identification of two C. 
glabrata-specific ORFs, CAGL0K05687g and CAGL0H01749g, which were 
required for virulence.  
 
Three ORFs with notable phenotypes were taken forward for further 
characterisation. An adapted genome-wide synthetic genetic interaction 
approach was used to create genetic interaction networks for C. glabrata ORFs 
over-expressed in S. cerevisiae. Genetic interaction analysis of a C. glabrata 
chromatin remodeler CAGL0D05434g revealed a role for this ORF in metal ion 
homeostasis and DNA damage repair. Genetic interaction profiling for an 
oxidoreductase encoded by CAGL0K05687g was used to reveal mechanisms 
related to transport by which this ORF may be required for virulence. 
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TNF-α   Tumour necrosis factor alpha 
tRNA   Transfer RNA  
TTSS   Type III secretion system  
UTR   Untranslated region 
UV   Ultraviolet 
U/µl   Units per microlitre 
V   Volts 
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v-SNARE  Vesicle associated SNARE 
v/v   Volume to volume ratio 
WGD   Whole genome duplication 
w/v   Weight to volume ratio 
XTT 2,3-Bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-
carboxanilide 
YFP   Yellow fluorescent protein 
YGOB   Yeast gene order browser 
YPD   Yeast extract peptone media 
YPS   GPI-linked aspartyl proteases  
ZnCl2   Zinc chloride 
°C   Degrees Celcius 
µg   Micrograms 
µg/ml   Micrograms per millilitre 
µl   Microlitre 
µM   Micromolar 
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Chapter 1: Introduction 
 
1.1 Candida Species: Disease and Epidemiology  
The fungal kingdom encompasses a diverse range of microorganisms 
estimated at 1.5 million species, which employ a plethora of different lifestyles 
and morphologies. Over 600 fungal species are known to infect humans and 
present an emerging threat to human health as the causative agents of billions 
of infections each year (Hawksworth, 2001; Brown et al., 2012; Fisher et al., 
2012). Despite this, pathogenic fungi remain less well studied and understood 
compared to other infectious microorganisms, in particular bacterial pathogens 
such as Mycobacterium tuberculosis or the protist Plasmodium falciparum, for 
example (Brown et al., 2012). In an expanding susceptible population with an 
increasing life expectancy, fungal infections have emerged as a prominent 
public health problem (Pfaller & Diekema 2007). 
The Candida species (Figure 1.1) are of particular interest as a group of 
significant pathogens of humans and are the fourth most commonly isolated 
pathogen from blood stream infections (Wisplinghoff et al., 2004; Klotz et al., 
2007). Surveillance programmes such as the PATH® Alliance report that 
Candida species are a major cause of invasive fungal infections, accounting for 
up to 73.4 % of diagnoses. The remainder of infections are attributed to 
Aspergillus species, Cryptococcus species, moulds and Mucormycetes (Azie et 
al., 2012) and similar trends have been noted worldwide (Sifuentes-Osornio et 
al., 2012; Pfaller & Diekema, 2007).  
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Figure 1.1: Phylogenetic representation of selected fungal species. 
Species highlighted in blue represent pathogens of plants. Species highlighted 
in red indicate human pathogens (Butler, 2010).  
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Candida species are frequently isolated as an asymptomatic commensal from 
the mucosa of healthy individuals, most commonly colonising the gut, oral or 
vaginal cavity. Colonisation by Candida species can lead to minor superficial 
infections of the mucosa which are usually cleared by the immune system. 
However, under certain circumstances colonisation can develop into more 
serious systemic blood stream infections which are associated with high rates of 
morbidity and mortality (Fidel et al., 1999; Miramón et al., 2013). A number of 
predisposing factors such as previous exposure to antifungal drugs, surgical 
procedures, immunosuppressive therapy, use of central venous catheters and 
diabetes are linked to the development of systemic Candida infections 
(Almirante et al., 2005; Pfaller et al., 2012). Recurrent oropharyngeal 
candidiasis is a common problem incurred by patients suffering from 
immunosuppressive diseases such as HIV (Lin et al., 2009). Reports following 
the outcomes of patients diagnosed with invasive Candida infections estimate 
mortality rates in the range of 40-75 % (Pfaller & Diekema, 2007; Almirante et 
al., 2005; Pfaller et al., 2012). The costs of increased length of stay in hospitals, 
administration of antifungal therapy and diagnostic procedures associated with 
Candida infections cost an estimated $216-281 in excess medical costs a year 
in North America (Pfaller & Diekema, 2007; Pelz et al., 2008; Rentz et al., 
1998). When it is considered that approximately two thirds of invasive Candida 
infections are hospital acquired (Pfaller et al., 2012), it obviates the need for 
effective diagnosis, treatment and understanding of Candida infections. 
 
Many Candida species are able to colonize and establish disease in the human 
host (Figure 1.1). 97 % of Candida infections are attributed to five species: 
Candida albicans (42.1 %), C. glabrata (26.7 %), C. parapsilosis (15.9 %), C. 
tropicalis (8.7 %) and C. krusei (3.4 %) (Pfaller et al, 2012; Figure 1.2). Although 
C. albicans remains the single most frequently isolated Candida species, the 
incidence of infections caused by non-albicans Candida species is increasing 
(Pfaller et al., 2012; Horn et al., 2009). C. glabrata is currently the second most 
frequently isolated Candida species (Figure 1.2) and its effective treatment is 
compromised by its innate resistance to the azoles - a major class of antifungal 
drugs used to treat Candida infections and its ability to acquire resistance to the 
echinocandins (Pfaller & Diekema, 2007; Pfaller et al., 2012; see  1.9).  
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Figure 1.2: Frequency of Candida species from 364 clinical blood stream 
isolates in North America. C. glabrata is the second most frequently isolated 
species causing 26.7 % of all Candida infections (Pfaller et al., 2012)  
 
1.2 The C. glabrata Genome  
Hemiascomycte yeasts have become model organisms for eukaryotic 
evolutionary and comparative genomic studies and the ease in which they can 
be genetically manipulated has led to their extensive use in genetic studies. The 
C. glabrata CBS138 genome sequence was published in 2004 simultaneously 
with the sequences of related species Kluyveromyces lactis, Debaryomyces 
hanseii and Yarrowia lipolytica as part of the Génolevures consortium (Dujon et 
al., 2004). Projects such as Génolevures (Sherman et al., 2004; Sherman et al., 
2013), YGOB (Byrne & Wolfe, 2005), SGD (yeastgenome.org) and CGD 
(candidagenome.org) have enabled large scale comparisons of 
hemiascomycetous yeast genomes. 
 
Although nomenclature and the pathogenic nature of C. glabrata has lead to its 
classification with the Candida species, comparative genomic analysis revealed 
that C. glabrata is more closely related to the relatively non-pathogenic yeast S. 
cerevisiae (Dujon et al., 2004). The C. glabrata genome is unlike those in the 
Candida clade which are distinguishable by a unique translation event whereby 
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the CUG codon is read (by a special tRNA-Ser) as serine rather than leucine 
(Santos & Tuite, 1995; Butler et al., 2009). Rather, C. glabrata genome features 
such as genome size and GC content (Table 1.1) much more closely resemble 
that of S. cerevisiae than C. albicans, and share 65 % amino acid identity 
between orthologous proteins. Thus it is postulated that C. glabrata and S. 
cerevisiae share a common ancestral lineage and that divergence from this 
ancestor occurred following a whole genome duplication (WGD) event (Figure 
1.3; Dujon et al., 2004; Kellis et al., 2004; Dujon, 2010).  
 
 
Figure 1.3: Phylogeny of Candida and Saccharomyces clade species. 
WGD indicates the occurrence of a whole genome duplication event in an 
ancestral lineage of S. cerevisiae and C. glabrata. CTG highlights a switch in 
the translation of the CUG codon as serine rather than leucine. C. glabrata lies 
in the WGD clade, distinct from the Candida clade.  
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Table 1.1: Summarised genome features of sequenced strains of S. 
cerevisiae S288C, C. glabrata CBS138 and C. albicans SC5314 (Dujon et al., 
2004; Byrne & Wolfe, 2005; Dujon, 2010). 
Feature S. cerevisiae C. glabrata C. albicans 
Number of 
chromosomes 
16 13 8 
Genome size (Mb) 12.1 12.3 14.3 
GC Content (%) 38.0 38.8 33.5 
Total Coding 
Sequences (CDS) 
5,807 5,283 6,107 
Average Gene 
Density (%) 
70.3 65.0 - 
Average CDS size 
(codons) 
485 493 489 
Ploidy Haploid Haploid Diploid 
No. of ohnologue 
pairs 
551 404 - 
 
Duplication of genetic material, such as a WGD event, provides scope for 
genetic novelty. Genes with new function can arise through gene duplications, a 
major evolutionary force which can lead to the adaptation of a species to new 
environments or the development of species-specific traits (Byrne & Wolfe, 
2005; Magadum et al., 2013). Duplicated genes may evolve completely novel 
function (neofunctionalisation) or differentiate by taking on different aspects of 
the parent gene function (subfunctionalisation) (Magadum et al., 2013). 
Alternatively, reciprocal loss of duplicated genes can lead to genetic isolation of 
populations and speciation (Byrne & Wolfe, 2005).   
 
Evidence suggests that post-WGD, the C. glabrata genome evolved in a 
reductive fashion with the frequent loss of genes that remain duplicated in S. 
cerevisiae - characteristic of an emerging pathogen adapting to the novel host 
niche (Dujon et al., 2004; Byrne & Wolfe, 2005). Fewer blocks of ancestral 
duplications are found in the C. glabrata genome compared to that of S. 
cerevisiae. Hence, there is a lower genetic redundancy in C. glabrata and a 
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reduced number of ohnologues, paralogous genes pairs arising from a WGD 
event (Dujon et al., 2004; Byrne & Wolfe, 2005). Compared with related yeast 
species studied as part of the Génolevures consortium, genes losses specific to 
C. glabrata  include those involved in galactose and phosphate metabolism, cell 
rescue, defence, virulence and nitrogen and sulphur metabolism (Dujon et al., 
2004). Instances where neofunctionalisation has aided adaptation of C. glabrata 
to a host niche lie in the phosphate starvation response where C. glabrata does 
not encode an orthologue of PHO5, a phosphate-repressible acid phosphatase, 
yet has retained both duplications of PHO2. Neofunctionalisation of C. glabrata 
PHO2 lead to functional replacement of PHO5 with PHO2, enabling phosphate-
starvation-inducible phosphatase activity in this species (Orkwis et al., 2010). 
 
Expansion of specific gene families can also generate genetic diversity. 
Uniquely to C. glabrata, expansions have occurred in the YPS gene cluster 
(GPI-linked aspartyl proteases) and at the MNT3 locus. The C. glabrata YPS 
gene cluster encodes six additional genes compared with that of S. cerevisiae 
while the MNT3 S. cerevisiae gene, encoding an ɑ -1.3-mannosyltransferase 
involved in cell wall biogenesis, has eight copies in C. glabrata (Dujon, 2010). 
Expansion of these gene clusters may contribute to C. glabrata virulence 
through restructuring of the cell wall and the YPS cluster are important for 
adaptation and survival in the host and for adhesion to host cells. Similar 
patterns of gene family expansion have occurred in other pathogenic Candida 
species. In these species, expanded gene families are enriched for function 
related to the fungal cell wall, cell surface transporters and GPI-linked proteins. 
These patterns highlight the importance of extracellular activity and the cell wall 
in virulence (Butler et al., 2009).  
 
1.2.1 Genetic Plasticity in C. glabrata Clinical Isolates 
Unlike many Candida species, blood stream isolates of C. glabrata from the 
same patient can have different karyotypes (Shin et al., 2007). Additional 
chromosomes comprising large segmental duplications of 120-420 bp have 
been identified in clinical isolates of C. glabrata (Poláková et al., 2009; Ahmad 
et al., 2013). These segments contain centromeric regions and have acquired 
telomeric regions but have reduced genetic stability. Alteration of gene dosage 
in this way could comprise an effective strategy employed by microorganisms to 
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overcome environmental stresses. Most interestingly, duplicated regions 
includes virulence-related genes encoding ABC transporters AUS1 
(CAGL0F01419g), PDH1 (CAGL0F02717g), CDR1 (CAGL0M01760g), DHA1 
(CAGL0I10384g) and members of the YPS cluster and predicted GPI-anchored 
protein PLB3 (CAGL0J11770g). As such, increase in gene dosage of genes 
implicated in drug resistance, virulence and survival in macrophages via new 
chromosome generation could be a unique strategy employed by C. glabrata to 
adapt to the host environment (Poláková et al., 2009; Ahmad et al., 2013).  
 
1.2.2 Phenotypic Plasticity of C. glabrata 
Candida species (including C. glabrata) are able to undergo phenotypic 
switching (Lachke et al., 2002; Lan et al., 2002). In C. glabrata, a phenotypic 
switching system has been described in which both lab strains and clinical 
isolates have been shown to switch between three main phases: white, light 
brown & dark brown (Lachke et al., 2000). Studies have shown the dark brown 
phenotype to have a pathogenic advantage as it is better adapted to colonize 
host organs in a murine infection model (Srikantha et al., 2008). Thus this form 
of phenotypic plasticity in C. glabrata may aid pathogenesis by producing 
variants that may better survive environmental challenges presented by the host 
and provide a mechanism for rapid adaptation (Srikantha et al., 2005). 
 
1.2.3 C. glabrata has no Apparent Sexual Cycle 
To date, all C. glabrata clinical isolates have been haploid with no apparent 
sexual cycle and existing mostly as a clonal population structure (Fidel Jr. et al., 
1999; Kaur et al., 2005; Brunke & Hube, 2013). This is contrary to many 
members of the WGD clade (to which C. glabrata belongs) which are able to 
create genetic diversity through mating and meiotic recombination. In S. 
cerevisiae, upon sensing of pheromone of the opposite mating type, haploid a 
and α cells form a polarized mating projection (shmoo) in the direction of the 
partner haploid cell. Upon contact, cells fuse and karyogamy takes place to 
form an a/α diploid (Merlini et al., 2013). In response to nitrogen starvation, the 
diploid nuclei undergoes chromosome segregation and meiosis to produce four 
haploid progeny nuclei which are packaged into spores which are encased by 
the mother cell to form a tetrad structure (Figure 1.4; Neiman, 2011). 
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Figure 1.4: The life cycle of S. cerevisiae (yeastgenome.org). In response to 
pheromone from the opposite mating type, haploid a and α cells form mating 
projections and upon contact, fuse to form a/α diploid cells. Under nitrogen 
starvation conditions, diploids undergo meiosis and sporulation forming tetrads 
which encase four haploid meiotic progeny (spores).  
 
Despite the lack of a sexual cycle, C. glabrata is closely related to sexual 
species Kluyveromyces delphensis, S. cerevisiae and members of the 
Saccharomyces clade. Although no sexual cycle has been identified, C. 
glabrata does exist in two haploid mating types: MATa (lab strain BG2) and 
MATα (lab strain CBS138), both of which (although mostly MATa) have been 
isolated from colonisation sites of patients (Brockert et al., 2003; Muller et al., 
2008; Butler, 2010). As in the case of S. cerevisiae, C. glabrata MAT loci and 
the silent MAT-like cassettes, HMLα and HMRa, are present (Srikantha et al., 
2003; Butler, 2010). Although these homologues encode the same proteins in 
both species, in S. cerevisiae these cassettes are located on the same 
chromosome. In C. glabrata, the MAT and HML-like cassettes are located on 
chromosome B while the HMR-like cassette is located to chromosome E, which 
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could signify differences in regulation (Muller et al., 2008). Unlike S. cerevisiae, 
few cases of mating type switching have been observed in C. glabrata (Brockert 
et al., 2003; Butler, 2010). 
Further to this, bioinformatic searches identified C. glabrata orthologues of 
numerous genes implicated in the mating and meiosis pathway of S. cerevisiae. 
They encode components of the mating signalling pathway, pheromone 
synthesis and response and meiosis and sporulation genes (Table 1.2; Wong et 
al., 2003). Although C. glabrata expresses both a- and α-factor receptors, cells 
of neither mating type show an observable response to pheromone (Muller et 
al., 2008; Butler, 2010). Since many components of the mating machinery have 
been retained in C. glabrata, it is unknown whether an undiscovered C. glabrata 
sexual cycle exists. Alternatively orthologues of the mating pathway may have 
emerged new functions as is the case for STE12 which regulates the response 
to pheromone in non-pathogenic S. cerevisiae yet has a role in virulence in C. 
glabrata (Calcagno et al., 2003). 
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Table 1.2: C. glabrata orthologues of S. cerevisiae genes involved in 
mating, meiosis and sporulation (Wong et al., 2003) 
 
C. glabrata ORF S. cerevisiae 
orthologue 
Role in S. cerevisiae 
CAGL0B02739g STE11 Mating signalling 
CAGL0I03498g STE7 
CAGL0J04290g FUS3 
CAGL0M01254g STE12 
CAGL0C01919g MFA2 Pheromone synthesis and response 
CAGL0L02651g STE13 
CAGL0K00363g STE6 
CAGL0I06138g FAR1 
CAGL0F05269g CDC42 
CAGL0H00759g SGS1 
CAGL0M09042g IME1 Meiosis and sporulation 
CAGL0F05357g UME6 
CAGL0E01683g MCK1 
CAGL0E03630g RIM4 
CAGL0G04455g IME2 
 
The lack of mating and meiotic recombination in C. glabrata is consistent with 
pathogenic fungal species (including Candida species), which have 
independently limited their sexual cycle and reproduce mitotically perhaps to 
maximise virulence (Butler, et al., 2009). Although C. albicans encodes 
homologues of key S. cerevisiae genes that could support a full sexual cycle, it 
exists in a mainly asexual lifecycle (Tzung et al., 2001). However, C. albicans 
undergoes a parasexual cycle in which diploid ɑ  and a cells conjugate, a 
process regulated by phenotypic switching, to form a/ɑ  tetraploids in which 
genetic recombination but not full meiosis can take place. Tetraploids undergo 
subsequent random chromosome loss to produce diploid progeny (although 
many are aneuploid for certain chromosomes) which contain assorted 
combinations of the 8 chromosomes (Forche et al., 2008). More recently, a 
haploid form of C. albicans was discovered which has arisen through concerted 
chromosome loss (Hickman et al., 2013).  
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1.3 The S. cerevisiae Molecular Toolkit 
The ease with which S. cerevisiae can be genetically manipulated has 
facilitated the production of a number of molecular tools which have enabled 
genome-wide studies in this model organism. Large collaborative projects have 
produced an array of deletion and ORF libraries which have become valuable 
resources for a plethora of downstream applications (Table 1.3).   
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Table 1.3: Summary outlining the molecular tools available for S. 
cerevisiae and examples of their applications where they have facilitated 
genome-wide molecular studies in this organism. 
S. cerevisiae tool Application 
ORF libraries: 
 Yeast ORF collection 
 Yeast YFP Fusion 
Kinase collection 
 Yeast TAP-tagged 
ORFs 
 Molecular Barcoded 
Yeast (MoBY) ORF 
collection 
 Yeast GST-tagged 
ORFs 
 Yeast HA tag 
collection 
 Yeast Barcoder 
Collection 
Global analysis of protein glycosylation (Gelperin et 
al., 2005) 
Protein localisation studies (Kumar et al., 2002; Ma et 
al., 2008) 
Identification of log-phase specific genes 
(Ghaemmaghami et al., 2003) 
Uncovering the genetic basis of drug resistance (Ho 
et al., 2009) 
Over-expression screens (Sopko et al., 2006) 
SDL screening (Sopko et al., 2006) 
Molecular barcoding (Yan et al., 2008) 
Deletion libraries: 
 Yeast essential 
collection 
 Yeast Heterozygous 
collection 
 Yeast Homozygous 
collection 
 Yeast mata/matα 
collection 
Functional profiling of the S. cerevisiae genome 
(Giaever et al., 2002; Deutschbauer et al., 2002; 
Fabrizio et al., 2010) 
Global synthetic genetic interaction profiling 
(Davierwala et al., 2005; Tong et al., 2001; Tong et 
al., 2005) 
Haploinsufficiency profiling (Giaever et al., 1999) 
Pooled competitive growth assays (Winzeler et al., 
1999) 
Aneuploidy profiling (Hughes et al., 2000) 
Genome-wide screens of human disease genes 
(Steinmetz et al., 2002) 
Drug/small molecule targets and MOA discovery 
(Hillenmeyer et al., 2010; dos Santos & Sá-Correia, 
2011; Zakrzewska et al., 2007; Troppens et al., 2013) 
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1.3.1 S. cerevisiae Deletion Collections and their Applications 
The generation and completion of S. cerevisiae deletion libraries has greatly 
facilitated annotation of the genome and made gene deletion studies possible 
on a genome-wide scale. Although the creation of such libraries is laborious, it 
offers advantages over forward genetic approaches for genome-scale studies. 
Firstly, full coverage of the entire genome is ensured as opposed to random 
mutagenesis methods in which a significantly greater number of mutants than 
genes must be created in order to achieve saturation of the genome. In addition 
targeted deletion mutants allow phenotypes to be rapidly linked to known 
genetic perturbations rather than using sequencing to map mutations in 
selected random mutants (Pierce et al., 2007). Lastly, deletion libraries provide 
a lasting resource for community use. 
 
The creation of similar genome-wide deletion libraries in pathogenic fungal 
species has been hampered by numerous factors. Most notably in some 
Candida species, the obligate diploid state and lack of a complete sexual cycle 
increases the difficulty and complexity of genetic manipulation and targeted 
gene deletion efforts (Xu et al, 2007). As such, information gleaned from the S. 
cerevisiae deletion collection has been used extensively as a basis for the 
generation of testable experimental hypothesis for other eukaryotic organisms. 
 
The largest collection of deletion mutants in a pathogenic fungal species exists 
in C. albicans. Thus far, a homozygous deletion collection covering 11 % of the 
genome has been generated and successfully used for the study of 
determinants of dimorphism and for in vivo studies in which the synthesis of 
sphingolipids were associated with virulence (Noble et al., 2010). Such studies 
have highlighted the need for molecular biology tools in medically relevant 
fungal pathogens as components of the glucosylceramide biosynthetic pathway, 
which are required for establishment of disease and proliferation in the murine 
kidney, are not present in S. cerevisiae (Noble et al., 2010). 
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1.3.1.1 Molecular Barcoding 
An attractive alternative to the timely analysis of individual mutants is the use of 
molecular barcoding to analyse mixed pools of mutants simultaneously. 
Molecular barcoding was originally developed by Hensel et al., 1995, for the 
identification of virulence genes in a murine model of typhoid fever.  Tagged-
transposon mutagenesis was used to create a mixed input pool of Salmonella 
typhimurium mutants which were studied in a murine model of infection. 
Analysis of barcodes recovered from the murine model identified inv/spa genes 
as novel S. typhimurium virulence factors – components of the type III secretion 
system (TTSS) required for entry into host cells (Hensel et al., 1995; Fàbrega & 
Vila, 2013). 
 
In the S. cerevisiae deletion collections, each mutant is tagged with two unique 
DNA sequences of 20 base pairs termed a molecular barcode, which allows for 
individual quantification of each mutant within a mixed population (Mazurkiewicz 
et al.,2006; Pierce et al., 2007; Delneri, 2010; Figure 1.5). Barcodes are flanked 
by universal sequences which can be used for amplification of barcodes in one 
reaction (Delneri, 2010). Detection of barcodes is subsequently performed by 
hybridisation to a tag microarray (Pierce et al., 2007) or more recently using 
next generation sequencing (Bar-seq) (Craig et al., 2008). Multiplexing of 
numerous samples of pooled DNA tags can increase the efficiency, throughput 
and reduce costs of barcode sequencing (Smith et al., 2010). Molecular 
barcoding has proven a robust technique for use in competitive growth assays. 
In these experiments, non-essential deletion mutants (and their associated DNA 
barcode) with decreased competitive fitness in specific conditions will be 
depleted from a mixed pool of mutants (Mazurkiewicz et al., 2006). Pooled 
deletion screening in vitro has already yielded numerous applications in the 
study of gene function, drug target identification and compound mode of action 
discovery (Pierce et al., 2007, Delneri, 2010). It offers particular advantages for 
characterising large number of mutants in vivo by reducing the number of 
animals required (Idnurm et al., 2009; Noble et al., 2010). 
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Figure 1.5: Competitive growth assays using mixed pools of S. cerevisiae 
mutants. 1) Mixed pools of S. cerevisiae deletion mutants are created whereby 
each mutant is equally represented. 2) The pool of mutants is grown under a 
defined stress condition. Mutants which have reduced fitness under a given 
stress condition will be depleted from the pool (red). Mutants with the greatest 
fitness with proliferate and become overrepresented within the pool (Blue). 3) 
DNA is isolated from pooled mutants. 4) PCR (using primers targeting universal 
sequences flanking the barcodes) is used to amplify barcodes from the DNA of 
pooled samples. 5) Amplified barcodes are hybridized to a barcode tag array (or 
alternatively barcodes can be sequences). 6) Tag intensities are used as a 
representative measure of individual strain fitness under the defined growth 
condition (Pierce et al., 2007).  
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Since its first use in S. typhimurium, STM has been widely used for the parallel 
analysis of pooled mutants in both prokaryotic and eukaryotic systems. This 
includes pathogenic bacterial species Mycobacterium tuberculosis (Cox et al., 
1999; Blumenthal et al., 2010), Pseudomonas aeruginosa (Bianconi et al., 
2011) and E. coli (Gonzalez et al., 2001; Antão et al., 2009). STM has also 
proven an effective method for the study of virulence genes in fungal pathogens 
including C. albicans (Noble et al., 2010), Aspergillus fumigatus (Brown et al., 
2000) and C. neoformans (Nelson et al., 2001; Idnurm et al., 2009). 
 
1.3.1.2 Chemical-Genomic Screening 
The availability of the S. cerevisiae deletion collections has increased the 
efficiency with which functional relationships between genes and chemical 
compounds can be uncovered in a systematic and unbiased fashion, enabling 
the annotation of genes with unknown function (Ho et al., 2011; Andrusiak et al., 
2012). Chemical-genomic screening has become a powerful tool in the 
identification of cellular drug targets and mode of action (MOA) of chemical 
compounds and bioactive molecules with no prior knowledge of the compound 
MOA required – a major challenge in the field of drug development (Ho et al., 
2011; Andrusiak et al., 2012). As well as bioactive compounds, chemical 
genomic screening has been used for MOA and cellular target discovery of 
bacterial secondary metabolites with fungicidal activity (Troppens et al., 2013). 
 
1.3.1.3 Haploinsufficiency profiling (HIP) 
Haploinsufficiency occurs when genes dosage is reduced from two to one copy 
in a diploid organism, resulting in reduced fitness. Given that in a heterozygous 
mutant a decreased dose of compound target yields increased compound 
sensitivity, the heterozygous S. cerevisiae deletion array allows 
haploinsufficiency profiling to be performed on a genome-wide scale (Ho et al., 
2011). An advantage of HIP is that it allows unbiased profiling of the whole 
genome, including essential genes which is not possible in haploid or 
homozygous deletion mutants (Delneri, 2010). However, HIP is not of use if 
deletion of one copy of the target gene does not confer a drug sensitive 
phenotype and HIP is only applicable to diploid organisms (Ho et al., 2011). 
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1.3.1.4 S. cerevisiae as a Model for Human Disease Genes and Drug 
Targets 
Twenty eight percent of known human genes implicated in disease have S. 
cerevisiae homologues (Foury, 1997). Thus the yeast deletion collection 
provides a powerful model for the study of genes associated with disease in 
mammalian systems. The heterozygous deletion collection has been of 
particular use for the study of cancers and HIV which are associated with 
abnormalities in gene copy number (Delneri, 2010).  
 
The deletion collection has also been exploited as a model for the identification 
of drug targets in mammalian systems. As an example, the collection was 
successfully used to identify novel secondary targets of nitrogen-containing 
bisphosphates (drugs for treatment of cancer-induced bone disease) and hence 
to understand the consequences of exposing cells to such compounds. 
Competitive growth of pooled mutants in sub-lethal concentrations of nitrogen-
containing bisphophates identified genes involved in DNA damage and 
cytoskeletal dynamics as putative secondary targets. Candidate yeast targets 
were further validated in a mammalian breast cancer cell line confirming that 
DNA damage and disruption of microtubule assembly were indeed involved in 
the cytotoxic effects of nitrogen containing bisphosphates (Bivi et al., 2009). 
 
1.3.2 Chemical-Genetic Screening in Clinically-Relevant Organisms 
Since the success of chemical-genomic screening in the model organism S. 
cerevisiae, molecular tools with applications of chemical-genomic screening are 
being developed in more clinically relevant pathogenic organisms, since 
knowledge of S. cerevisiae may not always be directly transferable to species 
with different lifestyles, morphology, genomic organisation or essential genes 
(Ho et al., 2011; Andrusiak et al, 2012).  
 
Haploinsufficiency profiling in C. albicans has successfully been used to 
examine nutrient- and drug-induced haploinsufficiency in a medically relevant 
system (Xu et al., 2007; Oh et al., 2010). Through the construction and 
screening of 3633 tagged heterozygous transposon mutants, a C. albicans 
haploinsufficiency profile was revealed with features distinct from S. cerevisiae 
such as increased emphasis on oxidative metabolism, nutrient sensing and 
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resistance to oxidative stress, which may be reflective of the C. albicans niche. 
Comparison of drug-induced haploinsufficiency between the two species 
identified Sec7p as the C. albicans target of Brefeldin A – a gene which was not 
identified in S. cerevisiae haploinsufficiency screens (Oh et al., 2010). In a 
smaller study of 2868 barcoded heterozygous deletion mutants covering 45 % 
of the C. albicans genome haploinsufficiency profiling successfully uncovered 
known targets of the azoles (ERG11 and NCP1). HIP was further used to 
uncover the mode of action of unknown chemical compounds as microtubule 
inhibitors (Xu et al., 2007). 
 
1.3.3 Genetic Interactions and the Synthetic Genetic Array (SGA) 
Genome-scale collections of deletion mutants have facilitated the mapping of 
quantitative genetic interactions throughout the S. cerevisiae genome. A genetic 
interaction arises when the phenotype of a double mutant is not explained by 
combining the phenotypes of single genetic variants in a multiplicative manner 
(Dixon et al., 2009). For example, a synthetic lethal interaction occurs when two 
mutations are individually non-lethal, but combined yield a lethal phenotype 
(Tong et al., 2001). Genetic interactions tend to occur in genes which function in 
parallel pathways which can buffer defects in the other, genes functioning within 
the same pathway or within the same protein complex (Hartman IV et al., 2001; 
Tong et al., 2001; Dixon et al., 2009). Hence, the study of genetic interactions is 
a powerful tool for uncovering gene function. 
 
The creation of ordered arrays of non-essential gene deletion collections has 
opened up the possibility of generating thousands of double mutants 
simultaneously using the Synthetic Genetic Array platform in which a number of 
pinning steps are used to facilitate mating, meiotic recombination and selection 
of haploid double mutants. Analysis of double mutants for positive or negative 
genetic interactions can subsequently be used to create visual networks of 
interactions for the chosen query gene (Tong et al., 2001; Tong et al., 2004; 
Tong et al, 2005). Collections of temperature sensitive conditional alleles or 
conditional expression alleles of S. cerevisiae essential genes has broadened 
the scope for SGA analysis to also include large scale genetic interaction 
profiling of essential genes (Davierwala et al., 2005). 
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Synthetic genetic interaction profiles covering 75 % of the S. cerevisiae genome 
(approximately 5.4 million gene pairs) has yielded the first functional map of the 
cell (Costanzo et al., 2010; Figure 1.6). The genetic landscape clustered genes 
based on similar genetic interaction profiles and found genes functioning in 
similar biological processes and pathways form clusters (Dixon et al., 2009; 
Costanzo et al., 2010; Figure 1.6). It also revealed that genetic interactions are 
more likely to occur between genes encoding components of parallel pathways 
which can buffer or compensate each other – in contrast to physical interactions 
which are more frequent between genes acting within the same pathway (Dixon 
et al., 2009). In addition, genetic interactions were enriched amongst genes 
which confer similar mutant phenotypes, genes encoding proteins with similar 
cellular localisation patterns, homologous genes and those which encode 
components of the same protein complex (Tong et al., 2004). 
 
Figure 1.6: The genetic landscape of a cell. Correlation network of ~5.4 
million gene pairs in which genes with similar genetic interaction profiles are 
clustered. Clusters of genes are coloured according to their molecular GO term 
(Costanzo et al., 2010).  
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Within the interaction network, individual genes share varying degrees of 
connectivity. Whilst some genes are poorly connected, others are highly 
connected and may be strongly clustered. Highly connected and strongly 
clustered genes which confer a fitness defect when individually deleted are 
denoted network hubs (Costanzo et al., 2010). Similarly, essential genes are 
highly connected and the density of genetic interactions in the essential gene 
network is five times that of the non-essential genetic interaction network, 
demonstrating the fundamental requirement of these genes for growth 
(Davierwala et al., 2005; Dixon et al., 2010). 
 
Given that genes with similar function have similar genetic interaction profiles, 
interaction networks are a useful tool in the characterisation of unknown genes 
based on their position within clusters of the genetic interaction landscape 
(Tong et al, 2004). Due to high levels of genetic redundancy in yeast and a high 
tolerance to deletion of single genes, a large proportion of S. cerevisiae ORFs 
remain uncharacterised following gene deletion studies (Tong et al., 2001). 
Genetic interaction profiling allows the annotation of such genes. For example 
uncharacterised S. cerevisiae ORF YMR299C clusters with components of the 
dynactin spindle orientation pathway in the genetic landscape. Indeed, further 
bioinformatic analysis of the encoding protein showed similarity to the 
mammalian dynein light intermediate chain and deletion of this ORF conferred 
defects in dynein-dynactin function, consistent with the position of this ORF 
within the dynactin cluster of the genetic interaction landscape (Tong et al., 
2004). 
 
The wealth of genetic interaction data produced has been deposited on the 
DRYGIN (data repository of yeast genetic interactions), which can be accessed 
as a community tool for genetic network analysis, visualisation and the 
integration of other data such as pathway information and physical interaction 
data (Koh et al., 2010). 
 
 1.3.3.1 Genetic Interaction Networks as Models for Human Disease 
Genetic interaction networks in yeast can be extrapolated to model networks in 
other eukaryotic systems. Evolutionarily conserved genetic interaction data was 
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used to construct a network of CIN (chromosome instability) genes in a cancer 
cell model, effectively identifying synthetic lethal interactors, such as FEN1, 
which could be potential anticancer drug targets (van Pel et al., 2013).  
 
1.3.3.2 Genetic Interaction Mapping in Non-Yeast Model Organisms 
High-throughput genetic interaction profiling has been employed for the study of 
the genetic landscape in model organisms, although none have yet to achieve 
the extensive coverage of the S. cerevisiae genetic landscape. Genetic 
interaction mapping in the fission yeast Schizosaccharomyces pombe currently 
covers 50 % of the genome, comprising approximately 1.6 million pairwise 
interactions (Roguev et al., 2007; Ryan et al., 2012). Smaller scale studies of 
genetic interactions exist in Escherichia coli (Typas et al., 2008), Drosophila 
melanogaster (Horn et al., 2011) and C. elegans (Lehner et al., 2006). 
 
Most recently, RNA interference (RNAi) methods in mice fibroblasts has 
enabled quantitative genetic interaction mapping in mammalian cells from 
11,000 pairwise knock-downs. Similarly to the genetic landscape of the yeast 
cell, the mammalian genetic interaction map highlighted known pathways and 
genes encoding components of the same protein complex showed correlated 
genetic interaction profiles (Roguev et al., 2013). 
 
1.3.3.3 Combining Chemical-Genetic & Genetic Interaction Data 
Typically SGA data has been generated using colony size measured by 
automated image analysis software as a phenotypic readout. Whilst this has 
been successfully used to map the genetic landscape of the cell (Costanzo et 
al., 2010), it ignores other phenotypes which arise from genetic perturbation. 
Automated high content screening was used to integrate quantitative 
morphological phenotypes with genetic interaction data sets in an unbiased, 
genome-wide fashion (Vizeacoumar et al., 2010). Having introduced GFP-
tubulin to the S. cerevisiae deletion collection, an automated image acquisition 
methodology analysed spindle morphogenesis phenotypes in live cells from 
both single and double mutant arrays. Thus, integration of multiple phenotypic 
readouts should greatly increase the accuracy with which genetic interaction 
profiling can define gene function. In this study alone 122 novel genes involved 
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in spindle formation were identified - some of which would remain undiscovered 
using fitness as a sole phenotypic measurement (Vizeacoumar et al., 2010). 
Integrating chemogenomic and genetic interaction data sets can provide a 
powerful tool for linking drug targets with their associated pathways. In a study 
by Parsons et al. (2004) chemical genetic interaction profiles of 12 bioactive 
molecules were overlaid with genetic interaction profiles of target genes 
resulting in a significant overlap. Clustering analysis revealed the chemical-
genetic profiles of bioactive compounds clustered with genetic interaction 
profiles of known target genes and their associated pathway, providing links 
between these compounds and their target pathways (Parsons et al., 2004). 
 
1.4 C. glabrata Lacks Molecular Tools 
Despite the prominence of C. glabrata as a pathogen of humans (see 1.5) the 
study of virulence in this species is hampered by a lack of molecular tools. 
Unlike S. cerevisiae, no genome-wide ORF or deletion collections are available 
for C. glabrata. Recently, the first large-scale deletion library in C. glabrata was 
generated, containing over 700 individually barcoded C. glabrata mutants 
(Schwartzmüller et al., 2013; Appendix 13). However, this collection is mostly 
biased towards C. glabrata ORFs with known orthologues in S. cerevisiae that 
are components of signalling pathways or transcription factors, for example, and 
may not be of use for the study of C. glabrata-specific traits such as virulence. A 
C. glabrata ORF collection is also under construction (personal communication, 
Dr. Hsueh-lui Ho, University of Exeter) which will greatly facilitate the functional 
characterisation of C. glabrata ORFs in the future. However, to date, no 
complete deletion or ORF collections are available for the study of C. glabrata 
biology. Much knowledge of C. glabrata biology is reliant on the extrapolation of 
knowledge of orthologous ORFs in S. cerevisiae. 
Due to the lack of deletion arrays and no apparent sexual cycle, genome-wide 
genetic interaction studies (such as the SGA platform used for S. cerevisiae) 
are also not applicable to C. glabrata. However, it has been shown that ORFs 
from non-S. cerevisiae species can be used in the S. cerevisiae SGA system to 
yield biologically relevant insights into ORFs function. Brown & Madhani, 2012, 
used an adapted S. cerevisiae SGA screen to uncover the molecular function of 
C. neoformans pathogenicity factor Liv7. Similarly, C. glabrata ORFs have been 
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shown to work in the S. cerevisiae SGA system (Personal communication, Dr. 
Jane Usher, University of Exeter).  
 
1.5 Establishment and Development of C. glabrata Infection in the Human 
Host 
Despite the significance of C. glabrata as a pathogen, the mechanisms by 
which C. glabrata is able to establish disease in the human host remains poorly 
understood. Since C. glabrata shares similar epidemiology and disease 
symptoms with infections caused by C. albicans, it has been assumed that their 
mechanisms of virulence would be similar also. Yet murine models comparing 
systemic infection with both species produce strikingly different outcomes. C. 
albicans-infected mice rapidly succumb to infection 3-4 days post infection 
whereas infection with comparable doses of C. glabrata results in chronic but 
non-fatal infection which leads to only a mild immunological response (Brieland 
et al., 2001; Jacobsen et al., 2010). The two species also share different life 
cycles, particularly with regards to morphology and ploidy (Sudbery, 2011; 
Brunke & Hube, 2013). Regardless of such differences adhesion to host cells, 
biofilm formation, traversing host barriers and immune evasion are critical for 
the establishment of infection by both species. 
 
1.5.1 C. glabrata Adhesion to Host Cells 
Adhesion of C. glabrata to host epithelial cells is primarily mediated by 
constituents of the fungal cell wall and is vital for colonisation and the 
successful establishment of infection. The ability of pathogenic yeasts such as 
C. glabrata to adhere to abiotic surfaces such as medical devices presents an 
opportunity to gain access to the blood stream and the internal organs of 
patients (Verstrepen & Klis, 2006; Brunke & Hube, 2013). Similarly to C. 
albicans and S. cerevisiae, the C. glabrata cell wall comprises a complex 
network of β-1,3 glucan, β-1,6 glucan, chitin and an outer layer predominantly 
consisting of mannoproteins which are at the forefront of the host-pathogen 
interaction (Figure 1.7; de Groot et al., 2008; El-Kirat-Chatel et al., 2013). Such 
proteins include glycosylphosphatidylinisol (GPI)-modified cell surface proteins 
which confer adherence of fungal cells to host and abiotic surfaces. These are 
linked to β-1,3 glucan in the fungal cell wall via a phosphodiester bridge with β-
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1,6 glucan. In C. albicans, the ALS (agglutinin-like sequence) adhesin family are 
a major family of GPI-modified cell wall proteins required for adherence and 
orthologues are present in most related Candida species which the exception of 
C. glabrata (Butler et al., 2009; Zhu & Filler, 2010). S. cerevisiae also encodes 
an array of GPI-anchored adhesins such as the FLO gene family which confer 
cell-cell adhesion (flocculation) and adhesion to abiotic substrates (Verstrepen 
& Klis, 2006; Soares, 2011). 
 
 
Figure 1.7: Structure of the fungal cell wall. The plasma membrane is 
surrounded by an inner cell wall layer consisting of β-1,3 glucan, β-1,6 glucan, 
chitin and an outer layer enriched with mannoproteins. (GPI)-modified cell 
surface proteins are linked to 1,3-β-glucan in the inner layer of fungal cell wall 
(Gow et al., 2012). 
 
The C. glabrata genome encodes a repertoire of 67 putative adhesin-like 
glycosylphosphatidylinositol (GPI) – modified cell wall proteins (Table 1.4), 
many of which are specific to this species (de Groot et al., 2008). Of these, the 
EPA family is the largest containing approximately 17 members (dependent on 
the isolate). Epa proteins contain an N-terminal adhesion domain resembling a 
Ca+-dependent lectin, a central serine- and threonine-rich domain and a C-
terminal anchor which covalently attaches the protein to the fungal cell wall 
(Frieman et al., 2002). EPA1 (CAGL0E06644g) is the main adhesin required for 
epithelial adhesion to N-acetyl lactosamine-containing glycoconjugates and its 
deletion renders C. glabrata non-adherent to human epithelial cells (Cormack et 
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al., 1999). Although single deletion of EPA1 has no direct effect on C. glabrata 
virulence, deletion of multiple EPA genes (EPA1-3) significantly reduces 
virulence in a murine model (De Las Penas et al., 2003). Adhesins Epa6 
(CAGL0C00110g) and Epa7 (CAGL0C05643g) have a role in C. glabrata 
adherence to epithelial cells yet they have not been fully characterised. It is 
known that these paralogues of Epa1 also bind glycans containing a terminal 
galactose residue although they vary in the specificity and range of glycans they 
bind to (Gallegos-Garcia et al., 2012; Zupancic et al., 2008). Studies examining 
EPA adhesion domain structure highlighted the importance of calcium-
coordinating loops CBL1 and CBL2 in differential ligand binding specificities 
(Maestre-Reyna et al., 2012). 
 
Table 1.4: Summary of putative GPI-linked adhesin proteins, their 
subgroups and localisation in C. glabrata. 
GPI family subgroup No. Of 
proteins 
No. with subtelomeric 
localisation 
I – Epa family 17 14 
II – Pwp family 7 1 
III 13 11 
IV 3 3 
V – includes Awp2 & 
Awp4 
13 12 
VI – includes Awp1 & 
Awp3 
7 1 
VII 5 2 
 
Similarly to S. cerevisiae FLO genes, C. glabrata EPA genes are mainly 
localised in clusters at subtelomeres (Table 1.4) where their expression is 
subject to epigenetic silencing by SIR complex (De Las Peñas et al., 2003; de 
Groot et al., 2008; Jandric & Schüller, 2011). The SIR complex and its 
interactors (SIR2-4, RAP and RIF1) achieve epigenetic silencing at the 
telomeres by enzymatic modification of nucleosomes and subsequent binding to 
modified nucleosomes forming a silent chromatin structure (Fox & McConnell, 
2005; Talbert & Henikoff, 2006). Reduction of SIR-dependent silencing and thus 
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mis-regulation of EPA genes by deletion of SIR complex components SIR3 
(CAGL0M00770g) and RIF1 (CAGL0B03399g) induces a hyper-adherent 
phenotype of C. glabrata cells. SIR complex mutants also yield enhanced organ 
colonisation due to increased expression of adhesins EPA1, EPA6 and EPA7 
which are normally transcriptionally silent (Castano et al.,2005). EPA genes are 
also subject to regulation by mechanisms independent of the silencing 
machinery. For example, a cis-acting negative regulatory element located at the 
intergenic region of EPA1 and EPA2 is known to repress EPA1 expression 
(Gallegos-García et al., 2012). Interestingly, within populations of C. glabrata 
cells, EPA1 expression can be heterogeneous. This variation is mediated at the 
RNA level and it is hypothesised that the presence of adherent variants masked 
within a non-adherent population could be an important virulence factor 
(Halliwell et al., 2012).  
 
To date, the main focus of C. glabrata adhesion research has been placed on 
the EPA family whilst other subgroups of putative adhesins have remained 
relatively uncharacterised (Table 1.4). Some studies have focused on members 
of the Pwp and Awp family, which have been shown to facilitate adhesion of C. 
glabrata cells to endothelial cells in vitro (Weig et al., 2004; de Groot et al., 
2008; Desai et al., 2011). Interestingly, many C. glabrata adhesin genes have 
no orthologue in S. cerevisiae or C. albicans (Desai et al., 2011). Although the 
role of many of these adhesin-like proteins remains unknown, such a broad 
repertoire of adhesins in C. glabrata could be the key to successful 
establishment of infection (Weig et al., 2004). 
 
1.5.2 Candida Biofilm Formation 
Candida species form surface-associated communities, termed biofilms, which 
acquire phenotypic properties distinct from planktonic cells such as increased 
tolerance to antifungal drugs and host molecules and increased protection to 
the host immune response (Silva et al., 2011; Tati et al., 2013). As such, the 
formation of Candida biofilms on host surfaces is an important virulence factor. 
In addition, the formation of biofilms on abiotic surfaces (such as medical 
devices) are a major source of bloodstream candidaemia (Francolini & Donelli, 
2010).  
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Biofilm structure, development and its regulation has to date been most 
comprehensively described in C. albicans. C. albicans biofilms are formed 
following the adherence of anchoring yeast cells to a surface and proliferation. 
A morphological switch to hyphal and pseudohyphal growth ensues forming a 
complex biofilm network embedded in extracellular matrix (Figure 1.8). From 
this structure, yeast cells are dispersed which may then go on to seed further 
sites of colonisation (Nobile et al., 2012). BCR1, TEC1, EFG1, NDT80, ROB1 
and BRG1 are the major transcriptional regulators of biofilm formation in C. 
albicans, putatively regulating 1,061 target genes in a complex interwoven 
regulatory network, and are required for normal biofilm formation in vitro and in 
vivo rat denture and catheter models (Nobile et al., 2012; Lin et al., 2013). The 
environmental cues that stimulate biofilm growth are unknown, however, it is 
noted that biofilm formation in C. albicans can be stimulated by pheromone (Lin 
et al., 2013). 
 
Figure 1.8: Comparison of biofilm structures formed by C. albicans and C. 
glabrata. A) Scanning electron microscopy (SEM) of C. albicans SC5314 
biofilm on a catheter model at 1000x magnification (Nobile et al., 2012) B) SEM 
image of C. glabrata ATCC2001 biofilm formed in SDB at 48 h at 1000x 
magnification. White bar represents 20 μM (Silva et al., 2009). 
 
Similarly, C. glabrata cells can form biofilm structures on both biotic and abiotic 
surfaces and acquire distinct drug resistant properties. Consequently, the 
presence of biofilms in C. glabrata infections increase the difficulty in which 
infections can be controlled and as such is associated with high mortality rates 
(Silva et al., 2011). However, in stark contrast to biofilms formed by most 
Candida species, C. glabrata biofilms exist as communities of surface-attached 
yeast cells only since C. glabrata has no hyphal growth form. Adhered C. 
glabrata yeast cells form compact multilayers or clusters of cells which are 
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embedded within an extracellular matrix high in protein and carbohydrate 
(Figure 1.8; Silva et al., 2009).  
 
Attachment of C. glabrata yeast cells to biotic or abiotic surfaces to enable 
biofilm formation is mediated by adhesins. Epa6 is the predominant adhesin 
required for biofilm formation in C. glabrata although the expression of several 
other Epa and non-Epa adhesins is also upregulated in biofilm forming cells, 
many of which likely facilitate surface attachment (Kraneveld et al., 2011). The 
regulatory circuit of biofilm formation is much less well studied in C. glabrata 
compared with C. albicans. However C. glabrata EPA6 expression is known to 
be subject to regulation by the kinase Yak1p and the Swi/Snf chromatin 
remodelling complex via the subtelomeric silencing machinery, Sir4p and Rif1p. 
EPA6 is also negatively regulated by Cst6p in a Yak1p-independent manner 
(Iraqui et al., 2005; Riera et al., 2012).  
 
To explore the drug resistant properties acquired by biofilm communities, 
differential protein expression studies observed that stress response proteins 
(namely heat and oxidative stress response proteins such as Hsp12p, Trx1p 
and Pep4p) were upregulated in biofilm-forming C. glabrata cells when 
compared to their planktonic counterpart (Seneviratne et al., 2010). Similar 
trends of increased oxidative stress response proteins were also reported in C. 
albicans biofilms (Seneviratne et al., 2008). The increased antioxidant capacity 
and response to stress could contribute to the stress resistant phenotype of 
Candida biofilms (Seneviratne et al., 2010). The role of the exopolymeric matrix 
encasing the biofilm structure in drug resistance has also been investigated by 
the treatment of C. glabrata biofilms with labelled fluconazole. The study found 
minimal amounts of labelled fluconazole located in the fungal cell wall or 
cytoplasm. Most of the labelled fluconazole was located within the β-1,3 glucan 
matrix and thus it has been proposed that the exopolymeric matrix may 
contribute to the antifungal resistance of biofilm structures by physically 
excluding xenobiotics from C. glabrata cells (Mitchell et al., 2013).  
 
1.5.3 Mechanisms of Host Invasion by Candida Species 
Mechanisms of Candida host invasion have been best described in C. albicans 
which utilises a morphological switch to gain entry into host epithelial cells. The 
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active penetration of host cells by C. albicans is achieved by anchoring of C. 
albicans cells to the host epithelia (mediated by the Als3 adhesin), the exertion 
of directed physical pressure by hyphal growth and the secretion of hydrolytic 
enzymes and other tissue damaging factors (Dalle et al., 2010; Wächtler et al., 
2012; Fu et al., 2013). Alternatively, C. albicans hyphae can gain entry into host 
epithelial cells by induced endocytosis in which Als3 (and other cell wall 
proteins) mediates an interaction with host cadherin, inducing actin cytoskeleton 
rearrangement and subsequent internalisation of Candida albicans hyphae 
(Phan et al., 2007; Sun et al., 2010; Wächtler et al., 2012; Fu et al., 2013). Post 
invasion, ALS3 contributes to fungal dissemination by mediating trafficking to 
the brain, renal cortex and contributes to fungal persistence in the kidney (Fu et 
al., 2013). Thus, epithelial invasion mechanisms in C. albicans are largely 
dependent on hyphal growth and Als adhesins. Although not truly polymorphic, 
the morphological switch to filamentous growth forms promotes colonisation 
and tissue invasion in C. tropicalis for example (Silva et al., 2011 C). Similarly to 
C. albicans, C. parapsilosis and C. tropicalis also encode SAPs (Secreted 
Aspartyl Proteases) which cause tissue damage and aid host cell invasion 
(Silva et al., 2009 B; Silva et al., 2011 C). 
 
The mechanism by which C. glabrata is able to traverse the host epithelial 
barrier and access the bloodstream and disseminate to internal organs is 
unclear. Since C. glabrata lacks polymorphism, the mechanisms by which it 
achieves host invasion must be independent of those employed by C. albicans, 
which relies heavily on a morphological switch to hyphal growth. Despite lacking 
this virulence attribute, C. glabrata is successful in the establishment of blood 
stream infections and thus must traverse the epithelial barrier by an unknown 
mechanism. In experimental systems, C. glabrata has been shown to enter 
deep tissues in a chicken embryo model of infection despite lacking a hyphal 
growth form (Jacobsen et al., 2011). Also in contrast to C. albicans, sites of C. 
glabrata colonisation of epithelial cells show significantly lower levels of tissue 
damage – perhaps a consequence of lacking SAPs (Silva et al., 2011 B). 
 
1.6 The Interaction of C. glabrata with Host Immune Cells 
1.6.1 Immune Defence Mechanisms Against Invading Microorganisms 
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Phagocytic cells (macrophages, dendritic cells and neutrophils) of the host 
innate immune system provide the first response against invading 
microorganisms and comprise a vital part of the host defence against challenge 
by Candida species. Detection of invading microorganisms is initially achieved 
by the recognition of pathogen-associated molecular patterns (PAMPs) on the 
fungal cell wall via a plethora of host pattern recognition receptors (PRRs) 
(Levitz, 2010; Miramón et al., 2013). For example C. albicans α-1,2-mannose 
cell wall residues and β-glucans are key for fungal recognition by macrophage 
mannose receptors, Toll-like receptors TLR2 and TLR4 and dectin-1 (Netea et 
al., 2008; Keppler-Ross et al., 2010; Hall et al., 2013). Although the mechanism 
by which macrophages recognise C. glabrata is less well understood, Epa1 is 
known to mediate C. glabrata recognition and attachment to macrophages by a 
yet-unidentified receptor (Kuhn & Vyas, 2012). Such interactions between the 
Candida cell wall and the phagocyte triggers the engulfment of the invading 
cells and subsequent destruction via the phagocytic pathway in which the 
pathogen-containing phagosome fuses with endosomal vesicles to form the 
mature phagolysosome (Viera et al., 2002; Miramón et al., 2013). As the 
phagolysosome matures and becomes increasingly acidified, engulfed Candida 
cells encounter carbon source limitation, nutrient limitation, acidic hydrolases, 
oxidative killing, reactive nitrogen species and the accumulation of antimicrobial 
peptides (Roetzer et al., 2010; Rai et al., 2012). Thus the harsh internal 
environment of the phagolysosome presents C. glabrata with a number of 
challenges which must be overcome for survival. Further to this, the phagocytic 
cell activates and recruits cells of the adaptive immune system through 
presentation of antigen and by secretion of cytokines and chemokines.  
 
In addition to phagocytosis, C. glabrata cells are subjected to the fungicidal 
activity of other immune cells. For example, the production of neutrophil 
extracellular traps (NETs) – structures consisting of chromatin and antimicrobial 
peptide calprotectin – by neutrophils plays a major part in the innate immune 
defence against  pathogens such as Candida species (Urban et al., 2009).  
 
1.6.2 C. glabrata Survives and Replicates within Macrophages 
Despite these challenges, C. glabrata is able to both survive and replicate within 
the internal macrophage environment (Figure 1.9 A and B; Kaur et al., 2007; 
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Rai et al., 2012). In a study of C. glabrata uptake by human MDMs (monocyte-
derived macrophages), the majority of C. glabrata cells were rapidly internalised 
within 3 hours post infection (Seider et al., 2011). Similarly, following 30 minutes 
incubation with neutrophils, 81 % of C. glabrata cells were internalised (Fukuda 
et al., 2011). Interestingly, the uptake of C. glabrata cells by macrophages is 
more efficient than that of C. albicans. Competitive uptake assays revealed a 
10-fold preference for the uptake of C. glabrata yeast cells over their C. albicans 
counterparts by J774 macrophages (Keppler-Ross et al., 2010). This could be 
reflective of C. albicans immune evasion strategies that are not shared with C. 
glabrata. Post internalisation, C. glabrata cells have been shown to replicate 
inside macrophages. Between 12 and 24-hours post co-incubation with 
macrophages a 3-fold increase in the number of internalised yeast cells was 
observed, indicative of intracellular replication (Seider et al., 2011). Similar 
studies also show evidence for replication of internalised C. glabrata cells (Kaur 
et al., 2007; Rai et al., 2012; Figure 1.9 A). In order for replication to take place, 
C. glabrata cells must employ a number of mechanisms to survive the internal 
phagosome environment, allowing them to adapt, replicate and ultimately lead 
to macrophage lysis and escape (Figure 1.9 B; Seider et al., 2011; Rai et al., 
2012). 
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Figure 1.9:C. glabrata interaction with macrophages A) C. glabrata survives 
and replicates in differentiated THP-1 cells. Confocal microscopy of GFP-
tagged C. glabrata cells 2 and 24 hours post infection of THP-1 cells. Nuclei are 
stained with DAPI. Scale bar represents 5 mm (Rai et al., 2012). 
B) C. glabrata survives and replicates within macrophages leading to cell 
macrophage lysis and escape. Time-lapse microscopy of MDMs and 
phagocytosed C. glabrata (black arrows in panels A–C). After three days, 
MDMs burst (black arrow in panel D) and C. glabrata cells were released (black 
arrows in panels E–G). Escaped C. glabrata cells were viable and proliferated in 
the surrounding media (black arrows in panels H & I). (Seider et al., 2011) 
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Phagocytosed C. glabrata cells cause little cytotoxicity to macrophages and are 
unable to rapidly escape or induce apoptosis in immune cells. This is in stark 
contrast to internalised C. albicans cells which cause significant levels of 
damage and killing of macrophages enabling rapid escape as soon as 3 hours 
post infection (Seider et al., 2011). This escape mechanism depends upon the 
formation and elongation of hyphae which stretch and pierce the macrophage 
membrane, ultimately leading to macrophage lysis and killing (McKenzie et al., 
2010). In addition, infection of macrophages with C. albicans also induces host 
cell apoptosis, a mechanism used by pathogens for survival (Navarre & 
Zychlinsky, 2000; Ibata-Ombetta et al., 2003; Seider et al., 2011), by eliciting 
caspase-3 and -7 activation and causing DNA fragmentation (Sieder et al., 
2011). 48 hours post infection, C. glabrata caused very low levels of 
macrophage cytotoxicity (comparable to levels of cytotoxicity reported for 
macrophage infection with S. cerevisiae) most likely due to the lack of hyphae 
formation (Sieder et al., 2011). C. glabrata-infected macrophage damage 
occurred as late as 3 days post infection, whereby increased fungal load (due to 
intracellular replication) caused macrophages to tighten and contract leading to 
cell lysis and the subsequent dissemination of viable C. glabrata cells (Sieder et 
al., 2011; Figure 1.9 B). C. glabrata was also unable to induce human 
macrophage apoptosis. Infection of macrophages with C. glabrata failed to elicit 
caspase-3 or-7 activation nor cause DNA fragmentation (Sieder et al., 2011). As 
such, the strategies by which C. albicans achieves rapid macrophage escape 
are not shared with C. glabrata. Therefore, C. glabrata must utilise alternative 
strategies to survive and escape the macrophage environment. 
 
One such strategy employed by C. glabrata for macrophage survival is the 
manipulation of the phagosome maturation pathway, a mechanism employed by 
phagocytic cells for the elimination and clearance of invading microorganisms. 
C. glabrata subverts phagosome maturation preventing progression from the 
late endosomal to the lysosomal stage in which the phagosome would normally 
fuse with lysosomes, acquiring acid hydrolases (such as cathepsin D) and 
becoming acidified. C. glabrata-containing phagosomes fail to display the 
lysosomal stage marker cathepsin D and do not undergo normal acidification, 
thus facilitating survival within the phagosome (Sieder et al., 2011; Rai et al., 
2012). Although it is unknown which C. glabrata attribute mediates the 
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modulation of phagosome maturation and acidification, it is likely a cell wall 
factor and is proposed to be independent of active transcription or translation 
(Seider et al., 2011). 
 
1.6.3 The Transcriptional Response of Phagocytosed C. glabrata Cells 
Upon engulfment by phagocytic cells, C. glabrata launches a transcriptional 
response vital for adaptation to the internal phagosome environment.  C. 
glabrata chromatin remodelling and histone modification genes RSC3 
(CAGL0D03850g), RTT109 (CAGL0D05786g) and SGS1 (CAGL0H00759g) 
have been shown to play key roles in the regulation of adaptation to the internal 
macrophage environment and as such are essential for full virulence in C. 
glabrata (Rai et al., 2012). 
 
Similarly to related species S. cerevisiae and C. albicans (Lorenz & Fink, 2001; 
Lorenz et al, 2004), substantial reprogramming of C. glabrata carbon 
metabolism, upregulation of the glyoxylate cycle and gluconeogenesis occur 
upon internalisation of C. glabrata cells by both macrophages and neutrophils 
which may provide scope for adaptation to the glucose-limited environment of 
the phagosome (Kaur et al., 2007; Rai et al., 2012; Fukuda et al., 2013). Of 
particular significance is the upregulation of glyoxylate cycle components which 
have been reported to be required for full virulence in C. albicans and other 
bacteria (Lorenz & Fink, 2001; Lorenz et al, 2004). In agreement with these 
findings, microscopic observations of peroxisome proliferation in C. glabrata 
support an ongoing adjustment of carbon metabolism which may facilitate 
utilisation of non-fermentable carbon sources within the phagosome (Roetzer et 
al., 2010). Phagocytosis also induces the upregulation of C. glabrata genes 
implicated in DNA damage, oxidative stress and the core stress response, most 
likely in response to damage elicited by ROS in the phagosome (Rai et al., 
2012; Fukuda et al., 2013). In particular, expression of the sole C. glabrata 
catalase CTA1 (CAGL0K10868g) is induced in the early stages of 
internalisation (Roetzer et al., 2010). Similarly to observations in the fungal 
pathogen C. neoformans (Palmer et al., 2008), the upregulation of autophagy-
related genes in engulfed C. glabrata cells facilitates survival in the nutrient-
deprived environment of the phagosome by sequestering and recycling 
intracellular resources (Roetzer et al., 2011; Fukuda et al., 2013). In particular, 
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autophagy of peroxisomes mediated by C. glabrata ATG11 (CAGL0H08558g) 
and ATG17 (CAGL0J04686g) is beneficial for macrophage survival during 
phagocytosis (Roetzer et al., 2010; Fukuda et al., 2013). Although autophagy is 
a less important virulence determinant in filamentous fungi which can actively 
escape and kill macrophages, it plays a more major role in C. glabrata which 
lacks a rapid strategy for macrophage escape and must survive prolonged 
nutrient starvation in the phagosome (Roetzer et al., 2010).  
 
The YPS genes are significantly upregulated upon C. glabrata uptake by both 
macrophages and neutrophils (Kaur et al., 2007; Bairwa & Kaur, 2011; Fukuda 
et al., 2013). C. glabrata YPS genes constitute a cluster of eleven GPI-linked 
aspartyl proteases, structurally related to S. cerevisiae yapsins, which are 
known to function in cell wall remodelling, cell wall integrity (Miyazaki et al., 
2011) and pH homeostasis (Bairwa & Kaur, 2011). YPS genes are required for 
C. glabrata macrophage survival and replication as upon deletion of some YPS 
cluster members, C. glabrata cells did not replicate and lost viability following 
macrophage uptake (Kaur et al., 2007). They were also required for virulence in 
a mouse model of disseminated candidiasis (Kaur et al., 2007). The YPS 
cluster, in particular YPS1 (CAGL0M04191g), may contribute to C. glabrata 
virulence through the regulation of pH homeostasis (crucial for the maintenance 
of vital physiological process) under the increased acidity of the phagolysosome 
(Bairwa & Kaur, 2011). The implication of YPS1 in cell wall integrity (through its 
regulation by the cell-wall-related calcineurin-Crz1 pathway) in C. glabrata could 
aid adaptation to various stresses in the phagosome and is postulated to 
prevent cell lysis at elevated temperatures (Miyazaki et al., 2011). YPS genes 
have also been implicated in immune evasion. Infection of macrophages with C. 
glabrata YPS mutants stimulate significantly more nitric oxide production, a 
marker of macrophage activation, than the parental strain. It is proposed that 
Yps proteins target GPI-linked cell wall proteins, most notably Epa1, as a 
substrate for proteolytic processing and thus removing it from the cell wall, 
perhaps masking C. glabrata from immune recognition (Kaur et al., 2007; Kuhn 
& Vyas, 2012).  
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1.6.4 Oxidative Killing of Candida Species 
The oxidative burst and the production of reactive oxygen species (ROS) and 
reactive nitrogen species (RNS) in the phagosome is a powerful strategy 
employed for the elimination of phagocytosed microorganisms. Driving the 
oxidative burst is the NADPH enzyme complex situated in the cytoplasmic and 
phagosomal membrane, generating superoxide radicals through the transfer of 
electrons from cytoplasmic NADPH to oxygen.  Superoxide radicals are further 
dismuted to produce hydrogen peroxide – a molecule with strong oxidative 
properties (Figure 1.10; Fang, 2004; Jandric & Schüller, 2011; Miramón et al., 
2013). The production of RNS in the phagocyte is catalysed by iNOS (inducible 
nitric oxide synthase) which uses molecular oxygen and arginine as substrates 
to produce nitric oxide. In the presence of superoxide, nitric oxide is converted 
into peroxynitrite which is subsequently decomposed yielding nitrogen dioxide 
and hydroxyl radicals (Fang, 2004; Figure 1.10). Although ROS are 
endogenous by-products of cellular aerobic metabolism in eukaryotes 
(Gutiérrez-Escobedo et al., 2013), elevated levels of ROS and RNS cause 
damage to DNA, lipids and proteins and are therefore highly toxic to fungal 
cells. In this way the production of free radicals contributes to Candida killing 
and is used as a major defence mechanism to clear Candida infection (Elahi et 
al., 2001; Donini et al., 2007). Rai et al., 2012, observed a 7-fold increase of 
intracellular ROS levels in macrophages incubated with C. glabrata compared 
with non-infected control cells (Rai et al., 2012). The importance of oxidative 
killing by macrophages has been well exemplified in murine models gp91phox-/- 
and gp47 phox-/- which have a defective phagocyte oxidative capacity. In such 
models where oxidative killing is impaired, intravenous injection of C. glabrata 
leads to lethal progressive infection within days compared with wild-type mice 
thus demonstrating the importance for oxidative killing of C. glabrata in this 
model system (Ju et al., 2002; Fukuda et al., 2013). Conversely, similar studies 
have noted that Candida species may possess mechanisms to actively 
downregulate ROS production by phagocytic cells given that only a minor 
fraction of engulfed C. glabrata cells shows signs of acute oxidative stress 
whereas most indicated a mild oxidative load (Roetzer et al., 2010; Seider et al., 
2011). 
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Figure 1.10: The production of ROS and RNS intermediates by mammalian 
cells as part of the oxidative burst (Fang, 2004). NADPH enzymes drive the 
conversion of molecular oxygen to superoxide anions. Superoxide is 
subsequently converted into hydrogen peroxide and hydroxyl radicals, 
molecules with strong oxidative capacity. The conversion of oxygen and 
arginine into nitric oxide is catalysed by iNOS. In the presence of superoxide, 
further RNS are generated such as peroxynitrite. 
 
1.6.5 C. glabrata Elicits a Robust Oxidative Stress Response  
Pathogenic microbes use multiple strategies to survive oxidative killing. C. 
glabrata is intrinsically more resistant to oxidative stress than S. cerevisiae or C. 
albicans (Cuéllar-Cruz et al., 2008; Kaloriti et al., 2012). Expression of 
catalases, superoxide dismutases and the production of glutathione and 
thioredoxin serve as strategies to adapt to oxidative stress in C. glabrata by the 
detoxification of ROS (Brown et al., 2009; Jandric & Schüller, 2011; Roetzer et 
al., 2011). 
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Upon encountering ROS and glucose starvation in the phagolysosome, 
expression of C. glabrata catalase, CTA1, is induced which enzymatically 
catalyses the conversion of hydrogen peroxide to neutral water and oxygen 
(Cuéllar-Cruz et al., 2008; Roetzer et al., 2010). Additionally, constitutive 
expression of a superoxide dismutase, SOD1 (CAGL0C04741g), also 
contributes to oxidative stress resistance through the conversion of cytotoxic 
superoxide radicals to hydrogen peroxide and water (Roetzer et al., 2011; 
Jandric & Schüller, 2011). The antioxidant molecule glutathione is essential in 
C. glabrata under normal conditions due to its role in the assembly of 
cytoplasmic Fe-S clusters, detoxification of metal ions and for maintaining ROS 
at physiologically low concentrations (López-Mirabel & Winther, 2008; Yadav et 
al., 2011; Gutiérrez-Escabedo et al., 2013). However under elevated levels of 
ROS, glutathione also participates in the oxidative stress response of C. 
glabrata by maintaining redox homeostasis. C. glabrata encodes orthologues of 
GSH biosynthesis genes, GSH1 (CAGL0L03630g) and GSH2 
(CAGL0F00825g), yet unlike S. cerevisiae does not encode a high affinity 
plasma membrane glutathione transporter (Yadav et al., 2011) but may uptake 
glutathione through another unknown transporter since the addition of external 
GSH increases oxidative stress resistance (Gutiérrez-Escobedo et al., 2013). 
Components of the thioredoxin antioxidant system, TRX1 (CAGL0K00803g), 
TRR1 (CAGL0I01166g) and TSA1 (CAGL0K06259g), are also upregulated in 
response to C. glabrata H2O2 treatment (Saijo et al., 2010). 
 
Components of the C. glabrata oxidative stress response are coordinated by 
transcription factors YAP1 (CAGL0H04631g) and SKN7 (CAGL0F09097g) 
(Roetzer et al., 2011) and partially upon transcriptional activators of the core 
stress response MSN2 (CAGL0F05995g) and MSN4 (CAGL0M13189g) 
(Cuéllar-Cruz et al., 2008). Yap1p, belonging to a family of basic leucine zipper 
domain transcription factors, controls the expression of 32 genes involved in 
oxidative stress resistance in C. glabrata (Cuéllar-Cruz et al., 2008) and is 
required for sustained survival in murine macrophage models (Roetzer et al., 
2011). Under oxidative stress, Skn7p is required for the transcriptional induction 
of components of the thioredoxin system (TRX1, TRR1 and TSA1) and catalase 
(CTA1) (Cuéllar-Cruz et al., 2008; Saijo et al., 2010). SKN7 deletion mutants 
display reduced virulence in a murine model of disseminated C. glabrata 
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infection (Saijo et al., 2010) thus exemplifying the requirement of an intact 
oxidative stress response for virulence.  
Despite its high tolerance to oxidative stress, studies suggest that C. glabrata is 
able to suppress the oxidative burst elicited by the phagocyte (Seider et al., 
2011). Roetzer et al., 2010, observed only a low oxidative load on engulfed C. 
glabrata cells and that only a minor fraction of engulfed cells showed signs of 
acute oxidative stress (Roetzer et al., 2010). 
 
1.6.5.1 Iron Scavenging is Required for Oxidative Stress Resistance and 
Pathogenicity 
Iron plays a crucial role in the tolerance of oxidative stress as a cofactor in 
catalase and superoxide dismutase enzymes crucial for the detoxification of 
ROS (Hood & Skaar, 2012). It is also essential for survival under normal 
conditions as an integral part of normal cellular biochemistry and its uptake and 
assimilation is required for virulence in many pathogens of mammals and plants 
(Eichhorn et al., 2006; Nairz et al., 2010; Albarouki et al., 2013). On the 
contrary, excess iron can be toxic to cells via induced oxidative damage (Lin et 
al, 2010) and thus maintenance of iron homeostasis is crucial in iron-fluctuating 
environments such as the host (Chen et al., 2011). In C. albicans, regulators of 
iron homeostasis (AFT1 and AFT2) are also linked to oxidative stress 
resistance and pathogenesis-related processes such as surface adhesion and 
hyphal development (Xu et al., 2013). 
As a strategy to eliminate invading microorganisms, macrophages limit iron 
availability by reducing iron transport, reducing bound iron from the serum and 
depleting iron from the phagolysosome (Hood & Skaar, 2012). Thus, pathogenic 
microorganisms must employ mechanisms for iron acquisition in the host niche 
– in particular during prolonged persistence in the nutrient-limited phagosome. 
Under iron-limited conditions, bacteria and fungi use siderophores, chelating 
molecules with high affinity for Fe3+, to scavenge available extracellular iron 
(Haas, 2003; Schrettl et al., 2004; Fischbach et al., 2006). An endogenous 
pathway for siderophore biosynthesis is absent in C. glabrata. However, C. 
glabrata is able to take up xenosiderophores (siderophores produced by other 
species) through siderophore transporter SIT1 (CAGL0E04092g) under iron 
deficient conditions. SIT1-mediated uptake of extracellular iron in this manner 
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contributes to C. glabrata survival from macrophage killing (Nevitt & Thiele, 
2011).  
 
1.7 Sensing the Host Environment 
Upon colonisation of the host, the success of a fungal pathogen relies on its 
ability to readily adapt to the host niche where it is exposed to changes in 
osmolarity, pH and temperatures (Jandric & Schüller, 2011). The mammalian 
host is colonised by a vast number of microorganisms and the acquisition of 
nutrients in the highly competitive environment is critical for survival and 
virulence. Adaptation can be achieved through changes in the transcriptional 
programme, global chromatin remodelling and epigenetic regulation in response 
to environmental cues.  
 
The response of C. glabrata to external niacin limitation experienced in the 
urinary tract has been well characterised. C. glabrata is auxotrophic for NAD+ 
and requires supplementation with NAD+ precursors (niacin) for growth. Thus 
under external niacin limitation, intracellular NAD+ levels are reduced which 
directly affect the activity of sirtuins Sir2 (CAGL0K01463g) and Hst1 
(CAGL0C05357g) which require NAD+ as a cofactor for the catalysis of 
deacetylation reactions. Thus the activity of the SIR silencing machinery, of 
which Sir2 constitutes the main enzymatic component, is reduced under niacin 
limited conditions leading to subsequent de-repression of the EPA adhesin 
genes which are normally subject to silencing by the SIR complex (Domergue et 
al., 2005; Ma et al., 2009; Figure 1.11). This is supported by in vitro data where 
EPA6 expression was induced in C. glabrata cells grown in urine thus linking 
increased adhesion to epithelial cells with niacin limitation (Domergue et al., 
2005; Jandric & Schüller, 2011). Similarly, the de-repression of HST1 targets 
also occurs under niacin-starvation. Most notably HST1 repression targets 
include high affinity niacin transporters TNA1 (CAGL0F08371g), TNR1 
(CAGL0L13354g) and TNR2 (CAGL0M14113g) which are mandatory for 
intracellular NAD+ homeostasis and promote growth in niacin-poor conditions 
such as human urine (Ma et al., 2009; Figure 1.11). Furthermore, HST1 is also 
implicated in the regulation of oxidative stress and drug resistance genes which 
may promote survival in the human host. Loss of HST1-mediated transcriptional 
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silencing increases C. glabrata oxidative stress resistance by increased 
expression of CTA1 and MSN4 (Orta-Zavalza et al., 2013; Figure 1.11). 
Similarly, HST1-inactivation leads to the induction of the ABC transporter gene 
CDR1 (CAGL0M01760g) and the major regulator of drug resistance PDR1 
(CAGL0A00451g) conferring azole drug resistance. Interestingly, regulation of 
stress-resistance genes by the HST1-silencing complex seems to be unique to 
C. glabrata as this regulation is not apparent in the non-pathogenic, yet closely 
related yeast, S. cerevisiae (Orta-Zavalza et al., 2013). The regulation of such 
pathogenesis-promoting factors in response to environmental stimuli may be an 
adaptation of C. glabrata to promote colonization of the human host.  
 
Figure 1.11: Model of niacin-dependent regulation of sirtuins HST1 and 
SIR2 in C. glabrata. Under niacin-limiting conditions, activity of sirtuins HST1 
and SIR2 is reduced, relieving derepression of their targets genes implicated in 
niacin uptake, drug resistance, stress resistance and adhesion (adapted from 
Orta-Zavalza et al., 2013).  
 
1.8 Evading the Immunological Response 
Infection of macrophages with C. glabrata induces a modest inflammatory 
cytokine cascade compared with infection by C. albicans (Seider et al., 2011; 
Rai et al., 2012). C. glabrata failed to elicit a significant pro-inflammatory (TNF-
α, IL-1β, IL-6, IL-8 or IFN-γ) or anti-inflammatory (IL-10) cytokine response in 
human macrophages in vitro – many of which were strongly induced upon 
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challenge with C. albicans or S. cerevisiae (Seider et al., 2011). This is in 
agreement with in vivo studies where C. glabrata infection induced only a mild 
immunological response in murine models (Jacobsen et al., 2010). GM-CSF 
(Granulocyte-Macrophage Colony-Stimulating Factor) is the sole cytokine 
significantly induced following the interaction of C. glabrata with macrophages 
or epithelial cells (Li & Dongari-Bagtzoglou, 2009; Jacobsen et al., 2010). GM-
CSF promotes the activation, proliferation and fungicidal activity of monocytes 
and neutrophils, providing protection against fungal pathogens such as C. 
glabrata (Quezada et al., 2007; Li & Dongari-Bagtzoglou, 2009; MacCallum et 
al., 2009).  
 
1.9 Evolution of Drug Resistance in C. glabrata Isolates 
In relation to other Candida species, C. glabrata is intrinsically more resistant to 
the azoles – the main class of antifungal drug used to treat Candida infections – 
and its ability to readily acquire cross resistance to other classes of antifungal 
drugs is a significant medical problem. A number of clinical studies have 
reported such isolates of C. glabrata with cross-resistance to both azoles and 
echinocandins. It was recently reported that 11.1 % of fluconazole-resistant 
clinical C. glabrata isolates also had elevated tolerance to echinocandins 
(Pfaller et al., 2012). 
 
1.9.1 Azole Resistance 
The azoles comprise a major class of antifungal drug used to treat Candida 
infections. Azoles exert fungistatic activity against Candida species through the 
targeted inhibition of cytochrome P450-dependent lanosterol demethylase 
encoded by ERG11 (CAGL0E04334g). Disruption of ergosterol biosynthesis in 
this manner results in an alteration of cell membrane fluidity, signalling and 
transport as cells are unable to build or renew membrane sterols (Jandric & 
Schüller, 2011). Increased expression of drug target Erg11 rescues azole 
susceptibility in C. glabrata. However, tolerance to azole drugs is dependent on 
extracellular iron availability as iron depletion impairs Erg11 function resulting in 
increased azole susceptibility (Hosogaya et al., 2013). 
 
C. glabrata PDR1 (CAGL0A00451g), the sole orthologue of S. cerevisiae 
multidrug resistance regulators PDR1 and PDR3, is a major regulator of azole 
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resistance in C. glabrata (Vermitsky & Edlind, 2004). PDR1 mediates azole 
resistance through the transcriptional regulation of drug efflux pumps and ATP-
binding cassette transporters CDR1 (CAGL0M01760g), CDR2/PDH1 
(CAGL0F02717g) and SNQ2 (CAGL0I04862g) and drug:H+ antiporter QDR2 
(CAGL0G08624g) which actively extrude xenobiotics from the cell (Costa et al., 
2013; Thakur et al., 2008). A role for STB5 (CAGL0I02552g) in the negative 
regulation of these PDR1 targets has more recently been uncovered (Noble et 
al., 2013). Similar PDR1-mediated mechanisms of azole resistance also exist in 
related fungal species S. cerevisiae and C. albicans (Anderson, 2005). Gain of 
function mutations in C. glabrata PDR1 occur frequently in vivo, activating the 
expression of its target genes and increasing azole resistance. Activation 
mutations in PDR1 are diverse and can fall in locations throughout the protein 
(including the activation domain, xenobiotic binding domain and the inhibition 
domain). To exemplify this diversity, a study of C. glabrata clinical isolates 
identified 57 amino acid substitutions in PDR1 alleles - all of which conferred 
PDR1 hypersensitivity and increased azole resistance and increased fitness in 
a murine infection model (Ferrari et al., 2009). Interestingly, the various PDR1 
gain of function isolates activate differential gene expression patterns with little 
overlap despite all conferring azole resistance (Ferrari et al., 2011 A). Direct 
binding of azole or other xenobiotic molecules to Pdr1p can also stimulate the 
expression of its target genes and can induce drug resistance in both C. 
glabrata and S. cerevisiae (Thakur et al., 2008). Therefore gain of function 
mutations in PDR1 and enhanced expression of ABC transporters provides a 
major mechanism for azole resistance in C. glabrata (Sanglard et al., 1999; 
Sanglard et al., 2001; Torelli et al., 2002; Caudle et al., 2011). 
 
Azole resistance in C. glabrata also arises in petite mutants which have been 
isolated directly from patients receiving azole treatment (Bouchara et al., 2000). 
The petite mutant phenotype has respiratory deficiency due to loss or deletions 
within mitochondrial DNA which is associated with increased cross resistance to 
azoles (Brun et al., 2003). In petite mutants, increased PDR1 expression and 
the consequential upregulation of ABC transporters contributes to azole 
resistance yet is independent of point mutations in PDR1 (Tsai et al., 2006). 
Transcriptome analysis of the C. glabrata petite phenotype revealed 
mitochondrial dysfunction was accompanied by the upregulation of genes 
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implicated in multidrug resistance and small molecule transporters (CDR1, 
CDR2, SNQ2, YOR1 (CAGL0G00242g), YBT1 (CAGL0C03289g) and YCF1 
(CAGL0L06402g)) which contribute to the azole-resistant phenotype of petite 
mutants (Ferrari et al., 2009).  
 
A number of studies have found azole-resistant C. glabrata isolates to have 
altered interaction with the host. Both PDR1 gain of function mutants and petite 
mutants had increased fitness in a murine model of systemic infection (Ferrari 
et al., 2009; Ferrari et al., 2011 B). In the petite mutants, cell wall biogenesis 
and maintenance genes and cell surface proteins were upregulated (Table 1.5) 
which could modify the interaction with the host and possibly explain the 
hypervirulent phenotype of the azole-resistant isolates in in vivo  infection 
models (Ferrari et al,. 2009; Ferrari et al., 2011 B). Gain of function PDR1 
mutants also showed both positively and negatively modified interaction with 
host cells. In one instance, increased adherence to epithelial cells yielded 
increased colonisation efficiency yet reduced adherence to macrophages lead 
to reduced uptake and successful evasion of phagocytosis (Vale-Silva et al., 
2013). Thus the emergence of azole-resistance and the associated increase in 
virulent properties in C. glabrata isolates poses a problem in the treatment of 
Candida infections. 
 
Table 1.5: C. glabrata cell surface and cell wall proteins significantly 
upregulated in an azole-resistant petite mutant (Ferrari et al., 2011 B) 
C. glabrata ORF Gene name Description 
CAGL0E01727g YPS3 GPI-anchored aspartic protease 
CAGL0E01815g YPS8 GPI-anchored aspartic protease 
CAGL0E01837g YPS9 GPI-anchored aspartic protease 
CAGL0E01859g YPS10 GPI-anchored aspartic protease 
CAGL0H05621g RLM1 Transcription factor, role in cell wall 
integrity 
CAGL0K13002g AGA1/AED2 GPI-anchored adhesin 
CAGL0K13024g MUC1 GPI-anchored glycoprotein 
 
 
67 | P a g e  
 
1.9.2 Echinocandin Resistance 
Echinocandins are the most recent class of antifungal drugs to reach clinical 
approval and have rapid fungicidal activity against Candida species by targeting 
the fungal cell wall through the inhibition of β-1,3-glucan synthesis (Denning, 
2002; Walker et al., 2010). The emergence of echinocandin resistance is 
becoming more frequent, particularly in C. glabrata where the prevalence of 
echinocandin resistance amongst clinical isolates from blood stream infections 
increased from 4.9 % to 12.3 % from 2001 to 2010, respectively (Alexander et 
al., 2013). Following treatment with caspofungin, C. albicans, C. parapsilosis 
and C. guillermondi exhibit elevated chitin levels which acts as a mechanism to 
reduce the efficacy of echinocandin drugs (Walker et al., 2008; Walker et al., 
2013). Intrinsic echinocandin-tolerance in the C. parapsilosis group (including C. 
orthopsilosis and C. metapsilosis) is conferred by a naturally occurring amino 
acid substitution (P660A) in Fks1p (Garcia-Effron et al., 2008). Similarly 
echinocandin-resistant clinical isolates of Candida species, in particular C. 
albicans and C. krusei and other fungal species, predominantly encode 
mutations in the FKS1 gene encoding β-glucan synthase (Balashov et al., 2006; 
Kahn et al., 2007; Walker et al., 2010). Although echinocandin resistance can 
arise following mutations in either C. glabrata FKS1 (CAGL0G01034g) and 
FKS2 (CAGL0K04037g), point mutations in FKS2, the catalytic subunit of 1,3-β-
D-glucan synthase, are found twice as frequently as those in FKS1 (Katiyar et 
al., 2012). Also in contrast to most Candida species, C. glabrata isolates do not 
alter the chitin content of the cell wall following treatment with caspofungin 
(Walker et al., 2013).  
 
Global analysis of C. glabrata mutations underlying the evolution of 
echinocandin resistance in vivo uncovered a sharp increase in echinocandin 
resistance conferred by an FKS2 T1987C mutation (Singh-Babak et al., 2012; 
Table 1.6). Resistance to echinocandins in C. glabrata is dependent on heat 
shock protein HSP90 and calcineurin, which control the expression of FKS2 in 
the presence of caspofungin (Katiyar et al., 2012; Singh-Babak et al., 2012). 
However, FKS2 mutations incurred a fitness cost in C. glabrata which was 
alleviated by further evolution, most notably by mutation in CDC55 
(CAGL0L06182g). Non-synonymous mutations in eight other genes, previously 
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not associated with drug resistance, also contributed to echinocandin resistance 
(Singh-Babak et al., 2012; Table 1.6). 
 
Table 1.6 Non-synonymous mutations accompanying the evolution of 
echinocandin resistance from a C. glabrata clinical isolate (Singh-Babak 
et al, 2012; yeastgenome.org).  
C. glabrata ORF S. cerevisiae 
orthologue 
Non-synonymous 
mutation 
GO Molecular 
Function 
CAGL0F04631g MOH1 Y5H Unknown 
CAGL0F04895g GPH1 H409Y Glycogen 
phosphorylase activity 
CAGL0K00605g CDC6 K171E ATPase activity 
CAGL0J08591g TCB1/2 A1161V Lipid binding 
CAGL0K04037g FKS2 S663P 1,3-beta-D-glucan 
synthase activity 
CAGL0A04257g DOT6 K347Stop Sequence-specific 
DNA binding 
CAGL0J09724g MRPL11 Y161H Structural constituent 
of ribosome 
CAGL0B03795g SUI2 I121M Translation initiation 
factor activity 
CAGL0L06182g CDC55 P155S Protein phosphatase 
regulator activity 
 
 
1.10 Conclusion 
The generation of genome-wide deletion libraries, ORF collections and the 
development of SGA technology has provided a powerful tool for uncovering 
gene function and lead to a greater understanding of the genetic wiring of the 
cell in the model organism yeast S. cerevisiae (Giaever et al., 2002; Costanzo 
et al., 2010). Such tools in S. cerevisiae have proved fundamental in the study 
of conserved pathways and processes in other eukaryotic systems (Dixon et al., 
2009). However, the need for a molecular toolbox to aid further understanding 
in the biology of pathogenic species such as C. glabrata has been recognised. 
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Comparative genomic studies of yeast genomes identified C. glabrata to be 
more closely related to non-pathogenic yeast S. cerevisiae than C. albicans. It 
is hypothesised that C. glabrata and S. cerevisiae shared a common ancestor 
and that divergence from this ancestor occurred an estimated 60 million years 
ago following a whole genome duplication event (Dujon et al., 2004). Since 
divergence, C. glabrata has evolved in a reductive fashion and the adaptation to 
the host niche has been accompanied by the expansion of gene families 
associated with cell wall and the loss of a full sexual cycle (Byrne & Wolfe, 
2005; Dujon, 2010). 
To date, C. albicans remains the most well characterised Candida species with 
regards to pathogenesis and adaptation to the host niche. Meanwhile, 
responses to physiologically relevant stresses have been dissected in the 
model yeast S. cerevisiae. Whilst in many instances extrapolation of knowledge 
from C. albicans and S. cerevisiae can yield useful insights to C. glabrata 
biology, it is not necessarily always relevant due to the non-pathogenic nature 
of S. cerevisiae and stark differences in biology (polymorphism, for example) in 
C. albicans. Hence, there is a need to study C. glabrata biology as many of its 
virulence attributes remain poorly understood. 
 
1.11 Aims of the Study 
This study aims to create molecular tools for the study of C. glabrata virulence 
attributes. In particular, this study sets out to identify C. glabrata ORFs with no 
orthologue in S. cerevisiae which may play a role in virulence. Characterisation 
of C. glabrata ORFs will be achieved through the generation of a deletion 
library, development of high-throughput phenotypic screening assays and the 
use of a recently established Drosophila melanogaster model of infection. 
Further, the use of genetic interaction mapping in S. cerevisiae as a tool for 
characterisation of C. glabrata ORFs will be explored.  
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Chapter 2: Materials and Methods 
 
2.1 Organisms, Strains and Plasmids 
 
2.1.1 Yeast strains 
Yeast strains used during this study are listed in Table 2.1 and Table 2.2.  
 
Table 2.1: C. glabrata strains used during this study. 
Strain Genotype Origin 
ATCC 2001 C. glabrata clinical isolate ATCC 
Cg2001 Δhis3 ATCC 2001 Δhis3 Jacobsen et al., 2009 
Deletion mutants ATCC 2001 
ΔgeneX::NAT1 
This study (Appendix 4 
Table 1) 
Cg2001 ΔHTL ATCC 2001 his3Δ::FRT 
leu2Δ::FRT trp1Δ::FRT 
Jacobsen et al., 2009 
Cg2001 Δhis3 p423GPD 
 
Empty Gateway® 
destination vector 
pAG423GPD-ccdB 
transformed into C. 
glabrata ATCC 2001 
Δhis3 
This study 
Cg2001 Δhis3 p423GPD-
D05434 
 
Gateway® destination 
vector pAG423GPD-
ccdB carrying C. glabrata 
CAGL0D05434g 
transformed into C. 
glabrata ATCC 2001 
Δhis3 
This study 
∆CAGL0D03850g 
p423GPD 
Empty Gateway® 
destination vector 
pAG423GPD-ccdB 
transformed into C. 
glabrata Cg2001 Δhis3 
This study 
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∆CAGL0D03850g 
∆CAGL0D03850g 
p423GPD-ScRSC30 
Gateway® destination 
vector pAG423GPD-
ccdB carrying S. 
cerevisiae RSC30 
transformed into C. 
glabrata Cg2001 Δhis3 
∆CAGL0D03850g 
This study 
 
 
Table 2.2: S. cerevisiae strains used during this study. 
 
Strain Genotype Origin 
BY4741 MATa his3Δ1 leu2Δ0 
met15Δ0 ura3Δ0 
Brachmann et al., 1998 
BY4742 MATalpha his3Δ1 leu2Δ0 
lys2Δ0 ura3Δ0 
Brachmann et al., 1998 
Haploid deletion 
collection 
MATalpha his3Δ1 leu2Δ0 
lys2Δ0 ura3Δ0 
GeneXΔ::KanMX 
Thermo Scientific 
Y7092 (SGA starter 
strain) 
MATa can1Δ::STE2pr-
Sp_his5 lyp1Δ his3Δ1 
leu2Δ0 ura3Δ0 met15Δ0 
Tong et al., 2005 
Y7093-D05434 Y7092 transformed with 
pAG416GPD-ccdB 
carrying CAGL0D05434g 
This study 
Y7094-D05434 Y7092 transformed with 
pAG426GPD-ccdB 
carrying CAGL0D05434g 
This study 
KH01 (SGA starter 
strain) 
MATa his3Δ1 leu2Δ0 
met15Δ0 ura3Δ0 
This study 
KH02 KH01 transformed with 
empty pAG416GPD-ccdB 
destination vector 
This study 
KH02-D05434 KH01 transformed with This study 
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pAG416GPD-ccdB 
carrying CAGL0D05434g 
KH03 KH01 transformed with 
pAG426GPD-ccdB 
destination vector 
This study 
KH03-D05434 KH01 transformed with 
pAG426GPD-ccdB 
carrying CAGL0D05434g 
This study 
KH03-K05687 KH01 transformed with 
pAG426GPD-ccdB 
carrying CAGL0K05687g 
 
Δime1 ime1::KanMx; 
MATA can1Δ::STE2pr-
SP-his5 lyp1Δ his3Δ1 
leu2Δ0 ura3Δ0 met15Δ0 
LYS2+ 
Gift from Dr. Jane 
Usher, University of 
Exeter 
Δime2 ime2::KanMx; 
MATA can1Δ::STE2pr-
SP-his5 lyp1Δ his3Δ1 
leu2Δ0 ura3Δ0 met15Δ0 
LYS2+ 
Gift from Dr. Jane 
Usher, University of 
Exeter 
Δime1-D05434 Δime1 transformed with 
pAG426GPD-ccdB 
carrying CAGL0D05434g 
This study 
Δime2-D05434 Δime2 transformed with 
pAG426GPD-ccdB 
carrying CAGL0D05434g 
This study 
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2.1.2 Bacterial Strains 
Bacterial strains used in the course of this study are listed in Table 2.3. 
 
Table 2.3: E. coli strains used during this study. 
Strain Genotype Origin 
DH5α fhuA2 lac(del)U169 phoA 
glnV44 Φ80' lacZ(del)M15 
gyrA96 recA1 relA1 endA1 
thi-1 hsdR17 
Gift received from Dr. 
Carol Munro, University 
of Aberdeen 
One Shot® ccdB 
Survival™ 
 
F-mcrA Δ(mrr-hsdRMS-
mcrBC) Φ80lacZΔM15 
ΔlacX74 recA1 araΔ139 
Δ(ara-
leu)7697galU galK rpsL 
(StrR) endA1 nupG fhuA::IS2 
Life Technologies™ 
 
 
2.1.3 Drosophila Strains 
Drosophila melanogaster strains used in this study are listed in Table 2.4. 
 
Table 2.4: Drosophila strains used during this study. 
Strain Genotype Origin 
Dif/Key Canton
S ∆dif ∆key Gift received from Dr. 
Petros Ligoxygakis, 
Oxford University 
Dros-GFP w- Drs-GFP Gift received from Dr. 
Petros Ligoxygakis, 
Oxford University 
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2.1.4 Plasmids 
Details of the plasmids used in the course of this study are listed in Table 2.5. 
For plasmid maps and features, see Appendix 15. 
 
Table 2.5: Plasmids used during this study. 
Plasmid name Description Origin 
pENTR™221 Gateway® entry vector. 
Contains attL1 and attL2 sites 
for site-specific recombination 
Life 
Technologies™ 
pAG413GPD-ccdB Low copy number Gateway® 
destination vector. Contains 
constitutive GPD promoter and 
his3 selectable marker. 
Addgene 
pAG423GPD-ccdB High copy number Gateway® 
destination vector. Contains 
constitutive GPD promoter and 
his3 selectable marker. 
Addgene 
pAG416GPD-ccdB Low copy number Gateway® 
destination vector. Contains 
constitutive GPD promoter and 
ura3 selectable marker. 
Addgene 
pAG426GPD-ccdB High copy number Gateway® 
destination vector. Contains 
constitutive GPD promoter and 
ura3 selectable marker. 
Addgene 
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2.2 Primers  
For a comprehensive list of primers used in the study, refer to Appendix 1. 
 
2.3 Storage, Media and Culture of Strains 
2.3.1 Yeast Media and Culture 
Yeast strains were cultured in rich YPD medium (1 % yeast extract, 2 % 
bacteriological peptone and 2 % glucose). For selection of mutants, YPD was 
supplemented with nourseothricin (NAT, Werner Bioagents) to a final 
concentration of 200 µg/ml. Synthetic complete (SC) medium was prepared with 
0.67 % yeast nitrogen base without amino acids (Formedium™), 2 % glucose 
and 0.079 % complete supplement mixture (Formedium™). For auxotrophic 
selection medium, complete supplement mixture was replaced with the 
appropriate drop-out mixture supplied by Formedium™ to the concentration 
recommended by the supplier. All broth cultures were incubated at 30 °C, 180 
rpm unless otherwise stated. For solid medium, YPD or SC was supplemented 
with 2 % agar.  
 
2.3.2 Bacterial Media and Culture 
Bacteria were cultured in Luria broth (LB, Formedium™) at 37 °C, 180 rpm. For 
solid medium, LB was supplemented with 2 % agar. For antibiotic selection, 
ampicillin or kanamycin were added to the media to a final concentration of 200 
µg/ml or 100 µg/ml, respectively.  
 
2.3.3 Storage of Yeast and Bacterial Strains 
For long term storage, strains were stored at -80 °C in the appropriate selective 
medium supplemented with 15 % glycerol. 
 
2.3.4 Drosophila Media and Growth 
Drosophila strains were incubated at 25 °C in fly bottles containing standard 
Drosophila medium (7.7 g/L agar, 69.2 g/L maize, 8.3 g/L soya, 14.0 g/L yeast 
extract, 69.2 g/L malt, 19.2 g/L molasses, 30 ml/L Nipagin stock (10 % in 
ethanol), 5 ml/L propionic acid and 0.34 ml/L orthophosphoric acid). Adult 
Drosophila were allowed to lay eggs for 24 hours at 25 °C and then transferred 
to a fresh fly bottle. After 5 days, larvae were harvested for infection assays. 
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2.4 General Molecular Techniques 
2.4.1 Preparation of Competent E. coli 
5 ml LB was inoculated with a single E. coli colony and incubated overnight at 
37 °C, 180 rpm. The overnight culture was subcultured into 100 ml LB and 
grown to an OD550 of 0.48. Cells were chilled for 5 minutes prior to being 
harvested by centrifugation at 5000 rpm for 5 minutes at 4 °C. The cell pellet 
was resuspended in 40 ml chilled Tfb1 solution (30 mM potassium acetate, 100 
mM KCl, 10 mM CaCl2.2H2O, 50 mM MnCl2.4H2O, 15 % glycerol, pH to 5.8 with 
acetic acid) and chilled on ice for 5 minutes. The cells were harvested at 5000 
rpm, 4 °C for 5 minutes and resuspended in 4 ml chilled TfbII solution (10 mM 
MOPs, 75 mM CaCl2, 10 mM KCl, 15 % glycerol, adjusted to pH 6.5 using 3 M 
KOH) and chilled for 15 minutes. Competent cells were dispensed into aliquots, 
snap frozen in liquid nitrogen or dry ice and stored at -80 °C for later 
transformation. 
 
2.4.2 E. coli Transformation 
Competent E. coli cells were thawed on ice. 100 ng of plasmid was added to 20 
µl competent cells and kept on ice for 30 minutes before being heat shocked at 
42 °C for 1 minute. Cells were subsequently chilled on ice for 5 minutes. After 
the addition of 150 µl LB, cells were incubated for 1 hour at 37 °C, 180 rpm, 
harvested and plated onto LB agar supplemented with antibiotic. 
 
2.4.3 Isolation of Plasmid DNA from E. coli 
For the extraction of plasmid DNA from E. coli cultures, the GenElute™ HP 
Plasmid Miniprep Kit (Sigma-Aldrich®) was used. 5 ml of E. coli overnight 
culture was harvested by centrifugation and the cell pellet resuspended in 200 
µl Resuspension Solution containing RNase A. 200 µl Lysis Buffer was added 
to the cell suspension and mixed by gentle inversion, allowing the mixture to 
become clear. 350 µl Neutralization/Binding Buffer was added to the lysis 
solution and gently inverted for precipitation of cellular debris. The mixture was 
centrifuged at 12,000 rpm for 10 minutes. To prepare the Miniprep binding 
column, 500 µl Column Preparation Solution was added to a column placed 
inside a microcentrifuge tube and centrifuged for one minute at 12, 000 rpm. 
The flow through was discarded. Clear supernatant containing plasmid DNA 
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was transferred to the binding column and centrifuged for 1 minute, discarding 
flow through. The column was washed with 500 µl Wash Solution 1 and 
subsequently with 750 µl Wash Solution 2 and the flow through discarded 
following centrifugation. To elute plasmid DNA, 100 µl Elution Solution was 
added to the binding column and incubated for 1 minute at room temperature 
before centrifugation for 1 minute to yield plasmid DNA. DNA was stored at -20 
°C. 
 
2.4.4 Extraction of genomic DNA from C. glabrata and S. cerevisiae  
Yeast DNA was isolated using the MasterPure™ Yeast DNA Purification kit 
(Epicentre®). Briefly, a single yeast colony was transferred into a 
microcentrifuge tube containing 300 µl Yeast Cell Lysis Solution and 
resuspended by vortex mixing. The cell solution was incubated for 15 minutes 
at 65 °C and then on ice for 5 minutes. 150 µl of MPC Protein Precipitation 
Reagent was added to the lysis solution and mixed by vortex for 10 seconds. 
Precipitated cellular debris was collected by centrifugation for 10 minutes at 
10,000 rpm followed by removal of the DNA-containing supernatant into a fresh 
microcentrifuge tube, carefully avoiding the cell precipitate. To precipitate DNA, 
500 µl was added to the supernatant, mixed by inversion 5 times followed by 
centrifugation at 10,000 rpm for 10 minutes. After removal of the supernatant, 
the DNA pellet was washed once with 70 % ethanol, air dried and suspended in 
35 µl TE buffer. DNA was stored at -20 °C. 
 
2.4.5 Resolution of DNA fragments by Gel Electrophoresis 
Agarose gel consisting of 1 % Agarose in 1 x TAE (4.84 g/L Tris base, 1.14 ml/L 
glacial acetic acid and 0.37 g/L EDTA) was prepared by heating in a microwave. 
Once cooled to approximately 50 °C, ethidium bromide was added to the gel 
mixture to a final concentration of 0.4 μg/ml. After mixing the gel was poured 
into a gel cast and allowed to set. The gel tank was filled with 1 x TAE buffer 
ensuring full coverage of the agarose gel. 5 µl of DNA sample mixed with 1 µl 
DNA loading buffer (30 % (v/v) glycerol, 0.25 % (w/v) bromophenol blue and 
0.25 % (w/v) xylene cyanol) were loaded into individual wells of the agarose gel. 
For standardisation of DNA fragment size, 2.5 µg (5 µl) of 1 kb or 100 bp DNA 
ladder (New England Biolabs) were loaded onto the gel. Samples were run for 
78 | P a g e  
 
approximately 30 minutes at 80 V. DNA fragments were visualised using in a 
Syngene G:BOX  gel imager. 
 
2.4.6 Purification of PCR Products from Agarose Gels 
Purification of PCR products from agarose gels was performed using the 
GenElute™ Gel Extraction Kit (Sigma-Aldrich®). Briefly, the DNA fragment was 
excised from the agarose gel, placed in 3 gel volumes of Gel Solubilization 
Solution and incubated at 50 °C until completely dissolved. To prepare the DNA 
binding column, 500 µl of Column Preparation Solution was added to a 
GenElute Binding Column which had been placed inside a 2 ml collection tube. 
The binding column was centrifuged for 1 minute at 12,000 rpm and the flow-
through discarded. Once melted, 1 gel volume of isopropanol was added to the 
solubilised gel mixture and mixed by inversion. The solubilised gel solution was 
added to the DNA binding column and centrifuged for 1 minute at 12,000 rpm 
discarding the flow through liquid. The binding column was washed with 700 µl 
Wash Solution and centrifuged twice at 12,000 rpm for 1 minute, discarding the 
flow-through to ensure the removal of excess ethanol. The column was then 
placed into a fresh collection tube. Lastly, to retrieve DNA from the binding 
column, 50 µl Elution Solution was added to the column and centrifuged for 1 
minute at 12,000 rpm. DNA was stored at -20 °C. 
 
2.4.7 C. glabrata Transformation by Electroporation 
A single C. glabrata colony was used to inoculate 5 ml YPD and grown 
overnight at 37 °C, 180 rpm. 1 ml of overnight culture was subcultured into a 
conical flask containing 50 ml YPD and grown for 3 hours to an OD600 of 1 – 1.5. 
Cells were harvested and washed once in 25 ml sterile water and then gently 
resuspended in 10 ml solution containing 1 x TE (10 mM Tris, 1 mM EDTA, pH 
8) and 100 mM lithium acetate and incubated for 30 minutes at 30 °C, 150 rpm. 
After the addition of 125 μl DTT (2 M stock in ethanol) the cell suspension was 
incubated for a further hour. Cells were harvested, washed with 25 ml chilled 
water followed by washing in chilled 1M sorbitol. Where possible competent 
cells were kept on ice between wash steps. Once washed, the competent cells 
were resuspended in 550 μl chilled 1 M sorbitol. 
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For electroporation, 55 μl competent cells were mixed with 6 μl fusion construct 
or plasmid in a pre-chilled electroporation cuvette. The mixture was 
electroporated at 1500 V in an Eppendorf Eporator® and transferred into a 
sterile 1.5 ml centrifuge tube containing 1 ml YPD.  After incubation at 30 °C, 
180 rpm for 4 hours, cells were harvested and plated onto YPD agar plates 
supplemented with 200 µg/ml NAT. 
 
2.4.8 Lithium Acetate-mediated Yeast Transformation 
An overnight culture from a single yeast colony was grown in YPD at 30 °C, 180 
rpm. 1.25 ml of overnight culture was transferred into 25 ml fresh YPD and 
grown for 4-5 hours at 30 °C, 180 rpm. Cells were harvested and washed twice 
in 15 ml sterile water and the pellet resuspended in 100 mM lithium acetate. 50 
μl of the cell suspension was mixed with 500 μl solution A (40 % (w/v) PEG 
3300, 100 mM lithium acetate and 10 mM Tris-HCl pH 7.5), 50 μl carrier DNA (2 
mg/ml) and 2 μg plasmid DNA and incubated at 30 °C, 100 rpm for 30 minutes. 
The mixture was subsequently heatshocked at 42 °C for 15 minutes. The cells 
were harvested and plated onto YPD agar plates containing the appropriate 
selection. 
 
2.5 Cloning of C. glabrata ORFs using Invitrogen Gateway® Technology 
2.5.1 Amplification of C. glabrata ORFs 
C. glabrata ORFs were amplified by PCR using a forward primer of 5’-AC AAA 
AAA GCA GGC TTC ATG-3’ followed by 27 bp specific to each ORF and a 
reverse primer of 5’-A CAA GAA AGC TGG GTC-3’ followed by 30 bp specific 
to each ORF but omitting the STOP codon (Appendix 1 Table 5).  ORF 
amplification was achieved using Platinum® Pfx DNA polymerase as per the 
manufacturer’s instructions. Amplification product size was verified by gel 
electrophoresis. 
 
2.5.2 Addition of attB Sites onto Amplification Products 
Recombination sites from the bacteriophage lambda (attB sites) were added 
onto the flanking ends of amplification products using a second PCR reaction. 
Primers AttB-For and AttB-Rev were universal for adding attB sites onto all 
amplification products due to homology with primers from the amplification step 
(Appendix 1 Table 4). Platinum® Pfx DNA polymerase was used for PCR 
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according to the manufacturer’s instructions. PCR products were verified by gel 
electrophoresis. 
 
 
2.5.3 BP Clonase® Reaction 
Amplification products were shuttled into pENTRY vector pDONR™221 (Life 
Technologies™; Figure 2.1) in a BP Clonase® reaction. 1 μl TE buffer, 0.5 μl 
pDONR™221 and 1 μl BP Clonase® were mixed on ice. To this reaction, 2 μl of 
the appropriate attB PCR product was added. The mixture was incubated at 25 
°C for a minimum of 2 hours, after which the reaction was either stored at -20 
°C for future use or directly transformed into E. coli DH5α cells. Transformed E. 
coli were plated onto LB Kanamycin to select for clones containing pENTRY 
vectors carrying the gene of interest. 
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Figure 2.1: Diagrammatic representation of the BP clonase® reaction. 
During the BP Clonase® reaction, the attB sites flanking the ORF of interest 
(GeneX ) recombine with attP of the pDONR™221 vector, yielding a pENTRY 
vector containing GeneX. 
 
Following transformation, single E. coli colonies were picked to inoculate 5 ml 
LB Kanamycin broth and grown overnight at 37 °C, 180 rpm. Cells from 
overnight cultures were harvested and plasmid was extracted using the 
GenElute™ HP Plasmid Miniprep Kit (Sigma; see 2.4.3). Integration of the 
correct size insertion into the pENTRY vector was verified by PCR amplification 
using primers M13-For and M13-Rev (Appendix 1 Table 4), which target regions 
of the vector flanking the insertion. Gel electrophoresis was used to check for 
correct size amplification product (target ORF size + 253 bp). 
 
2.5.4 LR Clonase® Reaction 
To shuttle the target ORF from the pENTRY vector to a chosen destination 
vector (pDEST), LR clonase® reactions were performed. 0.5 μl of the pENTRY 
vector were added to a mix of 3 μl TE buffer, 0.5 μl pDEST vector and 1 μl LR 
clonase® on ice. The reaction was incubated at 25 °C for 2 hours, transformed 
into E. coli DH5α cells and subsequently plated onto LB Ampicillin plates. The 
remaining LR Clonase® reaction mix was stored at -20 °C. Transformants were 
selected to inoculate 5 ml LB Ampicillin broth and grown overnight at 37 °C, 180 
rpm. Plasmid was extracted from overnight cultures using the GenElute™ HP 
Plasmid Miniprep Kit (Sigma; see 2.4.3). Correct shuttling of the insert was 
verified by PCR amplification of the target ORF using primers M13-For and 
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M13-Rev (See Appendix 1 Table 4). Correct destination vectors were 
transformed into C. glabrata or S. cerevisiae (see 2.4.7 and 2.4.8). 
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Chapter 3: Selection of C. glabrata 
specific genes for targeted gene 
deletion 
 
3.1 Overview 
The high number of sequenced Ascomycete species have made this group of 
fungi the focus of many comparative genomic studies (Souciet et al., 2000; 
Dujon et al., 2004; Butler et al., 2009; Moran et al., 2011). Such studies found 
the pathogenic yeast C. glabrata to be more closely related to the non-
pathogenic yeast S. cerevisiae and that both genomes are distinct from C. 
albicans and other members of the CTG clade (Dujon et al., 2004; Dujon, 2010; 
Figure 1.3). As yet, C. glabrata and its biology with respect to infection has 
remained poorly explored and much knowledge is inferred from orthologues 
from C. albicans and S. cerevisiae.  
The completion of full deletion libraries in S. cerevisiae has pushed this model 
organism to the forefront of genome-wide molecular biological studies, greatly 
accelerating the functional characterisation of genes and pathways, enabling 
high-throughput non-biased chemical-genetic studies and facilitating the 
creation of the genetic landscape of the cell through genome-wide genetic 
interaction studies (Giaever et al., 2002; Costanzo et al., 2010; see 1.3). 
Following the success of the S. cerevisiae deletion project, smaller scale gene 
deletion collections in C. albicans have proven a powerful tool which, for 
example, has facilitated the understanding of genetic regulation networks 
underlying biofilm formation – a medically important population structure in this 
species (Nobile et al., 2012). However, knowledge gained from the well-studied 
pathogen C. albicans is not always applicable or relevant to C. glabrata biology 
due to stark differences in their lifestyles (Brunke & Hube, 2013; see 1.5.1, 
1.5.2, 1.5.3). Similarly, whilst C. glabrata is closely related to S. cerevisiae and 
shares high levels of protein orthology (Dujon et al., 2004), S. cerevisiae is 
relatively non-pathogenic and generally regarded as safe and thus provides little 
insight into C. glabrata virulence factors.  Whilst data generated from these 
screens can often be extrapolated to yield useful functional information about 
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orthologues in related species, there is a need for molecular tools for the study 
of ORFs which are of relevance to pathogenicity in clinically relevant species. 
 
This study aims to gain insight into C. glabrata virulence attributes through the 
generation of molecular tools for the functional characterisation of C. glabrata 
ORFs which may play a role in pathogenicity. Firstly, to address the question of 
what factors have allowed C. glabrata to emerge as a pathogen, yet be so 
closely related to non-pathogenic yeast species such as S. cerevisiae, C. 
glabrata ORFs with no S. cerevisiae orthologue needed to be identified. This 
study hypothesises that C. glabrata ORFs with no orthologue in S. cerevisiae 
may be important for C. glabrata virulence (Desai et al., 2011). Such ORFs may 
have emerged since divergence of C. glabrata and S. cerevisiae from a 
common ancestor following a whole genome duplication event (Byrne & Wolfe, 
2005; see 1.2; Figure 1.3) or alternatively could have been retained in C. 
glabrata and lost from S. cerevisiae. Such changes have accompanied the 
emergence of C. glabrata as a human pathogen. Indeed this hypothesis has 
held true for the EPA genes and other C. glabrata adhesins which facilitate 
epithelial and immune-cell attachment in C. glabrata (Cormack et al., 1999; 
Butler et al., 2009; Desai et al., 2011). Therefore a number of bioinformatic 
approaches were used to identify and functionally annotate C. glabrata-specific 
ORFs. It was also hypothesised that the acquisition of prokaryotic genes by C. 
glabrata could have contributed to the adaptation to a new niche. To further fulfil 
the aims of this study, a deletion library of selected C. glabrata ORFs was 
generated to provide a molecular tool for the downstream functional 
characterisation of these ORFs. Thus, functional studies through the 
exploitation of such a deletion library may reveal C. glabrata virulence 
attributes. 
 
3.2 Materials and Methods 
3.2.1 Detection of Horizontal Gene Transfer Events between Prokaryotes 
and C. glabrata 
BLASTP searches of the C. glabrata proteome were performed against a 
bespoke database of 4,294,681 proteins from 680 bacterial genomes and 93 
fungal genomes to identify C. glabrata ORFs with significant similarity (e-value < 
1e-5) with bacterial protein sequences (Dr. Darren Soanes, University of 
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Exeter). Protein sequences for selected C. glabrata ORFs were retrieved from 
CGD (candidagenome.org) and sequences of the top 100 BLASTP hits 
(blast.ncbi.nlm.nih.gov/) were downloaded. Multiple sequence alignments were 
performed in ClustalW (genome.jp/tools/clustalw/) employing the Slow/Accurate 
pairwise alignment and downloaded in PIR format. Multiple sequence 
alignments were uploaded into Gblocks 
(molevol.cmima.csic.es/castresana/Gblocks_server.html) for the selection of 
conserved blocks to be later used for phylogenetic analysis. Selected blocks 
were subsequently run through ModelGenerator (Keane et al., 2006) to select 
the optimal amino acid substitution model for phylogenetic analysis. LG 
substitution models (Le & Gascuel, 2008) were selected for C. glabrata ORFs 
CAGL0D01210g, CAGL0K11066g and CAGL0M14091g. Having converted the 
GBlocks file to FASTA format using Readseq (ebi.ac.uk/Tools/sfc/readseq/), 
files were uploaded to the ATCG PhyML 3.0 (Guindon et al., 2010) applying a 
bootstrap of 100. The resultant estimated maximum tree file downloaded from 
PhyML was visualised in FigTree (tree.bio.ed.ac.uk/software/figtree/). Identical 
or duplicated sequences from the same species were removed from the 
analysis. 
 
3.2.2 Targeted Gene Deletion in C. glabrata 
3.2.2.1 Amplification of 5’ and 3’ Ends of the Target ORF 
Flanking regions of the target ORF were amplified incorporating ORF-specific 
barcode sequences and universal U1, U2, D1 and D2 sequences. Barcode 
sequences from the S. cerevisiae deletion collection (Winzeler et al., 1999) 
were used to tag C. glabrata mutants. 
 
For the 5’ flanking region, 500 bp upstream of but excluding the start codon was 
amplified using ORF-specific primers -500-F and -1-NAT-R  (Appendix 1 Table 
2) to generate the 5’ construct (Figure 3.1). Sequences universal to all deletions, 
regions U1 and U2, allow for amplification of barcodes from all deletion mutants 
in one reaction. Sequence U2 contains overlaps with that of the NATR cassette. 
 
For the 3’ flanking region, 500 bp downstream of but excluding the stop codon 
was amplified using ORF-specific primers +500-R and +1-NAT-F (Appendix 1 
Table 2) to generate the 3’ construct in (Figure 3.1). Sequences universal to all 
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deletions, regions D1 and D2 allow for amplification of barcodes from all 
deletion mutants in one reaction. Sequence D2 contains overlaps with that of 
the NATR cassette.  
 
Up- and down-stream flanking regions were amplified using Green Taq DNA 
polymerase as per manufacturer’s instructions in a Techne TC-4000 
thermocycler. PCR products were verified by gel electrophoresis. The 500 bp 
products were excised from the agarose gel, purified (see 2.4.6) and stored at -
20 °C. 
 
3.2.2.2 Amplification of the NATR Cassette 
The NATR cassette was amplified from the pCR2.1-SAT plasmid using primers 
U2-BC-NAT and D2-BC-NAT (Appendix 1 Table 1) to produce a DNA fragment 
with ends which overlap with the U2 and D2 regions of the 5’ and 3’ ends 
respectively. The cassette contains S. pombe TEF1 promoter, SAT gene 
conferring CloneNAT-resistance, and S. pombe TEF1 3’ UTR and FRT (flippase 
recognition target) sequence for subsequent removal and recycling of the NATR 
cassette as a marker (Figure 3.1). BIO-X-ACTTM short DNA polymerase was 
used for amplification of the NATR cassette as per the manufacturer’s 
instructions. The 1.3 kb NATR cassette PCR product was verified by gel 
electrophoresis, gel purified (see 2.4.6) and stored at -20 °C. 
 
3.2.2.3 Fusion PCR of the Deletion Construct 
Flanking 5’ and 3’ ends of the target ORF and NATR cassette were fused in a 
PCR reaction to produce a fusion deletion cassette (Figure 3.1).  
DNA mix per single reaction: 
 8 μl   2.5 mM ExTaq dNTP mix 
1.25 μl  forward primer (-500-F, 50 μM) 
1.25 μl  reverse primer (+500-R, 50 μM) 
2 μl   5’ and 3’ UTRs mix (gel purified) 
1 μl   NATR cassette (gel purified) 
16.5 μl  H2O 
 
The DNA mix was boiled for 10 minutes in a Techne TC-4000 thermocycler to 
ensure complete DNA denaturation and stored on ice for a minimum of 1 
minute. 
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Added to the DNA mix per single reaction: 
10 μl   10 x ExTaq buffer 
4 μl   25 mM MgCl2 
2 μl   2.5 mM ExTaq dNTP mix  
0.6 μl   ExTaq DNA polymerase (Lonza, 5 U/ μl) 
53.4 μl  H2O 
100 μl Final volume 
 
PCRs were replaced in the thermocycler for the following cycle: 
Temperature Time Cycles 
95 °C 30 seconds 3 
42 °C 30 seconds 
72 °C  2.5 minutes 
95 °C 30 seconds 30 
52 °C  30 seconds 
72 °C  2.5 minutes 
72 °C 10 minutes 1 
 
The fusion construct (~2.3-2.4 kb) was verified by gel electrophoresis. 
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Figure 3.1: Targeted gene deletion method in C. glabrata (Dr. Biao Ma, 
personal communication). Firstly, 5’ and 3’ ends of the target gene were 
amplified. The 5’ end (500 bp upstream of the start codon) was amplified using 
ORF specific primers -500-F and -1-NAT-R (Appendix 1 Table 2), incorporating 
universal sequences U1 and U2 as well as a 20bp unique “Up tag”. The 3’ end 
(500 bp downstream of the stop codon) was amplified using ORF-specific 
primers +1-NAT-F and +500-R (Appendix 1 Table 2), incorporating universal 
sequences D1 and D2 as well as a unique 20bp “Down tag”. Secondly, the 
NATR cassette was amplified using primers U2-BC-NAT and D2-BC-NAT 
(Appendix 1 Table 1), incorporating flanking FRT (flippase recognition targets) 
sites and U2 and D2 universal sequences. Lastly, a fusion PCR incorporated 5’ 
and 3’ ends with the NATR cassette using ORF-specific primers -500-F and 
+500-R (Appendix 1 Table 2) to yield the deletion construct. The deletion 
construct was transformed into competent C. glabrata cells by electroporation. 
Deletion mutants were verified using three PCR checks. Removal of the target 
ORF was verified using ORF specific primers int-F and int-R (Appendix 1 Table 
3). Insertion of the NATR cassette at the correct target locus was verified by 
amplification of the 5’ junction using universal primer NAT-5’-R (Appendix 1 
Table 1) and ORF specific primer -600-F (Appendix 1 Table 3). The 3’ junction 
was verified using universal primer NAT-3’-F (Appendix 1 Table1) and ORF 
specific primer +600-R (Appendix 1 Table 3).  
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3.2.2.4 Precipitation of Fusion Construct 
10 μl of Na-acetate (3 M, pH 5.2) and 800 μl of ethanol were added to 100 µl of 
the fusion PCR reaction, mixed and stored at -20°C for a minimum of 1 hour. 
The mixture was centrifuged at 13,000 rpm for 8 minutes to yield a DNA pellet 
which was subsequently washed with 1 ml of 70 % ethanol, air-dried, and 
dissolved in 50 μl of 0.1 x TE (1 mM Tris-HCl, pH 8.5, 0.1 mM EDTA).The DNA 
solution was directly used for transformation into competent C. glabrata Cg2001 
∆his3 cells by electroporation (see 2.4.7).  
 
3.2.2.5 Verification of C. glabrata Transformants 
C. glabrata transformants were initially verified by colony PCR. Firstly, presence 
of the target ORF was checked using ORF-specific primers int-F and int-R 
(Figure 3.1; Figure 3.9 A; Appendix 1 Table 3) which target sequences within 
the deleted ORF. Secondly, correct integration of the deletion cassette at the 
target locus was verified using ORF-specific primer -600-F and NAT-5’-R 
targeting the 5’ junction (Figure 3.1; Figure 3.9 B). Primers NAT-3’-F and +600-
R were used for verification of the 3’ junction (Figure 3.1; Figure 3.9 B). Correct 
insertion of the deletion cassette yielded a PCR product of 0.9 – 1.2 kb at both 
junctions. Primers NAT-5’-R and NAT-3’-F (Appendix 1 Table 1) target 
sequences within the NATR cassette whilst +600-R and -600-F are ORF-specific 
(Appendix 1 Table 1 and 3).  
 
Genomic DNA of transformants yielding PCR products indicative of correct 
integration of the deletion cassette was extracted and verified using the 
described PCR reactions.  
 
Where possible, three independent isolates of each deletion strain were 
collected and stored as glycerol stocks at -80 °C. 
 
3.3 Results 
3.3.1 Identification of C. glabrata ORFs with no S. cerevisiae Orthologue 
A bespoke BLAST-based bioinformatic search was used to identify C. glabrata 
ORFs which may have no orthologue in S. cerevisiae (Dr. Maxime Huvet, 
Imperial College London, personal communication). Reciprocal best hit (RBH) 
searches of the C. glabrata proteome (uniprot.org) against that of S. cerevisiae 
90 | P a g e  
 
identified 4000 C. glabrata proteins with orthologues in S. cerevisiae (Figure 
3.2). Amongst the remaining 1192 C. glabrata proteins with no strict S. 
cerevisiae orthologue, 465 were identified to have putative homologues in S. 
cerevisiae by BLAST search. To increase the stringency of searches, filters 
were applied at both sequence comparison stages to ensure 30 % sequence 
identity within a minimum of 50 % of the protein sequence. This approach 
identified 727 C. glabrata proteins which may have no orthologue in S. 
cerevisiae (Figure 3.2; Appendix 3 Table 1).  
 
 
Figure 3.2: Workflow of RBH searches used to identify C. glabrata ORFs 
with no orthologue in S. cerevisiae. RBH searches of the C. glabrata 
proteome were performed against that of S. cerevisiae. Filters were applied to 
RBH searches ensuring a minimum of 30 % sequence identity covering a 
minimum of 50 % of the protein sequence. RBH searches identified 4000 C. 
glabrata ORFs with strict S. cerevisiae orthologues. BLAST searches of the 
remaining 1192 C. glabrata ORFs identified S. cerevisiae orthologues for 465 
ORFs, leaving 727 C. glabrata proteins with no orthologue in S. cerevisiae.  
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3.3.2 Mapping the Chromosomal Location of C. glabrata ORFs with no 
Orthologue in S. cerevisiae 
The location of 727 C. glabrata ORFs identified by RBH searches to have no 
orthologue in S. cerevisiae were mapped on the C. glabrata chromosomes 
(Figure 3.3). C. glabrata-specific ORFs were distributed throughout all 13 C. 
glabrata chromosomes. Comparison of the proportion of C. glabrata-specific 
ORFs (identified in RBH searches) falling on each chromosome found no 
significant enrichment of these ORFs on any particular chromosome (Chi-
squared, p=0.997). However, statistical analysis identified 10 regions in which 
C. glabrata ORFs with no orthologues were statistically clustered compared with 
the distribution of coding sequences throughout the chromosome (Figure 3.3; 
Poisson distribution, p<0.05). The chromosome B cluster contains putative C. 
glabrata β-mannosyltransferases whilst clusters located on Chromosomes E 
and J contain putative adhesins. However, clusters of C. glabrata-specific ORFs 
are located at various regions on the chromosomes with no trend towards the 
centromere or telomere.  
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Figure 3.3: Chromosomal distribution of C. glabrata ORFs with no orthologue in S. cerevisiae. Blue horizontal lines represent C. 
glabrata chromosomes labelled A to M with centromeric locations denoted by a red circle. Vertical blue lines indicate the chromosomal 
locations of C. glabrata ORFs with no S. gerevisiae orthologue based on RBH searches (Appendix 3 Table 1). Black astericks show the 
location of C. glabrata EPA genes identified in RBH searches. Black horizontal lines lie above significant clusters of C. glabrata-specific 
ORFs (poisson distibution, p<0.05).  
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3.3.3 Alternative Approaches for the Identification of C. glabrata ORFs 
with no Orthologue in S. cerevisiae 
RBH searches identified a large proportion of C. glabrata ORFs, encompassing 
nearly 14 % of the genome, to have no orthologue in S. cerevisiae. Thus 
additional search criteria were required to generate a more stringent list of C. 
glabrata-specific ORFs. 
 
The Yeast Gene Order Browser (YGOB) was exploited to further investigate 
whether C. glabrata genes indentified in RBH searches do, in fact, have an S. 
cerevisiae orthologue. YGOB incorporates annotation of orthologous genes 
from the literature, annotation from automated BLASTP searches as well as 
manual editing. Syntenic information regarding S. cerevisiae genes and their 
orthologues can also be visualised (Byrne & Wolfe, 2005). Searches of the 
entire C. glabrata genome using YGOB identified 294 C. glabrata ORFs to have 
no S. cerevisiae orthologue (Appendix 3 Table 2), a comparably smaller number 
than those selected by RBH searches. Of these, 37 C. glabrata ORFs have 
orthologues in other closely related yeasts. For example, C. glabrata ORF 
CAGL0D05434g has no S. cerevisiae orthologue however orthologues are 
present in Vanderwaltozyma polyspora, Tetrapisispora phaffii, Naumovozyma 
dairenensis and Kluyveromyces lactis. Comparison of the number of C. glabrata 
genes predicted to have no S. cerevisiae orthologue by RBH- and YGOB-based 
approaches found only 197 ORFs common to both lists (Figure 3.4). YGOB and 
RBH searches identified 97 and 530 ORFs unique to each list, respectively, 
highlighting a stark difference between the two approaches (Figure 3.4). Thus, 
ORFs common to both searches were mostly focused on as C. glabrata ORFs 
with no orthologue in S. cerevisiae. 
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Figure 3.4: Comparison and overlap of C. glabrata ORFs with no 
orthologue in S. cerevisiae derived from two different bioinformatic 
approaches. RBH searches (red) identified 727 ORFs with no S. cerevisiae 
orthologue whilst YGOB identified only 294 ORFs with no S. cerevisiae 
orthologue. Bracketed numbers indicate the total number of C. glabrata ORFs 
identified by each search method.  
 
3.3.4 The Acquisition of Prokaryotic Genes by C. glabrata 
To assess whether the acquisition of prokaryotic genes by C. glabrata may 
have contributed to its adaptation to the host niche, protein BLAST searches 
were used to identify C. glabrata ORFs which had high similarity to prokaryotic 
sequences. Initial BLASTP searches against the bespoke database identified 
four C. glabrata ORFs for which the top BLASTP hits (to a maximum e-value of 
1e-5) were prokaryotic: CAGL0D01210g, CAGL0E00231g, CAGL0M14091g 
and CAGL0K11066g (Dr Darren Soanes, University of Exeter, personal 
communication). 
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Table 3.1: Summary of C. glabrata ORFs which yield top BLAST hits with 
prokaryotic sequences. 
C. glabrata 
ORF 
Putative 
molecular 
function/domains 
Top BLASTP hit 
species 
E-
value 
No. 
Bacterial 
species 
in top 100 
hits 
CAGL0D01210g Aspartate 
racemase 
 
Zymomonas 
mobilis subsp. 
Mobilis 
(Proteobacteria) 
1e-48 99 
CAGL0E00231g Adhesin-like protein Rickettsia 
prowazekii 
(Proteobacteria) 
1e-06 - 
CAGL0M14091g Quinone 
reductase/NADPH 
dehydrogenase 
Flavodoxin-like fold 
Salinispora 
arenicola 
(Actinobacteria) 
5e-44 83 
CAGL0K11066g Hexapeptide 
transferase 
 
Bacteroides 
vulgatus 
(Bacteroidetes) 
1e-56 93 
 
Putative C. glabrata GPI-anchored adhesin CAGL0E00231g was initially 
identified in BLASTP searches as a candidate for horizontal gene transfer due 
to its sequence similarity with a protein from the bacterial species Rickettsia 
prowazekii – a member of the Alphaproteobacteria (Table 3.1). However, 
BLASTP searches yielded only two significant hits (E-value 1e-5) for this 
protein, the second of which originated from the flagellated protozoan species 
Thecamonas trahens. Further to this, RBH searches did not identify this ORF to 
be specific to C. glabrata and YGOB predicted this ORF to be a pseudogene. 
Due to this and the lack of significant BLASTP hits in other species, further 
investigation into the origin of ORF CAGL0E00231g was not pursued. 
 
3.3.5 C. glabrata CAGL0D01210g: Acquisition of a Putative Aspartate 
Racemase 
Initial BLASTP searches for C. glabrata ORF CAGL0D01210g against the 
bespoke protein database scored high confidence hits with predominantly 
prokaryotic protein sequences (Table 3.1).  Functional annotations by CGD 
(candidagenome.org) and Interpro (ebi.ac.uk/interpro) predict CAGL0D01210g 
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to encode an aspartate racemase – an enzyme catalysing the interconversion 
of L-aspartate and D-aspartate enantiomers. Both RBH searches and YGOB 
found CAGL0D01210g to have no orthologue in S. cerevisiae (Appendix 3 
Table 1 and 2). Furthermore, Fungal BLAST searches (yeastgenome.org) did 
not identify orthologues of CAGL0D01210g in other fungal species with the 
exception of similar proteins in distantly related fungi Aspergillus terreus (E-
value 7.8e-27) and Penicillium chrysogenum (E-value 4.6e-22). Most 
importantly, no significantly similar sequences were found in the Candida or 
Saccharomyces species, bioinformatically confirming this ORF to have no 
orthologue in closely related species. Maximum likelihood phylogenies found 
the C. glabrata CAGL0D01210g encoding protein to be closely related to 
protein sequences of aspartate racemases from both Gram positive and Gram 
negative bacteria and also from Archaea. As shown in the phylogeny for 
CAGL0D01210g and related sequences (Figure 3.5), CAGL0D01210g was 
clustered within branches representing proteins from Lactobacillus coryniformis, 
Oenococcus kitaharae, Lactobacillus vaginalis, Lactobacillus acidophilus and 
Lactobacillus gigeriorum – all of which reside in the Firmicute phylum.  However 
branch support in some instances is low, most likely due to the high similarity 
between protein sequences. S. cerevisiae protein sequences most similar to 
CAGL0D01210g (YGL171W and YLL008W, E-value 0.41 and 0.99 respectively) 
were used as an out-group, lying distanced from the clusters of bacterial and 
archaeal protein sequences surrounding that of C. glabrata CAGL0D01210g 
with strong branch support (Figure 3.5). Due to the grouping of C. glabrata 
CAGL0D01210g with bacterial aspartate racemase protein sequences and the 
nature in which this group lies distinct from the most similar protein sequences 
in the close relative yeast S. cerevisiae, it could be hypothesised that C. 
glabrata CAGL0D01210g originated from bacterial species (most likely from 
Lactobacillus sp. or other Firmicute species). Thus, C. glabrata ORF 
CAGL0D01210g may encode an aspartate racemase recently acquired from 
bacteria by a horizontal gene transfer event due to a lack of orthologues in 
related yeast species. 
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Figure 3.5: Maximum likelihood 
phylogenetic tree for putative C. 
glabrata aspartate racemase 
encoded by CAGL0D01210g 
(highlighted in blue). Analysis was 
performed using 43 representative 
sequences retrieved from the top 100 
BLASTP hits with duplicates and 
identical sequences removed. Branch 
labels denote branch support by 
bootstrap 100 values. Top BLAST hits 
in S. cerevisiae were used as an 
outgroup. Species within the phylogeny 
are labelled according to Kingdom or 
Bacterial Phylum (Red - Firmicutes, 
Blue - Archaea, Proteobacteria - green, 
Yellow - Bacteroidetes, Actinobacteria - 
purple, black - Ascomycete, orange - 
other) 
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3.3.6 C. glabrata CAGL0K11066g is Highly Similar to Bacterial Acetyl 
Transferases 
In searches utilising the bespoke database of fungal and bacterial proteins, the 
C. glabrata CAGL0K11066g encoding protein scored significant BLASTP hits 
with 93 bacterial sequences, namely with proteins encoding bacterial acetyl 
transferases (Table 3.1). Functional analysis of the C. glabrata CAGL0K11066g 
protein sequence also predicted this protein to have transferase activity 
(GO:0016740; Appendix 4 Table 1) due to the presence of a Trimeric LpsA-like 
domain containing a hexapeptide transferase conserved site. However, RBH 
and YGOB searches did not identify this protein as C. glabrata-specific most 
likely due to similarity to a putative S. cerevisiae acetyl transferase encoded by 
ORF YJL218W. In contrast, phylogenetic analysis showed C. glabrata 
CAGL0K11066g to be more similar to acetyl transferases from bacterial species 
from the Phyla Firmicutes, Bacteroidetes, Actinobacteria, Proteobacteria and 
Fusobacteria (Figure 3.6). Similar sequences were also found in Archaea 
species Methanobrevibacter ruminantium. S. cerevisiae YJL218W was also 
included in the analysis but sits outside the cluster of bacterial sequences 
(which include C. glabrata) as an outgroup from which it separated by many 
branches of the phylogenetic tree. Within the groups of bacterial sequences, C. 
glabrata CAGL0K11066g groups with sequences from the closely related 
Ascomycete species Naumovozyma castelli and N. dairenensis (Figure 3.6). 
This analysis provides preliminary evidence for the occurrence of a horizontal 
gene transfer event from bacteria to an ancestral fungal species prior to the 
divergence of the three species. However, branch support for the phylogenetic 
analysis is very low and further validation is required. 
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Figure 3.6: Maximum 
likelihood tree for C. glabrata 
CAGL0K11066g (highlighted in 
blue) showing phylogenetic 
relationships with 42 
representative protein 
sequences from BLASTP 
searches. Identical sequences 
and duplicates were removed. 
Branch labels denote bootstrap 
100 values. S. cerevisiae 
YJL218W was used as an 
outgroup. Species within the 
phylogeny are labelled according 
to Kingdom or Bacterial Phylum 
(Red - Firmicutes, Blue - 
Archaea, Proteobacteria - green, 
Yellow - Bacteroidetes, 
Actinobacteria - purple, black - 
Ascomycete, orange = other)  
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3.3.7 C. glabrata CAGL0M14091g has Similarity to Prokaryotic NADPH 
Dehydrogenases 
Using both RBH and YGOB search criterion, C. glabrata CAGL0M14091g was 
identified to have no orthologue in S. cerevisiae (Appendix 3 Tables 1 and 2). 
The encoding protein encompasses a flavodoxin-like fold and may function as a 
NADPH dehydrogenase/quinine reductase enzyme (ebi.ac.uk/Interpro; 
candidagenome.org).  BLASTP searches and phylogenetic analysis identified 
C. glabrata CAGL0M14091g to have significant similarity to NADPH 
dehydrogenase enzymes encoded by both Proteobacteria and Actinobacteria 
species (Table 3.1; Figure 3.7). In the maximum likelihood phylogeny, C. 
glabrata CAGL0M14091g clusters with three Vanderwaltozyma polyspora 
proteins, two N. dairenensis proteins and three N. castellii proteins. This cluster 
of Ascomycetous proteins lies distantly separated to the most similar S. 
cerevisiae protein sequence encoded by YKL225W  (Figure 3.7)  suggestive of 
the acquisition of CAGL0M14091g in an ancestral species post divergence from 
S. cerevisiae but prior to the divergence of C. glabrata, V. polyspora, N. castellii 
and N. dairenensis. However, the acquisition of this ORF by a horizontal gene 
transfer event from bacteria cannot be confirmed due to low branch support in 
the phylogenetic analysis. 
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Figure 3.7: Maximum likelihood 
tree for C. glabrata 
CAGL0M14091g (highlighted in 
blue) showing phylogenetic 
relationships with 41 representative 
protein sequences from BLASTP 
searches. Identical sequences and 
duplicates were removed. Branch 
labels denote bootstrap 100 values. 
S. cerevisiae YKL225W was used as 
an outgroup. Species within the 
phylogeny are labelled according to 
Kingdom or Bacterial Phylum (Red - 
Firmicutes, Blue - Archaea, 
Proteobacteria - green, Yellow - 
Bacteroidetes, Actinobacteria - 
purple, black - Ascomycete, orange = 
other)  
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3.3.8 Functional Annotation and Selection of C. glabrata-specific Genes 
for Targeted Gene Deletion 
To prioritise ORFs for deletion, InterPro and InterProScan (ebi.ac.uk/interpro) 
were used to determine the potential function of selected C. glabrata ORFs 
(Appendix 4 Table 1). Interpro curates predictive models or signatures from 
multiple databases (such as Pfam, PANTHER and ProDom) against which 
protein sequences can be searched to yield information on protein families, 
functional domains and active sites. As such, this tool was used to gain insight 
into the function and associated GO terms inferred from matching sequences 
and signatures of C. glabrata genes with no S. cerevisiae orthologue (Quevillom 
et al., 2005; Hunter et al., 2012). Accordingly, a prioritised list of C. glabrata 
ORFs as candidates for characterisation was generated taking into account the 
presence of S. cerevisiae orthologues and the presence of functional domains 
in the encoding protein sequence. C. glabrata ORFs which were indentified in 
HGT studies were also targeted for deletion to enable their further 
characterisation. 
 
Barcoded fusion constructs targeting 100 C. glabrata ORFs (Appendix 4 Table 
1 and 2) were created using a PCR-based method (see 3.2.2). Fusion cassettes 
were designed to give deletion mutants a number of features, making them 
amenable to further downstream applications. FRT (flippase recognition targets) 
sites flanking the NATR cassette allows future removal and recycling of the 
NATR marker for further genetic manipulations (Figure 3.1). Two up- and down-
barcodes unique to each ORF targeted by the fusion construct were also 
included for use in downstream pooled growth assays (Figure 3.1; Appendix 1 
Table 2). Universal sequences U1, U2, D1 and D2 flanking up- and down-
barcodes respectively allow the universal amplification of barcode tags in a 
single reaction (Figure 3.1). Fusion constructs were validated by gel 
electrophoresis (Figure 3.8; Appendix 14). 
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Figure 3.8: Verification of fusion constructs by gel electrophoresis. ORF-
specific -500-F and +500-R primers (Appendix 1 Table 2) were added to a PCR 
reaction permitting the fusion of the NATR  cassette with homologous regions of 
ORF-specific 5’ and 3’ ends. Correct fusion produced a 2.3-2.4 kb amplification 
product, although several minor bands were also produced. For verification of 
all fusion constructs, see Appendix 14.  
 
Transformation by electroporation was performed, allowing the deletion 
construct to integrate into the target locus by homologous recombination. 
Following transformation into the Cg2001 ∆his3 background, insertion of the 
fusion construct at the correct locus was verified by three individual PCR 
reactions. Firstly, absence of the target ORF was verified by PCR using primers 
homologous to a short region internal of the ORF which yielded an amplification 
product in the parental Cg2001 ∆his3 strain but not in a correct transformant 
(Figure 3.9 A; Appendix 14). Secondly, PCR reactions were performed targeting 
the 5’ and 3’ junction sites where the fusion construct integrated into the target 
locus. To validate the 5’ junction, a forward primer targeting a region upstream 
of the homologous recombination site and a reverse primer targeting an internal 
region of the NATR cassette was used (Appendix 1 Table 1 and 2). Similarly to 
validate the 3’ junction, a forward primer targeting a region of the NATR cassette 
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and a reverse primer targeting a region downstream of the site of homologous 
recombination were used (Appendix 1 Table 1 and 2). For both junction checks, 
no amplification product was observed in the parental C. glabrata 2001 ∆his3 
strain whereas amplification products were observed for correct transformants 
(Figure 3.9 B). Transformants yielding correct amplification products in all three 
PCR reactions were considered validated deletion mutants. Where 
transformation by electroporation was not successful, the lithium acetate 
transformation protocol was used. A total of 35 of the 100 fusion constructs 
were not successfully transformed using either transformation method 
(Appendix 4 Table 2). These yielded either no transformants, targeted a region 
which may lie within an ARS sequence or were not able to be verified by PCR 
analysis.  
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Figure 3.9: PCR checks for the validation of putative C. glabrata 
∆CAGL0E06644g  transformants. A) 12 transformants (labelled 1-12) were 
checked for the presence of ORF CAGL0E06644g using ORF-specific primers 
E06644 int-F and E06644 int-R (Appendix 1 Table 3), yielding a 600bp product 
in the parental strain (labelled C) and no product in correct transformants. B) 
Junction PCR checks were performed on transformants 2, 5, 8, 10, and 11 
which passed the internal PCR check. For PCR amplification of the 5’ junction, 
primers E06600-600-F  (Appendix 1 Table 3) and NAT-5’-R (Appendix 1 Table 
1) were used, yielding a amplification product of 1-1.3 kb in transformants 
where the fusion construct has integrated at the correct locus. For the 3’ 
junction, primers E06600+600-R  (Appendix 1 Table 3) and NAT-3’-F (Appendix 
1 Table 1) were used, yielding a 0.9-1.2 kb amplification product in correct 
transformants. Thus, transformants 2, 5, 8, 10, 11 were deemed verified 
isolates of C. glabrata  ∆CAGL0E06644g .  
 
 Together, 65 fusion constructs were successfully transformed and verified in C. 
glabrata, forming an individually barcoded library of C. glabrata-specific deletion 
mutants (Appendix 4 Table 1). Where possible, up to three independent isolates 
of each deletion were retained. Of the 65 ORFs deleted, Interpro predicted 
functional domains or active sites in 44 of the encoding protein sequences 
(Figure 3.10; Appendix 4 Table 1). GO Molecular function assignments 
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predicted 17 of the deleted ORFs to have nucleic acid binding transcription 
factor activity – the most significantly represented GO function within the 
deletion library. Other deleted ORFs have protein signature sequences 
matching domains including kinase, transferase or phosphatase domains 
(Figure 3.10). However, no predicted functional domains were identified for 22 
deleted ORFs. 
 
 
Figure 3.10: Functional annotations of deleted C. glabrata ORFs according 
to InterPro (ebi.ac.uk/interpro). Segments represent GO Molecular function 
terms assigned by Interpro based on domain matches for 65 C. glabrata ORFs 
successfully targeted for deletion.  
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3.4 Discussion 
3.4.1 Identification and Location of C. glabrata ORFs with no Orthologue 
in S. cerevisiae 
In order to further elucidate virulence attributes of the pathogenic yeast C. 
glabrata, ORFs with no orthologue in the relatively non-pathogenic yeast S. 
cerevisiae were targeted in this study (see 3.1). Modified RBH-based searches 
identified 727 C. glabrata ORFs which may have no orthologue in S. cerevisiae 
(Appendix 3 Table 1; Personal communication, Dr. Maxime Huvet, Imperial 
College London). The resultant list was very broad (constituting 14 % of the C. 
glabrata genome) and as such it is likely that many of these ORFs do have an 
S. cerevisiae orthologue. In contrast, searches based on the Yeast Gene Order 
Browser (http://ygob.ucd.ie/) identified 294 C. glabrata ORFs which share no 
orthologue with any S. cerevisiae ORF (Appendix 3 Table 2). 
 
However, the two search approaches were validated by the correct inclusion of 
C. glabrata ORFs that are known to have no S. cerevisiae orthologue and which 
play a role in virulence. For example, RBH and YGOB searches identified many 
of the EPA genes and other GPI-anchored proteins (members of the AWP, AED 
and PWP adhesin gene families) which have been previously implicated in 
adhesion of C. glabrata to host cells, biofilm formation and the establishment of 
infection (see 1.5.1; Cormack et al., 1999; De Las Penas et al., 2003; Kraneveld 
et al., 2011; Desai et al., 2011). The search also identified members of the MNT 
gene cluster, which is known to be expanded in C. glabrata and encodes a 
number of ɑ -1,3 mannosyltransferases which are thought to be important for C. 
glabrata virulence due to their role in cell wall biogenesis (Dujon, 2010). YGOB 
searches identified members of the YPS cluster as well as phosphate starvation 
inducible acid phosphatases (PMU genes) which are associated with adaptation 
and survival in the mammalian host nice (Kaur et al., 2007; Orkwis et al., 2010).  
Thus the search approaches were validated for the identification of C. glabrata 
ORFs with no S. cerevisiae orthologue as a means for exploring C. glabrata 
ORFs which may contribute to virulence. 
 
Despite both search approaches identifying C. glabrata-specific genes which 
are implicated in virulence, both search results yielded different numbers of 
non-orthologous C. glabrata ORFs with RBH searches identifying twice the 
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number of ORFs identified by YGOB (Figure 3.4). Indeed, many C. glabrata 
ORFs identified by RBH searches have orthologues according to YGOB. 
Further to this, the two ORF lists have a surprisingly small overlap of 197 genes 
(Figure 3.4). Large numbers of genes were selected by one search method only 
– demonstrating the variability between the two methods and highlighting the 
need for more stringent search methods when defining orthologous gene pairs 
between two related species. The stark difference in defining C. glabrata ORFs 
with no orthologue in S. cerevisiae is likely due to the different search methods, 
criteria and stringency used by the two approaches. For example, YGOB 
incorporates annotation of orthologous genes from the literature, annotation 
from automated BLASTP searches as well as manual editing for comparisons of 
orthologous genes from related species (ygob.ucd.ie; Byrne & Wolfe, 2005). In 
contrast, RBH searches relied solely on sequence comparison methods 
provided by automated BLASTP searches, likely resulting in much less stringent 
search results compared with that of the YGOB database which curates data 
from a number of resources. In addition, filters applied in RBH searches likely 
limited the identification of orthologous gene pairs in S. cerevisiae and C. 
glabrata. For example, in instances where conservation of a functional domain 
only is required to retain orthologous gene function, the filters (30 % sequence 
identity within a minimum of 50 % of the protein sequence) would have 
excluded the identification of orthologous ORF due to the conserved domain 
representing less than 50 % of the protein sequence. As a consequence, RBH 
search approaches identified many C. glabrata ORFs which have an S. 
cerevisiae orthologue to be non-orthologous. However, C. glabrata ORFs 
identified in searches which do have S. cerevisiae orthologues may be 
interesting candidates for study since orthologous genes may not encode the 
same function and may have undergone functional reassignment over 
evolutionary time.  
 
During the course of this study, Desai et al., (2011) published work in which 
they identified 337 C. glabrata ORFs with no S. cerevisiae orthologue using 
genome-wide searches based on protein sequences from the Génolevures 
database (Sherman et al., 2009) and statistical algorithmic consensus clustering 
methods to compare protein families from the two species (Desai et al., 2011). 
The number of C. glabrata ORFs identified by Desai et al., (2011) much more 
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closely resembles that of YGOB, suggesting that the true number of C. glabrata 
ORFs with no S. cerevisiae orthologues is likely to be between 297 and 337. 
Through the study of C. glabrata-specific ORFs, Desai et al., (2011) continued 
to identify and characterise two novel C. glabrata ORFs which interact and 
contribute to adhesion of C. glabrata cells to human endothelial cells. Thus, this 
further supports the focus on C. glabrata ORFs with no orthologue in S. 
cerevisiae as a valid approach in the search for novel C. glabrata virulence 
attributes. 
 
Chromosomal location mapping of C. glabrata ORFs identified to have no S. 
cerevisiae orthologue by RBH searches revealed 10 significant clusters of C. 
glabrata-specific ORFs throughout the genome (Figure 3.3). However the 
location of clusters showed no trend towards either centromeric or telomeric 
localisation. This is contrary to a number of studies where it has been observed 
that virulence-associated genes of various pathogens are often associated with 
the subtelomere (Horn & Barry, 2005; Duraisingh et al., 2006) as is also the 
case for C. glabrata adhesins (De Las Peñas et al., 2003). In addition, no 
significant enrichment of the 727 C. glabrata ORFs identified by RBH searches 
were found on any particular chromosome. However, the lack of significant 
clustering at specific locations in on the chromosome could be an artefact of the 
broad nature of RBH searches including many C. glabrata genes which do have 
orthologues. Chromosomal location studies of smaller, more stringent lists of C. 
glabrata ORFs may reveal more significant data on the location patterns of C. 
glabrata-specific ORFs throughout the C. glabrata genome. 
 
3.4.2 HGT and the Acquisition of Prokaryotic Genes by C. glabrata 
Sequence comparison searches and phylogenetic analysis identified three 
possible HGT events from prokaryotes to C. glabrata. Analysis detected the 
putative transfer of an aspartate racemase (CAGL0D01210g) from species of 
the Firmicute phylum (Figure 3.5), an acetyl transferase (CAGL0K11066g; 
Figure 3.6) and an NADPH dehydrogenase (CAGL0M014091g) putatively 
acquired from Proteobacteria or Actinobacteria species (Figure 3.7). Transfer of 
CAGL0K11066g and CAGL0M14091g from Prokaryotes may have occurred 
prior to divergence of C. glabrata from closely related Naumovozyma species 
since sequences from these species cluster together in phylogenetic trees 
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(Figures 3.6 and 3.7) whereas acquisition of CAGL0D01210g seems to have 
occurred solely in C. glabrata (Figure 3.5). Although many examples of 
horizontal gene transfer from prokaryotes to Ascomycetous fungi exist, C. 
glabrata ORFs acquired by HGT as yet remain uncharacterised (Marcet-
Houben & Gabaldón, 2010). 
 
The acquisition of prokaryotic genes by fungi has previously been associated 
with the adaptation to a new host niche. As an example, HGT of an 
endogluconase enzyme from rumen bacteria Fibrobacter succinogenes to fungi 
Orpinomyces joyonii has enabled the latter species to degrade cellulose and 
other plant polysaccharides, thus allowing O. joyonii to establish a new niche in 
the rumen of herbivorous animals where cellulose is in abundance as a 
nutritional source (Garcia-Vallvé et al., 2000). Thus, it is possible that the 
horizontal gene transfer of prokaryotic ORFs could contribute to the adaptation 
of C. glabrata to a host niche. 
 
Of particular relevance to C. glabrata adaptation could be the acquisition of an 
aspartate racemase (CAGL0D01210g) from the Firmicutes, in particular the 
Lactobacilli species. Despite phylogenetic analysis in this work lacking strong 
statistical support, a large scale study of inter-domain HGT events into fungi 
from prokaryotes by Marcet-Houben & Gabaldón, 2010, also presented 
evidence for the horizontal gene transfer of an aspartate racemase 
(CAGL0D01210g) from bacteria to C. glabrata. Aspartate racemase enzymes 
are universal in prokaryotes and archaea. They catalyse the conversion of L-
aspartate to D-aspartate which is a constituent in the peptidoglycan layer of the 
bacterial cell wall (Yoshimura & Esaki, 2003). Although it is unclear what 
physiological role an aspartate racemase would play in C. glabrata (see 4.3.2), 
the observation of an acquired racemase enzyme is consistent with similar 
transfer events of racemases from prokaroytes to fungi in the literature. Marcet-
Houben & Gabaldón, 2010, identified seven instances of HGT from bacteria to 
Fusarium, Aspergillus and Candida species involving three racemases which 
target enantiomers of aspartate, hydantoin and mandelate as substrates. Prior 
to this, the horizontal transfer of a proline racemase from Proteobacteria to 
Candida parapsilosis was also reported (Fitzpatrick et al., 2008). It has been 
proposed that aspartate racemases acquired by fungi could detoxify or 
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assimilate D-isomers of amino acids found in bacterial cell walls or host tissues 
(Marcet-Houben & Gabaldón, 2010). Indeed, characterisation of an alanine 
racemase acquired from Proteobacteria by the fission yeast S. pombe found 
that the heterologous expression of this enzyme in S. cerevisiae remediated D-
alanine toxicity and enabled S. cerevisiae to assimilate D-alanine as a sole 
nitrogen source as is the case in S. pombe (Uo et al., 2001). The frequent 
occurrence of such transfers of bacterial racemase enzymes to fungal species 
such as C. glabrata suggests it could confer a growth advantage in a 
competitive environment such as the host niche perhaps by reducing the 
cytotoxity and allowing the assimilation of D-amino acid isomers encountered in 
the microflora of the host niche. 
 
It is also unclear what physiological role a putative acetyl transferase 
(CAGL0K11066g) or NADPH dehydrogenase (CAGL0M014091g) may have in 
C. glabrata (see 4.3.2). Interestingly, expression of CAGL0M14091g was found 
to be upregulated in an azole-resistant strain of C. glabrata (Vermitsky et al., 
2006), perhaps linking the acquisition of this ORF to drug resistance. However, 
further investigation is required to verify that these ORFs were in fact acquired 
through horizontal gene transfer events. Although outgroups of the most similar 
S. cerevisiae sequences showed these ORFs to be more closely related to 
bacterial sequences with high confidence, bootstrap support within the 
branches of bacterial sequences was low in many instances.   
 
3.4.3 Generation of a C. glabrata Deletion Library as a Molecular Tool for 
the Functional Characterisation of C. glabrata ORFs 
In this work, a deletion library of 65 C. glabrata deletion mutants was generated 
and verified (Appendix 4 Table 1), contributing to an existing collection of 700 C. 
glabrata deletion mutants (Schwartzmüller et al., 2013; Appendix 13). C. 
glabrata ORFs of interest were selected for deletion according to a set of criteria 
based on bioinformatic search results. ORFs were selected based on their lack 
of an S. cerevisiae orthologue (as identified by RBH and YGOB searches) and 
functional annotation of the encoding protein (CGD or predicted functional 
domains using InterProScan). ORFs suspected to have been acquired by HGT 
were also included. Fusion constructs targeting 100 C. glabrata ORFs were 
constructed, of which 65 were successfully transformed and verified for correct 
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integration in C. glabrata (Appendix 4 Table 1). However, 35 fusion constructs 
were not successfully transformed into C. glabrata (Appendix 4 Table 2). 
Although it was not further explored it is possible that some ORFs could be 
essential in C. glabrata, although it is unlikely this is true of all 35 ORFs for 
which constructs were made. Some constructs conferred ARS mutations in C. 
glabrata hence in future work, shortening of the ORF sequence included within 
the construct could remediate ARS mutations observed. 
 
The methodology chosen to construct the C. glabrata deletion library makes it 
amenable to a number of downstream applications. Similarly to the S. 
cerevisiae mutant collections, the incorporation of unique DNA barcodes into 
each C. glabrata deletion mutant allows each mutant to be detected within a 
mixed population of strains (see 1.3.1.1). To facilitate the ease with which 
barcode tags can be retrieved from pools of mutants, the tags were designed to 
be flanked by sequences universal to all strains to allow the amplification of all 
barcode tags in one PCR reaction.  Molecular barcoding has proven a valuable 
tool in the S. cerevisiae deletion collections (see 1.3.1.1) and has particular 
implications in virulence screens where the ability to pool mutants greatly 
reduces the number of animals required. Also, flippase recognition target sites 
were incorporated into the deletion constructs to allow the removal and 
recycling of the resistance cassette in further genetic manipulations. Deletion 
mutants from this study contribute to an existing library of over 700 C. glabrata 
deletion mutants previously constructed by the Haynes lab and collaborating 
groups (Schwartzmüller et al., 2013; Appendix 13) and provides a lasting 
community tool for the functional characterisation of C. glabrata-specific ORFs 
(see Chapter 4). 
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Chapter 4: Functional 
characterisation of the C. glabrata 
deletion library 
4.1 Overview 
A C. glabrata deletion library of 65 unique gene deletions was constructed (see 
3.3.8) to serve as a molecular tool for the study of C. glabrata ORFs with no 
orthologue in S. cerevisiae. It was hypothesised that the study of C. glabrata 
ORFs with no orthologue in S. cerevisiae may elucidate C. glabrata virulence 
determinants (see 3.1). Thus, a number of assays will be used to functionally 
characterise C. glabrata deletion mutants with particular emphasis on 
processes relevant to infection. 
 
4.1.1 Deletion Libraries and Chemical-Genetic Screening  
Deletion collections have previously provided a powerful tool in the functional 
annotation of uncharacterised ORFs in the model yeast S. cerevisiae (Giaever 
et al., 2002; Fabrizio et al., 2010; see 1.3.1) and fungal pathogens such as C. 
albicans (Noble et al., 2010) and C. neoformans (Liu et al., 2008). Recently, 
targeted gene deletion and phenotypic screens have proven a successful 
strategy for characterisation studies in C. glabrata (Schwarzmüller et al., 2013; 
Appendix 13). For fungal pathogens entering the host environment, strain 
fitness is an important virulence attribute. Altered strain fitness can affect the 
ability of strains to replicate within the host and influence the physiological 
robustness of invading pathogens in the diverse host niches they inhabit. In C. 
albicans, for example, homozygous deletion mutants with decreased growth 
phenotypes such as the ∆ssn6/∆ssn6 strain (Homann et al., 2009) have been 
associated with decreased virulence in a murine model system of infection 
(Hwang et al., 2003). In S. cerevisiae, fitness profiling of the homozygous 
deletion collection identified gene products important for growth (Giaever et al., 
2002). Furthermore in a recent study, fitness scoring of a C. glabrata mutant 
collection identified 71 strains with fitness defects and thus their encoded gene 
products were required for growth (Schwartzmüller et al., 2013; Appendix 13). 
However, their effect on virulence is as yet unexplored.   
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Chemogenomic screens of deletion mutants have been used to uncover the 
functional relationships between genes and stresses induced by chemicals 
(Wuster & Babu, 2008). Characterisation of previously unstudied genes can be 
achieved through phenotypic screening by identifying conditions under which 
genes are required for growth (see 1.3.1.2). In particular, chemogenomic 
screening can be used as a tool to identify components of stress response 
pathways or identify gene products required for survival under conditions 
relevant to the human host niche. For example genes required for osmotic and 
oxidative stress adaptation, tolerance to changes in pH, iron limitation or 
antifungal drug susceptibility (Giaever et al., 2002; Homann et al., 2009). High-
throughput phenotypic screening of the S. cerevisiae deletion libraries has 
validated the power of chemogenomic screening in the functional annotation of 
uncharacterised genes. For example, S. cerevisiae deletion mutants of 
uncharacterised genes YGR182C, GSC1 and YDL023C were found to confer 
osmosensitivity despite no previous association with the osmotic stress 
response (Giaever et al., 2002). Similarly, chemical-genetic screening of the C. 
glabrata deletion library lead to the identification of osmosensitive C. glabrata 
deletions ∆atm1, ∆arb1, ∆kre1, ∆anp1, ∆mps3 and ∆ptr3 which had not been 
previously linked to the osmotic stress response in related fungal species 
(Schwartzmüller et al., 2013; Appendix 13). 
 
4.1.2 Models of Candida Biofilm Formation and Virulence 
Biofilm formation by Candida species has been recognised as an important 
virulence factor (Silva et al., 2011; see 1.5.2) and in C. glabrata, biofilm 
formation is primarily mediated by members of the Epa family, a family of C. 
glabrata adhesins with no orthologue in S. cerevisiae (Kaur et al., 2005). In 
agreement with the importance of biofilm formation for C. glabrata infection, 
derepression of major biofilm adhesins Epa6 and Epa7 resulted in 
hypercolonisation of murine kidneys (Castaño et al., 2005). Two previous 
studies assessed the biofilm-forming ability of C. glabrata mutant collections, 
identifying mutants with both increased and decreased biofilm-forming capacity 
(Iraqui et al., 2005; Schwartzmüller et al., 2013; Appendix 13). Thus far only few 
EPA adhesins and components of the subtelomeric silencing machinery have 
been implicated in the regulation of biofilm formation by C. glabrata. The role of 
C. glabrata ORFs with no orthologue in S. cerevisiae in biofilm formation 
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remains relatively unexplored. Thus this work aims to increase our 
understanding of C. glabrata ORFs implicated in biofilm formation through 
screening of a C. glabrata-specific deletion library. Indeed, high-throughput 
screening of C. albicans deletion mutants for biofilm formation was highly 
successful in facilitating our understanding of the underlying regulatory circuitry 
governing biofilm formation in this species (Nobile et al., 2012). 
 
Various murine models of C. glabrata infection have been exploited to study the 
virulence of C. glabrata mutants, facilitating the identification of factors which 
contribute to pathogenesis. For example, previous studies have implicated 
PDR1 (CAGL0A00451g), encoding a major regulator of drug resistance; SKN7 
(CAGL0F09097g), encoding a regulator of the oxidative stress response; and 
YPS genes in pathogenesis (Kaur et al., 2007; Ferrari et al., 2009; Saijo et al., 
2010). However, mammalian host models are restricted to either the study of 
groups of pooled mutants or the individual study of small numbers of strains. As 
a consequence, they are not amenable to high throughput screening of 
individual strains from large deletion collections. Thus, a need for alternative 
models of Candida infection has been recognised. A comprehensive study 
exploited a chicken embryo model for the study of C. albicans and C. glabrata 
infection via the chlorio-allantoic membrane, demonstrating the ability of C. 
glabrata to colonise deep tissues despite causing low levels of mortality 
(Jacobsen et al., 2011). The use of non-mammalian models of infection has 
also been explored since these hosts are available in large numbers, are less 
labour intensive and avoid ethical issues surrounding the use of mammalian 
hosts. Thus these host models are amenable to higher throughput virulence 
studies of yeast strain collections. Galleria mellonella larvae have become an 
established infection model for pathogenic yeasts such as Candida species 
(Cotter et al., 2000; Brennan et al., 2002). However, infection by injection of C. 
glabrata cells into the larval haemolymph resulted in zero mortality thus 
eliminating this host as a viable insect model for pathogenicity of C. glabrata 
isolates (Cotter et al., 2000). Recently, Drosophila melanogaster was introduced 
as a model for gastrointestinal infection by C. albicans. Infection by feeding or 
injection of C. albicans cells was able to activate systemic immunity via the Toll 
pathway (Figure 4.1 B) in larvae and induce antimicrobial peptide production 
(Glittenberg et al., 2011 A). In addition, the ready availability and ease of 
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working with large sample sizes of D. melanogaster larvae increases the 
suitability of this host for virulence studies of deletion mutant collections. D. 
melanogaster provides a biologically relevant model for mammalian infection 
due to the presence of two major immune signalling pathways in D. 
melanogaster, the Toll and Immune deficiency (IMD) pathways, which are 
homologous to mammalian Toll-like receptor and tumour necrosis factor 
pathways (Figure 4.1 & 4.2; Wang & Ligoxygakis, 2006; Kounatidis & 
Ligoxygakis, 2012). In agreement, survival measurements of D. melanogaster 
larvae following infection with 15 C. albicans mutants correlated well with 
pathogenicity reports for these isolates in infection models in a murine host 
(Glittenberg et al., 2011 B), validating D. melanogaster as a suitable host for 
large scale Candida virulence studies. 
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Figure 4.1 Comparison of homologous mammalian TLR4 and D. 
melanogaster Toll pathway (Wang & Ligoxygakis, 2006). A) Presentation of 
PAMPS (such as LPS) to TLR4 activates interactions between the TLR4 TIR 
domain and MyD88 and recruitment of IRAK. IRAK interaction with TRAF6 
activates the IKK complex which phosphorylates inhibitor IĸB. IĸB is targeted for 
degradation leaving NF-ĸB free to translocate to the nucleus and activate 
transcription of its targets. B) Activation of Toll-ligand Spaeztle (Spz) is 
achieved by two protease cascades stimulated by either Gram+ bacterial or 
fungal PAMPs. Active Spz binds cleaved C-106. Upon interaction with C-106, 
Toll proteins dimerize and interact with dMyD88 through dimerized TIR 
domains. dMyD88 recruits Tube which activates Pelle. Pelle signals through 
dTRAF6 to activate an unknown Cactus kinase. Cactus is phosphorylated and 
targeted for degradation and Dif transclocates to the nucleus activating the 
transcription of its targets.   
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Figure 4.2 Comparison of mammalian TNFR-1 pathway and D. 
melanogaster IMD pathway (Wang & Ligoxygakis, 2006). A) Upon stimulation 
of TNFR1, TRADD (TNFR-associated death domain) is recruited which forms a 
signalling complex with RIP (receptor interacting protein) and FADD (Fas-
associated death-domain protein). RIP activates MEKK kinase which activates 
the IKKα, IKKβ, IKKγ/NEMO complex leading to the phosphorylation of IĸB. IĸB 
is targeted for degradation, releasing NF-ĸB to translocate to the nucleus and 
activate its transcriptional targets. B) Recognition of peptidoglycan from Gram 
negative bacteria results in dimerisation of LC isoforms of peptidoglycan 
recognition proteins (PGRP). DFADD is recruited to the intracellular domain of 
PGRP by IMD and interacts with DREDD. DREDD signals through dTAK1 to 
activate the IKK complex (Ird5 & Kenny (or Key)), releasing inhibition of Relish. 
Relish translocates to the nucleus to regulate transcription of its target genes.  
 
4.1.3 Aims  
1) Assess the impact on fitness conferred by deletion of C. glabrata ORFs with 
no orthologue in S. cerevisiae. 
2) Develop a high-throughput phenotypic screening platform to functionally 
characterise deleted C. glabrata ORFs and identify conditions under which 
ORFs are required for C. glabrata growth. 
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3) Investigate the impact of deletion of C. glabrata ORFs with no orthologue in 
S. cerevisiae on biofilm formation. 
4) Utilise a D. melanogaster gastrointestinal infection model of C. glabrata 
infection to identify C. glabrata deletion mutants with altered virulence. 
 
4.2 Materials & Methods  
4.2.1 Phenotypic Screening 
4.2.1.1 High-throughput Phenotypic Screening of C. glabrata Mutants 
C. glabrata mutants were arrayed into a 96-well plate and stored as glycerol 
stocks at -80 °C. Glycerol stocks were used to inoculate 200 μl YPD NAT in a 
fresh 96-well plate and grown overnight at 30 °C. Overnight cultures were 
diluted by a factor of 10 in sterile water and distributed in quadruplicate into a 
384 well plate. For example, cells from well A1 of the 96-well overnight were 
transferred into wells A1, A2, B1 and B2 of the 384-well plate and so forth. Cells 
were pinned from the 384-well plate onto YPD agar plates containing defined 
chemical agents (Appendix 2 Table 1) using a ROTOR HDA© robot (Singer 
Instruments) and incubated at 30 °C (unless stated otherwise) for 2-5 days. 
Images of colonies were acquired in a Syngene G:BOX and analysed for 
phenotypes. For example, if a mutant showed decreased fitness when grown on 
a given chemical compared with the YPD control plate, it was noted “sick”. 
Further, if a deletion was unable to grow on a given chemical but showed no 
fitness defect on YPD, it was noted “lethal”. 
 
4.2.1.2 Serial Dilution of C. glabrata Mutants 
The optical density (OD600) of C. glabrata overnight cultures was measured in a 
Jenway 7305 spectrophotometer. Cells were then diluted in sterile water to 
OD600 0.1 (approximately 10
6 cells per ml). 100 μl of cells were transferred into 
well A1 of a 96-well plate from which 10 μl were taken and transferred to well 
A2 containing 90 μl sterile water as such forming a 10-fold dilution. This step 
was repeated across a further four wells producing six 10-fold serial dilutions of 
C. glabrata cells in water. Using a multichannel pipette, 4 μl of cells were 
transferred from the 96-well plate and spotted onto YPD agar plates containing 
defined chemicals and incubated at 30 °C (unless otherwise specified) for 48 
hours. Images of serial dilutions were acquired in a Syngene G:BOX and 
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analysed for phenotypes by comparison of growth to a YPD control and the 
parental strain. 
 
4.2.2 Growth Analysis of C. glabrata and S. cerevisiae Strains 
The optical density (OD600) of C. glabrata overnight cultures was measured in a 
Jenway 7305 spectrophotometer. Accordingly, cells were diluted into fresh YPD 
broth to OD600 0.1 (approximately 10
6 cells per ml). 100 μl cells were distributed 
into a flat bottomed 96-well plate, covered with a sterile transparent film and 
placed into the VersaMax™ Absorbance Microplate Reader pre-warmed to 30 
°C. Optical density (OD600) readings were taken at 10 minute intervals over a 48 
hour period, with shaking between reads. 
 
Three measures of fitness were taken from C. glabrata and S. cerevisiae growth 
profiles. Lag time was measured as the time taken for cultures to reach an 
OD600 of 0.2 following inoculation. Doubling times Td were calculated according 
to the following formula, whereby q1 and q2 represent OD600 measurements at 
time points t1 and t2, respectively, for cells in exponential phase (approximately 
OD600 0.4 to 0.8): 
 
 
Final density was taken as the OD600 of cultures at 24 hours. Statistical analysis 
of C. glabrata growth profiles was performed using ANOVA, followed by 
Dunnett’s test using the following formula whereby Mi denotes the mean of the 
experimental group, Mc represents the mean of the control group, MSE 
represents mean square error and nh denotes the harmonic mean: 
 
 
 
4.2.3 Quantification of C. glabrata Biofilm Formation  
The ability of C. glabrata mutants to form biofilms was quantified using an 
enzymatic method adapted from Iraqui et al. (2005) in which the metabolic 
activity of cells adhered to a polystyrene plate was quantified by XTT reduction. 
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C. glabrata cells were grown overnight to stationary phase in SC at 37 °C, 180 
rpm. Cells were washed in sterile water and resuspended in SC to OD600 of 1. 
100 μl of the cell suspension was distributed into individual wells of a flat 
bottomed 96-well polystyrene plate and incubated at 37 °C for 24 hours. To 
remove loose cells, the biofilms were washed three times with sterile water and 
once with PBS. 100 μl XTT-menadione solution (0.5 mg/ml XTT in PBS, 1 μM 
menadione) was added to each well. After incubation for 1 hour at 37 °C in the 
dark, XTT reduction was measured in a VersaMax™ Absorbance Microplate 
Reader at 472 nm. 
 
4.2.4 Drosophila melanogaster Gastrointestinal Infection Model 
A single C. glabrata colony was picked to inoculate 10 ml YPD broth and grown 
overnight at 30 °C, 180 rpm. Cells were harvested by centrifugation at 3,000 
rpm for 5 minutes. 200 µl of C. glabrata pellet was transferred into a 
microcentrifuge tube to which 400 µl mashed banana and 50 5-day-old 
Drosophila larvae were added and mixed. Microcentrifuge tubes were sealed 
with foam bungs and left for the Drosophila to feed for 30 minutes at room 
temperature. Larvae were then transferred to fresh fly bottles and incubated at 
30 °C for 48 hours. Larvae survival counts compared to uninfected larvae were 
used as a read-out for C. glabrata virulence. To assess Drosophila Toll pathway 
activation, GFP expression in Dros-GFP larvae were viewed using a Nikon 
ECPLIPSE TE2000-U inverted microscope. Virulence assays were performed 
jointly by Dr. Ilias Kounatidis, University of Oxford, and Lauren Ames, University 
at Exeter. 
 
4.3 Results 
4.3.1 Growth Profiling of C. glabrata Deletion Mutants 
Following the generation of a C. glabrata deletion library (see 3.3.8), fitness 
profiling was performed on all C. glabrata strains to assess the contribution of 
C. glabrata ORFs with no orthologue in S. cerevisiae for fitness. Fitness profiles 
were generated for 64 of 65 C. glabrata deletion mutants in YPD broth at 30 °C 
(Appendix 8 Figures 1-64). Fitness profiles for CAGL0A03608g were 
inconsistent and thus were excluded from the liquid growth study. Where 
available, two independent isolates of each mutant were tested, yielding a total 
of 118 fitness profiles for C. glabrata mutants. Strain fitness was quantified 
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using three independent measures taking into account different aspects of the 
profiles: lag phase, doubling time and maximum density (see 4.2.2). 
Comparison of measures from fitness profiles identified instances where 
deletion of a given C. glabrata ORF gave rise to either reduced or increased 
fitness with that of parental strain Cg2001 Δhis3 (Appendix 7 Table 1).  
 
Firstly, the lag phase of C. glabrata mutants was measured (see 4.2.2). Deletion 
of 21 C. glabrata ORFs yielded a lag phase significantly increased or reduced 
compared with that of the parental strain Cg2001 Δhis3 (ANOVA, p=2.9e-222). 
Within this cohort, 14 deletion strains yielded an extended lag phase whilst 
seven deletion strains showed a reduction in lag (Appendix 7 Table 1). For 
example, the lag time of C. glabrata ΔCAGL0D03850g isolates were increased 
up to 75 minutes (Appendix 7 Table 1; Appendix 8 Figure 16), normalised to 
parental strain controls. In contrast, the lag phase of ΔCAGL0G10175g isolates 
was reduced by 107.5 minutes (Appendix 7 Table 1; Appendix 8 Figure 37). 
Secondly, the doubling time of deletion mutants was measured from cultures in 
the exponential growth phase (approximately OD600 0.4 to 0.8). A significant 
increase in doubling time was observed for 11 C. glabrata deletion mutants 
(Table 4.1) normalised to the parental strain (ANOVA, p=6.8e-240). However, 
no deletion strains yielded a reduced doubling time (Appendix 7 Table 1). 
Lastly, the maximum cell density of saturated C. glabrata cultures was 
measured 24 hours post inoculation. C. glabrata ΔCAGL0D04565g was the sole 
strain to show a significantly reduced final density (ANOVA, p=2.99e-25), 
becoming saturated at an optical density (OD600) 0.34 lower than that of 
parental strain Cg2001 Δhis3 (Table 4.1). 
 
Within the subset of C. glabrata deletion mutants showing significantly altered 
fitness in rich media, the majority scored distinct growth defects in one fitness 
measure only. For example, C. glabrata ΔCAGL0K10318g had a pronounced 
increase in lag phase yet showed no significant variation in doubling time or 
maximum culture density (Appendix 7 Table 1; Appendix 8 Figure 51). 
Significant deviation in fitness by at least two growth measurements were 
observed in 12 C. glabrata isolates corresponding to seven individual gene 
deletions (Table 4.1). Interestingly, this subset includes two computationally 
identified adhesins, encoded by CAGL0E00275g and CAGL0G10175g, 
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designated EPA20 and AWP6 (de Groot et al., 2008). Of all isolates tested, C. 
glabrata ΔCAGL0A04565g showed the most notable reduction in fitness (Figure 
4.3), scoring significant growth defects in all fitness measures. The lag phase 
for ΔCAGL0A04565g was extended by 110 minutes and the doubling time was 
increased approximately 2-fold that of the parental strain (Table 4.1). 
Furthermore, ΔCAGL0A04565g yielded a significantly lower final cell density 
compared with the parental strains.  
 
Figure 4.3 Growth profiles of C. glabrata ΔCAGL0A04565g and parental 
strain Cg2001 Δhis3. Cultures of C. glabrata ΔCAGL0A04565g and Cg2001 
Δhis3 at OD600 0.1 in YPD were transferred to a 96-well microtitre plate and 
growth was measured every 10 minutes over a 24 hour period at 30 °C with 
continuous shaking between reads. Blue and red lines represent the average 
optical density of replicate Cg2001 Δhis3 and ΔCAGL0A04565g cultures, 
respectively. Error bars denote the standard deviation across replicates.  
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Table 4.1: C. glabrata mutants with altered fitness. Table summarises seven 
C. glabrata mutants for which fitness significantly deviated from the parental 
strain in a minimum of two fitness measures (ANOVA p < 2.99e-25, Dunnet’s 
critical value 3.37). S. cerevisiae orthologues and predicted functional domains 
for C. glabrata ORFs are stated (ygob.ucd.ie; ebi.ac.uk/interpro/). All values 
indicate a significant change in each measurement compared to parental strain 
Cg2001 Δhis3. Lag time (minutes) the time taken for deletion strains to reach 
exponential growth at a threshold OD600 0.2. Doubling time (minutes) was 
measured as the maximum growth rate during exponential phase. Maximum 
density (OD600) indicates the final yield of cultures in saturation, 24 hours post 
inoculation. Fitness measures which did not significantly deviate from the 
parental strain are marked with an asterisk (*). 
C. glabrata isolate S. cerevisiae 
orthologue 
Functional 
domain 
Change in 
lag time 
(minutes) 
Change in 
doubling 
time 
(minutes) 
Change in 
maximum 
density 
(OD600) 
ΔCAGL0A04565g A SWI4 APSES-type 
DNA-binding 
domain 
+110.00 +109.03 -0.3452 
ΔCAGL0E00275g A - PA14; GLEYA 
adhesin 
domain 
+63.33 +11.80 * 
ΔCAGL0F05159g A VPS72 YL1 Nuclear +28.00 +21.94 * 
ΔCAGL0F05159g B +21.67 +18.87 * 
ΔCAGL0F08767g A - - -20.00 +23.50 * 
ΔCAGL0F08767g B -22.50 +15.34 * 
ΔCAGL0G04279g A - Alpha 
mannosyl-
transferase 
-20.00 +14.71 * 
ΔCAGL0G04279g B -16.67 +17.28 * 
ΔCAGL0G05522g A - - 40.00 +121.52 * 
ΔCAGL0G05522g B 44.00 +109.38 * 
ΔCAGL0G10175g A - - -48.00 +20.90 * 
ΔCAGL0G10175g B -107.50 +22.24 * 
 
  
 125 | P a g e  
 
4.3.2 High-throughput Phenotypic Screening of C. glabrata Deletion 
Mutants 
An automated, high-throughput phenotypic screening platform was optimised 
for the functional characterisation of C. glabrata strains. C. glabrata mutants 
were tested for growth on 61 conditions targeting a range of cellular structures 
and processes, singly or in combination (Table 4.2). Colony growth of strains in 
response to screening conditions was used as a phenotypic read-out for fitness. 
In addition to the library of 65 C. glabrata deletion mutants generated in this 
study (see 3.3.8), 67 C. glabrata deletion mutants and parental strain Cg2001 
ΔHTL from a previous study (Schwartzmüller et al., 2013; Appendix 13) were 
also screened due to their lack of an obvious S. cerevisiae orthologue in 
reciprocal best hit (RBH) searches (Appendix 9 Table 1; see 3.3.1). Previous 
phenotypic screening of these mutants included 5 screening conditions only. 
Together, a total of 132 individual C. glabrata gene deletion mutants were 
phenotypically screened on 61 conditions in a minimum of three biological 
replicates. Where available, two independent isolates of each deletion mutant 
were phenotypically screened to ensure phenotypes were not due to second 
site mutations. Initial screens identified a growth defect for C. glabrata 
ΔCAGL0A04565g on rich broth (Figure 4.3). Furthermore, ΔCAGL0A04565g 
growth was inhibited on all phenotypic screening conditions. 
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Table 4.2: Phenotypic screening conditions and the associated functional implications of 
phenotypes (Hampsey, 1997; Ram & Klis, 2006; Kaloriti et al., 2012). The total number of C. 
glabrata deletion mutants with phenotypes corresponding to each functional category are 
stated. All screens were performed on YPD agar in biological triplicate and incubated at 30 °C 
unless otherwise stated.  
Functional implication Screening condition No. of mutants 
displaying 
phenotype 
Reduced fitness on rich 
media 
YPD, SC 2 
General protein defect 
 
Reduced temperature (4 °C and 16 °C), Increased 
temperature (42 °C), Heat shock (55 °C), Ethanol 
5 
pH sensitivity, defective 
vacuole function 
pH 3 1 
Respiratory deficiency; 
inability to produce 
respiratory-competent 
mitochondria 
Glycerol 0 
Sensitivity to divalent cations 
and heavy metals; altered 
expression of membrane 
ATPases. 
LiCl, ZnCl2, CdCl2, CoCl2, BaCl2, FeCl2, CsCl, KCl, 
NaCl, MnCl2, CaCl2, CuSO4, MgCl2, CuCl2, Arsenic 
(III) oxide, Sodium metaarsenite 
15 
Defect in components of 
MAP kinase signalling 
pathways 
Caffeine 4 
Osmotic sensitivity Sorbitol, NaCl 0 
Deficiency in the utilisation of 
non-glucose carbon sources. 
Carbon source: Lactose, Starch, Galactose, 
Raffinose, Xylose, Sodium acetate, Ethanol, 
Sorbitol, Glycerol, Sucrose, Maltose, Trehalose 
1 
Defective DNA damage 
repair 
UV light, MMS 4 
Defective DNA replication Hydroxyurea 1 
Sensitivity to oxidative stress tBOOH, H2O2, Menadione 0 
Sensitivity to combinatorial 
stress 
H2O2 + NaCl, H2O2 + 42 °C 3 
Defective microtubule 
formation 
Benomyl 0 
Defective sterol biosynthesis Nystatin 1 
Defective protein 
glycosylation; secretory 
defects 
Sodium orthovanadate 1 
Defective in cell wall 
biosynthesis 
Calcofluor white, Congo red, SDS 9 
Defects in protein synthesis 
and cell cycle 
Cycloheximide 1 
Deficient iron uptake BPS 0 
Susceptibility to antifungal 
drugs 
 
Caspofungin, Fluconazole 3 
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Screens identified 22 C. glabrata deletion mutants (Table 4.2; Table 4.3) with 
growth altered from that of the parental strain on at least one screening 
condition. Phenotypes of C. glabrata mutants occurred on 29 of 61 screening 
conditions. In total, 110 C. glabrata deletion mutants displayed no observable 
growth phenotype on any tested condition. In particular, no phenotypes were 
observed for bioinformatically identified horizontal gene transfer ORFs 
CAGL0D01210g, CAGL0K11066g and CAGL0M14091g (see 3.3.4). For 
analysis, screening conditions were grouped according to the functional 
implications of associated phenotypes (Table 4.2). The largest number of 
phenotypes was found in the group encompassing metal and metalloid 
compounds on which 15 C. glabrata mutants showed phenotypes (Table 4.2; 
Table 4.3). Second to this, nine C. glabrata mutants (Table 4.2; Table 4.3) 
showed phenotypes on cell-wall perturbing agents calcofluor white, congo red 
or SDS, suggestive of a role for deleted C. glabrata ORFs in cell wall 
biogenesis. Four C. glabrata mutants were also found to be defective in DNA 
damage repair due to their sensitivity to DNA damage agent MMS (Table 4.2; 
Table 4.3). Antifungal susceptibility testing was performed by observing the 
growth of C. glabrata mutants on YPD supplemented with caspofungin or 
fluconazole. Importantly, deletion of C. glabrata CAGL0D03850g, 
CAGL0L07480g and CAGL0K05841g rendered C. glabrata sensitive to 
fluconazole, a member of the azole class of antifungal drugs (Figure 4.4). 
CAGL0D03850g, CAGL0L07480g and CAGL0K05841g encode putative zinc 
finger transcription factors with similarity to S. cerevisiae RSC30, NRG2 and 
HAP1 respectively.  
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Table 4.3: Chemogenomic screening of the C. glabrata deletion library. C. glabrata deletion mutants were pinned on YPD agar supplemented with stated 
chemicals and incubated at 30 ºC (unless otherwise stated). After 48 hours, colony phenotypes were inspected visually for growth. For each ORF, phenotypes 
corresponding to growth under the stated screening condition is listed, relative to the parental strain. Table includes C. glabrata ORFs for which deletion conferred 
altered growth under a minimum of one screening condition. Deletion mutants displaying no observable phenotypes are excluded from the table. Conditions under 
which no C. glabrata mutants showed growth phenotypes were also excluded.
S Sick
SS Severely sick
NG No growth
FG Fast growth
N Normal fitness
* decreased colony size
Condition 
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Figure 4.4 Fluconazole-sensitive C. glabrata mutants. C. glabrata deletion 
mutants and parental strains Cg2001 Δhis3 and Cg2001 ΔHTL were pinned in 
quadruplicate onto YPD agar supplemented with 32 μg/ml fluconazole and 
incubated at 30 °C for 48 hours. C. glabrata strains with reduced fitness on 
fluconazole (ΔCAGL0D03850g, ΔCAGL0L07480g and ΔCAGL0K05841g) were 
visually identified.  
 
Deletion of C. glabrata CAGL0D03850g conferred the most observed 
phenotypes in screens. Of the 61 conditions tested, ΔCAGL0D03850g isolates 
yielded altered growth phenotypes on 17 stress conditions (Figure 4.5) covering 
a broad range of functional categories. C. glabrata ΔCAGL0D03850g yielded 
sensitive or no growth phenotypes on compounds targeting cellular MAP kinase 
signalling (caffeine), compounds inducing cell membrane stress (SDS), DNA 
damage (MMS) and metal ion toxicity (MnCl2, CaCl2, LiCl and CdCl2). The 
mutant also exhibited phenotypes suggestive of a general protein defect 
(increased and decreased temperature, ethanol), sensitivity to combinatorial 
stress and susceptibility to antifungal drugs (Figure 4.5).  
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Figure 4.5 Phenotypic screening of C. glabrata ΔCAGL0D03850g isolates 
and parental strain Cg2001 Δhis3. C. glabrata parental strain Cg2001 ∆his3 
and ∆CAGL0D03850g isolates A and B were pinned in quadruplicate using a 
Singer HDA ROTOR© robot onto YPD agar plates supplemented with stated 
chemical agents. Plates were incubated for 48 hours at 30 °C unless otherwise 
stated and inspected manually for phenotypes.  
 
Bioinformatic searches predicted C. glabrata CAGL0D03850g to encode a 
putative Zn(2)-C6 fungal-type DNA-binding domain with sequence-specific DNA 
binding RNA polymerase II transcription factor activity (GO:0000981) (Appendix 
4 Table 1). Despite being identified as a C. glabrata ORF with no S. cerevisiae 
orthologue by RBH searches (Appendix 3 Table 1), YGOB assigned 
CAGL0D03850g as an orthologue of S. cerevisiae RSC30 (ygob.ucd.ie), a zinc 
cluster protein component of the RSC chromatin remodelling complex (Angus-
Hill et al., 2001). Therefore, complementation studies were used to identify 
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whether S. cerevisiae RSC30 is a functional orthologue of C. glabrata 
CAGL0D03850g. The complemented strain was tested for restoration of normal 
growth under two conditions (16 °C and 20 mM caffeine) for which C. glabrata 
ΔCAGL0D03850g conferred sensitive phenotypes. As expected, C. glabrata 
ΔCAGL0D03850g and a ΔCAGL0D03850g strain transformed with empty 
vector conferred sensitivity to growth on caffeine and to growth at 16 °C 
compared with parental strain Cg2001 Δhis3 (Figure 4.6). Complementation 
was achieved by expression of S. cerevisiae RSC30, restoring growth of C. 
glabrata ΔCAGL0D03850g to that of the parental strain at 16 °C. 
Complementation of growth was also observed on YPD supplemented with 
caffeine (Figure 4.6). Thus in these instances, S. cerevisiae RSC30 was able to 
functionally complement C. glabrata CAGL0D03850g and hence may be a 
functional orthologue. 
 
 
Figure 4.6: Complementation of C. glabrata ∆CAGL0D03850g with putative 
orthologue S. cerevisiae RSC30. Serial dilutions of C. glabrata parental strain 
Cg2001 ∆his3, deletion mutant ∆CAGL0D03850g, deletion mutant carrying 
empty vector ∆CAGL0D03850g p423GPD and deletion mutant expressing S. 
cerevisiae RSC30 ∆CAGL0D03850g p423GPD-ScRSC30 (See Table 2.1). Ten 
fold serial dilutions commencing at OD600 0.1 were spotted onto YPD agar 
plates and incubated at 30 °C for 48 hours unless otherwise specified.  
 
C. glabrata deletion mutants ΔCAGL0D05434g and ΔCAGL0D02750g also 
conferred multiple phenotypes in screens. Deletion of CAGL0D05434g, a 
predicted chromatin remodeler, yielded a general slow growth phenotype as 
well as sensitivities to seven conditions tested (see 5.3.1). Deletion of 
CAGL0D02750g rendered C. glabrata sensitive to 10 tested conditions. 
Phenotypes included sensitivity to metal ions, increased temperature, caffeine 
and SDS (Figure 4.7). CAGL0D02750g was identified to have no S. cerevisiae 
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orthologue by RBH searches (Appendix 3 Table 1) and bears no orthologue in 
any species included on the YGOB database (Figure 4.8; ygob.ucd.ie/). 
Bioinformatic searches of the protein encoded by CAGL0D02750g indicated the 
presence of a myosin and kinesin motor domain (cI00206; NCBI Conserved 
Domains). 
 
 
Figure 4.7: Phenotypic screening of ΔCAGL0D02750g. C. glabrata parental 
strain Cg2001 ∆HTL and ΔCAGL0D02750g isolates A and B were spotted in 
quadruplicate onto YPD supplemented with chemical agents described and 
incubated at 30 °C for 48 hours.  
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Figure 4.8 YGOB alignment of C. glabrata CAGL0D02750g (ygob.ucd.ie). 
The CAGL0D02750g pillar aligns with no ORFs from any species in the YGOB 
database.  
 
4.3.3 Screening C. glabrata Mutants for Biofilm Formation 
C. glabrata mutants were tested for their ability to form biofilms, a growth form 
of significant clinical relevance (see 1.5.2). Biofilm structures formed in vitro by 
C. glabrata mutants on a polystyrene surface were quantified using an XTT 
reduction assay which proportionately indicates the metabolic activity of the 
biofilm thus providing an estimate for biofilm size (Iraqui et al., 2005). 
Accordingly, the C. glabrata deletion library of 65 mutants (see 3.4.3) was 
screened for altered biofilm formation compared to that of the parental strain 
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Cg2001 ∆his3. C. glabrata ∆CAGL0A04565g was excluded from the biofilm 
screen due to its growth defect in rich broth medium (Figure 4.3). Screening 
identified eight C. glabrata mutants which showed increased XTT reduction and 
thus increased biofilm formation (Anova p< 1.45E-05; Figure 4.9). Increased 
biofilm forming mutants included deletion of CAGL0M01870g, encoding a 
putative zinc finger transcription factor, as well as deletion of C. glabrata 
CAGL0G03201g and CAGL0K05687g, both of which contain putative 
oxidoreductase domains in the encoding protein (Figure 4.9; Appendix 4 Table 
1). Deletion of CAGL0M10153g, a paralogue of S. cerevisiae MAP kinase 
signalling component STE20, conferred the greatest increase in biofilm 
formation amongst C. glabrata deletion mutants, yielding a 30.2 % average 
increase in XTT reduction (Appendix 11 Table 1). Less pronounced increases in 
biofilm formation were also observed for deletion mutants of CAGL0A02343g, 
CAGL0A02299g and CAGL0C04763g for which bioinformatic searches were 
unable to detect any known functional domains. Screens also identified six C. 
glabrata mutants with reduced biofilm forming capacity, indicated by decreased 
XTT reduction (Figure 4.9 B). Biofilm formation was most significantly 
decreased by 54.2 % for C. glabrata ∆CAGL0E00275g (Figure 4.9 B), encoding 
a putative PA14 domain adhesin belonging to the EPA family. Decreased 
biofilm formation was observed for C. glabrata deletion mutants of 
CAGL0D03850g, CAGL0F05159g and CAGL0L07480g – orthologues of S. 
cerevisiae RSC30, VPS72 and NRG2, respectively (ygob.ucd.ie). Screening 
revealed reduced biofilm formation in deletion mutants of C. glabrata ORFs 
CAGL0M02299g and CAGL0G04279g which have no orthologue in S. 
cerevisiae. CAGL0M02299g encodes a putative serine/threonine kinase and 
CAGL0G04279g encodes a putative alpha mannosyltransferase (Appendix 4 
Table 1). Biofilm formation for the remaining 51 C. glabrata deletion strains did 
not significantly deviate from that of the parental strain.  
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Figure 4.9: Biofilm formation by C. glabrata mutants. Cultures of C. glabrata 
were distributed in a polystyrene 96-well microtitre plate and incubated at 37 °C 
in SC broth for 24 hours to allow biofilm formation. Biofilm formation was 
subsequently quantified by measuring XTT reduction in a spectrophotometer. 
All OD492 measurements (n=18) were normalised to parental strain Cg2001 
∆his3 (Anova p<1.97E-05, Dunnett’s critical value 3.37). A) Percentage biolfilm 
formation of C. glabrata mutants with significantly increased biofilm-forming 
capacity relative to parental strain Cg2001 Δhis3. B) Percentage biolfilm 
formation of C. glabrata mutants with significantly decreased biofilm-forming 
capacity relative to parental strain Cg2001 Δhis3.   
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4.3.4 Virulence Screening of C. glabrata Mutants 
A Drosophila melanogaster model of Candida gastrointestinal (GI) infection was 
used to characterise the role C. glabrata ORFs with no S. cerevisiae 
orthologues which may play a role in virulence. Firstly, survival of 
immunocompromised Dif/Key D. melanogaster larvae, in which major signalling 
components of the IMD and Toll pathway are deactivated (Figure 4.1 and 4.2), 
was examined following C. glabrata infection (Figure 4.10 A). Secondly, Toll 
pathway activation in response to C. glabrata infection was examined in Drs-
GFP larvae in which Drosomycin, a major antimicrobial peptide produced upon 
Toll pathway activation following pathogen recognition, was GFP-tagged thus 
serving as an indicator of innate immune activation (Figure 4.10 B).  
 
Figure 4.10: A D. melanogaster model of C. glabrata GI infection. A) 
Infection of D. melanogaster Dif/Key larvae with C. glabrata parental strain 
Cg2001 ∆his3 resulted in 90-100 % death of larvae 48 hours post infection 
compared with non-infected controls in which 90 – 100 % Dif/Key larvae 
survived. B) Infection of D. melanogaster Drs-GFP larvae with C. glabrata 
parental strain Cg2001 ∆his3 caused activation of the Toll pathway and 
subsequent expression of Drs-GFP 48 hours post infection. No Drs-GFP 
expression was observed in non-infected controls.   
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Challenge of immunocompromised Dif/Key larvae with C. glabrata parental 
strain Cg2001 ∆his3 in positive controls resulted in 0-10 % Dif/Key larvae 
survival 48 hours post infection (Figure 4.11 A). Conversely, uninfected Dif/Key 
larvae controls yielded 90-100 % larvae survival (Figure 4.11 A). Infection of 
immunocompromised larvae with 59 of 65 C. glabrata mutants resulted in low 
levels of larvae survival, showing similar levels of virulence to parental strain 
Cg2001 ∆his3 (Appendix 10 Table 2). However, six C. glabrata mutants were 
attenuated for virulence in Dif/Key larvae which resulted in increased larvae 
survival (Figure 4.11 A). Despite being initially identified to have no S. 
cerevisiae orthologue in RBH searches (see 3.3.1), YGOB (ygob.ucd.ie) 
indicated the presence of S. cerevisiae orthologues for four of the six C. 
glabrata ORFs which upon deletion rendered C. glabrata attenuated for 
virulence in the immunocompromised D. melanogaster infection model. These 
included C. glabrata CAGL0D03850g, a putative orthologue of S. cerevisiae 
RSC chromatin remodelling complex component RSC30; CAGL0B00726g, an 
orthologue of glucokinase GLK1; CAGL0L03674g, an orthologue of putative 
zinc-finger transcription factor GSM1; and CAGL0L07480g, an orthologue of 
transcriptional repressor NRG2 (ygob.ucd.ie). Also attenuated for virulence in 
the immunocompromised infection model were two C. glabrata ORFs, 
CAGL0K05687g and CAGL0H01749g, which were found to have no orthologue 
in both RBH and YGOB searches (Appendix 3 Table 1 and 2). Bioinformatic 
searches identified an oxidoreductase domain in the CAGL0K05687g encoding 
protein (Appendix 4 Table 1). However, searches were unable to 
bioinformatically identify any recognisable functional domains within the 
CAGL0H01749g protein coding sequence. 
 
All C. glabrata deletion mutants, including those which were attenuated for 
virulence in immunocompromised larvae, induced GFP expression following 
infection of D. melanogaster Dros-GFP larvae (Figure 4.11 B; Appendix 10 
Table 1). Thus all C. glabrata mutants tested were able to activate innate 
immune signalling via the Toll pathway and subsequent production of 
antimicrobial peptide Drosomycin. 
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Figure 4.11 C. glabrata mutants attenuated for virulence in a D. 
melanogaster model of C. glabrata infection. A) Average percentage of 
surviving Dif/Key larvae 48 hours post infection with C. glabrata mutants, 
parental strain Cg2001 ∆his and uninfected controls. B) Average number of 
Dros-GFP larvae expressing GFP 48 hours following challenge by C. glabrata 
mutants, parental strain Cg2001 ∆his3 and parental controls. 
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Screening the C. glabrata Deletion Library: Summary 
Taken together, four different screening approaches identified 23 C. glabrata 
ORFs with no orthologue in S. cerevisiae (using both RBH and YGOB criteria) 
which showed phenotypes in at least one screen (Table 4.4). The majority of 
deletion mutants showed observable phenotypes in one screening method only. 
No C. glabrata mutants showed phenotypes in all screens, however two 
mutants (∆CAGL0F05159g and ∆CAGL0E00275g) showed phenotypes in three 
out of four screens (Table 4.4). 
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Table 4.4: Summary of all phenotypes conferred by deletion of C. glabrata ORFs with no orthologue in S. cerevisiae. Table 
includes deletions of C. glabrata ORFs which were defined to have no S. cerevisiae orthologue by both RBH and YGOB searches 
(Appendix 3 Table 1 and 2) and predicted function domains (interpro.ebi.ac.uk). “+” represents increased fitness for the given strain in 
fitness profiling or chemogenomic screens or increased biofilm formation. “–“ denotes decreased fitness in fitness and chemogenomic 
screens, reduced biofilm formation or reduced virulence in the D. melanogaster immunocompromised infection model. “None” indicates 
no significant increase or decrease in fitness was conferred by deletion of the C. glabrata ORF under the given screen. 
 
C. glabrata strain Predicted functional domain Fitness profling Chemogenomic 
screens 
Biofilm formation Virulence in D. 
melanogaster 
∆CAGL0A01892g None None - None None 
∆CAGL0A02299g None None None + None 
∆CAGL0A02343g None None None + None 
∆CAGL0A04565g APSES-type DNA-binding 
domain; Ankyrin repeat-
containing domain 
- None None None 
∆CAGL0C03311g None None - None None 
∆CAGL0C04763g None None None + None 
∆CAGL0D02750g None None - None None 
∆CAGL0D05434g Repressor Rox1, High mobility 
group box domain 
None - None None 
∆CAGL0D05654g None None - None None 
∆CAGL0E00275g PA14; GLEYA adhesin domain - - - None 
∆CAGL0F05159g YL1 Nuclear - - - None 
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∆CAGL0F08767g None - None None None 
∆CAGL0G03201g FMN-binding split barrel; Flavin-
reductase-like, FMN-binding 
None + + None 
∆CAGL0G04279g Alpha mannosyltransferase - None - None 
∆CAGL0G05522g None - None None None 
∆CAGL0G10175g None - None None None 
∆CAGL0H01749g None None None None - 
∆CAGL0K03245g None None - None None 
∆CAGL0K05687g Aldolase-type TIM barrel; 
NADH:flavin 
oxidoreductase/NADH oxidase, 
N-terminal 
None None + - 
∆CAGL0K05851g None None - None None 
∆CAGL0M01870g Zinc finger, C2H2 None None + None 
∆CAGL0M01914g Tetratricopeptide-like helical None - None None 
∆CAGL0M02321g None None - None None 
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4.4 Discussion  
The C. glabrata deletion library provided a molecular tool for the study of C. 
glabrata ORFs with no orthologue in S. cerevisiae. In this work, the 
development of high-throughput phenotypic screening platforms, biofilm 
screening and the establishment of D. melanogaster as a host for infection 
studies facilitated the functional characterisation of C. glabrata deletion mutants. 
Most notably, this study has contributed function information regarding 
previously unstudied C. glabrata genes, facilitating our understanding of C. 
glabrata genes required for growth and for virulence in this medically important 
pathogen. 
 
4.4.1 Fitness Analysis of the C. glabrata Deletion Library 
Upon encountering the varied environment of the host niche, fitness can be a 
vital prerequisite for survival and the establishment of infection. Fitness profiling 
revealed seven C. glabrata ORFs which when genetically perturbed conferred a 
significant variation in C. glabrata fitness in rich media. More specifically, 
deletion of these ORFs resulted in altered lag phase and increased doubling 
time. Alterations in lag phase could be indicative of the ability of cells to adapt to 
the environment whilst altered doubling times reflects the capacity of cells to 
proliferate. Fitness profiling highlighted a significant impairment of C. glabrata 
growth upon deletion of CAGL0A04565g. Despite bioinformatically being 
classified as a C. glabrata-specific ORF (Appendix 3 Table 1), CGD and YGOB 
databases identified CAGL0A04565g to encode an orthologue of S. cerevisiae 
SWI4, the DNA-binding component of the SBF complex which regulates the 
transcription of G1-specific genes (ygob.ucd.ie; candidagenome.org). It is likely 
that orthology between the two encoding proteins was not recognised in RBH 
searches due to the conserved APSES-type DNA-binding domain 
encompassing approximately 10 % of the total protein sequence. Hence 
orthology was not detected by RBH searches due to filters requiring sequence 
conservation throughout a minimum of 50 % of orthologous protein sequences. 
In S. cerevisiae, SWI4 and the SBF complex is known to regulate the 
expression of genes involved in cell budding, cell wall morphogenesis and 
membrane biosynthesis during the G1/S transition of the cell cycle (Iyer et al., 
2001; Levin, 2005). S. cerevisiae ∆swi4 mutants were viable yet no reduction of 
fitness has been observed (Gaiever et al., 2002; Córcoles-Sáez et al., 2012) as 
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opposed to the distinct fitness defect incurred upon deletion of putative C. 
glabrata orthologue CAGL0A04565g (Figure 4.3). However, S. cerevisiae ∆swi4 
cells showed delayed cell cycle progression and showed increased 
susceptibility to cell wall perturbing agents (Levin, 2005; White et al., 2009). 
Thus further experimentation could explore the hypothesis that inhibition of 
growth in C. glabrata ∆CAGL0A04565g is due to cell cycle delay or defective 
cell wall biogenesis. 
 
A limitation of the fitness profiling approach lies in the analysis of growth in rich 
media under laboratory conditions. Although this methodology identified C. 
glabrata ORFs that were required for normal growth under defined laboratory 
conditions in rich media, it is unclear whether fitness data could be extrapolated 
to the human host niche in which invading microorganisms encounter multiple 
stresses simultaneously and in competition with the existing host microflora. 
Thus for fitness screening more relevant to the host niche, more extensive 
fitness profiling could explore growth of C. glabrata mutants in minimal media at 
elevated temperatures. Furthermore, to reflect competition for nutrients in the 
host niche, barcode tags in the C. glabrata deletion mutant collection could be 
exploited in pooled growth experiments whereby mixed cultures of C. glabrata 
mutants are analysed for competitive fitness. Such approaches have been 
extensively used for S. cerevisiae deletion collections and other organisms with 
available barcoded deletion libraries (Mazurkiewicz et al., 2006; see 1.3.1.1). 
 
4.4.2 Phenotypic Screening of the C. glabrata Deletion Library 
Development of an automated, high-throughput screening platform facilitated 
the functional characterisation of C. glabrata deletion mutants, identifying 
conditions under which certain gene products were required for growth. Most 
notably, together with deletion mutants generated from a previous gene deletion 
study (Schwartzmüller et al., 2013; Appendix 13), phenotypic screens revealed 
novel phenotypes associated with the deletion of 22 previously unstudied C. 
glabrata ORFs, accounting for 17 % of the deletion mutants tested (Table 4.3). 
Growth phenotypes were found for uncharacterised C. glabrata putative 
transcription factors encoded by CAGL0D05434g, CAGL0D03850g and 
CAGL0D05170g as well as for putative kinases encoded by CAGL0F03905g, 
CAGL0K06479g and CAGL0M02299g (Table 4.3). A total of 110 C. glabrata 
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mutants did not yield any observable alteration of growth in phenotypic screens. 
This could be due to the presence of genes with similar function in C. glabrata 
masking phenotypes. Alternatively, two C. glabrata ORFs targeted for gene 
deletion may have been dubious ORFs due to misannotation. For example, C. 
glabrata ORF CAGL0B02946g was removed from CGD during the course of the 
study and thus is unlikely to encode a transcribed ORF (candidagenome.org). 
 
C. glabrata ∆CAGL0D03850g, a putative orthologue of S. cerevisiae RSC30 
was found to be defective for growth on a number of conditions such as 
increased temperature, NaCl, caffeine, SDS and fluconazole (Figure 4.5). 
These phenotypes are contrary to a study by Rai et al., 2012, of a Tn7 insertion 
mutant of CAGL0D03850g (in which CAGL0D03850g was designated an 
orthologue of S. cerevisiae RSC3) which found this strain to show no altered 
phenotype in response to growth on these compounds (Rai et al., 2012). 
Rather, the CAGL0D03850g Tn7 insertional mutant from the Rai et al., (2012) 
study was found to have increased susceptibility to H2O2 and hydroxyurea. The 
discrepancy between the two studies could be a consequence of the different 
methods by which C. glabrata ORF CAGL0D03850g was genetically altered 
since insertional mutagenesis introduces an interruption into the still-present 
target ORF whereas in the current study, the target ORF was completely 
replaced by a Nourseothricin resistance cassette (see 3.2.2). Alternatively, 
differences could be attributed to different phenotypic screening techniques, 
conditions or concentrations used. However, both studies demonstrate the 
requirement of CAGL0D03850g for growth on a number of stress conditions 
with functional implications including general protein defects and decreased 
tolerance to metal compounds and antifungal drugs in C. glabrata. In S. 
cerevisiae, RSC30 comprises a DNA-binding component of the RSC chromatin 
remodelling complex (Shim et al., 2005). Through the mobilisation of 
nucleosomes, the RSC complex regulates genes implicated in stress response, 
cell wall integrity, cell cycle progression and the repair of double stranded DNA 
breaks (Angus-Hill et al., 2001; Shim et al., 2005). In particular, RSC30, MRE11 
and Ku encoded proteins are required for recruitment of RSC30 to double 
strand breaks in DNA (Shim et al., 2005). Consistent with its S. cerevisiae 
orthologue RSC30, deletion of CAGL0D03850g rendered C. glabrata unable to 
grow on DNA-damaging agent MMS and sensitive to osmotic and cationic 
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stressor NaCl (Figure 4.5; Angus-Hill et al., 2001; Shim et al., 2005). 
Furthermore, S. cerevisiae RSC30 was able to complement deletion of 
CAGL0D03850g on two tested conditions (Figure 4.6). Thus, contrary to the 
study by Rai et al., 2012, this work provides evidence for C. glabrata 
CAGL0D03850g being a functional orthologue of S. cerevisiae RSC30 (Rai et 
al., 2012). 
 
All C. glabrata deletion mutants were screened for increased or decreased 
susceptibility to antifungal drugs caspofungin and fluconazole, since the 
antifungal resistance of C. glabrata poses a significant challenge for treatment 
of infections in the clinical setting (see 1.9). Screening deletion collections for 
growth on antifungal compounds can facilitate our understanding of genes 
which contribute to drug resistance in pathogenic microorganisms (Homann et 
al., 2009; Schwartzmüller et al., 2013; Appendix 13). Three C. glabrata mutants 
showed decreased resistance to fluconazole in this study: ΔCAGL0D03850g, 
ΔCAGL0L07480g and ΔCAGL0K05841g (Figure 4.4). C. glabrata 
CAGL0L07480g is designated as an orthologue of S. cerevisiae NRG1 
(candidagenome.org) or NRG2 (ygob.ucd.ie), encoding paralogous zinc finger 
transcriptional repressors of carbon-source responsive genes, stress response, 
filamentous growth and response to alkaline pH (Vyas et al., 2005; Santangelo, 
2006). In C. albicans, NRG1 and NRG2 are known to negatively regulate 
filamentous growth and chlamydospore formation (Uhl et al., 2003; Staib et al., 
2005; Kadosh & Johnson, 2005). Similarly to C. glabrata ΔCAGL0L07480g, 
NRG1 deletion mutants yield increased susceptibility of C. albicans to 
fluconazole (Homann et al., 2009). C. albicans NRG1 deletion also increased 
sensitivity to caspofungin (Wheeler et al., 2008) however no consistent 
phenotype for C. glabrata ΔCAGL0L07480g was observed in response to 
growth on caspofungin in this study. Contrary to S. cerevisiae Δnrg1 and Δnrg2 
mutants (Vyas et al., 2005), increased tolerance to osmotic or oxidative stress 
was not observed for deletion of their putative C. glabrata orthologue 
CAGL0L07480g. Phenotypic screening identified a second C. glabrata deletion 
mutant of putative transcription factor CAGL0K05841g which when deleted 
rendered C. glabrata sensitive to fluconazole. CAGL0K05891g is orthologous to 
S. cerevisiae HAP1 and C. albicans ZCF20 (candidagenome.org). C. albicans 
ZCF20 was found to be upregulated more than 7-fold in a fluconazole-resistant 
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lab strain, which was hypothesised to regulate ERG2 due to decreased 
ergosterol in the fluconazole-resistant strain (Yan et al., 2008 B). However, 
targets of CAGL0K05841g (HAP1) and their role in fluconazole tolerance have 
not been investigated in C. glabrata.  
 
4.4.3 Screening of C. glabrata Deletion Mutants for Biofilm Formation 
This study sought to investigate the role C. glabrata ORFs with no orthologue in 
S. cerevisiae may play in biofilm formation due to the medical relevance of this 
growth form both as a source of Candida infections associated with medical 
devices and for its enhanced virulence properties. Studies into the mechanisms 
underlying C. glabrata biofilm formation have uncovered a crucial role for Epa6 
and Epa7 in biofilm formation whose expression is primarily regulated by the 
subtelomeric silencing machinery (Iraqui et al., 2005; see 1.5.2). A number of 
Epa and Awp family proteins were found to be expressed in biofilm forming cells 
however the influence they have on biofilm formation is unknown (Kraneveld et 
al., 2011). Further to this, bioinformatic studies identified 67 putative adhesins in 
C. glabrata, many of which have no orthologue in S. cerevisiae or other 
Candida species and three of which were included in the deletion library (de 
Groot et al., 2008). Screening the C. glabrata deletion library identified C. 
glabrata mutants with increased or decreased biofilm forming capacity – further 
expanding the repertoire of C. glabrata ORFs known to affect biofilm formation. 
Biofilm quantification of the C. glabrata deletion library identified 14 mutants 
with significantly altered biofilm forming capacity (Figure 4.9 A and B). The 
greatest reduction in biofilm-forming capacity was observed in a deletion mutant 
of C. glabrata CAGL0E00275g (Figure 4.9 B), which was previously identified 
bioinformatically as a member of the Epa family (de Groot et al., 2008). Similarly 
to many adhesins in C. glabrata, CAGL0E00275g (or EPA20) is located at the 
telomere of the left arm of chromosome E and encodes a PA14 GLEYA adhesin 
domain (Appendix 4 Table 1). This study presents the first experimental 
evidence of the involvement of uncharacterised adhesin EPA20 in C. glabrata 
biofilm formation. Further experimentation could more extensively validate the 
role of EPA20 as an adhesin implicated in biofilm formation and whether EPA20 
is subject to subtelomeric silencing similarly to EPA6 and EPA7 (see 1.5.2; 
Iraqui et al., 2005). Screening also implicated 3 putative transcription factors 
(encoded by CAGL0M01870g, CAGL0D03850g and CAGL0L07480g) and 4 
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ORFs encoding predicted kinase domains (CAGL0G02607g, CAGL0M10153g, 
CAGL0G03201g and CAGL0M02299g) in C. glabrata biofilm formation (Figure 
4.9 A and B). Deletion of CAGL0L07480g, orthologue of S. cerevisiae 
transcriptional repressors NRG1 or NRG2, reduced biofilm formation in C. 
glabrata (Figure 4.9 B). This is contrary to reports of improved adherence and 
biofilm formation in an S. cerevisiae Δnrg1Δnrg2 double mutant (Kuchin et al., 
2002) whereas deletion of C. albicans NRG1 resulted in no detectable alteration 
in biofilm formation (Nobile et al., 2012). Hence the effect on biofilm formation 
following deletion of CAGL0L07480g could be specific to C. glabrata. 
Interestingly, eight deletion mutants of C. glabrata ORFs with no orthologue in 
S. cerevisiae showed altered biofilm formation including putative zinc-finger 
transcription factor CAGL0M01870g, putative kinase CAGL0G03201g, 
oxidoreductase CAGL0K05687g and mannosyltransferase CAGL0G04279g 
(Appendix 4 Table 1). No functional domains were detected bioinformatically for 
the remaining C. glabrata ORFs. Further investigation of biofilm altered mutants 
could explore whether the identified transcription factors regulate EPA6 or 
EPA7 adhesin expression during biofilm formation in C. glabrata. 
 
4.4.4 Virulence Screening of C. glabrata deletion mutants 
Due to the size of the C. glabrata deletion library and the unsuitability of a 
murine infection model in this instance, a D. melanogaster larvae model of C. 
glabrata gastrointestinal infection was used to study the virulence of C. glabrata 
mutants. All C. glabrata mutants caused Toll pathway (Figure 4.1) activation to 
similar levels as the parental strain in D. melanogaster Dros-GFP larvae 48 
hours post infection (Figure 4.11 B; Appendix 10 Table 1). However, six C. 
glabrata mutants were attenuated for virulence in immunocompromised Dif/Key 
larvae (Figure 4.11 A). Attenuated mutants included deletions of 
CAGL0L07480g and CAGL0D03850g which are orthologues of S. cerevisiae 
NRG1/2 and RSC30, respectively.  
 
During the course of the study, a role for C. glabrata CAGL0D03850g in 
virulence was reported (Rai et al., 2012). Firstly, ∆CAGL0D03850g survival and 
replication was found to be decreased in THP-1 macrophages. Secondly, C. 
glabrata ∆CAGL0D03850g was attenuated for virulence in a murine model of 
disseminated Candidiasis. This report provided validation for the use of D. 
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melanogaster larvae as an alternative to mammalian infection models since C. 
glabrata ∆CAGL0D03850g was found to be attenuated for virulence in this host 
also (Figure 4.11 A). Transcriptional profiling highlighted the regulation of genes 
involved in metabolic adaptation by RSC30 upon macrophage internalisation. It 
was also proposed that the remodelling of chromatin architecture by RSC30 is a 
prerequisite for adaptation to the macrophage environment (Rai et al., 2012). 
Although it has not previously been reported for C. glabrata, avirulence in NRG1 
deletion mutants has been described in a number of fungal pathogens. For 
example, NRG1 mutants were attenuated for virulence in murine models of both 
C. albicans and C. neoformans infection (Braun et al., 2001; Cramer et al., 
2006). Subsequently, the avirulence of C. albicans NRG1 deletion strains has 
made them candidates for vaccine development in which a C. albicans tet-
NRG1 strain was administered in a murine model as a vaccine protecting 
against disseminated Candidiasis (Saville et al., 2009). Thus, the attenuation of 
virulence of C. glabrata ΔCAGL0L07480g is also consistent with previous 
reports for NRG mutants in other fungal pathogens. 
 
Two C. glabrata ORFs with orthologues in related species but no previous 
association with pathogenicity were also found to be required for virulence in C. 
glabrata. Virulence of deletion strains ΔCAGL0B00726g and ΔCAGL0L03674g 
was attenuated in the D. melanogaster immunocompromised Dif/Key larvae 
infection model (see 4.3.4), allowing increased larvae survival (Figure 4.11 A). 
Firstly, C. glabrata CAGL0B00726g encodes an orthologue of S. cerevisiae 
GLK1, a glucokinase involved in glucose metabolism (yeastgenome.org). In the 
pathogenic yeast C. albicans, GLK1 is a member of a subset of metabolic 
genes regulated by Efg1 during filamentation and is also upregulated following 
fluconazole exposure (Doedt et al., 2004; Copping et al., 2005). Despite 
morphogenesis and drug resistance being contributing factors to the 
pathogenicity of C. albicans, no direct role for GLK1 in C. albicans virulence has 
been described. The sole report exploring the role of GLK1 in virulence exists in 
the plant pathogen Botrytis cinerea which found GLK1 not to be required for 
pathogenicity (Rui & Hahn, 2007). Thus, this work provides the first evidence for 
the implication of GLK1 (CAGL0B00726g) in virulence in C. glabrata. The role 
C. glabrata GLK1 may play in virulence however remains unclear. Since C. 
glabrata does not undergo a morphological switch it could be proposed that 
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attenuated virulence in the ΔCAGL0B00726g strain could be due to altered 
glucose metabolism. Alternatively, attenuated virulence of ΔCAGL0B00726g 
could be conferred by an altered core stress response, although no stress-
related phenotypes were observed in phenotypic screens. Concordantly in C. 
albicans, GLK1 transcripts are regulated by osmotic, oxidative and heavy metal 
stress as a constituent of the core stress response (Enjalbert et al., 2005). 
Secondly, C. glabrata CAGL0L03674g was identified as an orthologue of S. 
cerevisiae GSM1 (ygob.ucd.ie), a zinc cluster transcription factor also 
implicated in energy metabolism (yeastgenome.org). Together, the alteration in 
virulence for C. glabrata CAGL0B00726g and CAGL0L03674g suggests 
glucose metabolism is an important contributor to C. glabrata virulence in a D. 
melanogaster larvae infection. This study also provides the first evidence of a 
role for C. glabrata CAGL0B00726g (GLK1) and CAGL0L03674g (GSM1) in 
pathogenicity. 
 
Screening identified the requirement for C. glabrata CAGL0K05687g and 
CAGL0H01749g for full virulence in immunocompromised D. melanogaster 
larvae. Both ORFs are C. glabrata-specific and have no orthologue in S. 
cerevisiae. Bioinformatic searches revealed a NADH:flavin oxidoreductase 
domain in the CAGL0K05687g encoding protein with predicted zinc ion binding 
(GO:0008270) and ubiquitin-protein ligase activity (GO:0004842). Thus, 
functional characterisation of a C. glabrata deletion library identified C. glabrata 
ORFs with no orthologue in S. cerevisiae which could be implicated in virulence. 
Indeed, D. melanogaster has proven a useful model for the evaluation of 
virulence in large strain collections. The requirement of candidate C. glabrata 
ORFs for virulence could be further verified in a mammalian infection model.  
 
This study took a four-pronged approach for the functional analysis of a C. 
glabrata deletion library. Each of the screening methods employed highlighted 
the requirement of C. glabrata ORFs for growth, taking into consideration 
different aspects of C. glabrata fitness under a variety of environmental stresses 
and by analysing growth forms relevant to infection. Individually, phenotypic 
analyses identified C. glabrata ORFs implicated in particular cellular processes. 
In total, novel phenotypes in at least one screen associated with the deletion of 
23 C. glabrata ORFs with no strict S. cerevisiae orthologue were found in this 
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study (Table 4.4). However, together the different analyses complemented each 
other and highlighted the importance of ORFs such as CAGL0D03850g for 
growth and virulence in C. glabrata. As such, the utilisation of such tools aids 
the dissection of the roles of C. glabrata-specific ORFs for which the inference 
of gene function through study of orthologues in model organisms such as S. 
cerevisiae is not possible. This platform has also proved useful for the study of 
C. glabrata ORFs with orthologues in S. cerevisiae and has allowed the 
comparison of datasets between related species, highlighting the evolutionary 
differences between the two species. For example, the orthologue of S. 
cerevisiae RSC30 has been implicated in virulence in C. glabrata, suggesting 
genetic rewiring between the two species and highlighting the importance for 
the direct study of medically-relevant pathogens. The study has also highlighted 
similarities between pathogenic species through the identification of common 
ORFs which are required for virulence such as C. albicans NRG1 and its 
putative C. glabrata orthologue CAGL0L07480g. 
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Chapter 5: Functional 
Characterisation of 
CAGL0D05434g and 
CAGL0K05687g 
5.1 Overview 
High-throughput phenotypic screening of the C. glabrata deletion library (see 
Chapter 4) identified novel phenotypes associated with the deletion of 
previously uncharacterised C. glabrata ORF CAGL0D05434g. CAGL0D05434g 
has no orthologue in S. cerevisiae and was a prime candidate for functional 
characterisation as a possible novel regulator of the stress response in C. 
glabrata due to predicted DNA-binding functional domains (Appendix 4 Table 
1). The work presented herein aims to gain insight into the function of 
CAGL0D05434g through examining phenotypes associated with deletion and/or 
overexpression mutants in C. glabrata and the identification of conditions under 
which CAGL0D05434g is required for C. glabrata growth. 
 
Due to the limited molecular tools available for the functional characterisation of 
genes in C. glabrata (see 1.4), this chapter aims to exploit the Synthetic Genetic 
Array (SGA) system established in the model yeast S. cerevisiae to further 
dissect the pathways CAGL0D05434g may function within through the 
generation of genome-wide genetic interaction maps. The development of SGA 
has proven a powerful tool for the functional annotation of S. cerevisiae both 
essential and non-essential genes (see 1.3.3). For example, examination of the 
essential genetic interaction network enabled the annotation of uncharacterised 
S. cerevisiae gene PGA1 in protein sorting or modification in the endoplasmic 
reticulum (Davierwala et al., 2005). Interrogation of genetic interaction clusters 
also assigned uncharacterised genes PAR32, ECM30 and UBP15 to be 
members of the Gap1-sorting module based on genetic network connectivity 
(Costanzo et al., 2010).  
 
SGA profiling in species such as C. glabrata is hindered by the lack of an 
apparent sexual cycle and genome-wide deletion arrays. However, S. 
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cerevisiae SGA mediated genetic interaction profiling has been extended to the 
characterisation of non-S. cerevisiae ORFs. Using SGA methods, Brown & 
Madhani, 2012, were able to successfully predict the function of genes required 
for virulence in a murine model of C. neoformans infection. Comparison of 
genetic interaction profiles of C. neoformans LIV7 with those of the S. 
cerevisiae genetic landscape found a strong correlation with the genetic 
interaction profile of S. cerevisiae TRS33, a vesicle tethering complex involved 
in ER-to-Golgi transport. Further experimentation validated the function of LIV7 
in Golgi transport in C. neoformans. Additionally, LIV7 was found to genetically 
interact with TRS33 in C. neoformans, as inferred from genetic interaction 
profiling in S. cerevisiae (Brown & Madhani, 2012). Thus following from genetic 
interaction studies for C. neoformans ORFs and C. glabrata ORFs with S. 
cerevisiae orthologues (personal communication, Dr. Jane Usher, University of 
Exeter), the S. cerevisiae SGA platform will be used to dissect the function of C. 
glabrata ORFs with no orthologue in S. cerevisiae. 
 
Aims of the chapter: 
1) Study the impact on deletion and/or overexpression of 
CAGL0D05434g on C. glabrata fitness. 
2) Identify conditions under which CAGL0D05434g is required for C. 
glabrata growth using high-throughput phenotypic screening. 
3) Perform genome-wide genetic interaction profiling to reveal functional 
information for CAGL0D05434g and CAGL0K05687g through the use 
of S. cerevisiae SGA methods. 
 
5.2 Materials and Methods 
5.2.1 Quantification of C. glabrata Colony Size 
Images of plates from phenotypic screens (see 4.2.1.1) were acquired using a 
Syngene G:BOX and uploaded into Gene Tools for automated quantification of 
colony volume. 
 
5.2.2 Synthetic Genetic Interaction Profiling of C. glabrata ORFs  
S. cerevisiae query strains overexpressing C. glabrata CAGL0D05434g were 
generated for genome-wide genetic interaction profiling. An SGA methodology 
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previously described by Tong et al., (2005) was used to study genetic 
interactions of C. glabrata CAGL0D05434g with the S. cerevisiae non-essential 
deletion array. All automated pinning steps were performed using a Singer 
ROTOR HDA robot, Singer PlusPlates© and Singer Repads©. 
 
5.2.2.1 Construction of the SGA Query Strain 
C. glabrata ORF CAGL0D05434g was amplified using primers GW-D05434-F 
and GW-D05434-R (Appendix 1 Table 5), cloned into pENTRY vector 
pDONR™221 (Life Technologies™; see 2.5) and shuttled into pDEST vectors 
pAG426GPD-ccdB and pAG416GPD-ccdB (Addgene; Table 2.5). Correct 
clones were verified by colony PCR using ORF specific primers GW-D05434-F 
and GW-D05434-R (Appendix 1 Table 5) or plasmid specific primers M13-For 
and M13-Rev (Appendix 1 Table 4). Destination vectors carrying C. glabrata 
ORF CAGL0D05434g were transformed into S. cerevisiae SGA starter strains 
Y7092 and KH01 (see 2.4.7). Correct transformants were selected for on SC-
ura agar. Three correct transformants of each SGA query strain were stored.  
 
5.2.2.2 Condensing the S. cerevisiae Deletion Array 
The S. cerevisiae haploid MAT α deletion collection was pinned from 96-well 
microtiter plate glycerol stocks onto YPD G418 agar PlusPlates© in 96-format 
and incubated for 24 hours at 30 °C. The deletion array was condensed into 
1536-format on fresh YPD G418 PlusPlates©, pinning two technical replicates 
of each strain. Condensed deletion arrays were incubated at 30 °C for 24 hours.  
 
5.2.2.3 Automated Pinning Steps for the Generation of Double Mutants 
SC –ura broth was inoculated with a single colony of S. cerevisiae SGA query 
strains Y7093-D05434, Y7094-D05434, KH02-D05434, KH03-D05434 (see 
Table 2.2) and grown overnight. 1 ml of overnight culture was transferred and 
spread onto PlusPlates© containing Sc –ura agar and grown overnight at 30 °C 
to produce lawns of the SGA query strain. To allow mating to take place 
between the SGA query strain and the S. cerevisiae deletion mutants, cells from 
the SGA query lawn and the deletion array were pinned onto mating 
PlusPlates© and incubated for 48 hours at 30 °C. For selection of diploids, cells 
from mating PlusPlates© were pinned onto diploid selection agar and incubated 
for 48 hours at 30 °C. Diploids were transferred onto sporulation agar and 
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incubated for 5 to 21 days at room temperature, checking daily for tetrads. 
Following observation of approximately 70 % tetrad formation, cells were pinned 
onto two rounds of MAT a haploid selection plates and incubated at 30 °C for 48 
hours. Further rounds pinning onto KanR plates and Double Mutant Selection 
plates allowed for the selection of meiotic progeny and double mutants, 
respectively. All SGA screens were performed in triplicate biological replicates. 
The resultant double mutant PlusPlates© were imaged in a Syngene G:BOX 
imager. Analysis of genetic interactions was performed by visual inspection 
using colony growth as a read-out for strain fitness. Genetic interactions were 
categorised as SS (synthetic sick), SL (synthetic lethal), S (suppressor) or NI 
(no interaction) in instances where a minimum of two out of three biological 
replicates were in agreement. Functional classification and enrichment analysis 
of genetic interaction datasets was performed in FunSpec 
(funspec.med.utoronto.ca; Robinson et al., 2002). 
 
5.2.2.4 Visualisation of Genetic Interactions 
Text files containing interaction data were uploaded into Osprey version 1.2.0 
for the visualisation of genetic interaction networks. 
 
5.3 Results 
5.3.1 Phenotypic Screening of C. glabrata ΔCAGL0D05434g 
Initial selection of C. glabrata CAGL0D05434g for deletion was based on the 
lack of an orthologue in S. cerevisiae according to both Reciprocal Best Hit 
(RBH) and Yeast Gene Order Browser (YGOB) based searches (Appendix 3 
Table 1 and 2). Additionally, InterproScan searches of the CAGL0D05434g 
encoding sequence identified the presence of a putative DNA-binding domain, 
predicting this ORF to regulate transcription in response to stress 
(GO:0043618) and to have nuclear chromatin localisation (GO:0000790) 
(ebi.ac.uk/interpro/; Appendix 4, Table 1).  
 
The deletion of CAGL0D05434g altered the growth of C. glabrata both on rich 
media and on phenotypic screening conditions. On YPD rich medium, visual 
inspection found ΔCAGL0D05434g formed smaller colonies than their Cg2001 
Δhis3 counterparts (Figure 5.1 A). Volume quantification of 336 individual 
colonies formed by the parental strain (Cg2001 Δhis3) and ΔCAGL0D05434g 
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revealed a significant difference (T-test, p=4.19e-56) in average colony size. 
Cg2001 Δhis3 colonies yielded an average colony size of 8187.56 units 
(Syngene Gene Tools) compared to an average volume of 7642.56 units 
(Syngene Gene Tools) for ΔCAGL0D05434g colonies (Figure 5.1 B). 
Subsequently, FACS analysis was used to decipher whether reduced colony 
size in the ΔCAGL0D05434g mutant was accountable to a reduced cell volume 
in this strain. However, comparison of FACS forward scatter profiles (FSC) 
revealed Cg2001 Δhis3 and ΔCAGL0D05434g to have similar cell volume 
(Figure 5.1 C). Thus, it is proposed that deletion of C. glabrata CAGL0D05434g 
has a negative impact on C. glabrata fitness that is independent of cell volume. 
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Figure 5.1: Deletion of CAGL0D05434g confers reduced C. glabrata colony 
size. A) Comparison of colony size between parental strain Cg2001 Δhis3 (“wt”) 
and mutant ΔCAGL0D05434g  (“∆”) following 48 hours growth on YPD, 30 °C. 
Strains were spotted from a cell suspension of OD600 0.1 in quadruplicate onto 
agar plates using a Singer ROTOR HDA robot. B) Volume quantification 
(Syngene Gene Tools) of 336 C. glabrata colonies after 48 hours growth on 
YPD plates at 30 °C. Bars represent average volume for each strain. Error bars 
denote standard deviation. C) FACS forward scatter (FSC) profiles for 
populations of 20,000 Cg Δhis3 and ΔCAGL0D05434g  cells.  
 
High-throughput phenotypic screening highlighted the requirement for C. 
glabrata CAGL0D05434g under specific growth conditions. As was observed on 
YPD controls, ΔCAGL0D05434g isolates A and B showed a reduced colony 
size on all screening conditions tested (Figure 5.2). However, ΔCAGL0D05434g 
mutants showed increased sensitivity to cobalt chloride (1 mM CoCl2) (Figure 
5.2). Moreover, growth of ΔCAGL0D05434g isolates was completely inhibited 
on YPD agar containing arsenic compounds sodium metaarsenite (0.5 mM) and 
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arsenic (III) oxide (1 mM) as well as manganese chloride (30 mM MnCl2) and 
caesium chloride (250 mM CsCl) (Figure 5.2). Therefore, C. glabrata 
CAGL0D05434g is required for growth on arsenic-containing compounds and 
some metal chlorides, implicating CAGL0D05434g in metal and metalloid 
tolerance. 
 
Figure 5.2: Phenotypic screening of ΔCAGL0D05434g. Images show growth 
of parental strain Cg2001 Δhis3 and two ΔCAGL0D05434g  isolates, A and B, 
in phenotypic screens. Strains were pinned in quadruplicate using a Singer 
ROTOR HDA robot onto YPD agar plates supplemented with stated chemical 
agents and incubated at 30 °C for 48 hours. Images not shown for conditions 
which induced no observable growth defect in deletion mutants.  
 
 To further investigate the requirement of C. glabrata CAGL0D05434g for 
growth, liquid growth time courses were performed in YPD broth. In contrast to 
phenotypic screens, growth profiling of ∆CAGL0D05434g mutants in YPD broth 
found little significant difference in growth compared with the parental strain 
Cg2001 ∆his3 (Figure 5.3). C. glabrata ∆CAGL0D05434g isolates yielded a 
significantly extended lag phase, 50-55 minutes longer than that of the parental 
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strain (ANOVA p<0.05; Appendix 7 Table 1). However, no significant difference 
in doubling times and saturation density were observed between strains thus 
highlighting differences between using broth- and agar-based assays for 
measuring strain fitness. As such, the impact on growth incurred by deletion of 
C. glabrata CAGL0D05434g observed in phenotypic screens performed on agar 
was not fully supported by liquid growth profiles of C. glabrata 
ΔCAGL0D05434g mutants. It could be hypothesised that growth phenotypes 
are exacerbated in phenotypic screening assays where strains are densely 
pinned and consequently may need to compete for nutrients. In contrast, the 
monocultures used for liquid growth time courses do not experience competition 
for nutrients. 
 
Figure 5.3: Growth profile of two C. glabrata ∆CAGL0D05434g  isolates A 
and B (red and green lines) compared with the parental strain Cg2001 
∆his3 in YPD. Starting cultures of OD600 0.1 were incubated at 30 °C for 48 
hours in a VersaMax™ Absorbance Microplate Reader (Molecular Devices). OD 
readings were taken at 10 minute intervals with 550 seconds shaking between 
reads.  
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5.3.2 C. glabrata CAGL0D05434g Encodes a Putative HMG box Chromatin 
Remodeler 
To further elucidate the functional role CAGL0D05434g may have in C. 
glabrata, functional domains encoded by the ORF were predicted 
bioinformatically. Conserved domain searches of the C. glabrata 
CAGL0D05434g protein sequence predicted a High Mobility Group-box (HMG-
box) domain at the C-terminus of the protein. The HMG superfamily of 
chromatin remodelers are well conserved in eukaryotes and are the most 
prevalent non-histone chromatin-binding proteins in eukaryotic cells (Štros et 
al., 2007). HMG-box proteins influence transcription, replication, recombination, 
DNA repair and stability in the cell by binding chromatin via the HMG-box DNA-
binding motif and inducing structural changes (Štros, 2010). Multiple sequence 
alignments of C. glabrata CAGL0D05434g with well characterised HMG-box 
proteins HMGB1 and HMGB2 from Homo sapiens and HMO1 and NHP6A from 
S. cerevisiae shows conservation of the HMG-box DNA binding domain in these 
sequences, further confirming bioinformatically the presence of an HMG-box 
DNA binding domain in C. glabrata CAGL0D05434g (Figure 5.4). The N-
terminus of the C. glabrata CAGL0D05434g protein sequence however shows 
no alignment, nor does it produce any significant BLASTP hits (e-value < 1e-5) 
with any other sequences.  
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Figure 5.4: Multiple sequence alignment of C. glabrata CAGL0D05434g 
with characterised HMGB proteins HMGB1 & HMGB2 (Homo sapiens) and 
HMO1 & NHP6A (S. cerevisiae) showing conservation of a DNA-binding 
HMG-box domain highlighted in blue. The N-terminus of the protein shows 
no significant sequence similarity.  
 
 
More specifically, NCBI Conserved domain searches 
(ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi) further identified the DNA-binding 
domain of C. glabrata CAGL0D05434g to belong to the MATA HMG-box (NCBI 
cd01389) group, a class I member of the HMG superfamily. Known MATA HMG 
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proteins includes fungal MAT locus genes including Candida albicans MTLa, 
Yarrowia lipolytica MATA2, Kluyveromyces lactis MATa2 (Butler et al., 2004) 
and Aspergillus fumigatus MAT1-2 (Paoletti et al., 2005) and this group are 
characterised by the presence of a single HMG-box domain which binds DNA in 
a strict sequence specific manner (NCBI cl00082). Hence, CAGL0D05434g 
may regulate transcription in C. glabrata through binding DNA in a sequence-
specific manner via an HMG MATA DNA-binding domain. The prevalence of 
class I HMG-box proteins associated with the MAT locus in both sexual and 
asexual fungi could implicate a role for CAGL0D05434g in a yet unelucidated 
sexual cycle in C. glabrata. 
 
Although C. glabrata CAGL0D05434g has no orthologue in S. cerevisiae, 
YGOB assigned orthologues for CAGL0D05434g in twelve sequenced species 
(ygob.ucd.ie/). CAGL0D05434g orthologues are present in the non-pathogenic 
species Vanderwaltozyma polyspora, Naumovozyma dairenensis, Lachancea 
species and the cotton pathogen Eromothecium gossypii (Table 5.1). However, 
all orthologues remain uncharacterised in these species. In contrast to C. 
glabrata, all species with orthologues of CAGL0D05434g have a known sexual 
cycle. S. cerevisiae, Naumovozyma castellii and Kazachstania africana do not 
encode orthologues of C. glabrata CAGL0D05434g and thus it is hypothesised 
that CAGL0D05434g orthologues may have been lost in these species. 
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Table 5.1: Orthologues of C. glabrata CAGL0D05434g in related yeast 
species (ygob.ucd.ie/) 
Species Orthologue Sexual 
reproduction 
Pathogen 
Vanderwaltozyma 
polyspora 
401.4 Yes No 
Tetrapisispora phaffi TPHA0C04350 Yes No 
Tetrapisispora blattae TBLA0J01680 Yes No 
Naumovozyma 
dairenensis 
NDAI0E03570 Yes No 
Naumovozyma 
castellii 
- Yes No 
Kazachstania 
naganishii 
- Yes No 
Kazachstania 
africana 
KAFR0G02830 Yes No 
Saccharomyces 
cerevisiae 
- Yes No 
Zygosaccharomyces 
rouxii 
ZYR0D15312g Yes No 
Torulaspora 
delbrueckii 
TDEL0H02760 Yes No 
Kluyveromyces lactis KLLA0B11495g Yes No 
Eromothecium 
gossypii 
AAR026W Yes Yes 
Lachancea kluyveri SAKL0F03872g Yes No 
Lachancea 
thermotolerans 
KLTH0F13926g Yes No 
Lachancea waltii 55.21061 Yes No 
 
5.3.3 SGA Analysis of C. glabrata CAGL0D05434g 
To dissect the functional role of C. glabrata CAGL0D05434g and due to the lack 
of molecular tools available in C. glabrata, further functional analysis was 
performed in S. cerevisiae. In particular the SGA platform was exploited for 
genetic interaction analysis with the hypothesis that genetic interaction profiling 
of C. glabrata ORF CAGL0D05434g in S. cerevisiae may elucidate the 
pathways and processes it may regulate.  
 
5.3.3.1 Expression of C. glabrata CAGL0D05434g Inhibits Growth in S. 
cerevisiae 
Firstly, C. glabrata CAGL0D05434g was cloned using the Gateway® system. 
Destination vectors containing CAGL0D05434g were transformed into S. 
cerevisiae SGA strains Y7092 and KH01 for SGA analysis. SGA strains Y7093-
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D05434 and KH02-D05434 expressed CAGL0D05434g from low copy number 
destination vector pAG416GPD-ccdB (Addgene; Table 2.2). SGA strains 
Y7094-D05434 and KH03-D05434 expressed CAGL0D05434g from high copy 
number destination vector pAG426GPD-ccdB (Addgene; Table 2.2).  
Growth inhibition was observed for all S. cerevisiae SGA strains expressing C. 
glabrata CAGL0D05434g. Liquid growth profiling of SGA query strains KH02-
D05434 and KH03-D05434 and their respective control strains, KH02 and 
KH03, containing empty vector revealed significantly increased doubling times 
and a reduced final optical density in strains expressing CAGL0D05434g 
(Figure 5.5; Appendix 5 Table 1). The most pronounced difference in doubling 
times were observed in S. cerevisiae strain KH03-D05434 and control strain 
KH03 which during exponential phase growth, yielded maximum doubling times 
of 451 and 283 minutes, respectively (two sample T-test, p=1.35e-11). Similarly, 
S. cerevisiae KH03-D05434 reached a significantly lower (87.7 %) final 
saturation OD600 of 0.674, compared with a final OD600 of 0.768 for control strain 
KH03 (two sample T-test, p=1.98e-14). A less pronounced trend was observed 
for S. cerevisiae KH02-D05434 compared with respective empty vector control 
KH02 (Appendix 5 Table 1). The lag time for S. cerevisiae KH03-D05434 was 
also significantly increased compared with empty vector controls (two sample T-
test, p=4.94e-5; Appendix 5 Table 1). For all three measures of growth fitness, 
a greater impact on S. cerevisiae growth was observed upon expression of C. 
glabrata CAGL0D05434g from a high-copy number plasmid. Thus, growth 
profiling of strains suggested the expression of C. glabrata CAGL0D05434g in 
S. cerevisiae inhibits growth in a dose dependent manner (Figure 5.5).  
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Figure 5.5 Growth profile of S. cerevisiae SGA strains expressing C. 
glabrata ORF CAGL0D05434g. KH02-D05434 expresses CAGL0D05434g 
from a low copy number plasmid pAG416GPD-ccdB (empty vector control 
KH02). KH03-D05434 expresses CAGL0D05434g from a high copy number 
plasmid pAG426GPD (empty vector control KH03). The optical density of 
cultures of strains at a starting OD600 of 0.1 were measured every ten minutes 
for 30 hours at 30 °C with continuous shaking.  
 
5.3.3.2 Expression of C. glabrata CAGL0D05434g Inhibits the Formation of 
Double Mutants by SGA 
Four SGA screens were performed using two S. cerevisiae query strains 
expressing C. glabrata CAGL0D05434g: KH02-D05434, KH03-D05434, Y7093-
D05434 and Y7094-D05434 (see Table 2.2). Following selection of diploid cells, 
no tetrad formation was observed up to 30 days post transfer in all screens. To 
confirm that sporulation had not taken place, cells from sporulation plates were 
taken forward for continuation of the Mata haploid and double mutant selection 
stages of the SGA screen. However, no S. cerevisiae mutants overexpressing 
C. glabrata CAGL0D05434g were obtained following double mutant selection. 
Thus, SGA screens using an S. cerevisiae starter strain overexpressing C. 
glabrata ORF CAGL0D05434g were unable to yield double mutants for genetic 
interaction analysis (Figure 5.6).  
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Figure 5.6: Schematic describing the formation of double mutants by 
SGA. S. cerevisiae SGA query strains expressing C. glabrata CAGL0D05434g 
were mated with the S. cerevisiae non-essential deletion array. From mating 
plates, diploid cells were selected (-met, -lys) and allowed to sporulate. 
Following sporulation, 3 rounds of pinning enabled the selection of haploid 
meiotic progeny (-his, -met –lys, 100 mg/ml canavanine, 200 µg/ml G418). 
Lastly, S. cerevisiae deletion mutants expressing CAGL0D05434g were 
selected on double mutant selection agar (-ura, -his, -met –lys, 100 mg/ml 
canavanine, 200 µg/ml G418). A) SGA query strains expressing 
CAGL0D05434g were unable to proceed past the diploid selection stages of 
SGA and no tetrads were formed. B) Expression of CAGL0D05434g in S. 
cerevisiae ΔIME1 or ΔIME2 starter strains enabled progression through all 
selection stages of SGA forming S. cerevisiae mutants expressing C. glabrata 
CAGL0D05434g.  
 
Due to the inability of S. cerevisiae query strains expressing C. glabrata 
CAGL0D05434g to generate double mutants, the impact of expressing C. 
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glabrata CAGL0D05434g in S. cerevisiae backgrounds lacking major regulators 
of meiosis was investigated. In S. cerevisiae IME1 encodes the major 
transcriptional regulator of meiosis and IME2 encodes a meiosis-specific kinase 
(Kassir et al., 2003). As such C. glabrata CAGL0D05434g was transformed into 
S. cerevisiae ΔIME1 or ΔIME2 background strains on a high copy number 
plasmid yielding two SGA strains: ΔIME1-D05434 or ΔIME2-D05434 (see Table 
2.2). Following mating and selection for diploids, ΔIME1-D05434 and ΔIME2-
D05434 were able to form viable tetrads. Therefore, ΔIME1-D05434 and 
ΔIME2-D05434 query strains were used to investigate the genetic interactions 
of C. glabrata CAGL0D05434g (personal communication Dr. Jane Usher, 
University of Exeter; Figure 5.6). 
 
5.3.3.3 Genetic Interactions for C. glabrata CAGL0D05434g 
SGA screens were performed on S. cerevisiae query strains ΔIME1-D05434 
and ΔIME2-D05434. In order to examine genetic interactions specifically 
associated with the expression of C. glabrata ORF CAGL0D05434g, genetic 
interaction data from ΔIME1-D05434 or ΔIME2-D05434 SGA screens were 
compared with that of S. cerevisiae ΔIME1 and S. cerevisiae ΔIME2 (Figure 
5.7; personal communication Dr Jane Usher, University of Exeter). Surprisingly, 
few genetic interactions were common between two or more query strains. 
Whilst the majority of genetic interactors were unique to each query strain, Sc 
ΔIme1-D05434 and Sc ΔIme1 shared four genetic interactions including S. 
cerevisiae DDC1, encoding a DNA damage checkpoint protein; threonine 
synthase, THR4; DNA-dependent ATPase, RDH54; and inner mitochondrial 
membrane protein, MDM31 (Figure 5.8). Similarly, just 4 genetic interactions 
were common to both query strains Sc ΔIme2-D05434 and Sc ΔIme2. The 
majority of interacting genes were unique to each query strain (Figure 5.9). 
Common interactors included S. cerevisiae polyubiquitin gene UBI4; alanine 
transaminase, ALT1; mitochondrial fatty acid synthase, OAR4; and KES1, a 
negative regulator of Golgi secretory function. 
 
 167 | P a g e  
 
  
Figure 5.7: Genetic interaction 
maps for SGA query strains S. 
cerevisiae ΔIME1 “ScdelIME2” 
and ΔIME2 “ScdelIME2” and S. 
cerevisiae ΔIME1 and ΔIME2 
overexpressing C. glabrata 
CAGL0D05434g “ScdelIME1 
CgD05434” and “ScdelIME2 
CgD05434” respectively. Query 
strains are represented by central 
grey nodes. Edges connecting 
nodes represent genetic 
interactions between genes. 
Nodes are coloured according to 
associated GO terms.  
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Figure 5.8: Genetic interaction maps for SGA query strains S. cerevisiae 
ΔIME1 “ScdelIME1” and S. cerevisiae ΔIME1-D05434 overexpressing C. 
glabrata CAGL0D05434g “ScdelIME1 CgD05434” represented by enlarged 
grey nodes. Edges represent genetic interactions between connected genes 
represented by their respective node. Nodes are coloured according to 
associated GO terms.  
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Figure 5.9: Genetic interaction maps for SGA query strains S. cerevisiae 
ΔIME2 “ScdelIME2” and S. cerevisiae ΔIME2 over-expressing C. glabrata 
CAGL0D05434g “ScdelIME2 CgD05434” represented by enlarged grey 
nodes. Edges connecting nodes represent genetic interactions between genes. 
Nodes are coloured according to associated GO terms.  
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S. cerevisiae Sc ΔIme1-D05434 and Sc ΔIme2-D05434 showed genetic 
interactions with 79 and 57 S. cerevisiae genes, respectively (Figure 5.7; 
Appendix 6 Table 1 & 2). Common to both CAGL0D05434g-expressing query 
strains were genetic interactions with TPP1, encoding a DNA 3’-phosphatase 
required for the repair of endogenous DNA damage; WHI2, an activator of the 
general stress response; and VMA4, which encodes a V1 subunit of V-ATPase 
and whose abundance is increased in response to DNA replication stress 
(yeastgenome.org). To elucidate the pathways C. glabrata CAGL0D05434g 
may function within, functional classification analysis of interacting S. cerevisiae 
genes from Sc ΔIme1-D05434 and ΔIme2-D05434 SGA screens was 
performed using FunSpec (funspec.med.utoronto.ca/). For S. cerevisiae genes 
which yielded genetic interactions with the Sc ΔIme1-D05434 query strain, 
analysis found six significantly enriched GO Biological Process terms (Table 
5.2). Protein deacetylation was significantly represented (p=0.0020552) in the 
genetic interaction list due to interactions with sirtuins HST1 and HST4, NAD(+)-
dependent histone deacetylase components of the transcriptional silencing 
machinery associated with maintenance and silencing at telomeres. The 
presence of core stress response activator WHI2, autophagy-specific gene 
ATG29 and an uncharacterised ORF YOR019W in the genetic interaction list 
significantly represent mitochondrion degradation (p=0.004815). Functional 
classification also highlighted significant enrichment of genes implicated in 
vesicle-mediated transport (p=0.00638; Table 5.2) including endosomal 
vacuolar trafficking pathway genes, RCR1 and RCR2, and regulator of coated 
vesicle formation, ARF2. Enrichment of DNA damage (p=0.002314), sporulation 
(p=0.007581) and ion homeostasis (p=0.008631) genes were also significantly 
represented in the ΔIme1-D05434 genetic interaction list (Table 5.2). 
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Table 5.2: Significantly enriched GO Biological Process terms amongst S. 
cerevisiae genes which showed genetic interactions with C. glabrata 
CAGL0D05434g in SGA screens of query strain ΔIme1-D05434 
(funspec.med.utoronto.ca/). “k” represents the number of genes from the input 
cluster in a given category. “f” represents the number of genes total in a given 
category. 
Category p-value In Category from Cluster k F 
protein deacetylation 
[GO:0006476] 
0.002055 HST4 HST1 2 6 
response to DNA damage 
stimulus [GO:0006974] 
0.002314 RDH54 TDP1 MSH5 CTK2 
HAM1 BDF1 TPP1 DDC1 
8 197 
mitochondrion degradation 
[GO:0000422] 
0.004815 YOR019W WHI2 ATG29 3 29 
vesicle-mediated transport 
[GO:0016192] 
0.00638 RCR1 APM3 ARF2 RCR2 
TVP38 TRS33 
6 140 
sporulation resulting in 
formation of a cellular 
spore [GO:0030435] 
0.007581 OAF1 ADY3 IME1 BDF1 HST1 5 103 
cellular ion homeostasis 
[GO:0006873] 
0.008631 FYV5 MDM31 2 12 
 
 
Automated functional specification analysis of ΔIME2-D05434 interactors 
yielded functional annotation of low significance. However, manual inspection 
and annotation of both ΔIME1-D05434 and ΔIME2-D05434 genetic interaction 
datasets identified three major groups of S. cerevisiae genes implicated in DNA 
replication/damage stress, metal ion homeostasis and mating, meiosis and 
sporulation. Firstly, a total of 16 S. cerevisiae genes with known functional roles 
in mating, meiosis and sporulation were identified within ΔIME1-D05434 and 
ΔIME2-D05434 genetic interaction datasets (Appendix 6 Tables 1 & 2). Genetic 
interactors included meiosis genes MSH5, a facilitator of homologue crossover 
during meiosis; RMD6, required for meiotic nuclear division; and spore wall 
formation genes SPO75 and ADY3. Secondly, manual inspection of the genetic 
interaction datasets also identified 27 S. cerevisiae genes associated with DNA 
replication stress and DNA damage repair (Appendix 6 Tables 1 & 2), for 
example DDC1, a known major DNA-damage checkpoint protein; TPP1, a DNA 
3’-phosphatase required for the repair of endogenous damage to double-
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stranded DNA; and MRC1, an S-phase checkpoint protein required for DNA 
replication. Within the genetic interaction datasets were also genes whose 
protein abundance increase in response to DNA damage including ATG29, 
CDC73, HAM1, COA6, CUP9 and MRP8 (Appendix 6 Tables 1 & 2). Lastly, a 
group of metal ion homeostasis and transport genes were represented in the 
genetic interaction dataset. Of particular interest were iron transporter, MRS4; 
an iron/copper reductase involved in iron homeostasis, FRE8; and FRA1, a 
negative regulator of cellular iron concentration. Also present in the list are zinc-
regulated transcription factor, ZAP1, and zinc transporter, ZRT1 (Appendix 6 
Tables 1 & 2). Taken together, S. cerevisiae genetic interaction data can be 
used to drive hypotheses relating to a putative functional role for C. glabrata 
CAGL0D05434g DNA replication/damage stress, metal ion homeostasis or in 
meiosis and sporulation, perhaps in an undiscovered sexual cycle.  
 
5.3.4 C. glabrata CAGL0D05434g is required for growth in response to 
DNA damage 
Genetic interaction profiling of C. glabrata CAGL0D05434g revealed significant 
enrichment of genetic interactions with S. cerevisiae genes implicated in DNA 
damage response (Table 5.2). To investigate whether genetic interaction data 
for C. glabrata ORFs gained in S. cerevisiae could be extrapolated to reveal 
relevant insights into C. glabrata biology, the role of C. glabrata 
CAGL0D05434g was explored by phenotypic screening of deletion and 
overexpression mutants in response to DNA damage agents (Figure 5.10). In 
support of this hypothesis, deletion mutant ΔCAGL0D05434g showed greatly 
reduced growth on YPD supplemented with 50 mM HU (hydroxyurea) and 0.05 
% MMS (methyl methanesulfonate) (Figure 5.10). HU inhibits ribonucleotide 
reductase hence preventing dNTP production and DNA synthesis (Hampsey, 
1997) thus sensitivity of ΔCAGL0D05434g to growth on HU implies a defect in 
DNA replication. Sensitivity to growth on MMS, an alkylating agent inducing 
DNA damage (Hampsey, 1997), also signifies defective DNA damage repair in 
ΔCAGL0D05434g. Consistent with these observations, C. glabrata 
CAGL0D05434g overexpression strain (Cg2001 Δhis3 p423GPD-D05434) 
showed increased resistance to growth on 0.1 % MMS and 100 mM HU 
compared with an empty vector control strain (Cg2001 Δhis3 p423GPD) (Figure 
5.10). Surprisingly, ΔCAGL0D05434g showed no reduction in growth compared 
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with parental strain Cg2001 Δhis3 in response to exposure to UV light which 
induces DNA damage (Figure 5.10). Thus ΔCAGL0D05434g growth was 
inhibited by chemically-induced DNA damage only.  
 
 
Figure 5.10: Phenotypic screening of C. glabrata CAGL0D05434g deletion 
and overexpression mutants on DNA damage agents hydroxyurea (HU), 
methyl methanesulfonate (MMS) and UV light. Deletion mutant Cg 
ΔCAGL0D05434g and parental strain Cg2001 Δhis3 were grown on YPD and 
incubated at 30 °C for 2 days. Overexpression mutant Cg2001Δhis3 p423GPD-
D05434 and empty vector control strain Cg2001 Δhis3 p423GPD were 
incubated at 30 °C for 3 days.   
 174 | P a g e  
 
5.3.5 Genetic Interactions of C. glabrata CAGL0K05687g 
Deletion of CAGL0K05687g rendered C. glabrata attenuated for virulence in an 
immunocompromised Drosophila melanogaster larvae model of infection 
(Figure 4.11 A). In addition, ΔCAGL0K05687g strains were observed to have 
increased biofilm forming capacity compared with parental strain Cg2001 Δhis3 
(Figure 4.9 A). Bioinformatic searches identified an NADH:flavin oxidoreductase 
domain throughout the CAGL0K05687g encoding protein (Appendix 4 Table 1). 
However, phenotypic screens yielded no observable phenotypes for 
ΔCAGL0K05687g isolates (Table 4.3). Following the successful use of genetic 
interaction profiling to identify a role for C. glabrata CAGL0D05434g in the DNA-
damage response (Table 5.2; see 5.3.4), systematic genetic interaction analysis 
was employed to identify pathways or processes C. glabrata CAGL0K05687g 
may act within and thus uncover how CAGL0K05687g may contribute to C. 
glabrata virulence. SGA screens were performed for S. cerevisiae query strain 
KH03-K05687, expressing C. glabrata CAGL0K05687g. Double mutant analysis 
found C. glabrata CAGL0K05687g to genetically interact with 115 S. cerevisiae 
ORFs (Figure 5.11; Appendix 12 Table 1). 
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Figure 5.11: Genetic interaction 
maps for SGA query strains 
KH03-K05687 expressing C. 
glabrata CAGL0K05687g. Query 
strains are represented by central 
grey nodes. Edges connecting 
nodes represent positive and 
negative genetic interactions 
between genes. Nodes are 
coloured according to associated 
GO terms.  
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Table 5.3: Significantly enriched GO terms relating to the molecular 
function, biological process and cellular component of S. cerevisiae 
genes which showed genetic interactions with C. glabrata CAGL0K05687g 
in SGA screens of query strain KH03-K05687 (funspec.med.utoronto.ca/). “k” 
represents the number of genes from the input cluster in a given category. “f” 
represents the number of genes total in a given category. 
Category p-value In Category from Cluster K f 
Molecular Function 
SNAP receptor activity 
[GO:0005484] 
0.003204 SYN8 SNC1 GOS1 3 24 
nucleobase 
transmembrane 
transporter activity 
[GO:0015205] 
0.00658 FUI1 FCY22 2 10 
Biological process 
regulation of cell size 
[GO:0008361] 
0.000496 CLN3 KAP122 PRS3 
RPA49 
4 30 
nucleobase transport 
[GO:0015851] 
0.00658 FUI1 FCY22 2 10 
histone exchange 
[GO:0043486] 
0.007977 SWC3 ASF1 2 11 
Cellular Component 
integral to membrane 
[GO:0016021] 
0.007835 MDM10 SYN8 YAL018C 
FRT2 SNC1 ERV46 FLC2 
PEX22 CNE1 YAL065C 
SEO1 NUP60 YAR023C 
UIP3 YAR028W PRM9 
FUI1 FCY22 KAP122 
GOS1 TRK1 MNN11 
GPT2 HUT1 CTR1 VPS66 
26 1303 
 
Statistical analysis of the S. cerevisiae genetic interaction dataset found a 
significant enrichment of genes implicated in SNAP receptor activity 
(GO:0005484; p=0.003204) (Table 5.3). This category included S. cerevisiae 
SYN8, an endosomal SNARE (SNAP receptor protein), as well as vesicle 
associated SNARES (v-SNARES) SNC1 and GOS1 (yeastgenome.org) 
implicated in vesicle-mediated transport of cargo between cellular organelles 
(Bonifacino & Glick, 2004). Manual inspection of the genetic interaction dataset 
further identified two S. cerevisiae genes VSP8 and ERV46 which are also 
implicated in vesicle tethering and membrane fusion (Appendix 12 Table 1; 
yeastgenome.org). Additionally, C. glabrata CAGL0K05687g showed genetic 
interactions with 26 membrane proteins (GO:0016021, p=0.007835), including 
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nucleobase transporters FUI1 and FCY22 (GO:0015851; p=00.658) and high 
affinity potassium and copper transporters TRK1 and CRT1 (Appendix 12 Table 
1). Genetic interactions of C. glabrata CAGL0K05687g was also observed 
amongst S. cerevisiae histone exchange genes (GO:0043486, p=0.007977) 
including SWC3, a component of the SWR chromatin remodelling complex, and 
ASF1, a nucleosome assembly factor with anti-silencing properties (Table 5.3; 
yeastgenome.org). Genetic interactions were also identified with transcriptional 
silencing factors SWD1 and FUN30 (Appendix 12 Table 1). 
 
5.4 Discussion  
Bioinformatic searches identified uncharacterised C. glabrata ORF 
CAGL0D05434g to encode a putative transcription factor with no orthologue in 
S. cerevisiae (Appendix 3 Table 1 and 2). In this chapter, screening of a 
CAGL0D05434g mutant for growth phenotypes was used to uncover novel 
phenotypes associated with the deletion of this uncharacterised ORF and 
elucidate the functional role this ORF may play in C. glabrata. The use of the S. 
cerevisiae SGA system for mapping genome-wide genetic interactions of C. 
glabrata ORFs was explored as tool to identify pathways CAGL0D05434g may 
regulate. 
 
5.4.1 C. glabrata CAGL0D05434g is required for fitness and growth on 
metal and metalloid compounds 
Phenotypic screens revealed reduced fitness of CAGL0D05434g deletion 
strains on rich media, resulting in reduced colony size (Figure 5.1 A and B) and 
raising speculation that CAGL0D05434g may be important for fitness in C. 
glabrata. Further, C. glabrata CAGL0D05434g was found to be required for 
growth on metal compounds (cobalt-, manganese- and caesium chloride) and 
metalloid  compounds (arsenic (III) oxide and sodium metaarsenite) (Figure 
5.2). Whilst low levels of metals are required for normal cell physiology (Hood & 
Skaar, 2012), for example as cofactors of enzymes or for protein structure 
(Ragsdale, 2006), increased levels of metals/metalloids are highly toxic to cells 
(Avery, 2001; Lin et al., 2010). In yeast, the accumulation of reactive oxygen 
species (ROS) and depletion of cellular glutathione (GSH) is a major cause of 
metal/metalloid-induced cytotoxicity and thus could contribute to the sensitive 
growth phenotype of C. glabrata CAGL0D05434g mutants (Avery, 2000; 
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Wysocki & Tamás et al., 2010; Thorsen et al., 2012). Yeast cells exposed to 
metals and metalloids, in particular arsenic, elicit an oxidative stress 
transcriptional response mediated by Yap1p, accompanied by chronic activation 
of Msn2p and Msn4p, regulators of the general stress response (Hosiner et al., 
2009). However, it is unlikely that oxidative stress encountered as a 
consequence of metal/metalloid toxicity inhibited growth of C. glabrata 
CAGL0D05434g deletion mutants since no phenotypes were observed for these 
strains in response to oxidative stress-inducing agents hydrogen peroxide 
(H2O2), t-butyl hydroperoxide (tBOOH) or menadoine. It is more likely that the 
metal/metalloid-induced growth defect in C. glabrata CAGL0D05434g was 
caused by other mechanisms of metal/metalloid-induced toxicity such as 
impaired DNA repair, inhibition of enzyme function or disturbance of cell cycle 
progression (Wysocki & Tamás, 2010). Therefore, it was hypothesised that C. 
glabrata CAGL0D05434g may function in the tolerance to cytotoxicity induced 
by metal and metalloid compounds. 
 
5.4.2 C. glabrata CAGL0D05434g Encodes a Putative MATA HMG-box 
Domain 
Bioinformatic analysis revealed the presence of a conserved HMG-box domain 
at the C- terminus of the CAGL0D05434g encoding protein, which is highly 
similar to that of other chromatin remodelling HMG-box proteins in yeast and 
humans (Štros, 2010; Figure 5.4). In particular, the HMG-box domain of C. 
glabrata CAGL0D05434g was assigned to the class I MATA HMG-box family. 
MATA HMG-box proteins are present at the MAT loci of many fungi where they 
play regulatory roles in the mating systems of these species (Butler et al, 2004). 
In filamentous fungi such as the Aspergillus species, MATA HMG proteins drive 
the expression of sex-specific genes, sexual development and the coordination 
of ascospore formation (Shiu & Glass, 2000; Paoletti et al., 2005; O’Garman et 
al., 2009; Czaja et al., 2011). In several hemiascomycete species (excluding S. 
cerevisiae) HMG-box protein MATa2 are found in the MATa idiomorph (Butler et 
al., 2004), expression of which has been shown to regulate mating in Y. 
lipolytica and C. albicans (Kurischko et al., 1999; Tsong et al., 2003). Despite C. 
glabrata CAGL0D05434g belonging to the MATA HMG domain family, 
CAGL0D05434g is not an orthologue of the MATA2 gene. However, C. glabrata 
CAGL0D05434g has uncharacterised orthologues in a number of related 
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species - many of which have a sexual cycle, although it is unknown whether 
these ORFs encode proteins implicated in mating, meiosis or sporulation (Table 
5.1). Due to a high number of genetic interactions with mating, meiosis and 
sporulation genes and the association of MATA HMG-box proteins with the 
MAT loci, C. glabrata CAGL0D05434g is hypothesised to play a role in an 
undiscovered sexual cycle, or may have evolved new functions following the 
loss of a sexual cycle in C. glabrata. 
 
5.4.3 C. glabrata CAGL0D05434g Genetic Interactions  
Previous work has shown the utility of the S. cerevisiae SGA platform for 
genetic interaction profiling of C. glabrata ORFs with orthologues in S. 
cerevisiae (personal communication, Dr. Jane Usher, University of Exeter). This 
present study aimed to use the S. cerevisiae SGA platform to uncover genetic 
interaction networks for C. glabrata ORF CAGL0D05434g, for which there is no 
orthologue in S. cerevisiae, to reveal the pathways this ORF may function in. It 
was hypothesised that due to the conservation of genetic interactions between 
yeasts (Dixon et al., 2008; Ryan et al., 2012), genetic interaction data for C. 
glabrata ORFs in the closely related yeast S. cerevisiae would hold true 
biological relevance to ORF function in C. glabrata. Indeed, such hypotheses 
are supported by recent work in which genetic interaction mapping in S. 
cerevisiae was used for functional characterisation of more distantly related C. 
neoformans virulence factors, which also have no orthologue (Brown & 
Madhani, 2012). In this study, genome-wide genetic interaction analysis of C. 
glabrata CAGL0D05434g found enrichment of interacting genes implicated in 
meiosis and sporulation, ion homeostasis and DNA damage repair and 
replication (Figure 5.7). 
 
5.4.4 C. glabrata CAGL0D05434g – a Role in Meiosis? 
Consistent with the prevalence of HMG MATA proteins in fungal mating 
systems, functional characterisation of C. glabrata CAGL0D05434g in S. 
cerevisiae implied a role for CAGL0D05434g in the mating process. Firstly, S. 
cerevisiae SGA query strains expressing C. glabrata CAGL0D05434g did not 
form tetrads following mating thus preventing the formation of double mutants 
for genetic interaction analysis (Figure 5.6). Although growth on auxotrophic 
selection implied CAGL0D05434g-expressing S. cerevisiae strains were 
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successful in the formation of diploids, further experimentation and verification 
is required to dissect at which step in mating, meiosis or sporulation inhibition 
occurred and whether this is directly linked to the expression of C. glabrata 
CAGL0D05434g. However, it seems likely to be associated with expression of 
C. glabrata CAGL0D05434g since the SGA platform has previously been 
successfully used for the genetic interaction profiling of numerous C. glabrata 
ORFs (personal communication, Dr. Jane Usher, University of Exeter). 
Secondly, examination of CAGL0D05434g genetic interactions in S. cerevisiae 
ΔIME1 and ΔIME2 strains uncovered significant enrichment of interacting genes 
with known functions in mating, meiosis and sporulation (Table 5.2; Appendix 6 
Tables 1 and 2). Since genetic interactions often occur between genes within 
the same or related biological pathways (Dixon et al., 2009; see 1.3.3), genetic 
interactions provide a strong indicator for gene function thus proposing a 
putative function for CAGL0D05434g in the mating machinery. Although the 
presence of a mating-associated gene does not comply with the asexual 
lifestyle of C. glabrata, numerous orthologues of the mating machinery have 
been described in this species (Wong et al., 2003) – some of which, for 
example STE12, are able to complement mating in their respective S. 
cerevisiae deletion mutants but uniquely to C. glabrata has emerged as an 
important virulence attribute (Calcagno et al., 2003). Thus, in agreement with 
the universal function of MATA HMG-box proteins in fungal mating systems 
taken together with genetic interaction data, it is proposed that C. glabrata 
CAGL0D05434g may have a functional role in mating, meiosis or sporulation. 
Alternatively, through evolutionary driven genetic rewiring, CAGL0D05434g may 
also have evolved a novel role specific to C. glabrata as has been shown for 
other mating-associated C. glabrata genes (Calcagno et al., 2003). 
 
5.4.5 CAGL0D05434g and the DNA-damage Response 
Genetic interaction mapping of C. glabrata CAGL0D05434g revealed an 
enrichment of genetic interactions with S. cerevisiae genes implicated in DNA 
replication stress and DNA damage repair (Table 5.2; Appendix 6 Table 1 and 
2), driving the hypothesis that CAGL0D05434g may be involved in the DNA 
damage response of C. glabrata. Further investigation confirmed this 
hypothesis, demonstrating experimentally by phenotypic screening the 
requirement of CAGL0D05434g for C. glabrata growth on MMS and 
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hydroxyurea as well as increased tolerance to these compounds upon 
overexpression of CAGL0D05434g (Figure 5.10). MMS is a DNA-damaging 
agent which physically impedes and reduces the rate of DNA replication fork 
progression by alkylation of genomic DNA. Previously, MMS-induced 
cytotoxicity has been found to occur when cells are allowed to enter S-phase 
with DNA alkylation damage, often as a result of mutation of vital checkpoint 
control genes (Tercero & Diffley, 2001). In DNA repair-competent cells, MMS-
induced DNA damage is remediated by a group of base excision repair proteins 
including RAD6, a checkpoint control protein involved in replication repair and 
double stranded DNA break repair; RAD52, which functions in the repair of 
double strand DNA breaks during meiosis; MEC1, a genome integrity 
checkpoint protein and component of the signal transduction pathway in 
response to DNA damage; and RAD53, a protein kinase required for DNA 
damage-induced cell cycle arrest (Hanway et al., 2002). Treatment of yeast with 
hydroxyurea reversibly inhibits ribonucleotide reductase, preventing the 
reduction of ribonucleotides to deoxyribonucleotides (dNTPs), thereby 
diminishing cellular dNTP pools, hampering DNA synthesis and progression 
through S-phase (Hampsey, 1997; Alvino et al., 2007). Similarly to MMS-
induced DNA damage, checkpoint genes MEC1 and RAD53 are engaged in 
response to hydroxyurea treatment, prohibiting a lethal passage through the cell 
cycle into mitosis (Alvino et al., 2007). Due to the sensitivity of C. glabrata 
CAGL0D05434g to DNA damage agents MMS and hydroxyurea (Figure 5.10), it 
is proposed that CAGL0D05434g is a novel regulator of the DNA damage 
response in C. glabrata. Further experimentation to investigate whether 
CAGL0D05434g confers tolerance to MMS and hydroxyurea could explore the 
regulation of DNA damage checkpoint controls such as RAD53, MEC1, RAD6 
or RAD52 by CAGL0D05434g. In agreement with such hypotheses, C. glabrata 
CAGL0D05434g showed genetic interactions with S-phase DNA damage 
checkpoint proteins encoded by MRC1 and DDC1; and MSH1, COA6, TDP3, 
TOM6 and UBI4 which are required for growth on MMS (Appendix 6 Tables 1 
and 2; Hanway et al., 2002). Such involvement of CAGL0D05434g in DNA 
damage regulation could also explain the sensitivity of CAGL0D05345g deletion 
mutants to metals and arsenic compounds since treatment of yeast cells with 
metal and arsenic compounds has been associated with increased DNA 
mutation and damage frequency (Yu et al., 2009; Litwin et al., 2013). The 
 182 | P a g e  
 
involvement of C. glabrata CAGL0D05434g in DNA replication and damage 
repair could also be linked to the proposed role of CAGL0D05434g in mating, 
meiosis and sporulation since double strand breaks and their repair is a vital 
stage in meiosis (Haber, 2000; Murakami & Keeney, 2008). However, further 
experimentation of CAGL0D05434g function is required to validate such 
speculation.  
 
5.4.6 Genetic Interaction Mapping of C. glabrata CAGL0K05687g – a Role 
in Transport?  
This work exploited the SGA platform to investigate the genome-wide genetic 
interactions of putative C. glabrata oxidoreductase CAGL0K05687g. 
CAGL0K05687g was previously identified to be required for full C. glabrata 
virulence in an immunocompromised D. melanogaster infection model (Figure 
4.11 A) and deletion modulated the biofilm-forming capacity of C. glabrata 
(Figure 4.9 A). However, chemogenomic screening of a CAGL0K05687g 
deletion mutant revealed no phenotypes (Table 4.3). As such, the pathways 
CAGL0K05687g may act within and how this relates to C. glabrata virulence 
remains unclear.  
 
Systematic genetic interaction profiling of C. glabrata CAGL0K05687g identified 
genetic interactions with 115 S. cerevisiae genes (Figure 5.11). In particular, 
genetic interactions were enriched amongst integral membrane proteins, 
SNARE proteins and membrane transporters (Table 5.3). In S. cerevisiae, 
SNAREs comprise a diverse group of C-terminal anchored transmembrane 
proteins which together constitute the machinery governing vesicle targeting 
and fusion and as such play an important role in endo- or exo-cytosis and the 
transport of cargo between organelles (Bonifacino & Glick, 2004). Thus, given 
that C. glabrata CAGL0K05687g genetically interacts with a number of 
SNAREs, it could be proposed that CAGL0K05687g functions in vesicle-
mediated transport. Additionally, CAGL0K05687g was found to genetically 
interact with 26 membrane proteins, some of which (such as CTR1 and TRK1) 
have transporter activity which could implicate CAGL0K05687g in nutrient 
transport. Further experimentation could be used to validate genetic interaction-
driven hypotheses and explore the implications this may have on C. glabrata 
virulence. Genetic interactions with histone modification and chromatin 
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remodelling proteins encoded by S. cerevisiae SWC3, ASF1, SWD1 and 
FUN30  were also uncovered (Appendix 12 Table 1), many of which are 
involved in telomeric silencing (Daganzo et al., 2003; Mueller et al., 2006). It 
could be further studied whether interactions between CAGL0K05687g and 
chromatin remodelers in C. glabrata have an impact on subtelomeric silencing. 
Such an interaction could alter expression of the EPA adhesins and provide a 
link with the increased biofilm-forming capacity of the CAGL0K05687g deletion 
mutant. 
 
Chemogenomic screening of deletion mutants has been used as an effective 
tool in the functional characterisation of previously unstudied genes in yeasts 
(Winzeler et al., 1999; Homann et al., 2009; Schwartzmüller et al., 2013; see 
1.3.1.2). However, dissection of ORF function is hampered when gene deletion 
confers no observable phenotypes in chemogenomic screens. For many ORFs, 
genetic redundancy or the presence of parallel pathways which are able to 
functionally compensate for the other may mask growth phenotypes (Dixon, 
2009). Alternatively, gene deletion may confer a phenotype other than alteration 
of colony growth or fitness. Thus, alternative approaches for functional 
characterisation must be employed for ORFs with no observable screening 
phenotypes. In this instance, the SGA platform was used due to its application 
in uncovering redundant gene function (Tong et al., 2001).  
 
Taken together, approaches to functionally characterise CAGL0D05434g have 
lead to the hypothesis that this ORF may play a role in meiosis, sporulation or 
the regulation of the DNA damage and replication response in C. glabrata. 
Further, high-throughput genetic interaction profiling of a C. glabrata-specific 
ORF in S. cerevisiae was used to drive hypotheses regarding C. glabrata 
function which were experimentally validated in C. glabrata. 
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Chapter 6: Discussion 
 
6.1 Overview 
The development of molecular tools (such as barcoded deletion libraries and 
ORF collections) have enabled genome-wide studies in the model yeast S. 
cerevisiae leading to rapid and systematic characterisation of unstudied genes, 
uncovering novel regulatory networks, protein-protein interactions and genetic 
interaction networks (Giaever et al., 2002; Tong et al., 2004; Krogan et al., 
2006; Costanzo et al., 2010). Such tools have been instrumental in the 
understanding of orthologous gene function in related yeasts such as C. 
glabrata. However the non-pathogenic nature of S. cerevisiae limits the use of 
these tools in the dissection of traits specific to pathogenic yeast species. As a 
result, this study addresses problems posed by the lack of molecular tools 
available for the large-scale study of ORF function in non-model organisms, 
focusing on the pathogenic yeast C. glabrata. 
 
A focus on C. glabrata ORFs with no orthologue in S. cerevisiae was driven by 
comparative genomic studies which found C. glabrata to be more closely 
related to the non-pathogenic yeast S. cerevisiae (Dujon et al., 2004; see 1.2). 
In particular, phylogenetic analysis found C. glabrata to lie in the WGD (whole 
genome duplication) clade, distinct from other pathogenic yeast species 
constituting the Candida clade (Figure 1.3). It was thus hypothesised that C. 
glabrata and S. cerevisiae shared a common ancestor and following divergence 
from this ancestor C. glabrata emerged as a pathogen of humans (Byrne & 
Wolfe, 2005). Therefore, this study aimed to address C. glabrata attributes 
which may contribute to virulence in this species through the direct comparison 
of orthologous genes between C. glabrata and S. cerevisiae. It was 
subsequently hypothesised that genes specific to C. glabrata may elucidate 
virulence factors.  
 
A bespoke reciprocal best hit (RBH) pipeline (see 3.3.1) was used to 
bioinformatically identify 727 C. glabrata ORFs which may have no orthologue 
in S. cerevisiae. Further refinement criteria were used to supplement RBH 
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searches and select candidate C. glabrata ORFs to be taken forward for 
functional characterisation. This was mainly achieved through the detection of 
predicted functional domains in the encoding protein sequences and 
identification of orthologous genes in other related species using the Yeast 
Gene Order Browser (YGOB; ygob.ucd.ie) and the Candida Genome Database 
(CGD; candidagenome.org).  A resultant list of 100 C. glabrata ORFs of interest 
was taken forward for targeted gene deletion. Subsequently, a total of 65 C. 
glabrata ORFs were individually deleted (see 3.4.3) to produce a barcoded C. 
glabrata deletion library to be used as a molecular tool for their study. This work 
further contributed to a collaborative gene deletion project of approximately 700 
C. glabrata mutants constructed in the Haynes, Kuchler and Cormack labs, 
providing a lasting resource for the study of C. glabrata biology (Schwartzmüller 
et al., 2013; Appendix 13). 
 
A series of assays were used to characterise the C. glabrata deletion library, 
facilitating the dissection of ORF function with respect to growth conditions and 
growth forms relevant to virulence. Data presented in this study highlights seven 
C. glabrata ORFs found to be required for C. glabrata fitness in vitro (see 4.3.1) 
and 22 C. glabrata ORFs required for growth under stress conditions tested in 
phenotypic screens (Table 4.3). As a result, screening provided a link between 
unstudied ORFs and functional processes such as tolerance to heavy metals, 
the DNA damage response and resistance to antifungal drugs (Table 4.2). 
Additionally, 14 C. glabrata ORFs were implicated in biofilm formation (see 
4.3.3) and 6 ORFs were required for virulence in a Drosophila melanogaster 
infection model (see 4.3.4), providing the first evidence for the involvement of 
these ORFs in virulence and pathogenesis-related growth forms. Hence, the 
multi-faceted approach to the functional characterisation of the C. glabrata 
deletion library has led to the identification of C. glabrata ORFs which play a 
role in a variety of aspects related to C. glabrata biology. The use of a D. 
melanogaster infection model has also broadened the availability of animal 
models applicable to large strain collections. Together, the screening platforms 
developed in this work are applicable to other fungal pathogens to facilitate the 
functional characterisation of ORFs in these species. 
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This work also introduced the S. cerevisiae synthetic genetic array (SGA) 
method for the functional characterisation of C. glabrata ORFs with no 
orthologue in S. cerevisiae (see 5.3.3). Genetic interaction networks were 
presented representing genetically interacting partners of C. glabrata 
CAGL0D05434g, a putative HMG-box chromatin remodeler (Figure 5.7). 
Analysis of genetic interactions led to the finding that C. glabrata 
CAGL0D05434g was required for growth on DNA-damaging agents (see 5.3.4). 
Preliminary genetic interaction profiling was also used to uncover the pathways 
the virulence-associated ORF CAGL0K05687g may act within and how this may 
relate to virulence.  
 
6.2 Defining C. glabrata ORFs with no Orthologue in S. cerevisiae 
This study focused on C. glabrata ORFs with no S. cerevisiae orthologue as an 
approach for the identification of C. glabrata virulence attributes as it was 
hypothesised that the emergence of C. glabrata-specific genes may have 
accompanied the adaptation of C. glabrata to the human host niche and 
evolution of pathogenicity. During the course of this study Desai et al., 2011, 
also focused on C. glabrata-specific ORFs leading to the identification of novel 
endothelial adhesin factors Pwp7 and Aed1. Also supporting the hypothesis that 
C. glabrata-specific ORFs play important roles in infection related processes, 
expression profiling of macrophage-internalised C. glabrata cells found 15-30 % 
of all differentially regulated genes were either specific to C. glabrata or had 
uncharacterised S. cerevisiae orthologues (Rai et al., 2012). The study of 
species-specific ORFs could be applied to other fungal pathogens for the 
identification of pathogenicity factors. 
 
The current study also explored the possibility that the acquisition of prokaryotic 
genes by C. glabrata may have accompanied the emergence of this species as 
a human pathogen. More specifically, three ORFs encoding a putative aspartate 
racemase (CAGL0D01210g), an NADPH dehydrogenase (CAGL0M14091g) 
and transferase enzyme (CAGL0K11066g) were proposed to be of prokaryotic 
origin, most likely from horizontal gene transfer events from species in the 
Firmicute, Proteobacteria or Actinobacteria phyla (see 3.3.4). It was previously 
reported that HGT events from prokaryotes to fungi may accompany the 
adaptation of pathogens to a new host niche. In particular the acquisition of 
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racemase enzymes could facilitate the detoxification of D-amino acid forms 
found in mammalian tissues or the peptidoglycan layer of the bacterial cell wall 
(Yoshimura & Esaki, 2003; Marcet-Houben & Gabaldón, 2010). It is 
hypothesised that horizontal gene transfer between bacterial and yeast species 
could take place in the competitive environment of the host mircroflora and that 
such transfer could confer a fitness advantage in the host niche. 
 
The identification of C. glabrata ORFs with no orthologue in S. cerevisiae in the 
current study highlighted discrepancies in orthologue assignment by different 
search methods and databases. RBH searches in this study initially identified 
727 C. glabrata ORFs to have no orthologue in S. cerevisiae (see 3.4.1). 
Contrarily, comparison of orthologues in S. cerevisiae and C. glabrata by Desai 
et al., 2011, identified 337 ORFs unique to C. glabrata whilst YGOB identified 
294 ORFs (Desai et al., 2011; ygob.ucd.ie). It is likely that filters assigned to 
RBH searches (requiring 30 % sequence identity throughout 50 % of the coding 
sequence) greatly increased the number of C. glabrata genes which were 
identified in these searches and consequently many of the 727 C. glabrata 
ORFs may have orthologues. This was exemplified through the study of C. 
glabrata CAGL0D03850g which was identified to be C. glabrata-specific by 
RBH searches but was assigned as an orthologue of S. cerevisiae RSC30 by 
YGOB (ygob.ucd.ie). Complementation experiments provided evidence that S. 
cerevisiae RSC30 can functionally compensate for deletion of C. glabrata 
CAGL0D03850g (Figure 4.6), despite sequence identity lying in only 200 bp of 
the ORF sequence encompassing the Zn(2)-C6 fungal-type DNA-binding 
domain (yeastgenome.org). Thus it is proposed that some of the 727 C. 
glabrata ORFs identified by RBH searches may have S. cerevisiae orthologues, 
however, these were not identified due to the functional orthology lying within 
less than 50 % of the encoding sequence.  
 
Sequence comparison-based bioinformatic searches were the main criterion 
used for the selection of C. glabrata ORFs for gene deletion in this study (see 
3.4.3). Based on this selection, 65 C. glabrata deletion mutants were generated 
to create a library with defined features making the library compatible with the 
Schwartzmüller et al., 2013 study (Appendix 13). Each deletion mutant was 
tagged with two unique DNA barcodes and universal flanking sequences 
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enabling their amplification by PCR and flippase recognition target (FRT) sites 
to allow further downstream genetic manipulations such as recycling the 
resistance cassette to delete a second ORF. Subsequent screening of the 
deletion library facilitated the functional characterisation of previously unstudied 
C. glabrata ORFs (see Chapter 4). Of particular note was the identification of 
three ORFs required for tolerance of antifungal drug fluconazole (Figure 4.4) 
and the implication of putative chromatin modeller CAGL0D05434g in tolerance 
to DNA damage-inducing agents, metal and metalloid compounds. 
Furthermore, screening implicated 16 C. glabrata ORFs in biofilm formation 
(Figure 4.9) and identified six gene products required for virulence in an 
immunocompromised D. melanogaster larvae infection model (Figure 4.11).  
 
However, a large proportion of C. glabrata mutants showed no phenotype in 
any screen. For example, in chemogenomic screens 110 of 132 deletion 
mutants did not yield altered growth under any tested condition, likely due to the 
presence of compensatory pathways masking the effects of genetic perturbation 
(see 4.3.2). Alternatively, the ORFs targeted by gene deletion could be dubious 
ORFs or pseudogenes. Selection of ORFs for functional characterisation could 
be improved by the incorporation of experimental data in combination with 
bioinformatic selection criterion. For example, C. glabrata expression data could 
be used to identify C. glabrata-specific ORFs which are differentially regulated 
in response to stress, since stress resistance is a vital prerequisite to surviving 
the host environment. As such a more targeted strategy for ORF selection may 
increase the number of deletion mutants showing observable phenotypes.  
 
Taking both RBH- and YGOB-based searches into account, this study proposes 
that 197 C. glabrata ORFs have no strict orthologue in S. cerevisiae (Figure 
3.4). Of the 65 C. glabrata ORFs deleted in this study, 37 have no S. cerevisiae 
orthologue according to YGOB (ygob.ucd.ie). Within this list, 23 C. glabrata 
ORFs were associated with novel phenotypes during the course of this study 
(Table 4.4), expanding the functional annotation of uncharacterised ORFs in 
this species and the role they may play in C. glabrata stress adaptation and 
survival of the host environment. 
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6.3 The Use of a Non-Mammalian Host for Virulence Studies of C. glabrata 
Strains 
The current study introduced the use of a D. melanogaster larvae infection 
model for virulence analysis of large collections of C. glabrata mutants. In this 
instance, in vitro studies of C. glabrata –immune cell interactions were not 
selected as a model for virulence since macrophage studies of C. glabrata 
virulence were previously found to not correlate well with in vivo murine models 
of C. glabrata infection (personal communication, Dr. Hsueh-lui Ho, University 
of Exeter). Although murine models remain the mammalian host model of 
choice for Candida infection studies, their use is limited by high labour intensity 
(in particular to achieve statistically significant sample sizes), high costs and 
ethical issues. As such, mammalian host models are not amenable to high-
throughput virulence screens. This work addressed the requirement for 
alternative non-mammalian model host for virulence studies of Candida 
species. Such a model host is required for C. glabrata in particular due to the 
unsuitability of Galleria mellonella as a host for this species (Cotter et al., 2000). 
Alternative models such as zebrafish have been used to study C. albicans 
infection (Chao et al., 2010) however such a host model requires the availability 
of specialist aquarium equipment. A D. melanogaster infection model offers a 
number of advantages including the ready availability of large sample numbers 
of larvae thus providing statistically sound experimental pool sizes. In addition, 
the maintenance of Drosophila stocks requires only a fraction of the cost and 
labour required of a mammalian host. As a model organism, a variety of 
Drosophila tools (such as flybase.org), strain collections (RNAi collections) and 
stock centres (Bloomington Stock Centre) exist, enabling the analysis of C. 
glabrata virulence in a variety of chosen strain backgrounds. The ability to 
screen collections of C. glabrata deletion mutants in different D. melanogaster 
backgrounds offers the opportunity to study host-pathogen interactions – for 
example, dissecting interactions with components of host immunity. The use of 
a non-mammalian infection model also alleviates any ethical issues surrounding 
the use of animals for experimentation. The biological relevance of D. 
melanogaster as a model host for virulence studies has previously been 
validated in C. albicans in which both D. melanogaster and murine hosts 
showed strong correlation (Glittenberg et al., 2011 B). Thus, with the increasing 
availability and size of strain collections of pathogenic fungi, the use of non-
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mammalian infection models for high-throughput pathogenesis studies is likely 
to increase. During the course of this study, another group published work in 
which D. melanogaster was used as a model host for the study of C. glabrata 
infection, showing similarities to results obtained from mammalian host models. 
Namely, as has been observed in murine host models (Calcagno et al., 2003; 
Calcagno et al., 2004; Kaur et al., 2007), components of MAPK signalling 
pathways and yapsins were required for virulence in wild-type D. melanogaster 
(Quintin et al., 2013). They also found that wild-type D. melanogaster was 
unable to kill C. glabrata cells (administered by injection) but rather C. glabrata 
infection was contained via a Toll-pathway mediated mechanism (Quintin et al., 
2013). Together, these studies have extended the utility of D. melanogaster as 
a suitable host for C. glabrata virulence studies. The use of such models will 
subsequently reduce the number of strains tested in mammalian hosts. 
 
The implementation of D. melanogaster as a model for C. glabrata virulence 
studies uncovered six deletion mutants which were attenuated for virulence 
(see 4.3.4; Figure 4.11 A). Of the deleted C. glabrata ORFs identified, five had 
no previous implication in C. glabrata pathogenicity. Infection of 
immunocompromised D. melanogaster larvae with all six C. glabrata mutants 
resulted in increased larvae survival compared with infection with parental 
strains (Figure 4.11 A). However, all mutants were able to activate the Toll 
Pathway, signifying that all C. glabrata mutants were recognised by D. 
melanogaster PRRs (pathogen recognitions receptors), instigating innate 
immune signalling (Figure 4.11 B). Activation of the Toll pathway, allows D. 
melanogaster larvae to control (but not clear) C. glabrata infection resulting in 
survival of larvae following infection (Quintin et al., 2013). 
 
Most strikingly, three of the six C. glabrata ORFs (CAGL0D03850g, 
CAGL0B00726g and CAGL0L03674g) required for virulence in the D. 
melanogaster immunocompromised infection model have S. cerevisiae 
orthologues with known function in metabolic adaptation, most notably with 
regard to glucose metabolism. C. glabrata CAGL0L03674g shares orthology 
with S. cerevisiae GSM1, encoding a zinc finger transcription factor implicated 
in the regulation of energy metabolism; and CAGL0B00726g has orthology with 
S. cerevisiae GLK1 which encodes a glucokinase which functions in glucose 
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metabolism pathways (yeastgenome.org). C. glabrata CAGL0D03850g, which 
is orthologous to S. cerevisiae RSC30, has been shown to regulate metabolic 
adaptation genes in C. glabrata including carbohydrate metabolism (Rai et al., 
2012). Therefore, in agreement with Rai et al., 2012, this study proposes that 
remodelling of carbon metabolism may be a vital prerequisite for C. glabrata 
pathogenicity. The ability to readily alter carbohydrate metabolism could be an 
important factor in adaptation to the host niche, in which invading 
microorganisms such as C. glabrata experience competition for limited nutrients 
and must survive host-driven nutrient starvation strategies. As such, effective 
remodelling of carbon metabolism via ORFs such as CAGL0D03850g, 
CAGL0B00726g and CAGL0L03674g may confer a competitive advantage in 
the host environment and promote survival under nutrient-depleted conditions 
such as the phagosome. Such a theory is corroborated by the Rai et al., 2012, 
study in which CAGL0D03850g was found to be required for macrophage 
survival and for full virulence in a murine model of C. glabrata infection (Rai et 
al., 2012). Given its requirement for C. glabrata survival in macrophages and 
virulence, carbon metabolism pathways could be pursued as a potential drug 
target in the treatment of C. glabrata infections. 
 
A limitation of the D. melanogaster infection model used in this study lies in its 
restriction for detecting mutants with virulence levels either similar or reduced 
compared to that of the parental strains. Due to the 90 – 100 % killing levels of 
D. melanogaster larvae following infection with C. glabrata parental strains, this 
host model does not provide scope for identifying C. glabrata mutants with 
enhanced virulence. As such, adaptation of the model or use of another 
virulence model may be required for identifying mutants with enhanced 
virulence. 
 
6.4 Genetic Interaction Analysis Facilitates the Functional 
Characterisation of C. glabrata ORFs 
Virulence screening also identified two C. glabrata ORFs with no detectable 
orthologue in S. cerevisiae which were required for virulence in D. 
melanogaster: CAGL0K05687g and CAGL0H01749g. However, the lack of 
other observable phenotypes associated with the deletion of either ORF in C. 
glabrata prevented the identification of functional mechanisms by which these 
 192 | P a g e  
 
ORFs may contribute to virulence. As such, alternative strategies were required 
for functional characterisation of C. glabrata ORFs. This study exploited the 
synthetic genetic array (SGA) platform as a tool to identify genetic interactors of 
C. glabrata ORFs in S. cerevisiae. The large scale study of genetic interactions 
in S. cerevisiae has greatly facilitated functional annotation of previously 
unknown genes based on genetic interactions most frequently occurring 
between genes which lie in the same or parallel functional pathways, form part 
of the same protein complex and which share a similar cellular location (Tong et 
al., 2004). Comparison of networks of evolutionary distanced yeasts S. 
cerevisiae and Schizosaccharomyces pombe showed that genetic interaction 
networks retained conserved features with highly similar connectivity between 
different biological processes (Ryan et al., 2012). As such, it was hypothesised 
that systematic analysis of genetic interactions of C. glabrata ORFs in S. 
cerevisiae would reveal relevant functional information about ORFs that could 
be extrapolated back to C. glabrata biology. In this instance, genetic interaction 
analysis of C. glabrata CAGL0K05687g led to the implication of 
CAGL0K05687g in transport due to the high number of genetic interactions with 
S. cerevisiae membrane proteins, transporters (for example TRK1, CTR1 and 
FUI1) and SNAREs (SNAP receptor proteins) (see 5.4.6). Thus it could be 
speculated that the attenuation of C. glabrata ∆CAGL0K05687g in D. 
melanogaster could be due to defects in transport processes.   
 
SGA was also used to further dissect the function of putative C. glabrata 
chromatin remodeler CAGL0D05434g, following the observation that 
CAGL0D05434g was required for C. glabrata growth on metal and metalloid 
compounds in phenotypic screens (Figure 5.2). In agreement with screening 
observations, CAGL0D05434g was found to interact with a number of metal ion 
transporters (Appendix 6 Table 1 and 2). Genetic interactions and phenotypic 
screens also implied a role for CAGL0D05434g in DNA damage and replication 
stress which could impact fitness of C. glabrata cells upon macrophage uptake 
where DNA-damage repair mechanisms are crucial for survival (Rai et al., 
2012). Subsequent analysis of the C. glabrata ∆CAGL0D05434g mutants 
confirmed that CAGL0D05434g was required for growth under DNA damage 
and replication stresses, thus validating the biological relevance of studying C. 
glabrata genes in S. cerevisiae. During the course of this study, Brown & 
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Madhani, 2012, reported the use of SGA in S. cerevisiae in the characterisation 
of Cryptococcus neoformans virulence factors. Together, the current study and 
work by Brown & Madhani et al., 2012, extend the scope of systematic genetic 
interaction profiling using SGA to non-S. cerevisiae species. Such approaches 
could be applied to dissect the function of ORFs in other fungal species, 
inclusive of ORFs with or without an S. cerevisiae orthologue. 
 
6.5 Future work 
6.5.1 Studying the Evolutionary Differences of C. glabrata CAGL0D03850g 
and S. cerevisiae RSC30 
Preliminary complementation studies confirmed that S. cerevisiae RSC30 was 
able to functionally complement phenotypes associated with the deletion of 
CAGL0D03850g despite sequence identity lying in the N-terminal zinc-finger 
DNA binding domain only. Thus it is predicted that the functional domains only 
of these proteins are required for maintaining orthologous gene function. 
Further experimentation using truncated C. glabrata CAGL0D03850g and S. 
cerevisiae RSC30 mutants could investigate whether the DNA-binding domain 
is sufficient to complement orthologue function. Additionally, the evolutionary 
differences between orthologues could be explored since C. glabrata 
CAGL0D03850g was found to be required for virulence in the D. melanogaster 
infection model yet its orthologue RSC30 has been retained in the non-
pathogenic yeast S. cerevisiae. Thus it could be of interest to consider whether 
complementation of C. glabrata CAGL0D03850g with S. cerevisiae RSC30 
extends to the virulence phenotype. Exploiting technologies such as ChIP-seq 
could be used to compare different target genes of the two transcription factors 
and identify instances of genetic rewiring that may have accompanied the 
emergence of C. glabrata as a pathogen. Comparison of S. cerevisiae RSC30 
orthologues in pathogenic S. cerevisiae isolates and recently identified 
emerging pathogens of the C. glabrata clade (Gabaldón et al., 2013) could also 
identify whether RSC30 orthologues are more similar to C. glabrata RSC30 and 
whether this RSC30 is also related to pathogenicity in these species. 
 
6.5.2 Understanding the Role of Horizontal Gene Transfer in C. glabrata 
To complement bioinformatic analysis which linked three C. glabrata ORFs to 
horizontal gene transfer (HGT) events from bacteria, experimental analysis 
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could verify the functionality of C. glabrata ORFs in bacterial species. For 
example, expression of CAGL0D01210g in bacterial species (such as model 
organism E. coli or alternatively in Lactobacillus species from which it was 
predicted to originate from) could investigate whether CAGL0D01210g confers 
increased tolerance to D-aspartate enantiomers. It has been predicted that the 
ability to metabolise and detoxify D-aspartate by C. glabrata may confer a 
competitive advantage in the host niche or enhances virulence. This could be 
investigated using competitive growth experiments in a mammalian host, 
exploiting the unique barcodes built into the C. glabrata deletion library, to verify 
whether the presence of aspartate racemase encoded by CAGL0D01210g does 
confer a competitive advantage. It could also be tested whether 
∆CAGL0D01210g mutants are altered for virulence or stress resistance 
following treatment with D-aspartate. Such work would greatly enhance 
understanding regarding the physiological role of fungal genes acquired from 
bacteria and the impact such genes have with regards to adaptation to the host 
environment. Although some such studies exist (Garcia-Vallvé et al., 2000; Uo 
et al., 2001), the wider implication HGT may have in the evolution of 
pathogenicity remains relatively unstudied. 
 
6.5.3 Exploiting Barcoded C. glabrata Mutants for Competitive Growth 
Analysis 
Both C. glabrata deletion libraries constructed in this study and by 
Schwartzmüller et al., 2013, incorporated two unique 20 bp DNA barcodes into 
each individual deletion mutant, making the prevalence of each strain 
detectable within mixed populations of mutants (see 1.3.1.1). In the current 
study, the functional characterisation assays were performed using 
monocultures of each individual mutant. Whilst this yielded biological insight into 
the function of previously uncharacterised ORFs under controlled conditions in 
vitro, it does not reflect the environmental conditions and the competition C. 
glabrata cells would experience in the mammalian host. Therefore, competitive 
growth assays or STM-like screens in a murine host could be of use for the 
identification of mutant phenotypes which could otherwise have been masked in 
non-competitive growth assays performed using rich media and could increase 
the biological relevance of phenotypic screening observations. 
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6.5.4 Further Characterising C. glabrata Fluconazole-Susceptible Mutants 
Importantly, phenotypic screens in this study highlighted three C. glabrata ORFs 
which were found to be required for fluconazole tolerance (Figure 4.4), all of 
which encode putative transcriptional regulators. To further validate the role of 
identified C. glabrata ORFs in fluconazole resistance, increased tolerance to 
fluconazole following overexpression of CAGL0D03850g, CAGL0L07480g and 
CAGL0K05841g could be tested. Furthermore, future work could uncover the 
mechanisms by which deletion of CAGL0D03850g, CAGL0L07480g and 
CAGL0K05841g confer fluconazole susceptibility in deletion strains.  In 
particular, it is predicted that susceptibility to fluconazole in these strains could 
be dependent on the major regulator of drug resistance encoded by PDR1 
(CAGL0A00451g) or (see 1.9.1). This could be investigated using techniques 
such as RT-PCR or northern blotting to identify whether transcripts of PDR1 or 
its targets (such as CDR1, CDR2, SNQ2, QDR1) are altered in deletion mutants 
compared with parental strains. As a result, this work could expand our 
understanding of the mechanisms underlying drug resistance in C. glabrata.  
 
6.5.5 Dissecting the Role of Novel Biofilm-Associated ORFs in C. glabrata 
Following the identification of C. glabrata mutants with altered biofilm forming 
capacity in high-throughput screens (see 4.3.3), the role selected C. glabrata 
ORFs may play in biofilm formation could be further investigated using more 
direct methods to measure biofilm mass. In this study, enzymatic screens in 
which the colourimetric change accompanying XTT reduction in response to 
cellular metabolism was used as a readout for biofilm size. To increase the 
confidence of hits identified in biofilm screens, direct measurement of dried C. 
glabrata biofilm mass could be employed. Additionally, scanning EM could be 
used to observe altered structure of biofilms in biofilm-altered mutants. Lastly, 
candidate C. glabrata mutants from biofilm screens could be explored for 
altered expression (by Northern blotting or RT-PCR) or for interactions (protein 
pull-downs) with EPA6 (CAGL0C00110g) and EPA7 (CAGL0C05643g), which 
encode the major adhesins mediating biofilm formation in C. glabrata (see 
1.5.2). The adhesion-properties of the ∆CAGL0E00275g should be explored 
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further since biofilm formation was most significantly stunted in this strain. 
CAGL0E00275g encodes a protein encompassing a PA14 adhesin domain 
which was previously denoted EPA20 (de Groot et al., 2008). As such, future 
work should explore the possibility that EPA20 could be required for biofilm 
formation in C. glabrata. It is predicted that overexpression of EPA20 in C. 
glabrata may increase adherence and biofilm forming capability of cells both in 
vitro and in vivo. Studying the interaction of EPA20 with immune cells could 
validate such hypotheses. 
 
6.5.6 Validating C. glabrata ORFs Required for Virulence 
Previous studies have shown a strong correlation between D. melanogaster and 
murine models of C. albicans infection, making D. melanogaster a suitable 
model for C. albicans virulence studies (Glittenberg et al., 2011 B). Recent work 
by Quintin et al., 2013, also presented similarities in both host and pathogen 
factors required for the establishment of C. glabrata infection in both 
mammalian and D. melanogaster infection models. However, C. glabrata 
mutants identified to be attenuated for virulence in the immunocompromised D. 
melanogaster infection model (see 4.3.4) should be further validated in a murine 
model of C. glabrata infection. 
 
6.5.7 Functional Characterisation of C. glabrata CAGL0D05434g 
C. glabrata CAGL0D05434g was bioinformatically predicted to encode a 
chromatin remodeler acting in response to stress (GO:0043618; Appendix 4 
Table 1). To experimentally verify the role of CAGL0D05434g as a chromatin 
remodeler, MNase (micrococcal nuclease) assays could be used to investigate 
chromatin dynamics in ∆CAGL0D05434g and parental strains in response to 
stress.  In this work, C. glabrata CAGL0D05434g was found to be required for 
growth following stress induced by metals, metalloids and DNA-damaging 
agents (Figure 5.2 and 5.10). Therefore it is predicted that CAGL0D05434g may 
play a role in regulating adaptation to stress in C. glabrata. Further 
experimentation could verify genetic interactions of C. glabrata CAGL0D05434g 
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with DNA damage checkpoint control proteins encoded by RAD53, MEC1, 
RAD6 or RAD52 in C. glabrata (Appendix 6 Table 1 and 2) and whether 
CAGL0D05434g influences the DNA damage response through these proteins. 
Additionally, ∆CAGL0D05434g cells could be tested for altered survival 
following uptake by macrophages. It is predicted that survival of 
∆CAGL0D05434g would be reduced following macrophage uptake due to the 
finding that C. glabrata mutants defective in DNA repair mechanisms are more 
susceptible to macrophage killing (Rai et al., 2012). Such a finding would 
provide a link between phenotypes observed in vitro with in vivo phenotypes.  
Further to this, the HMG-box domain encoded by CAGL0D05434g belongs to 
the MATA group of HMG-box proteins, many of which are found at the mating 
type loci of other fungal species (Butler et al., 2004; Paoletti et al., 2005). In 
addition, expression of C. glabrata CAGL0D05434g in S. cerevisiae inhibited 
the formation of double mutants by classical mating methods in the SGA 
platform (see 5.3.3.2). As such it was hypothesised that CAGL0D05434g may 
function in mating, despite C. glabrata yielding no natural sexual cycle. 
Following the engineering of mating C. glabrata strains (Dr. Jane Usher, 
University if Exeter, personal communication), the involvement of 
CAGL0D05434g could be further investigated in these strains. It could be 
observed whether the presence or absence of CAGL0D05434g in these strains 
positively or negatively affects the efficiency of mating. The stage at which 
CAGL0D05434g may inhibit the sexual cycle of S. cerevisiae could also be 
further dissected since tetrads were never observed for S. cerevisiae strains 
expressing CAGL0D05434g.  
 
6.6 Conclusion 
In order to explore C. glabrata attributes associated with virulence, orthologous 
genes between C. glabrata, a significant pathogen of humans, and the non-
pathogenic yeast S. cerevisiae were compared. C. glabrata-specific ORFs were 
selected to generate a C. glabrata deletion library. A multifaceted approach was 
taken for the functional characterisation of the C. glabrata deletion library 
leading to the identification of C. glabrata ORFs required for fitness and for 
survival under a plethora of stress conditions. The study highlighted C. glabrata 
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ORFs implicated in biofilm formation, most notably that deletion of putative 
adhesin EPA20 results in decreased C. glabrata biofilm formation. Use of a D. 
melanogaster infection model highlighted novel C. glabrata ORFs required for 
virulence including a putative oxidoreductase encoded by CAGL0K05687g and 
unannotated ORF CAGL0H01749g. Synthetic genetic interaction profiling of C. 
glabrata ORFs in S. cerevisiae was used to uncover functional pathways 
proteins encoded by C. glabrata CAGL0K05687g and CAGL0D05434g may act 
within. Study of genetic interactions lead to the hypothesis that reduced 
virulence of a ΔCAGL0K05687g strain may be due to altered nutrient transport. 
Further, genetic interaction profiling may lead to the finding that putative 
chromatin modeller CAGL0D05434g may function in the DNA damage 
response of C. glabrata. 
Together, this work has expanded the molecular toolkit available to the Candida 
community for the study of C. glabrata ORFs. Phenotypic analysis of the C. 
glabrata deletion library has enabled the functional characterisation of 
previously unstudied C. glabrata ORFs and highlighted novel functions for C. 
glabrata ORFs in stress resistance, biofilm formation and virulence. 
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Appendix 1: List of 
oligonucleotides used in this 
study 
Table 1: General oligonucleotides used in this study for the generation of 
the C. glabrata deletion library. 
 
Primer Sequence 
U2-BC-NAT CGTACGCTGCAGGTCGACGCCTTCCGCTGCTAGGCGC 
D2-BC-NAT CTACGAGACCGACACCGTCGGGCCGCTGACGAAGTTC 
NAT-5’-R CATCCAAAGTAGTAGAC 
NAT-3’-F ATGTCTATGCCATGTCC 
 
 
Table 2: ORF-specific oligonucleotides used for the construction of C. 
glabrata fusion cassettes for targeted gene deletion. Underlined 
sequences represent Up- and Down- barcode sequences. 
 
Primer name Sequence ORF deleted 
A01870-500-F ACTCAGTGGAGTGATGC CAGL0A01870g 
A01870+500-R CTTGCAGAAGTAGAAGG 
A01870-1-NAT-R GCGTCGACCTGCAGCGTACGTTGAGGAGACCACTTAC
GCCCACGGCGCGCCTAGCAGCGG 
GACATTGAAGGAGATAC 
A01870+1-NAT-F CGACGGTGTCGGTCTCGTAGGGAGACTCTTTGTGCGT
ATAGTCAGCGGCCGCATCCCTGCGTGTATGTTCCGGT
AGG 
A02255-500-F CTGAAGCAAATG GATGC CAGL0A02255g 
A02255+500-R GGTTAACCACGCTCTCC 
A02255-1-NAT-R GCGTCGACCTGCAGCGTACGGACTTCACGAGCCTTAT
CAGCACGGCGCGCCTAGCAGCGGGCGAATGTAGTGAA
TGG 
A02255+1-NAT-F CGACGGTGTCGGTCTCGTAGGTATTATTCACATCTCCC
GGGTCAGCGGCCGCATCCCTGCCCAATGTGATGCTCA
CT 
A02299-500-F GAAAGTGGGATGTAGAC CAGL0A02299g 
A02299+500-R CACTACCAACTGATCAC 
A02299-1-NAT-R GCGTCGACCTGCAGCGTACGGATGAGCTTCAGTGTAC
TTCCACGGCGCGCCTAGCAGCGGGGAACTACTATGAG
TGAG 
A02299+1-NAT-F CGACGGTGTCGGTCTCGTAGTTAGAGACGAGACCACG
CTCGTCAGCGGCCGCATCCCTGCGACATCTCTCGCAA
ACA 
A02343-500-F CAGAGACCTGCGTAGTAC CAGL0A02343g 
A02343+500-R GATCTATCGAGAGACAC 
A02343-1-NAT-R GCGTCGACCTGCAGCGTACGCACCGATCTGACTCAAT
GATCACGGCGCGCCTAGCAGCGGCTCCTGTACAGCCG
TGT 
A02343+1-NAT-F CGACGGTGTCGGTCTCGTAGCATGGCATTGAAGCTCA
CTCGTCAGCGGCCGCATCCCTGCAGAGATCGGTGCTA
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GAT 
A03608-500-F CCAGTGACTTCTGTTGC CAGL0A03608g 
A03608+500-R GACAAGAGTAAGACTTC 
A03608-1-NAT-R GCGTCGACCTGCAGCGTACGGCCTATTTCAAACGAGG
GAACACGGCGCGCCTAGCAGCGG 
ACAATACGGAGCGACCG 
A03608+1-NAT-F CGACGGTGTCGGTCTCGTAGAGGTATAATAAGGTGCC
CGCGTCAGCGGCCGCATCCCTGCTCTGCATGCTTTGT
CGA 
A04257-500-F CGTACAAACACCTGACCC CAGL0A04257g 
A04257+500-R AACTGAAGAAAGCGACCC 
A04257-1-NAT-R GCGTCGACCTGCAGCGTACGCGATGGGTGATAGTCAT
ACCCACGGCGCGCCTAGCAGCGGCCAAGCAAAACAGC
AATC 
A04257+1-NAT-F CGACGGTGTCGGTCTCGTAGGAAATCCACTGTCACATT
CGGTCAGCGGCCGCATCCCTGCTAACAAAGTCTGGCT
GGC 
A04565-500-F GCCTGTCTAGGGCTTTC CAGL0A04565g 
A04565+500-R CCTCTTGAACTCTTCCT 
A04565-1-NAT-R GCGTCGACCTGCAGCGTACGCGCGGAACTGTCCATAC
TGTCACGGCGCGCCTAGCAGCGGCTTCTGATTAACCA
CCTC 
A04565+1-NAT-F CGACGGTGTCGGTCTCGTAGAAAGGCCAGTGGATTAC
ATGGTCAGCGGCCGCATCCCTGCCTCATATCCTTTAAG
GG 
B00726-500-F ACCGTGAAGGTGATTCAA CAGL0B00726 
B00726+500-R ACTTAGCTTCCACCGCTC 
B00726-1-NAT-R GCGTCGACCTGCAGCGTACGCATGCTGGTCCCTACTA
GAGCACGGCGCGCCTAGCAGCGGAGATCGAGTTAATA
GGTGTC 
B00726+1-NAT-F CGACGGTGTCGGTCTCGTAGATGATGTAACTAGAGCG
CAGGTCAGCGGCCGCATCCCTGCGCATTTCTCACCTA
CAA 
B01287-500-F CGATGTGATCCTGTTTCG CAGL0B01287g 
B01287+500-R GGTCTTGCTGTAGGGAT 
B01287-1-NAT-R GCGTCGACCTGCAGCGTACGGACCCGTTCAACTATCT
GTTCACGGCGCGCCTAGAGCGGCTGAAAGTAAAGGTA
CC 
B01287+1-NAT-F CGACGGTGTCGGTCTCGTAGAGCCAGCGTACATTATCT
TCGTCAGCGGCCGCATCCCTGCCGAATATGAATCCAG
GG 
B02882-500-F GCGTTTACTGTAAGGTG CAGL0B02882g 
B02882+500-R CCAGTAATCTGCTCTTC 
B02882-1-NAT-R GCGTCGACCTGCAGCGTACGGTGAGCTAATACTCGAT
CAGCACGGCGCGCCTAGCAGCGGGTTGTCTTTGTCTT
TAGC 
B02882+1-NAT-F CGACGGTGTCGGTCTCGTAGCTCCAATGTCGAGTGAT
ATGGTCAGCGGCCGCATCCCTGCAGGAGTTTGGCGTT
TCT 
B02926-500-F TGTTGCGGTAGGTGGAC CAGL0B02926g 
B02926+500-R CATCTACCATCTCAAGC 
B02926-1-NAT-R GCGTCGACCTGCAGCGTACGATACAGTAGACAGATGT
GGCCACGGCGCGCCTAGCAGCGGGGAGAAAGAGCAA
TTGG 
B02926+1-NAT-F CGACGGTGTCGGTCTCGTAGGCAACCTTCAATGCGCT
TAGGTCAGCGGCCGCATCCCTGCGTCCATGAATCATC
CTC 
B02948-500-F TGGCGACGACTGGCTCA CAGL0B02948g 
B02948+500-R GGTGACTTCGTGTGTCT 
B02948-1-NAT-R GCGTCGACCTGCAGCGTACGATATCTTTGCGCCCGGT
GGTCACGGCGCGCCTAGCAGCGG 
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AGGAGGACGAGTTGGTC 
B02948+1-NAT-F CGACGGTGTCGGTCTCGTAGTTATCTCCTTTCCACGAG
GGGTCAGCGGCCGCATCCCTGC 
CGCAGGCAACTCACGAG 
B02970-500-F ACCACTTTGCTTCTGTG CAGL0B02870g 
B02970+500-R GACTTCGTGTGTCTTC 
B02970-1-NAT-R GCGTCGACCTGCAGCGTACGTTGAGGACTCGCCACAA
TGCCACGGCGCGCCTAGCAGCGGGCATCTGAGTTATG
CAAG 
B02970+1-NAT-F CGACGGTGTCGGTCTCGTAGGCAAACTTCCGCGCTGT
GTTGTCAGCGGCCGCATCCCTGCGGCTTACGCAGGCA
ACT 
B03223-500-F CTTAGGAGAAGCCAGTG CAGL0B03223g 
B03223+500-R TCTCCATTCTCACCACG 
B03223-1-NAT-R GCGTCGACCTGCAGCGTACGGCGACCACTCGAATAAG
GACCACGGCGCGCCTAGCAGCGGTGCTAAGTC 
TGTGCGCT 
B03223+1-NAT-F CGACGGTGTCGGTCTCGTAGGGTTTGGTAATACTTAGC
GCGTCAGCGGCCGCATCCCTGC 
CCAGTGATGTTCGTATG 
B03883-500-F GACTGAGCACAAATACC CAGL0B03883g 
B03883+500-R CTTGCCATGAGATGGTC 
B03883-1-NAT-R GCGTCGACCTGCAGCGTACGGTTTACACCACTGTTCG
GTACACGGCGCGCCTAGCAGCGGTGCTGTTGGTCTGC
TGG 
B03883+1-NAT-F CGACGGTGTCGGTCTCGTAGGCGCTAACATTACTCAA
GACGTCAGCGGCCGCATCCCTGCCATCGATATTTCCG
CCG 
C00110-500-F GAACAGGTACTCTATTCC CAGL0C00110g 
C00110+500-R CAACTCTTTCTCTACGA 
C00110-1-NAT-R GCGTCGACCTGCAGCGTACGAGGCAGATACGATTAGT
ACGCACGGCGCGCCTAGCAGCGGAGACCTCACCTCAT
GTT 
C00110+1-NAT-F CGACGGTGTCGGTCTCGTAGCCGAAGTGTCATCGAAT
CTTGTCAGCGGCCGCATCCCTGCTGTGATACCACATTT
CC 
C00253-500-F CCATAGCGAAGTCCTTG CAGL0C00253g 
C00253+500-R CTCGGTAGGTGTTATGC 
C00253-1-NAT-R GCGTCGACCTGCAGCGTACGGCCTTGCACAAATGCTC
AAACACGGCGCGCCTAGCAGCGG GAATGTCGA 
AGTTCACC 
C00253+1-NAT-F CGACGGTGTCGGTCTCGTAGGCGTCAAATATCGGATT
CCAGTCAGCGGCCGCATCCCTGCCCTGAACTCTTCCA
ACA 
C00847-500-F CCTAAAGGCAAGCTCTAG CAGL0C00847g 
C00847+500-R TGTAATGGCGGTCAAGG 
C00847-1-NAT-R GCGTCGACCTGCAGCGTACGCATACACCTCTCGGATA
GTACACGGCGCGCCTAGCAGCGGGATGTAAACCTTGA
TCG 
C00847+1-NAT-F CGACGGTGTCGGTCTCGTAGTTTGTGCGACGCTCACC
GATGTCAGCGGCCGCATCCCTGCCCATCACTGTGTATT
GTG 
C01837-500-F TCAAGCACACTGTGTGG CAGL0C01837g 
C01837+500-R CGCCATCCTTACGCTGG 
C01837-1-NAT-R GCGTCGACCTGCAGCGTACGGAGTCGTCTCTCACTGC
GTTCACGGCGCGCCTAGCAGCGGCACCTGAAACACTA
CTG 
C01837+1-NAT-F CGACGGTGTCGGTCTCGTAGGTTCTCGCTGTCTG
TCCAAAGTCAGCGGCCGCATCCCTGC 
CATTCGAACGAGATCAG 
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C02277-500-F CTTCACTGTCACTGCTG CAGL0C02277g 
C02277+500-R GAAACAACAGCCAATGC 
C02277-1-NAT-R GCGTCGACCTGCAGCGTACGAGACGGACGCGATCCTA
TATCACGGCGCGCCTAGCAGCGGGTATGTGTGTTGCT 
TTC 
C02277+1-NAT-F CGACGGTGTCGGTCTCGTAGAGAAGTGACGGGCTCTC
CATGTCAGCGGCCGCATCCCTGCCTGCCATTACAGATA
CC 
C04763-500-F TGCACTCAGCATCATTG CAGL0C04763g 
C04763+500-R CGAGACACTACTACGAA 
C04763-1-NAT-R GCGTCGACCTGCAGCGTACGTTCGACGCGAGACTCTA
GTGCACGGCGCGCCTAGCAGCGGGCGTCTAATAC 
TCAGAG 
C04763+1-NAT-F CGACGGTGTCGGTCTCGTAGCACGGATATGAGTGGAA
ATCGTCAGCGGCCGCATCCCTGCTCCCACTTCTTTAGG
CC 
D03850-500-F CCACAGACACACTCGAT CAGL0D03850g 
D03850+500-R CTGAGTTAGCCAACCCTG 
D03850-1-NAT-R GCGTCGACCTGCAGCGTACGCCTCTCCGTGGCAAGTG
TATCACGGCGCGCCTAGCAGCGGAGCAATAGACGGGA
CTC 
D03850+1-NAT-F CGACGGTGTCGGTCTCGTAGACCGTTACGAGATGTAT
GTG GTCAGCGGCCGCATCCCTGC 
CAATTCTGGTGTTATGGAC 
D00682-500-F CAGACAGCAGCGCAGAG CAGL0D00682g 
D00682+500-R CTACAAGGTGTGACACA 
D00682-1-NAT-R GCGTCGACCTGCAGCGTACGGTGCTCCACAGTAATAC
AACCACGGCGCGCCTAGCAGCGGGGTTATTGAG 
AGCCACT 
D00682+1-NAT-F CGACGGTGTCGGTCTCGTAGGTCTAAATTCCGTTACTG
CGGTCAGCGGCCGCATCCCTGCGCTTCGTAACTACAT
AAC 
D01210-500-F CGTGTTGCTTGTCCTTAC CAGL0D01210g 
D01210+500-R TCCTCCTCAACTACCTC 
D01210-1-NAT-R GCGTCGACCTGCAGCGTACGGCAAGGTATGTGAGCTA
ATCCACGGCGCGCCTAGCAGCGG 
GAGTCTTCAACCAAACC 
D01210+1-NAT-F CGACGGTGTCGGTCTCGTAGAGAGCAGAGACATTATT
CCCGTCAGCGGCCGCATCCCTGCGCAGCAAGAGCACT
AAC 
D03872-500-F TCAACGCTCCTCTTGTG CAGL0D03872g 
D03872+500-R GTGCGAGCTGTTCAGTG 
D03872-1-NAT-R GCGTCGACCTGCAGCGTACGGAGGCAACTGTCTAGGT
ATCCACGGCGCGCCTAGCAGCGG 
GATCCTGACTCAATTGA 
D03872+1-NAT-F CGACGGTGTCGGTCTCGTAGAACCATTCCTGAAGACG
GTCGTCAGCGGCCGCATCCCTGCCGTGCTCTACAAGA
AAG 
D05170-500-F GCAGGATGTTCGCAACA CAGL0D05170g 
D05170+500-R TGTTGATTGCAGCTGGG 
D05170-1-NAT-R GCGTCGACCTGCAGCGTACGTGTAGCTGTTTCATCCG
CGCCACGGCGCGCCTAGCAGCGGGGTGTCTAGCTGG
TCAG 
D05170+1-NAT-F CGACGGTGTCGGTCTCGTAGATATGGATGCCGCACTC
CTGGTCAGCGGCCGCATCCCTGCCTACAGATACTCCA
AGAC 
D05434-500-F GTCCTCTTGCTACCAGAC CAGL0D05434g 
D05434+500-R GAGTTAGATCGTGGATG 
D05434-1-NAT-R GCGTCGACCTGCAGCGTACGTTATTGGCAGACGCCCA
TCGCACGGCGCGCCTAGCAGCGGGTCGGGACTGCCA
GGGC 
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D05434+1-NAT-F CGACGGTGTCGGTCTCGTAGCGAATGGTAAATAGTGC
GTCGTCAGCGGCCGCATCCCTGCGCATCGTTCCCACC
GAAC 
D06226-500-F TGTTGGATCGGCTTTGA CAGL0D06226g 
D06226+500-R CAGAGAAGAGCAAGGAG 
D06226-1-NAT-R GCGTCGACCTGCAGCGTACGATAGAGCCGTGCCACTC
GATCACGGCGCGCCTAGCAGCGG GATG 
CTAGAAGAGT GTC 
D06226+1-NAT-F CGACGGTGTCGGTCTCGTAGCATGCGCTGCCGTCAGA
TAAGTCAGCGGCCGCATCCCTGCAGCTCCGCACACTC
TAC 
D06380-500-F CCGGAGTTCTTCCACTG CAGL0D06380g 
D06380+500-R GAGTTGGTGAACGTGAC 
D06380-1-NAT-R GCGTCGACCTGCAGCGTACGCGGTGCTATACGGTGTT
ACTCACGGCGCGCCTAGCAGCGGGACTCTTAGTAGCT
TTCC 
D06380+1-NAT-F CGACGGTGTCGGTCTCGTAGTACCTACACGGGAGTAA
GCGGTCAGCGGCCGCATCCCTGCTGCAACCAGCGTCT
ACA 
E00275-500-F GTCAACGTAATAGTGGG CAGL0E00275g 
E00275+500-R GATCAAGGAGTACGTTG 
E00275-1-NAT-R GCGTCGACCTGCAGCGTACGCGGTTAAGGCGCGTTAC
CAACACGGCGCGCCTAGCAGCGG 
GACCAAATGTTTGCCTG 
E00275+1-NAT-F CGACGGTGTCGGTCTCGTAGCGTCGAGTATCATATTTC
CGGTCAGCGGCCGCATCCCTGCGAGAACTCTTTG 
GCTACC 
E06600-500-F GGTATGATCTGAAGGCA CAGL0E06600g 
E06600+500-R GATCGCATCTGGCAGGC 
E06600-1-NAT-R GCGTCGACCTGCAGCGTACGGAGGTCTTCCGCTCGCT
TAACACGGCGCGCCTAGCAGCGG 
TCAGATCAGAGGCATTAC 
E06600+1-NAT-F CGACGGTGTCGGTCTCGTAGGTTTACCACTAATCGTCG
TCGTCAGCGGCCGCATCCCTGCAGTTATCCTTTGCACT
G 
E06644-500-F GCTGTGCGATATCGCTG CAGL0E06644g 
E06644+500-R GGTCTAACTTCATGGAC 
E06644-1-NAT-R GCGTCGACCTGCAGCGTACGAATGGAATGCCCACTCT
CGGCACGGCGCGCCTAGCAGCGGCCAACATGGGTAC
GAAC 
E06644+1-NAT-F CGACGGTGTCGGTCTCGTAGTAGAAACACACACCCGT
GGGGTCAGCGGCCGCATCCCTGCGAGCAGGGACCAT
TGTT 
F00627-500-F GTCACAGATCAGCTCAC CAGL0F00627g 
F00627+500-R TCTCCAAATAGTTCTGG 
F00627-1-NAT-R GCGTCGACCTGCAGCGTACGACACTTCTCTCAGTTGC
GGTCACGGCGCGCCTAGCAGCGGCTATCGCTTGCAGG
TGG 
F00627+1-NAT-F CGACGGTGTCGGTCTCGTAGAAACCAGGTCATCACTC
AGTGTCAGCGGCCGCATCCCTGCCTGATCAAGTGTCA
AGCG 
F01265-500-F CTGTATCCCCTCCACTG CAGL0F01265g 
F01265+500-R CCAAGAATGGTGCAGCTGC 
F01265-1-NAT-R GCGTCGACCTGCAGCGTACGGAGGATTATTAAACCTG
GGCCACGGCGCGCCTAGCAGCGGCGAGATGCCGATG
GCCTC 
F01265+1-NAT-F CGACGGTGTCGGTCTCGTAGATCAGAGGCACATTCCG
GTCGTCAGCGGCCGCATCCCTGCGATTTGTTAGGCGT
TTG 
F01815-500-F ACTGAGAGCACTAGGAG CAGL0F01815g 
F01815+500-R GGC TGCACTGGGCAATT 
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F01815-1-NAT-R GCGTCGACCTGCAGCGTACGTAGGACGAGTCACTGCA
TCGCACGGCGCGCCTAGCAGCGGAGT GTTGTGTCTC 
TTGG 
F01815+1-NAT-F CGACGGTGTCGGTCTCGTAGCGAATGACTGTCCCAGC
TAGGTCAGCGGCCGCATCCCTGCGCAGTGTGAGTGTA
TGC 
F02057-500-F TTGTTAAGACAGCACTG CAGL0F02057g 
F02057+500-R ACTCTCGGATGGTGTTG 
F02057-1-NAT-R GCGTCGACCTGCAGCGTACGTCATGTGTTAGAATGCT
GGCCACGGCGCGCCTAGCAGCGG AAG TAGCGTTCTT 
ATGC 
F02057+1-NAT-F CGACGGTGTCGGTCTCGTAGAACAACTCTATCAGCCG
ATGGTCAGCGGCCGCATCCCTGCGTTCAGACTACATC
ACA 
F03069-500-F AGAAAGAGATGGACTCC CAGL0F03069g 
F03069+500-R CAAAGAATGCATCGTTCC 
F03069-1-NAT-R GCGTCGACCTGCAGCGTACGTCACTTGGACCAGTTTG
GCGCACGGCGCGCCTAGCAGCGGCCACTGACACGCT
TATC 
F03069+1-NAT-F CGACGGTGTCGGTCTCGTAGAGGTAATCTGGCGACCG
TCAGTCAGCGGCCGCATCCCTGCCAATAATGCATAGC
GGC 
F03905-500-F CCCGTTAAGACTAGGGC CAGL0F03905g 
F03905+500-R CGCTGCTGCTGTCGCCGC 
F03905-1-NAT-R GCGTCGACCTGCAGCGTACGCCGTGTACTGAATTACG
ATCCACGGCGCGCCTAGCAGCGG GCCCTTATCA 
GAATCCA 
F03905+1-NAT-F CGACGGTGTCGGTCTCGTAGCCTCACATTACCAAAGAT
GGGTCAGCGGCCGCATCCCTGCCCCCAGTCATCAGAG
AC 
F05159-500-F GTTCGTCGCAGTAAATTTC CAGL0F05159g 
F05159+500-R AATACTGGAGTAGCTGA 
F05159-1-NAT-R GCGTCGACCTGCAGCGTACGTGGCCGCATTTCGCAGA
TGTCACGGCGCGCCTAGCAGCGGCCAGTTCACTCACC
GAC 
F05150+1-NAT-F CGACGGTGTCGGTCTCGTAGTCATGCTGTACCATATTG
GGGTCAGCGGCCGCATCCCTGCGATCATCAATGGACG
GG 
F04081-500-F ACTTCATCGTAACTGAG CAGL0F04081g 
F04081+500-R GGAACCTCAAGTAGGCA 
F04081-1-NAT-R GCGTCGACCTGCAGCGTACGTGGCCGCATTTCGCAGA
TGTCACGGCGCGCCTAGCAGCGGGTCAGGTTTTGCTT
CTAAG 
F04081+1-NAT-F CGACGGTGTCGGTCTCGTAGTCATGCTGTACCATATTG
GGGTCAGCGGCCGCATCCCTGCGTATGATTCTAGTCG
TCC 
F05973-500-F GGTCTTGCTGTAGGGAT CAGL0F05973g 
F05973+500-R CGATGTGATCCTGTTTCG 
F05973-1-NAT-R GCGTCGACCTGCAGCGTACGAATTACAGCGACTCGAT
GCGCACGGCGCGCCTAGCAGCGGCAATATGAATCCAG
GG 
F05973+1-NAT-F CGACGGTGTCGGTCTCGTAGGCATCAAGTGGTGTCAG
TCTGTCAGCGGCCGCATCCCTGCCTGAAAGTAAAGGT
ACC 
F06237-500-F CGCGATGATCTGCTCG CAGL0F06237g 
F06237+500-R TCAACTGCCTAGCTTCC 
F06237-1-NAT-R GCGTCGACCTGCAGCGTACGACACCAGGGAAAGGGCT
TCACACGGCGCGCCTAGCAGCGGGCGTACAGAGTGTA
TAG 
F06237+1-NAT-F CGACGGTGTCGGTCTCGTAGGAGGTTACTCGGTCTTA
GCTGTCAGCGGCCGCATCCCTGCGAGGTCTCTACTGG
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TTA 
F08195-500-F CCAGAGATAGCATCTAC CAGL0F08195g 
F08195+500-R CACTACCAATGGACAACC 
F08195-1-NAT-R GCGTCGACCTGCAGCGTACGTCGCCACCTTTACGAAT
GTTCACGGCGCGCCTAGCAGCGGCTGCATTGCAAGTG
AAAGGC 
F08195+1-NAT-F CGACGGTGTCGGTGTCGTAGAAGATAGAGTAACCCGC
CTCGTCAGCGGCCGCATCCCTGCGTGTGCCAGTTAGA
CCA 
F08767-500-F GTAGACAACTGGGTGTG CAGL0F08767g 
F08767+500-R GGTTCTCCACGAACGAG 
F08767-1-NAT-R GCGTCGACCTGCAGCGTACGCGGTGTGAGATGATATA
CTCCACGGCGCGCCTAGCAGCGGCTACTAGGGCTGTC
TCTC 
F08767+1-NAT-F CGACGGTGTCGGTCTCGTAGTTATCCATGCGGTGCAA
GCGGTCAGCGGCCGCATCCCTGCTGGCTACACCACGG
CTC 
F09229-500-F CTTCCTATCAGAGCATA CAGL0F09229g 
F09229+500-R GAACTTGTGACGGCTCC 
F09229-1-NAT-R GCGTCGACCTGCAGCGTACGAGCGTACTAGGCATCTA
TTGCACGGCGCGCCTAGCAGCGGCAGCGTGGGTATAA
CCGG 
F09229+1-NAT-F CGACGGTGTCGGTCTCGTAGCGAGCGAATGATCTACT
ATCGTCAGCGGCCGCATCCCTGCGTAAGTCGTAGAGG
CT 
G02607-500-F GTAAGCCTACTTCCCCG CAGL0G02607g 
G02607+500-R CTGATGGTGCCGCTGCTC 
G02607-1-NAT-R GCGTCGACCTGCAGCGTACGATAGCATGAACATCACG
GCCCACGGCGCGCCTAGCAGCGGCGGGTTGATTCATA
ACTC 
G02607+1-NAT-F CGACGGTGTCGGTCTCGTAGAATGCCGAAAGCTCCAG
CAGGTCAGCGGCCGCATCCCTGC 
CCTAGCGCTGTGTAATA 
G03201-500-F GAACGGAGCTGCTCCTG CAGL0G03201g 
G03201+500-R ATCTAGTTGCAGCCGCT 
G03201-1-NAT-R GCGTCGACCTGCAGCGTACGTCGTAGTACAGATCAGG
TAGCACGGCGCGCCTAGCAGCGG 
CTGCCAGTTCTTTCATGC 
G03201+1-NAT-F CGACGGTGTCGGTCTCGTAGCGTGGAAATGCTGGTAA
TACGTCAGCGGCCGCATCCCTGCGATCACATCACGGT
TGG 
G03421-500-F TGCAGTGCCATCTAAACC CAGL0G03421g 
G03421+500-R TTTCGGCATAATACTGGG 
G03421-1-NAT-R GCGTCGACCTGCAGCGTACGCGCCTGTTACAAAGTCT
GTTCACGGCGCGCCTAGCAGCGGCCTTATTTGGTTTG
GTG 
G03421+1-NAT-F CGACGGTGTCGGTCTCGTAGATGATTGACCCGCAGAC
TCGGTCAGCGGCCGCATCCCTGCCACTACACTCATTCA
TTTCG 
G04279-500-F GAATCCAAATGAGTGCG CAGL0G04279g 
G04279+500-R GGCGGCATCCGTTTATG 
G04279-1-NAT-R GCGTCGACCTGCAGCGTACGCCGGTTGCCAAAGCGAG
AAACACGGCGCGCCTAGCAGCGGCCGGATTACTTTAG
C TG 
G04279+1-NAT-F CGACGGTGTCGGTCTCGTAGGTGGGAACTTCTTCTCCT
CGGTCAGCGGCCGCATCCCTGCGTTAACGGTGCTTGA
AC 
G04389-500-F GCACTTTATCGGCACCTG CAGL0G04389g 
G04389+500-R AACGCTGGTTTTGACGC 
G04389-1-NAT-R GCGTCGACCTGCAGCGTACGCGATGGCTGCGTATCCC
TAACACGGCGCGCCTAGCAGCGGCTAGATGCTTCTCA
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CTC 
G04389+1-NAT-F CGACGGTGTCGGTCTCGTAGTTAAGATACCTGCCCATT
CGGTCAGCGGCCGCATCCCTGCTTCGCGTAGTTAGAC
GC 
G05522-500-F CTCCTTGAGCAAATGCG CAGL0G05522g 
G05522+500-R CGTTATCCATGGCTCAC 
G05522-1-NAT-R GCGTCGACCTGCAGCGTACGCCGCCTTAACACTATGG
GATCACGGCGCGCCTAGCAGCGGGGCGTTTGAGTTGT
CGG 
G05522+1-NAT-F CGACGGTGTCGGTCTCGTAGTATTCTTGACGCAGCTC
GGGGTCAGCGGCCGCATCCCTGCCCCGTTTAGGTATT
TCC 
G10175-500-F CGTGGACATTGAACGGC CAGL0G10175g 
G10175+500-R CAGTATCTTATCAGGCC 
G10175-1-NAT-R GCGTCGACCTGCAGCGTACGGCAGCAATGTGGTCCGC
TATCACGGCGCGCCTAGCAGCGGGATAGACAAGCAGT
CTC 
G10175+1-NAT-F CGACGGTGTCGGTCTCGTAGCCGTCGTATGAATCTACA
TCGTCAGCGGCCGCATCCCTGCCGGCGCATATTTTGA
CA 
H01749-500-F CACTTCTCAGGGTATCC CAGL0H01749g 
H01749+500-R GGTATACTGTGCAAACG 
H01749-1-NAT-R GCGTCGACCTGCAGCGTACGGAGGTGCATCTCACTCC
ATGCACGGCGCGCCTAGCAGCGGCTCTAGCGGTGCT 
TTCT 
H01749+1-NAT-F CGACGGTGTCGGTCTCGTAGGCATGTCATTCATACTAC
GGGTCAGCGGCCGCATCCCTGCCAACTCTGTGAACTT
CC 
H04037-500-F GTGTCAAGACGAGAAGG CAGL0H04037g 
H04037+500-R CACTCTGAACTGTGGTA 
H04037-1-NAT-R GCGTCGACCTGCAGCGTACGCATTATGCACGATGGAT
GCGCACGGCGCGCCTAGCAGCGGCAGGTCGAAGAAG
TGTAC 
H04037+1-NAT-F CGACGGTGTCGGTCTCGTAGCTGCAACATGGCCGCTG
ATAGTCAGCGGCCGCATCCCTGCGGTCGGAAATAGGT
TGC 
 
H06765-500-F TCGTCCGGATGTTGCTC CAGL0H06765g 
H06765+500-R GTAGGTCTGGCCAGACA 
H06765-1-NAT-R GCGTCGACCTGCAGCGTACGAATCATCAGTAAGGAGG
GTCCACGGCGCGCCTAGCAGCGGGCATCCAGCATCAG
TCG 
H06765+1-NAT-F CGACGGTGTCGGTCTCGTAGGAAGATATTATGACCGA
GCGGTCAGCGGCCGCATCCCTGCAGCGTCTAACATAC
GCC 
H08712-500-F ATAGAAGCAGACGTGTC CAGL0H08712g 
H08712+500-R AGACACGAAG GCCTGCA 
H08712-1-NAT-R GCGTCGACCTGCAGCGTACGCATTCATTGTGAGCATG
GTGCACGGCGCGCCTAGCAGCGG CCTGGTGTT 
TTGTTCTG 
H08712+1-NAT-F CGACGGTGTCGGTCTCGTAGGCATGGGTGTGAATACT
ATCGTCAGCGGCCGCATCCCTGC 
CACAACATGTGTTGCTAC 
H09592-500-F GCTTGTG GACACAGAAG CAGL0H09592g 
H09592+500-R CAACGGATTGGTCTGCG 
H09592-1-NAT-R GCGTCGACCTGCAGCGTACGACAAACTCGGGCGCTAG
GATCACGGCGCGCCTAGCAGCGG 
GAAATTATGAGCGAGTG 
H09592+1-NAT-F CGACGGTGTCGGTCTCGTAGCTGGCTGGGAAACCGAA
ACA GTCAGCGGCCGCATCCCTGC CTATTGCA 
GGGCTTATAG 
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H09988-500-F CTTTAACGACCTGCATC CAGL0H09988g 
H09988+500-R CGACCCTGATGAGCTTG 
H09988-1-NAT-R GCGTCGACCTGCAGCGTACGAAGGATGTCTAACACTC
TCCCACGGCGCGCCTAGCAGCGGTAGTCGTTTGGGCG
CCA 
H09988+1-NAT-F CGACGGTGTCGGTCTCGTAGGAGGGAGCTTCCACCCA
TATGTCAGCGGCCGCATCCCTGCGCATTCATGGACATT
GC 
H10208-500-F ATCTATTCCTCGGTGCTC CAGL0H10208g 
H10208+500-R CTCCCTCCTTTCCTT 
H10208-1-NAT-R GCGTCGACCTGCAGCGTACGTTACGGAGGCTTGGCAT
ATTCACGGCGCGCCTAGCAGCGG TATTTGGCCT 
TTCCATTGTG TA 
H10208+1-NAT-F CGACGGTGTCGGTCTCGTAGGGAGCCGTTCGGACCAT
ATTGTCAGCGGCCGCATCCCTGC 
GTGAGAAACAAGCTACC 
I02244-500-F CTTCGTACCTAGCACTG CAGL0I02244g 
I02244+500-R TTGATCTGATCGCCGCT 
I02244-1-NAT-R GCGTCGACCTGCAGCGTACGAGGCATTTGTCACACTG
GTGCACGGCGCGCCTAGCAGCGG 
GAGAACGATTAACTAGC 
I02244+1-NAT-F CGACGGTGTCGGTCTCGTAGGCATGGCTTCCAATGTC
TGTGTCAGCGGCCGCATCCCTGC 
CAATGTGCTGAAGTGTC 
I08151-500-F GAAGCAGACCACCACGA CAGL0I08185g 
I08151+500-R GTTAGAGTAGCTGTTGG 
I08151-1-NAT-R GCGTCGACCTGCAGCGTACGCGATGTATCCCGCTGTC
GAACACGGCGCGCCTAGCAGCGG 
GAGGAAACTAAGACGAC 
I08151+1-NAT-F CGACGGTGTCGGTCTCGTAGTACAAACCAAGAGTGTG
TCGGTCAGCGGCCGCATCCCTGCCATGACATGTAACA
GCC 
I08437-500-F GATCAGTCGGTCATTCG CAGL0I08437g 
I08437+500-R CGACTTGTTGCGACATC 
I08437-1-NAT-R GCGTCGACCTGCAGCGTACGTATGCCTCTTGCTCCTA
GAACACGGCGCGCCTAGCAGCGG 
CCGACATCAACTTACCG 
I08437+1-NAT-F CGACGGTGTCGGTCTCGTAGGCGGATATAACAGTAGT
CACGTCAGCGGCCGCATCCCTGC GCA CACGAAGCAG 
GTCT 
I08613-500-F AGACAATACCGCACAGG CAGL0I08613g 
I08613+500-R CCTCTCCATTCGTCCTTG 
I08613-1-NAT-R GCGTCGACCTGCAGCGTACGGCGCATTAAGTCCATTG
AAGCACGGCGCGCCTAGCAGCGG 
GCTTGTCCTGTTCTGCT 
I08613+1-NAT-F CGACGGTGTCGGTCTCGTAGCTGTAATGGACTGGTAG
CTTGTCAGCGGCCGCATCCCTGCGCCTCCACCTACAA
TTT 
I10362-500-F GTGCCTATTT TCTGTCT CAGL0I10362g 
I10362+500-R AGACGCTGCAGATGTGC 
I10362-1-NAT-R GCGTCGACCTGCAGCGTACGTCTCTCTGTTGATCGCC
GGACACGGCGCGCCTAGCAGCGG 
GTGGACACAAACTAGAC 
I10362+1-NAT-F CGACGGTGTCGGTCTCGTAGGCGCGACACTAATTTATC
ACGTCAGCGGCCGCATCCCTGCCGGAAATGTTCCGTG 
J01177-500-F AACACGCTAAGCACAGG CAGL0J01177g 
J01177+500-R ACAGCTATCTAGACAGG 
J01177-1-NAT-R GCGTCGACCTGCAGCGTACGCGGTGTACTCGGATCTC
GATCACGGCGCGCCTAGCAGCGGTTGTGTTCTCGTTG
GCG 
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J01177+1-NAT-F CGACGGTGTCGGTCTCGTAGACTACCATCGCAGTTGA
GGGGTCAGCGGCCGCATCCCTGCCTTAAATGGTAGCT
CCA 
J02530-500-F CTTCCGAACCAGGAACG CAGL0J02530g 
J02530+500-R TACCCACGGAGCGAAGA 
J02530-1-NAT-R GCGTCGACCTGCAGCGTACGGATGATAGACCATACCT
CGCCACGGCGCGCCTAGCAGCGG GGCAAAACGA 
GAGTTTC 
J02530+1-NAT-F CGACGGTGTCGGTCTCGTAGTCTGATTCTTGCTCGGG
AGAGTCAGCGGCCGCATCCCTGC 
GCAGGATCAGGTCAAGC 
J04972-500-F GAGTCTTGGAGTTGCTAG CAGL0J04972g 
J04972+500-R GCGAGATAGCGAGAGAG 
J04972-1-NAT-R GCGTCGACCTGCAGCGTACGAATACTGGCAGAAGAGT
TGCCACGGCGCGCCTAGCAGCGG 
TGCAATACGTGGCATCC 
J04972+1-NAT-F CGACGGTGTCGGTCTCGTAGTCGTCCATAACAGGCAA
CTA GTCAGCGGCCGCATCCCTGC GAAGATC 
GACAACAAGG 
J05786-500-F CCACTTCGTACTCTACC CAGL0J05786g 
J05786+500-R CTCGTGCTTGAAGAAAC 
J05786-1-NAT-R GCGTCGACCTGCAGCGTACGAGTCTACCCACATGCTTT
AGCACGGCGCGCCTAGCAGCGGCAAGAACTTCGCTTG
AC 
J05786+1-NAT-F CGACGGTGTCGGTCTCGTAGCCGGCAAGTGTCCGATG
AATGTCAGCGGCCGCATCCCTGCCAGATGGCAAAGAC
AG 
J05852-500-F CCAGATCGAAGTTGCCG CAGL0J05852g 
J05852+500-R CTCTGTGTCCATGTCTG 
J05852-1-NAT-R GCGTCGACCTGCAGCGTACGTCTACGTGCGTCAGGTA
TGTCACGGCGCGCCTAGCAGCGG AGCAGTTCT 
CAGGTGCT 
J05852+1-NAT-F CGACGGTGTCGGTCTCGTAGTACCACACTTGGAAGAG
TCTGTCAGCGGCCGCATCCCTGC 
TGTTCTCAACGGTGCCG 
K02013-500-F CCTATTCTTGCCACTATG CAGL0K02013g 
K02013+500-R TCGGTGAATATCCGTGG 
K02013-1-NAT-R GCGTCGACCTGCAGCGTACGCGTGTGAATGAATGGCC
TCTCACGGCGCGCCTAGCAGCGGCATACGAGCTTCCA
TCAG 
K02013+1-NAT-F CGACGGTGTCGGTCTCGTAGTAGACATCTGTTCAAGTC
GCGTCAGCGGCCGCATCCCTGCCTGGCATATGTGAGA
GG 
K02145-500-F CGCTTTGGATTATAGCCG CAGL0K02145g 
K02145+500-R CAAAAGATCGGACCTCA 
K02145-1-NAT-R GCGTCGACCTGCAGCGTACGAGCGGGCATCGTAGCAT
ACTCACGGCGCGCCTAGCAGCGG 
CGTATACTGCGGCAGAA 
K02145+1-NAT-F CGACGGTGTCGGTCTCGTAGGCACGTATCACAATGAC
GCAGTCAGCGGCCGCATCCCTGCGGTATTTGCTT 
GAATGC 
K02585-500-F TTCATCAGCCAGTTCGC CAGL0K02585g 
K02585+500-R GAGTTACTCTGCTGCTC 
K02585-1-NAT-R GCGTCGACCTGCAGCGTACGTATGTCGCAGCCACTTC
AGGCACGGCGCGCCTAGCAGCGGCCACGTATTAACCT
TGAC 
K02585+1-NAT-F CGACGGTGTCGGTCTCGTAGGCAATCATGTTAGAACCT
CGGTCAGCGGCCGCATCCCTGCGGCTATTTGAGTCGT
CTG 
K05687-500-F GCCAGAGCTTTAGGGTTGG CAGL0K05687g 
K05687+500-R GGCAGTTCGTCTAGCAA 
 209 | P a g e  
 
K05687-1-NAT-R GCGTCGACCTGCAGCGTACGCAGTGATAGGGATGATA
CACCACGGCGCGCCTAGCAGCGG 
AGAGAGATACGTCGACAG 
K05687+1-NAT-F CGACGGTGTCGGTCTCGTAGCCATCCATGAGATATGT
GAGGTCAGCGGCCGCATCCCTGCGTCACTTAAGTTGA
CTG GC 
K07634-500-F TCCTTGCTCCCATGTTC CAGL0K07634g 
K07634+500-R GCCTTGTGGGTCATTCT 
K07634-1-NAT-R GCGTCGACCTGCAGCGTACGCGTCTACGAGTATTTGC
AGTCACGGCGCGCCTAGCAGCGGGCTAGGAGAGTGG
ACTA 
K07634+1-NAT-F CGACGGTGTCGGTCTCGTAGAAAGATCCTACATACGCT
CGGTCAGCGGCCGCATCCCTGCCTGGGTAATGGTAAT
CGC 
K08294-500-F GTGGCAGACCTGGGTCGG CAGL0K08294g 
K08294+500-R GGAGAACAGAACGGAACC 
K08294-1-NAT-R GCGTCGACCTGCAGCGTACGTATGTTGTCCCATCCGA
CGGCACGGCGCGCCTAGCAGCGGTCCCAGCTGTAAG
GCGG 
K08294+1-NAT-F CGACGGTGTCGGTCTCGTAGAGCCTAAGTGCCGAGAC
CTAGTCAGCGGCCGCATCCCTGCGCCTATCAAGACAT
AAGC 
K10318-500-F CACGCTCTCGCAACGCC CAGL0K10318g 
K10318+500-R CTCAGCACACAGAACTCC 
K10318-1-NAT-R GCGTCGACCTGCAGCGTACGCATGAGCTGAGTGCGAT
CCACACGGCGCGCCTAGCAGCGGAACGGCCCTGGTA
ACTA 
K10318+1-NAT-F CGACGGTGTCGGTCTCGTAGCGAGAAGTGTCGATAAT
CAGGTCAGCGGCCGCATCCCTGCCAAGCAAAGACTAA
CTGG 
K11066-500-F GTCCCAGT TCTTGTCGAC CAGL0K11066g 
K11066+500-R GACTCCTGTAGAATCGC 
K11066-1-NAT-R GCGTCGACCTGCAGCGTACGGGCTGTCCTGTGGCTTA
CATCACGGCGCGCCTAGCAGCGGGGGCAATGAGACTC
TG 
K11066+1-NAT-F CGACGGTGTCGGTCTCGTAGGTACACTTTGTCAACGAT
CCGTCAGCGGCCGCATCCCTGCTGCTATCTCCATGTC
GG 
L03916-500-F GGCTCACCAAGGTCATC CAGL0L03916g 
L03916+500-R GGTTGACGAGTTCTCTGG 
L03916-1-NAT-R GCGTCGACCTGCAGCGTACGATCAGCTACCTCATTGC
GATCACGGCGCGCCTAGCAGCGGAGAGAGAACTGGAA
ATG 
L03916+1-NAT-F CGACGGTGTCGGTCTCGTAGCATGCGGATGCGTCCAC
ATTGTCAGCGGCCGCATCCCTGCTCGGTGAACACCTA
ACA 
L06072-500-F CAAGTTTTCCTCTCTTG CAGL0L06072g 
L06072+500-R GCTGCATTGAGAAGGAC 
L06072-1-NAT-R GCGTCGACCTGCAGCGTACGGCCGTAGTAACAAGCTC
ACACACGGCGCGCCTAGCAGCGGCACTTCGGAACCTT
AGA 
L06072+1-NAT-F CGACGGTGTCGGTCTCGTAGATACACATGACTACGAGT
GCGTCAGCGGCCGCATCCCTGCGTTCTTTGTGTTTGCA
TC 
L06776-500-F AGTATCTGTGGGCTGAT CAGL0L06776g 
L06776+500-R CATCAATAGAGAGTGCG 
L06776-1-NAT-R GCGTCGACCTGCAGCGTACGTCATAGACTTGTAGCAG
TGGCACGGCGCGCCTAGCAGCGG 
GGCGTGTTCTAAGAAAC 
L06776+1-NAT-F CGACGGTGTCGGTCTCGTAGCGATGCACTAAATGACC
TCAGTCAGCGGCCGCATCCCTGC A GATAGCGTGT 
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CGGAAC 
L07480-500-F CACTATACTCAGGACAC CAGL0L07480g 
L07480+500-R CTGAATCTAAAGGCTAG 
L07480-1-NAT-R GCGTCGACCTGCAGCGTACGGGGTCATCACGGCTCAT
CATCACGGCGCGCCTAGCAGCGG TGCAAAT 
GAGGCTTGTG 
L07480+1-NAT-F CGACGGTGTCGGTCTCGTAGGCCATAGCTTCGACACG
ATTGTCAGCGGCCGCATCCCTGC 
GAAAGTCACCTTCACGC 
M00770-500-F CCGTGGCCACGGCCTTG CAGL0M00770g 
M00770+500-R CTTACTTACCCGATCAGG 
M00770-1-NAT-R GCGTCGACCTGCAGCGTACGTCGCGCTTGGTGCAAAT
TCTCACGGCGCGCCTAGCAGCGG  
M00770+1-NAT-F CGACGGTGTCGGTCTCGTAGCGCCGCAAGTATGGTAA
ATAGTCAGCGGCCGCATCCCTGCGACAAGTCTCATCTC
CTC 
M01716-500-F CTATTCGTTGTCGTTCTC CAGL0M01716g 
M01716+500-R AGTCGTTGCTGGTAGTG 
M01716-1-NAT-R GCGTCGACCTGCAGCGTACGTTGTACCCACTAGACGT
GCGCACGGCGCGCCTAGCAGCGG GAGG 
GCGTTATTTG TGG 
M01716+1-NAT-F CGACGGTGTCGGTCTCGTAGAGGGTATGCCGGACACT
CAAGTCAGCGGCCGCATCCCTGC 
GAGAGATGTAGGAATGC 
M01870-500-F AGTAGATGGGATTACCA CAGL0M01870g 
M01870+500-R CCATAGCCTTCCAAGAT 
M01870-1-NAT-R GCGTCGACCTGCAGCGTACGCTTCATTCAGGATCAGA
GGGCACGGCGCGCCTAGCAGCGG CTA 
TCAGCGAGATATTG 
M01870+1-NAT-F CGACGGTGTCGGTCTCGTAGCCATAGCTTAAAGGCGC
TTCGTCAGCGGCCGCATCCCTGC 
CACTATCCCTCCATTAG 
M01914-500-F CAAGGATTGACCCATCT CAGL0M01914g 
M01914+500-R CACTGGCATTCTGGTCC 
M01914-1-NAT-R GCGTCGACCTGCAGCGTACGCTACAAGCTCTGCGGTG
CATCACGGCGCGCCTAGCAGCGGCCTTGTACTTTCCTT
GC 
M01914+1-NAT-F CGACGGTGTCGGTCTCGTAGCAGCATTGGCAACGAGT
TTAGTCAGCGGCCGCATCCCTGCCAATGGCTCATAT 
TTCAC 
M02299-500-F GGCA CCGCACTGTGCTA CAGL0M02299g 
M02299+500-R TCGCTGACATGAACGAG 
M02299-1-NAT-R GCGTCGACCTGCAGCGTACGACCGTACTGAGACATCC
TGACACGGCGCGCCTAGCAGCGG 
CTATGCGTCTATGTGACC 
M02299+1-NAT-F CGACGGTGTCGGTCTCGTAGAGAGCCTTCCAATATCC
GTAGTCAGCGGCCGCATCCCTGC 
GAACCACCATGCAAT CA 
M02321-500-F CCTTCAGGAACGCCATC CAGL0M02321g 
M02321+500-R CAGACAACGACGAAACTG 
M02321-1-NAT-R GCGTCGACCTGCAGCGTACGCAGCCTAGTACATTAGC
TTCCACGGCGCGCCTAGCAGCGG CCAATCGCT 
AAGTGAGT 
M02321+1-NAT-F CGACGGTGTCGGTCTCGTAGTAAAGACATTGCCC
TCACTGGTCAGCGGCCGCATCCCTGC 
GATTGCATGGTGGTTCT 
M04543-500-F TCGCGGCACACATTGTT CAGL0M04543g 
M04543+500-R GCATTGGTCAACAGATCG 
M04543-1-NAT-R GCGTCGACCTGCAGCGTACGCAACCAGTGGACGGTAA
TCTCACGGCGCGCCTAGCAGCGG 
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CTTTACAATTGGCCAGT 
M04543+1-NAT-F CGACGGTGTCGGTCTCGTAGAAGTACGCTTCATCCTTC
GTGTCAGCGGCCGCATCCCTGC GCA 
AGACATGTCAAATG 
M05137-500-F ACGGAGAGGGAGAGAA CAGL0M05157g 
M05137+500-R CCGAAGATCGAAGAAGC 
M05137-1-NAT-R GCGTCGACCTGCAGCGTACGTGACATCTTGTATTCGC
GGCCACGGCGCGCCTAGCAGCGG 
TACGGTCAGTACCTAGC 
M05137+1-NAT-F CGACGGTGTCGGTCTCGTAGCAACCGTGAGGAGATCA
TGTGTCAGCGGCCGCATCCCTGCCGTACGTGAAAGAG
ATGC 
M10065-500-F TCTTCGCATGTGGC TAG CAGL0M10065g 
M10065+500-R AGTAGAGAGACAGCCAC 
M10065-1-NAT-R GCGTCGACCTGCAGCGTACGTGACATCCTTTAGTAGCT
GGCACGGCGCGCCTAGCAGCGG 
CTTCCAACTTCCTTCAGG 
M10065+1-NAT-F CGACGGTGTCGGTCTCGTAGAAGCCTTCAGTGCGTCA
TGT GTCAGCGGCCGCATCCCTGC GAAGTCC 
TGCCACATTC 
M10153-500-F ATACTATCAGAGTCCAC CAGL0M10153g 
M10153+500-R GCATTTGCCAGTGGGAT 
M10153-1-NAT-R GCGTCGACCTGCAGCGTACGATGTCAGAGACGGTACT
ACGCACGGCGCGCCTAGCAGCGGGAAGGGAAAGGTA
GTGC 
M10153+1-NAT-F CGACGGTGTCGGTCTCGTAGCCGACATATCCCTAGAG
TATGTCAGCGGCCGCATCCCTGCGTATACACTACCATA
CG 
M10978-500-F ACTGGCTTACAGCATCC CAGL0M10978g 
M10978+500-R CGACAACGAACAATAGTG 
M10978-1-NAT-R GCGTCGACCTGCAGCGTACGTACTGAGCGGCATGTCA
CTGCACGGCGCGCCTAGCAGCGG 
GTAGGGCAGTTTACGTT 
M10978+1-NAT-F CGACGGTGTCGGTCTCGTAGCTCAATGTGCAGTGGTA
TGCGTCAGCGGCCGCATCCCTGC 
TCGAGCTATCAGTAGCG 
M12881-500-F CCTTGGCCATGGACTAC CAGL0M12881g 
M12881+500-R CTAGAAGCTGTCCAGCTG 
M12881-1-NAT-R GCGTCGACCTGCAGCGTACGATGACGCGGGCTGTACT
ACTCACGGCGCGCCTAGCAGCGGGCTTCAGGCTTTAT
CCAG 
M12881+1-NAT-F CGACGGTGTCGGTCTCGTAGAATTCACGAGGCGTCAG
GCTGTCAGCGGCCGCATCCCTGCCATTTCCGCCGTCT
AGA 
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Table 3: ORF-speciific oligonucleotides for the verification of C. glabrata 
deletion mutants 
 
Primer name Sequence Deletion verified 
A01870 int-F GGTATCATGGTCGCGCA CAGL0A01870g 
A01870 int-R CGGAATCCTCTTCTGCT 
A01870-600-F GGCTGATTGGCTTGAGA 
A01870+600-R GGAAAGATCCGACATGG 
A02255 int-F GGTGACTTGGATGTCGT CAGL0A02255g 
A02255 int-R CATCTGGTCCAGCATTC 
A02255-600-F CCAGAGGACTTCTAATGC 
A02255+600-R AGTGCTCACACCGTGTG 
A02299 int-F GGAGAGCATACGTCCCA CAGL0A02299g 
A02299 int-R GTGCATTCCTGTGTCTG 
A02299-600-F CATTGGCAGCCATTCGG 
A02299+600-R CCGAAAGAGATGACAGC 
A02343 int-F CGGGTGTTCTACTCTGG CAGL0A02343g 
A02343 int-R GATGGAAATCCCTGCAC 
A02343-600-F GTTGGGCAGCTCATCGG 
A02343+600-R GCGTTTCTGCGATGAGAG 
A03608 int-F GTTTGCTCGCCTTGAAC CAGL0A03608g 
A03608 int-R GCTGACAGCGCTGATCT 
A03608-600-F GGACTCTGCTCCTATGTC 
A03608+600-R GCATCAGCAGCCATGGA 
A04257 int-F CCCGAGTATGCGAATATG CAGL0A04257g 
A04257 int-R GCCATGTGCATTTTCTTC 
A04257-600-F GAGAGGTACATCCTGGGG 
A04257+600-R GCACGTAAAGCTCCCTCT 
A04565 int-F TCACACAGCAAGACGAA CAGL0A04565g 
A04565 int-R CACTGAGTTCGACAAGG 
A04565-600-F GCACAATACGGTACTCAG 
A04565+600-R CACAACATGGTTAATACCG 
B00726 int-F GTGACTTCCGAATCCCTT CAGL0B00726g 
B00726 int-R ACATGCACCACCAATTTC 
B00726-600-F CAACAGACATAAAGGCGG 
B00726+600-R ACTGAAGCAGAAGCAGTCA 
B01287 int-F AATTAGGGATACCATGG CAGL0B01287g 
B01287 int-R AGGAGCGAAAGCGGCAG 
B01287-600-F GGCTTTGAATCCCGGTT 
B01287+600-R CAACCAACAACGCGTTG 
B02882 int-F GCAATGCTAGCAGAGG CAGL0B02882g 
B02882 int-R GAGACTGTCTATCTCGT 
B02882-600-F AAGGTGCAGTGGAACGC 
B02882+600-R CCCAGCTCCAGTATAAT 
B02926 int-F CTGGAGACTTGCGTTTC CAGL0B02926g 
B02926 int-R GTACCCGAACAAAGGAT 
B02926-600-F TCTAGAACTCAGCGTGC 
B02926+600-R GCACGGATTCGATTGGA 
B02948 int-F GATGGGACGCTAGAGCC CAGL0B02948g 
B02948 int-R GTCTGCCTCGCTGAAGG 
B02948-600-F CCTACGCACACCGTATG 
B02948+600-R GCGTCTGATGGGAAGAG 
B02970 int-F CAGCCTATAGATACCAC CAGL0B02970g 
B02970 int-R TATCCAAGACCGTTGGA 
B02970-600-F ATCGTACTCGGAAACGC 
B02970+600-R GCGTCTGATGGGAAGAG 
B03223 int-F GAGTGCGATGTGAACTC CAGL0B03223gg 
B03223 int-R TGTTGTGGCGACGCTTC 
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B03223-600-F GGCGAAATTCACCAACG 
B03223+600-R CGAGAATCCTGAATTCC 
B03883 int-F GGCAGTGGTGCTGGTAT CAGL0B03883g 
B03883 int-R CCTTCTGTACCACATCG 
B03883-600-F GCTGCCTTCTTGTACAG 
B03883+600-R CTCGAAGTCCATCACAC 
C00110 int-F CTATCTCATCGATCACC CAGL0C00110g 
C00110 int-R GCCTCTGTTCTGTTACG 
C00110-600-F GTGCAGAGGATAACTGA 
C00110+600-R CAGTCCTTTCCGTACAAG 
C00253 int-F CAGACAGCACACTGTTC CAGL0C00253g 
C00253 int-R CGAGGTGGAATACACTG 
C00253-600-F CATGTTGAGCTCGACCC 
C00253+600-R CTGAGATGATCACAGGAG 
C00847 int-F CCAGGAACAG ACATTCC CAGL0C00847g 
C00847 int-R TTGGACTTGGCGATGGA 
C00847-600-F CAAGAAGGAGTGGCTCC 
C00847+600-R GTGTGCGCTGCCTTCAA 
C01837 int-F GAAGCTGGACGTCGGCG CAGL0C01837g 
C01837 int-R CATGACGCGTACATCTC 
C01837-600-F CCATGGAATTCCGTCC 
C01837+600-R GTGGTATCCGAAGTGCC 
C02277 int-F GTCTCATCTTCTGAACGA CAGL0C02277g 
C02277 int-R GAATACTCTGGTCATCG 
C02277-600-F CAATGGACTTATCACGC 
C02277+600-R GTCTTCCTTCGATCCTT 
C04763 int-F AAGAGCACCAGGTGTTG CAGL0C04763g 
C04763 int-R AAGAGCACCAGGTGTTG 
C04763-600-F CAGATTGACCGACGAGG 
C04763+600-R GAGCACGCAAAGTAGAG 
D00682 int-F CACAGACAGGCAAATGC CAGL0D00682g 
D00682 int-R GATCTGGAGC AGCATGA 
D00682-600-F ATCACGGCAGAGACTGG 
D00682+600-R GTTGTCAGAAGGGCAAG 
D01210 int-F CGAGATGGTGGTTGAGAG CAGL0D01210g 
D01210 int-R CATCAAGTCCATGCTCC 
D01210-600-F GTGACCGGTGGTAGTAG 
D01210+600-R CCTGCAGGAAGTGGCTG 
D03850 int-F GGGCAAGTAGGGCAGTTG CAGL0D03850g 
D03850 int-R CCTAGCAGCCAACAGTTG 
D03850-600-F GGAGCTAACACTATGGC 
D03850+600-R ACATTGGATCTAGGCAC 
D03872 int-F CAATCTACACGGTGAGC CAGL0D03872g 
D03872 int-R AGGCACAACTTGGCATG 
D03872-600-F CGAAGCATACCGTAAGC 
D03872+600-R CATCCGTCCTGCAGAGA 
D05170 int-F CAGCGGATTACAGCACG CAGL0D05170g 
D05170 int-R CCGATGCTGCCACCAGT 
D05170-600-F GACCGGTATGCATTACC 
D05170+600-R CCTATTGGGCGAAGATC 
D05434 int-F GCTACCTCTTGTGGGACC CAGL0D05434g 
D05434 int-R CTAGCGAGCTCATTCCAG 
D05434-600-F CCACAACTCAGTGCAACCC 
D05434+600-R GGCGAGGACTAGTTAGAG 
D06226 int-F CGTCTGTTACTCACACC CAGL0D06226g 
D06226 int-R GCAAGACCGTCAAGGTT 
D06226-600-F GCACTCAGCTTGAGTAG 
D06226+600-R GCTCAGCATGTGAGTTG 
D06380 int-F CGAAGCTCGCCAATGAG CAGL0D06380g 
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D06380 int-R ACGGTGCCTTCGACCAG 
D06380-600-F GCACTGGGAACAATGCAG 
D06380+600-R CACAGTCTCGTCTCGGT 
E00275 int-F CACAGAAAGGCCAACTG CAGL0E00275g 
E00275 int-R GGATGGCTTGACACAAC 
E00275-600-F TACATCAGATAGCAGTC 
E00275+600-R CCGGGACAATCAAAACCT 
E06600 int-F CAGCTACTCGACTAGCG CAGL0E06600g 
E06600 int-R GAATGTGCAGCAGGTGT 
E06600-600-F GATCGTGGGAATCCTGT 
E06600+600-R GTGGTGAATATGCGCAC 
E06644 int-F CAGTTCGCAGAAGACTC CAGL0E06644g 
E06644 int-R CTTAGGACAGATGAGCTC 
E06644-600-F ATCGCAA GCATGCGATC 
E06644+600-R GTTAGTTCTTGTGTCCAG 
F00627 int-F AACTTGTCCCGCACCA CAGL0F00627g 
F00627 int-R CCGCCACGGCTGTAAGA 
F00627-600-F GCACCTTACCTACTGATGC 
F00627+600-R CTGATAAACGGGTTAGTTGGC 
F01265 int-F GGTGCTAGTCCCAACGG CAGL0F01265g 
F01265 int-R TCAGCTGGAGTCCCGGC 
F01265-600-F GGCTCTCCGCCTCCTAC 
F01265+600-R CATCTTCCTCCTCCACAC 
F01815 int-F GGCAAGAGACCATCACC CAGL0F01815g 
F01815 int-R GGTCTGTTG GTCGAGGA 
F01815-600-F ACACGAAGCAGAACATG 
F01815+600-R GGCTGTAGGTTATCTGA 
F02057 int-F GCTAGCATTACCTTAGAG CAGL0F02057g 
F02057 int-R CTGTCTGAGTTGTCCTC 
F02057-600-F TATCTCTTCGGACCTTG 
F02057+600-R TGCAAACACGCGATTCA 
F03069 int-F CCGATAAGCAAGCGGAT CAGL0F03069g 
F03069 int-R GACAGCTGTTAGCTTTG 
F03069-600-F CTGATATGGGCGATGAG 
F03069+600-R ATCGACGACGTCAGCGA 
F03905 int-F CTGGGCCAAATGGCAGAC CAGL0F03905g 
F03905 int-R ATAAGACGGGAAGTCCCC 
F03905-600-F GAGAGTACTGAGAACCG 
F03905+600-R GGCTTCTAAGAGCACATCG 
F04081 int-F GGACACGACAAGTGGCC CAGL0F04081g 
F04081 int-R TGCTGGGTAGCTGTAGC 
F04081-600-F TCCCGCACTTGACGTCA 
F04081+600-R CTACATATTCCGCCTTC 
F05159 int-F CGTCAGAAGATGAGCCGG CAGL0F05159g 
F05159 int-R CCCTTCCAGCCTGAGCC 
F05159-600-F CGCCGACAATGTTAAACC 
F05159+600-R ACCATCTGCAATTGACG 
F05973 int-F AGGAGCGAAAGCGGCAG CAGL0F05973g 
F05973 int-R GGAGGTCTCGGCAATCC 
F05973-600-F CAACCAACAACGCGTTG 
F05973+600-R GGCTTTGAATCCCGGTT 
F06237 int-F CAGGGACACAAGTACTG CAGL0F06237g 
F06237 int-R GGACCCTTGCCCTGTTG 
F06237-600-F GCAACTGTGAGAATACCC 
F06237+600-R GCCTTCAGCAACTTCTT 
F08195 int-F CTGGAATGACGACGAGA CAGL0F08195g 
F08195 int-R CCTGATTCGATTTCCCGG 
F08195-600-F CGCCAATAACTTCACCA 
F08195+600-R CCGGCTGCACCAATAGA 
F08767 int-F GTGCTTCCTTCCAGCCA CAGL0F08767g 
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F08767 int-R CGACTTACACGTGTTTCG 
F08767-600-F CCAAGACCAAGACCAAG 
F08767+600-R GCTTTGTATCCTAGGGC 
F09229 int-F ATGATGGGGAGGGATCG CAGL0F09229g 
F09229 int-R CGTGTCTATGTGGTCTTG 
F09229-600-F CAGCTAGTTTCTATGTTG 
F09229+600-R CCACAACTTCAAGCGGCAG 
G02607 int-F TGGATCAGTCAGTGGTG CAGL0G02607g 
G02607 int-R GTCCCTGTGGAAG AAAGCTC 
G02607-600-F TGAAACTTGCCTGGTCC 
G02607+600-R CAAATACGGCAAGATCC 
G03201 int-F CATGTCGTGACACAGCA CAGL0G03201g 
G03201 int-R GCAGATGATAGCCAGTT 
G03201-600-F CTTGATGCGAAACCAAAC 
G03201+600-R GCCTCCAGCCTCACCAT 
G03421 int-F  CAGL0G03421g 
G03421 int-R  
G03421-600-F GAGAGCACAGGAGCACAG 
G03421+600-R ACCTTGGTAATAGTTTGGG 
G04279 int-F GGGCTTTGCTGCATGCG CAGL0G04279g 
G04279 int-R GTACCGGTTGAACAGTG 
G04279-600-F TGAGCAGCCAGCACCCA 
G04279+600-R GCGCTTATCTGATCTTG 
G04389 int-F CCGCGCCAGTCTGTAAG CAGL0G04389g 
G04389 int-R CTGCCTCTTCTAATTGGC 
G04389-600-F CGTGTTGTGAAGCTGGC 
G04389+600-R GTTGCAGGTGGTGGTGC 
G05522 int-F GGCAAGCGAAGTCCACG CAGL0G05522g 
G05522 int-R GCATTTGCCATAACCGG 
G05522-600-F CCTCGACGCTAACTTTG 
G05522+600-R TCAAGCTGGCCACAACC 
G10175 int-F GCAAGATTGGCTGACGC CAGL0G10175g 
G10175 int-R GCCGATGATGGCTCTGT 
G10175-600-F CTCATCTCGTATCTGAG 
G10175+600-R GTAATGGTCATGCAGTG 
H01749 int-F ACGACAGGATGCAGCAT CAGL0H01749g 
H01749 int-R CCGTATCGCTGCTTCTG 
H01749-600-F TGGATTCTCCTCGCATC 
H01749+600-R TGACCTGCGTTTTGGGT 
H04037 int-F  CAGL0H04037g 
H04037 int-R TCTCAGATCCTTAGCAG 
H04037-600-F CAGTGCAAGAGGAATCAG 
H04037+600-R GCTCAACTCTCTCCAAC 
H06765 int-F GTGTCTGTTGTGCAGTC CAGL0H06765g 
H06765 int-R GAGATCTTGCAGACCAA 
H06765-600-F AACGTGTCGATGAACTC 
H06765+600-R GCAGCATTTGCTGCGTT 
H08712 int-F GAGGATTCAAGACTCCG CAGL0H08712g 
H08712 int-R CTGAGCAAGGCGTGCAA 
H08712-600-F GGCTTCTCGAAGCCATT 
H08712+600-R CGAGTTCGAAACTGCTG 
H09592 int-F GCTAACTTGCCAGCTGG CAGL0H09592g 
H09592 int-R AGAAGATGGAGCAGCAG 
H09592-600-F CGCTTCATTGTTCTCGC 
H09592+600-R GTACTACGTCTCATAGG 
H09988 int-F TACCGAACAGCCCCAAG CAGL0H09988g 
H09988 int-R GTAGCTACCTCGGTTGG 
H09988-600-F GTCATGACATCTGGCTATG 
H09988+600-R GCCGGACGACTCAAACT 
H10208 int-F TGTACACACAACTCCGC CAGL0H10208g 
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H10208 int-R GGCTTCGAGG CAGTGT 
H10208-600-F GAGGTACCGTAACCTCTC 
H10208+600-R AGATAGT ATGGCATGTGG 
I02244 int-F GATTGATGACGCAGGCG CAGL0I02244g 
I02244 int-R GTCTGCTCATCCACAGC 
I02244-600-F TGAACCAAACTACAGTG 
I02244+600-R GAGTAAGATCGACTGTCC 
I08151 int-F GCTGGTGAGCAAGAGGA CAGL0I08185g 
I08151 int-R TGCAGACCACGACAAGG 
I08151-600-F GGTTGCTCTAGCGTAAC 
I08151+600-F CCATCAAGGAGACGATTC 
I08437 int-F GTCGTTGAGTGTGGAAG CAGL0I08437g 
I08437 int-R GCATACAGGAGTCATCC 
I08437-600-F GACTGCTCAATCCACAG 
I08437+600-R GACAGGTCTTACCACAG 
I08613 int-F CATCATGCTTGTGCGTG CAGL0I08613g 
I08613 int-R CTCAGCGAGATGTCGGA 
I08613-600-F TGTTGTCTCTCTGCGTG 
I08613+600-R TCCTGCCAGTCTCCGCT 
I10362 int-F GACGACTGTTGTGACTG CAGL0I10362g 
I10362 int-R CAACTGGGAACTACCAG 
I10362-600-F CTGGAGGCTAGTTGAAGC 
I10362+600-R CAAGTCAAGAGAGCTGC 
J01177 int-F AGCGTCAGACCTAACTC CAGL0J01177g 
J01177 int-R CTTTCTTCTGGTTCTGC 
J01177-600-F TGTGGCAGTGGTATGCC 
J01177+600-R GGTCAGATCACTGAGAG 
J02530 int-F GTTGAGCCATCCTCATC CAGL0J02530g 
J02530 int-R CTGGAGGTACTCCAGGA 
J02530-600-F CCACACATAGCCGGTGT 
J02530+600-R AGGCAGTGACCTACTAG 
J04972 int-F GACATGCATCTTCGAGAC CAGL0J04972g 
J04972 int-R CAACACTGGAAAGCGCT 
J04972-600-F GACCCTATCACTGACAC 
J04972+600-R GTGTTTACCCTGGCGTC 
J05786 int-F GAACGTATGCGTGACAC CAGL0J05786g 
J05786 int-R GAGACTGTTGTACGTAG 
J05786-600-F GTCTACTGTATGCAC 
J05786+600-R GAGAGAGGCCATTGTAG 
J05852 int-F CGTTGTCAGTGGCTGCG CAGL0J05852g 
J05852 int-R GGTGCCAGTCTCTCTGC 
J05852-600-F CATCCTATAGCTGCTAC 
J05852+600-R CAACAGCAGGCGAGTACC 
K02013 int-F ACCTGTGTTTGCGTGCC CAGL0K02013g 
K02013 int-R CAGGCTGTTTCCTCGCA 
K02013-600-F GTCGAGAAGATGAAGGAG 
K02013+600-R CAAGGTCACTAGCTTGC 
K02145 int-F CGAGATGCTCAAACGAC CAGL0K02145g 
K02145 int-R TCAGGCACTAAAGAAGG 
K02145-600-F GCACACACATACAAACG 
K02145+600-R GCTCCATTCCTTTAGGC 
K02585 int-F ATAGTGCGAACTTGACC CAGL0K02585g 
K02585 int-R TGCTTAGCACCTTCTGC 
K02585-600-F TTAACACGCAGAACGTC 
K02585+600-R CACTTTCGCTGTTCTTC 
K05687 int-F CCCTTGAAGATTAGGGC CAGL0K05687g 
K05687 int-R TTTCGGACTTGGGACCG 
K05687-600-F CCTCGAACA GCTAAGACGG 
K05687+600-R GCCTACAGTCACCATGA 
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K07634 int-F TGATGACAAAGGCACCT CAGL0K07634g 
K07634 int-R CTCAGTGCTACTGACAC 
K07634-600-F AGTATTCTCAACTGCTGAAATAA 
K07634+600-R GTGGCCGATGATTGGTA 
K08294 int-F GGCCTGTTGTGCTCACC CAGL0K08294g 
K08294 int-R GCAAGCACGACTCGATG 
K08294-600-F CCCGCAGACTTAGTTGA 
K08294+600-R GGTGATAAAGCATTCTTC 
K10318 int-F GTGCTGTATCAGAGAAGC CAGL0K10318g 
K10318 int-R CCTCTAGCCTCACTAATC 
K10318-600-F CCTCTTGTCACAACGTC 
K10318+600-R GGGATCCGATTCTGATT 
K11066 int-F CTGGAGAACCAGTCTTC CAGL0K11066g 
K11066 int-R CCTGCTGCAACAACTGC 
K11066-600-F CAGGCGCTAAGCCC AAG 
K11066+600-R CCGTACGATGTGGAACG 
L03916 int-F CAACAATACTCCCTACGG CAGL0L03916g 
L03916 int-R GATCGTTTGTGGGTGGTAC 
L03916-600-F GCATTCCCCTTGACAACG 
L03916+600-R GACGGCCTATATTACCA 
L06072 int-F CTGGATATGTCGTCGCT CAGL0L06072g 
L06072 int-R CACTTCTGCTGAAAGAC 
L06072-600-F TGTAAGAAACACCAGTG 
L06072+600-R CTATCGCGCACCTTAAT 
L06776 int-F GTATCCAGATTGGAGAG CAGL0L06776g 
L06776 int-R CTCTAGAGCTTCCTATC 
L06776-600-F TAAGTCCAGGTTGGGAA 
L06776+600-R CTGAACCCACTTGTCCT 
L07480 int-F GGTACTCATCTCAAGTC CAGL0L07480g 
L07480 int-R CGTGTCTGCTGAAGCTT 
L07480-600-F CTAGCAATCGTTGCTAC 
L07480+600-R TGCTGGTTCCAAGACAT 
M00770 int-F GGAGTTCAAGCCCGAGT CAGL0M00770g 
M00770 int-R ACAATCTTGCTCCTCGG 
M00770-600-F CACGCACTAGCAAGTGA 
M00770+600-R CACTGTTAACCATGCGGC 
M01716 int-F CCACAACAGACTGATGA CAGL0M01716g 
M01716 int-R CGTGTATGAGTTCTGGA 
M01716-600-F CTCGCCAAAAGGATGGA 
M01716+600-R GAACGCTTGATACAGAA 
M01870 int-F CTCCAGAAGAGATACTC CAGL0M01870g 
M01870 int-R TCTGATGGGTAGCCATC 
M01870-600-F CTGTATCAACCGTAGAT 
M01870+600-R CTCTTGATGCCCTGTTG 
M01914 int-F GCTGTTGACTACGCTCTG CAGL0M01914g 
M01914 int-R ATAGCGTAGCAGCATGG 
M01914-600-F GATGAGAAGGACAGGAAG 
M01914+600-R TCTTGTCGATAGCGAGG 
M02299 int-F GGTGCTG TACACTACGC CAGL0M02299g 
M02299 int-R CCACCCGAACGGAAAGC 
M02299-600-F CGCC AATACTCATCCCGC 
M02299+600-R GAGACTCACTGATCCTG 
M02321 int-F CACTGATACTGCTGGCG CAGL0M02321g 
M02321 int-R AGTCTGTGCGCCATATAG 
M02321-600-F GTGGTGTGTAGATGGCT 
M02321+600-R CTAGATTTGGAGCACATC 
M04543 int-F GCTAGAGTTGCATGGAG CAGL0M04543g 
M04543 int-R TCACTGATACGTAAGGC 
M04543-600-F AGACACTAGTGCCGAGT 
M04543+600-R TCACTGGACACTCGTGG 
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M05137 int-F GACGGGTGTCAGACATG CAGL0M05137g 
M05137 int-R ACGTCAGCCGATATCGT 
M05137-600-F CATAAGAGAGGAACCAAC 
M05137+600-R ACTTCCAAGACGTCCGC 
M10065 int-F CACGATCACG GGCACAG CAGL0M10065g 
M10065 int-R CCTCAGTAACAGACGC 
M10065-600-F TGGATGCCTTCTAGTCC 
M10065+600-R CGGCTACAAGATCTATG 
M10153 int-F CCAGGAACACCTGAGGA CAGL0M10153g 
M10153 int-R CTTCTCTACACACAGCA 
M10153-600-F GGCTGAGCTATTGGTGA 
M10153+600-R GCGAAGCCAAAACTGAG 
M10978 int-F CATTGTACGCTATGAGC CAGL0M10978g 
M10978 int-R AACGGAGACCTCTCAGC 
M10978-600-F CCTTGTGTATCAATCGTG 
M10978+600-R GTTCCATGATGCTGAAGG 
M12881 int-F CGGTAGTGCCGGTTACT CAGL0M12881g 
M12881 int-R CCAAGGTTCACAGCAAGC 
M12881-600-F GAGCAACTCCTCAGTTC 
M12881+600-R ACTACTGAAGCCCAATC 
 
 
Table 4: General oligonucleotides for cloning of C. glabrata ORFs into the 
Invitrogen Gateway® System. 
 
Primer Sequence 
AttB-For GGGACAAGTTTGTACAAAAAAGCAGGCTTC 
AttB-Rev GGGGACCACTTTGTACAAGAAAGCTGGGTC 
M13-For GTAAAACGACGGCCAG 
M13-Rev CAGGAAACAGCTATGAC 
 
Table 5: ORF-specific primers for amplification of C. glabrata and S. 
cerevisiae ORFs for cloning into the Gateway® System. 
 
Primer Sequence 
GW-D05434-F ACAAAAAAGCAGGCTTCATGCAATCTAACGTTACTCTTCCACCTATC 
GW-D05434-R TACAAGAAAGCTGGGTCTAACACTAGTGGTGAAGAGTTTGCGTTCTT 
GW-RSC30-F ACAAAAAAGCAGGCTTCATGATGGACATGCAAGTGAGAAAAGTGAC 
GW-RSC30-R TACAAGAAAGCTGGGTCCTAATTATAAAATGCATCATAGAAATCGTT 
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Appendix 2: Phenotypic 
Screening Media 
 
Table 1: Summary of conditions used for phenotypic screens. For 
chemicals added to the media, stock concentrations, solutes and final 
concentrations are listed. All screening was performed on YPD agar plates and 
incubated at 30 °C (unless otherwise stated). For chemicals listed as “carbon 
source”, glucose was omitted from the media. All filter sterilised stocks were 
added to YPD agar following autoclaving. 
Chemical/condition Stock 
concentration 
Final 
concentration 
Notes 
YPD - - - 
Reduced temperature - - Incubation at 16 °C 
Increased temperature - - Incubation at 42 °C 
Heat shock - - Heat shock for 1 hour at 55 
°C, return to incubation at 30 
°C 
Glycerol 100 % 3 % - 
LiCl 4 M 80 mM Filter sterilise stock 
SDS (Sodium dodecyl 
sulphate) 
20 % 0.1 % and 0.05 % - 
ZnCl2 1 M 8 mM Filter sterilise stock 
CdCl2 100 mM 2 mM Filter sterilise stock 
CoCl2 100 mM 1 mM and 2 mM Filter sterilise stock 
BaCl2 2 M 50 mM Filter sterilise stock 
FeCl2 100 mM 200 μM Filter sterilise stock 
CsCl 5 M 250 mM Filter sterilise stock 
KCl 2.5 M 200 mM and 400 
mM 
Filter sterilise stock 
NaCl - 0.5 M, 1 M and 1.5 
M 
- 
Ethanol 100 % 6 % - 
Caffeine 150 mM 10 mM and 20 mM Filter sterilise stock 
Sorbitol - 1 M - 
MnCl2 1 M 30 mM Filter sterilise stock 
CaCl2 5 M 0.5 M Filter sterilise stock 
CuSO4 1 M 7.5 mM Filter sterilise stock 
 220 | P a g e  
 
MgCl2 5 M 600 mM Filter sterilise stock 
CuCl2 100 mM 5 mM Filter sterilise stock 
Lactose (carbon source) - 2 % No glucose 
Starch (carbon source) - 2 % No glucose 
Galactose (carbon 
source) 
- 2 % No glucose 
Raffinose (carbon 
source) 
- 2 % No glucose 
Xylose (carbon source) - 2 % No glucose 
Sodium acetate (carbon 
source) 
- 2 % No glucose 
Ethanol (carbon source) - 2 % No glucose 
Sorbitol (carbon source) - 2 % No glucose 
Glycerol (carbon 
source) 
- 2 % No glucose 
Sucrose (carbon 
source) 
- 2 % No glucose 
Maltose (carbon source) - 2 % No glucose 
Maltose (carbon source) 
+ bromocresol purple 
 2.5 % bromocresol 
purple 
No glucose. Bromocresol 
stock dissolved in ethanol. 
Filter sterilise stock. 
Trehalose (carbon 
source) 
- 2 % No glucose 
Nitrogen starvation - - YNB no ammonium sulphate 
Arsenic (III) oxide 50 mM 1 mM Filter sterilise stock 
UV light - 800 J/M
2
 - 
MMS (methyl 
methanesulphonate) 
99 % 0.05 % - 
Sodium metaarsenite 5 mM 0.5 mM Filter sterilise stock 
Hydroxyurea 2 M 100 mM Filter sterilise stock 
tBOOH (t-butyl 
hydroperoxide ) 
7.2 M 5 mM - 
H2O2 8.8 M 5 mM - 
H2O2 + NaCl - 2 mM H2O2 + 0.5 M 
NaCl 
- 
H2O2 + 42 °C - 2 mM H2O2 Incubate at 42 °C 
Benomyl 10 mg/ml 1 μg/ml Stock solute DMSO. Filter 
sterilise stock. 
Nystatin 8 mg/ml 5 μg/ml Stock solute DMSO. Filter 
sterilise stock. 
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Sodium orthovanadate 200 mM 2.5 mM Filter sterilise stock 
Calcofluor white 50 mg/ml 1 mg/ml Stock solute DMSO. Filter 
sterilise stock. Store in dark. 
Congo red 10 mg/ml 250 μg/ml Filter sterilise stock 
Menadione 50 mM 50 μM Stock solute ethanol 
Caspofungin   Filter sterilise stock 
Cycloheximide 50 mg/ml 1 μg/ml Stock solute DMSO. Filter 
sterilise stock. 
BPS 
(bathophenanthroline 
disulfonic acid) 
10 mM 0.1 mM Filter sterilise stock. 
Fluconazole 2 mM 32 μg/ml Filter sterilise stock. 
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Appendix 3: C. glabrata ORFs 
with no orthologue in S. 
cerevisiae 
 
Table 1: List of 727 C. glabrata ORFs identified by RBH searches to have 
no orthologue in S. cerevisiae. ORFs with no coordinates have been 
disregarded by CGD during the course of this study (candidagenome.org).                                                                                                                                                                                      
ORF name C. glabrata 
Gene name 
Chromosome Start 
coordinate 
Stop 
coordinate 
Strand 
      
CAGL0A00143g      
CAGL0A00165g  ChrA_C_glabrata_CBS138 18876 18037 C 
CAGL0A00583g  ChrA_C_glabrata_CBS138 65286 67226 W 
CAGL0A00649g  ChrA_C_glabrata_CBS138 70937 71320 W 
CAGL0A00715g  ChrA_C_glabrata_CBS138 73333 73623 W 
CAGL0A00913g  ChrA_C_glabrata_CBS138 92985 97265 W 
CAGL0A01364g      
CAGL0A01366g EPA9 ChrA_C_glabrata_CBS138 140305 144693 W 
CAGL0A01408g  ChrA_C_glabrata_CBS138 145388 146833 W 
CAGL0A01474g  ChrA_C_glabrata_CBS138 153155 154933 W 
CAGL0A01650g  ChrA_C_glabrata_CBS138 163770 164126 W 
CAGL0A01694g  ChrA_C_glabrata_CBS138 169167 167242 C 
CAGL0A01870g  ChrA_C_glabrata_CBS138 193719 191335 C 
CAGL0A01892g  ChrA_C_glabrata_CBS138 194560 194826 W 
CAGL0A02024g  ChrA_C_glabrata_CBS138 213901 211829 C 
CAGL0A02255g  ChrA_C_glabrata_CBS138 244683 245501 W 
CAGL0A02277g  ChrA_C_glabrata_CBS138 248522 249340 W 
CAGL0A02299g  ChrA_C_glabrata_CBS138 250851 251690 W 
CAGL0A02343g  ChrA_C_glabrata_CBS138 254861 255127 W 
CAGL0A02596g  ChrA_C_glabrata_CBS138 278467 281085 W 
CAGL0A02838g  ChrA_C_glabrata_CBS138 300358 297872 C 
CAGL0A02882g  ChrA_C_glabrata_CBS138 302262 302576 W 
CAGL0A03344g  ChrA_C_glabrata_CBS138 340501 342378 W 
CAGL0A03410g  ChrA_C_glabrata_CBS138 348708 349451 W 
CAGL0A03608g  ChrA_C_glabrata_CBS138 366934 366290 C 
CAGL0A03872g  ChrA_C_glabrata_CBS138 394454 392922 C 
CAGL0A03883g  ChrA_C_glabrata_CBS138 394613 395029 W 
CAGL0A04081g  ChrA_C_glabrata_CBS138 408064 409188 W 
CAGL0A04257g  ChrA_C_glabrata_CBS138 424289 422355 C 
CAGL0A04565g  ChrA_C_glabrata_CBS138 450575 453700 W 
CAGL0A04609g      
CAGL0A04631g  ChrA_C_glabrata_CBS138 456156 457241 W 
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CAGL0A04763g      
CAGL0A04851g      
CAGL0B00242g  ChrB_C_glabrata_CBS138 11136 10582 C 
CAGL0B00440g  ChrB_C_glabrata_CBS138 31504 32313 W 
CAGL0B00572g  ChrB_C_glabrata_CBS138 49506 48898 C 
CAGL0B00726g  ChrB_C_glabrata_CBS138 63903 65153 W 
CAGL0B00946g  ChrB_C_glabrata_CBS138 83143 84327 W 
CAGL0B00968g  ChrB_C_glabrata_CBS138 84713 85951 W 
CAGL0B01287g BUD5 ChrB_C_glabrata_CBS138 114832 118575 W 
CAGL0B01353g SPT20 ChrB_C_glabrata_CBS138 122519 120462 C 
CAGL0B01595g  ChrB_C_glabrata_CBS138 146542 148740 W 
CAGL0B01743g  ChrB_C_glabrata_CBS138 161784 162653 W 
CAGL0B01793g  ChrB_C_glabrata_CBS138 165053 165349 W 
CAGL0B01859g  ChrB_C_glabrata_CBS138 168976 170844 W 
CAGL0B02277g  ChrB_C_glabrata_CBS138 216745 216053 C 
CAGL0B02299g  ChrB_C_glabrata_CBS138 217341 219272 W 
CAGL0B02409g  ChrB_C_glabrata_CBS138 231172 230087 C 
CAGL0B02860g  ChrB_C_glabrata_CBS138 278657 278007 C 
CAGL0B02882g BMT2 ChrB_C_glabrata_CBS138 281184 279334 C 
CAGL0B02904g BMT6 ChrB_C_glabrata_CBS138 283910 282093 C 
CAGL0B02926g BMT3 ChrB_C_glabrata_CBS138 286753 284897 C 
CAGL0B02948g BMT4 ChrB_C_glabrata_CBS138 289799 288006 C 
CAGL0B02970g BMT5 ChrB_C_glabrata_CBS138 293137 291248 C 
CAGL0B02992g MNT3 ChrB_C_glabrata_CBS138 294942 297019 W 
CAGL0B03025g      
CAGL0B03179g  ChrB_C_glabrata_CBS138 312599 309816 C 
CAGL0B03201g  ChrB_C_glabrata_CBS138 314195 313239 C 
CAGL0B03223g  ChrB_C_glabrata_CBS138 314992 314690 C 
CAGL0B03861g  ChrB_C_glabrata_CBS138 383336 382452 C 
CAGL0B04235g SCP120 ChrB_C_glabrata_CBS138 416601 415660 C 
CAGL0B04763g  ChrB_C_glabrata_CBS138 458314 457409 C 
CAGL0B04895g  ChrB_C_glabrata_CBS138 475072 476955 W 
CAGL0C00110g EPA6 ChrC_C_glabrata_CBS138 4284 2137 C 
CAGL0C00209g AWP7 ChrC_C_glabrata_CBS138 12939 11626 C 
CAGL0C00253g  ChrC_C_glabrata_CBS138 23710 18884 C 
CAGL0C00583g  ChrC_C_glabrata_CBS138 62224 63396 W 
CAGL0C00781g  ChrC_C_glabrata_CBS138 81411 82193 W 
CAGL0C00803g      
CAGL0C00825g      
CAGL0C00847g EPA8 ChrC_C_glabrata_CBS138 86130 88502 W 
CAGL0C00869g      
CAGL0C00968g  ChrC_C_glabrata_CBS138 96914 100018 W 
CAGL0C01111g      
CAGL0C01133g  ChrC_C_glabrata_CBS138 114805 117915 W 
CAGL0C01155g  ChrC_C_glabrata_CBS138 119007 119954 W 
CAGL0C01265g GLM4 ChrC_C_glabrata_CBS138 134389 129884 C 
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CAGL0C01463g  ChrC_C_glabrata_CBS138 162501 160384 C 
CAGL0C01485g  ChrC_C_glabrata_CBS138 164613 162991 C 
CAGL0C01617g  ChrC_C_glabrata_CBS138 174618 175334 W 
CAGL0C01837g  ChrC_C_glabrata_CBS138 193387 191463 C 
CAGL0C01859g  ChrC_C_glabrata_CBS138 196167 193730 C 
CAGL0C01969g  ChrC_C_glabrata_CBS138 208511 206652 C 
CAGL0C01991g  ChrC_C_glabrata_CBS138 208793 209806 W 
CAGL0C02057g  ChrC_C_glabrata_CBS138 213539 213180 C 
CAGL0C02167g  ChrC_C_glabrata_CBS138 220619 222061 W 
CAGL0C02277g GLN3 ChrC_C_glabrata_CBS138 232967 230496 C 
CAGL0C02299g KRE29 ChrC_C_glabrata_CBS138 233339 234424 W 
CAGL0C02365g  ChrC_C_glabrata_CBS138 239122 238940 C 
CAGL0C02431g  ChrC_C_glabrata_CBS138 246581 243792 C 
CAGL0C02519g  ChrC_C_glabrata_CBS138 253051 254007 W 
CAGL0C02739g  ChrC_C_glabrata_CBS138 276663 277250 W 
CAGL0C02915g      
CAGL0C03311g  ChrC_C_glabrata_CBS138 334443 333898 C 
CAGL0C03575g  ChrC_C_glabrata_CBS138 358209 356203 C 
CAGL0C03740g  ChrC_C_glabrata_CBS138 372123 370762 C 
CAGL0C03872g  ChrC_C_glabrata_CBS138 380268 379501 C 
CAGL0C04026g  ChrC_C_glabrata_CBS138 399213 397303 C 
CAGL0C04213g  ChrC_C_glabrata_CBS138 412104 411409 C 
CAGL0C04763g  ChrC_C_glabrata_CBS138 445881 444934 C 
CAGL0C04785g  ChrC_C_glabrata_CBS138 447874 447029 C 
CAGL0C04829g  ChrC_C_glabrata_CBS138 451489 451151 C 
CAGL0C05577g  ChrC_C_glabrata_CBS138 536419 538278 W 
CAGL0C05621g      
CAGL0D00286g BMT1 ChrD_C_glabrata_CBS138 37583 39784 W 
CAGL0D00374g  ChrD_C_glabrata_CBS138 45775 46086 W 
CAGL0D00462g  ChrD_C_glabrata_CBS138 55305 57443 W 
CAGL0D00682g  ChrD_C_glabrata_CBS138 90825 89194 C 
CAGL0D00726g  ChrD_C_glabrata_CBS138 93895 93272 C 
CAGL0D01210g  ChrD_C_glabrata_CBS138 137954 138646 W 
CAGL0D01254g  ChrD_C_glabrata_CBS138 140355 141038 W 
CAGL0D01276g  ChrD_C_glabrata_CBS138 142618 143949 W 
CAGL0D01364g  ChrD_C_glabrata_CBS138 152033 155479 W 
CAGL0D01474g  ChrD_C_glabrata_CBS138 163480 161495 C 
CAGL0D02200g  ChrD_C_glabrata_CBS138 224941 228159 W 
CAGL0D02222g  ChrD_C_glabrata_CBS138 229223 228285 C 
CAGL0D02310g  ChrD_C_glabrata_CBS138 239213 237084 C 
CAGL0D02486g  ChrD_C_glabrata_CBS138 253763 256399 W 
CAGL0D02750g  ChrD_C_glabrata_CBS138 288647 289021 W 
CAGL0D02794g  ChrD_C_glabrata_CBS138 292034 293425 W 
CAGL0D03234g  ChrD_C_glabrata_CBS138 334913 336145 W 
CAGL0D03608g  ChrD_C_glabrata_CBS138 364790 363465 C 
CAGL0D03630g  ChrD_C_glabrata_CBS138 366246 367025 W 
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CAGL0D03850g  ChrD_C_glabrata_CBS138 384689 387193 W 
CAGL0D03872g  ChrD_C_glabrata_CBS138 387624 388433 W 
CAGL0D03938g  ChrD_C_glabrata_CBS138 392433 394304 W 
CAGL0D04400g  ChrD_C_glabrata_CBS138 432398 432126 C 
CAGL0D04444g  ChrD_C_glabrata_CBS138 437288 435564 C 
CAGL0D04488g  ChrD_C_glabrata_CBS138 438456 439238 W 
CAGL0D04840g  ChrD_C_glabrata_CBS138 471574 472164 W 
CAGL0D05104g      
CAGL0D05148g  ChrD_C_glabrata_CBS138 493013 492687 C 
CAGL0D05170g PHO4 ChrD_C_glabrata_CBS138 493897 495498 W 
CAGL0D05236g  ChrD_C_glabrata_CBS138 499006 500337 W 
CAGL0D05324g  ChrD_C_glabrata_CBS138 512450 510087 C 
CAGL0D05434g  ChrD_C_glabrata_CBS138 518767 518042 C 
CAGL0D05456g  ChrD_C_glabrata_CBS138 521445 522071 W 
CAGL0D05544g  ChrD_C_glabrata_CBS138 530217 527482 C 
CAGL0D05610g  ChrD_C_glabrata_CBS138 536192 534849 C 
CAGL0D05654g  ChrD_C_glabrata_CBS138 538337 537378 C 
CAGL0D05764g  ChrD_C_glabrata_CBS138 547259 549880 W 
CAGL0D06226g  ChrD_C_glabrata_CBS138 588725 586395 C 
CAGL0D06380g  ChrD_C_glabrata_CBS138 601040 602083 W 
CAGL0D06622g  ChrD_C_glabrata_CBS138 632859 629323 C 
CAGL0D06644g  ChrD_C_glabrata_CBS138 634224 636926 W 
CAGL0D06666g  ChrD_C_glabrata_CBS138 638537 638737 W 
CAGL0D06710g  ChrD_C_glabrata_CBS138 643127 641982 C 
CAGL0E00165g      
CAGL0E00187g  ChrE_C_glabrata_CBS138 13227 12511 C 
CAGL0E00275g EPA20 ChrE_C_glabrata_CBS138 25881 28523 W 
CAGL0E01265g  ChrE_C_glabrata_CBS138 119454 113167 C 
CAGL0E01375g      
CAGL0E01397g  ChrE_C_glabrata_CBS138 131689 129962 C 
CAGL0E01661g  ChrE_C_glabrata_CBS138 160703 164950 W 
CAGL0E02057g  ChrE_C_glabrata_CBS138 203578 205509 W 
CAGL0E02145g  ChrE_C_glabrata_CBS138 212223 213179 W 
CAGL0E02893g  ChrE_C_glabrata_CBS138 273462 276254 W 
CAGL0E03025g  ChrE_C_glabrata_CBS138 285579 285911 W 
CAGL0E03069g  ChrE_C_glabrata_CBS138 288878 286341 C 
CAGL0E03135g      
CAGL0E03421g  ChrE_C_glabrata_CBS138 315140 315493 W 
CAGL0E03498g  ChrE_C_glabrata_CBS138 324961 324476 C 
CAGL0E03542g  ChrE_C_glabrata_CBS138 328583 326046 C 
CAGL0E03652g  ChrE_C_glabrata_CBS138 342099 341431 C 
CAGL0E03696g      
CAGL0E03718g SNF6 ChrE_C_glabrata_CBS138 348294 347116 C 
CAGL0E04026g  ChrE_C_glabrata_CBS138 386039 387946 W 
CAGL0E04202g      
CAGL0E04224g  ChrE_C_glabrata_CBS138 404636 405310 W 
 226 | P a g e  
 
CAGL0E04268g  ChrE_C_glabrata_CBS138 406619 407983 W 
CAGL0E04466g  ChrE_C_glabrata_CBS138 427512 428360 W 
CAGL0E04554g  ChrE_C_glabrata_CBS138 439395 440117 W 
CAGL0E04862g  ChrE_C_glabrata_CBS138 466023 469223 W 
CAGL0E05852g      
CAGL0E05984g  ChrE_C_glabrata_CBS138 595299 595727 W 
CAGL0E06116g  ChrE_C_glabrata_CBS138 606786 604945 C 
CAGL0E06402g  ChrE_C_glabrata_CBS138 643478 643768 W 
CAGL0E06578g      
CAGL0E06600g  ChrE_C_glabrata_CBS138 658435 661332 W 
CAGL0E06622g      
CAGL0E06644g EPA1 ChrE_C_glabrata_CBS138 665110 668214 W 
CAGL0E06666g EPA2 ChrE_C_glabrata_CBS138 674692 670430 C 
CAGL0E06688g EPA3 ChrE_C_glabrata_CBS138 683331 680404 C 
CAGL0F00209g  ChrF_C_glabrata_CBS138 23731 22109 C 
CAGL0F00627g  ChrF_C_glabrata_CBS138 67393 65516 C 
CAGL0F00781g      
CAGL0F00803g GAL11B ChrF_C_glabrata_CBS138 88454 90970 W 
CAGL0F00935g PEX15 ChrF_C_glabrata_CBS138 101230 102354 W 
CAGL0F01067g      
CAGL0F01177g  ChrF_C_glabrata_CBS138 123471 121015 C 
CAGL0F01265g YAP7 ChrF_C_glabrata_CBS138 131725 133596 W 
CAGL0F01441g      
CAGL0F01463g TIR1 ChrF_C_glabrata_CBS138 149905 150570 W 
CAGL0F01485g TIR2 ChrF_C_glabrata_CBS138 152334 151321 C 
CAGL0F01507g  ChrF_C_glabrata_CBS138 153593 154864 W 
CAGL0F01683g  ChrF_C_glabrata_CBS138 168297 167401 C 
CAGL0F01815g  ChrF_C_glabrata_CBS138 180414 179470 C 
CAGL0F01881g  ChrF_C_glabrata_CBS138 186169 186711 W 
CAGL0F02057g  ChrF_C_glabrata_CBS138 199689 197149 C 
CAGL0F02475g  ChrF_C_glabrata_CBS138 240391 239243 C 
CAGL0F02783g  ChrF_C_glabrata_CBS138 271798 274317 W 
CAGL0F03003g  ChrF_C_glabrata_CBS138 289923 293480 W 
CAGL0F03069g CAD1 ChrF_C_glabrata_CBS138 303110 301650 C 
CAGL0F03377g      
CAGL0F03619g  ChrF_C_glabrata_CBS138 354565 352409 C 
CAGL0F03905g  ChrF_C_glabrata_CBS138 380088 377962 C 
CAGL0F03971g  ChrF_C_glabrata_CBS138 386224 390591 W 
CAGL0F04037g      
CAGL0F04059g      
CAGL0F04081g  ChrF_C_glabrata_CBS138 406151 407998 W 
CAGL0F04125g  ChrF_C_glabrata_CBS138 412378 411161 C 
CAGL0F04147g      
CAGL0F04169g      
CAGL0F04521g  ChrF_C_glabrata_CBS138 453943 453083 C 
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CAGL0F04543g  ChrF_C_glabrata_CBS138 456591 456866 W 
CAGL0F04785g  ChrF_C_glabrata_CBS138 482637 484547 W 
CAGL0F05159g  ChrF_C_glabrata_CBS138 525230 527617 W 
CAGL0F05357g  ChrF_C_glabrata_CBS138 541830 543635 W 
CAGL0F05533g  ChrF_C_glabrata_CBS138 558329 557208 C 
CAGL0F05687g  ChrF_C_glabrata_CBS138 570280 572649 W 
CAGL0F05709g  ChrF_C_glabrata_CBS138 573128 574174 W 
CAGL0F05819g  ChrF_C_glabrata_CBS138 586189 584882 C 
CAGL0F05973g  ChrF_C_glabrata_CBS138 597353 595752 C 
CAGL0F06237g  ChrF_C_glabrata_CBS138 619632 618976 C 
CAGL0F06259g  ChrF_C_glabrata_CBS138 621027 620431 C 
CAGL0F06567g  ChrF_C_glabrata_CBS138 646495 648012 W 
CAGL0F06699g  ChrF_C_glabrata_CBS138 659539 658958 C 
CAGL0F06787g  ChrF_C_glabrata_CBS138 665038 666156 W 
CAGL0F06985g  ChrF_C_glabrata_CBS138 684832 686724 W 
CAGL0F07271g  ChrF_C_glabrata_CBS138 709510 707309 C 
CAGL0F07359g  ChrF_C_glabrata_CBS138 718650 717856 C 
CAGL0F07513g  ChrF_C_glabrata_CBS138 730505 729306 C 
CAGL0F07667g MSS11 ChrF_C_glabrata_CBS138 746653 744275 C 
CAGL0F07909g  ChrF_C_glabrata_CBS138 776659 779808 W 
CAGL0F07997g  ChrF_C_glabrata_CBS138 788613 785803 C 
CAGL0F08019g PEX21 ChrF_C_glabrata_CBS138 791508 790810 C 
CAGL0F08195g  ChrF_C_glabrata_CBS138 813050 814027 W 
CAGL0F08591g  ChrF_C_glabrata_CBS138 855132 855620 W 
CAGL0F08767g  ChrF_C_glabrata_CBS138 867394 867789 W 
CAGL0F08811g  ChrF_C_glabrata_CBS138 869467 871308 W 
CAGL0F08833g  ChrF_C_glabrata_CBS138 873849 876659 W 
CAGL0F09141g  ChrF_C_glabrata_CBS138 904448 904239 C 
CAGL0F09229g  ChrF_C_glabrata_CBS138 910693 908186 C 
CAGL0F09251g      
CAGL0G00198g      
CAGL0G00396g  ChrG_C_glabrata_CBS138 40467 39655 C 
CAGL0G00836g  ChrG_C_glabrata_CBS138 74216 74605 W 
CAGL0G00968g  ChrG_C_glabrata_CBS138 88130 85791 C 
CAGL0G01012g  ChrG_C_glabrata_CBS138 90335 91672 W 
CAGL0G01122g  ChrG_C_glabrata_CBS138 106218 105880 C 
CAGL0G01408g  ChrG_C_glabrata_CBS138 134524 134928 W 
CAGL0G01562g  ChrG_C_glabrata_CBS138 146521 145796 C 
CAGL0G01848g  ChrG_C_glabrata_CBS138 168670 168200 C 
CAGL0G02123g  ChrG_C_glabrata_CBS138 186276 187691 W 
CAGL0G02387g  ChrG_C_glabrata_CBS138 212288 214417 W 
CAGL0G02409g  ChrG_C_glabrata_CBS138 215952 214837 C 
CAGL0G02431g      
CAGL0G02519g  ChrG_C_glabrata_CBS138 229958 228822 C 
CAGL0G02607g  ChrG_C_glabrata_CBS138 242310 240244 C 
CAGL0G03201g  ChrG_C_glabrata_CBS138 299668 299021 C 
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CAGL0G03421g FLO8 ChrG_C_glabrata_CBS138 330883 327833 C 
CAGL0G03531g  ChrG_C_glabrata_CBS138 343866 343363 C 
CAGL0G03553g  ChrG_C_glabrata_CBS138 345689 345057 C 
CAGL0G03685g  ChrG_C_glabrata_CBS138 354696 354923 W 
CAGL0G03751g  ChrG_C_glabrata_CBS138 360146 361096 W 
CAGL0G03949g  ChrG_C_glabrata_CBS138 375421 375924 W 
CAGL0G03993g  ChrG_C_glabrata_CBS138 379229 378876 C 
CAGL0G04125g  ChrG_C_glabrata_CBS138 393879 396170 W 
CAGL0G04279g  ChrG_C_glabrata_CBS138 406126 404144 C 
CAGL0G04389g  ChrG_C_glabrata_CBS138 414764 413376 C 
CAGL0G04477g      
CAGL0G04565g  ChrG_C_glabrata_CBS138 435706 434012 C 
CAGL0G04609g PKH2 ChrG_C_glabrata_CBS138 440059 437162 C 
CAGL0G04785g  ChrG_C_glabrata_CBS138 456307 456011 C 
CAGL0G04829g  ChrG_C_glabrata_CBS138 459677 462151 W 
CAGL0G04939g  ChrG_C_glabrata_CBS138 474854 473085 C 
CAGL0G05467g  ChrG_C_glabrata_CBS138 518000 516813 C 
CAGL0G05511g  ChrG_C_glabrata_CBS138 524050 522026 C 
CAGL0G05522g  ChrG_C_glabrata_CBS138 524170 524448 W 
CAGL0G05544g  ChrG_C_glabrata_CBS138 527250 524827 C 
CAGL0G05588g  ChrG_C_glabrata_CBS138 533711 531450 C 
CAGL0G05808g  ChrG_C_glabrata_CBS138 560227 558635 C 
CAGL0G05830g  ChrG_C_glabrata_CBS138 564474 561943 C 
CAGL0G05896g  ChrG_C_glabrata_CBS138 568221 567337 C 
CAGL0G06050g  ChrG_C_glabrata_CBS138 581306 581530 W 
CAGL0G06160g  ChrG_C_glabrata_CBS138 587971 588246 W 
CAGL0G06182g  ChrG_C_glabrata_CBS138 589050 591095 W 
CAGL0G06446g  ChrG_C_glabrata_CBS138 622068 622394 W 
CAGL0G06600g  ChrG_C_glabrata_CBS138 631430 630714 C 
CAGL0G06644g  ChrG_C_glabrata_CBS138 634825 634475 C 
CAGL0G06710g  ChrG_C_glabrata_CBS138 643070 642819 C 
CAGL0G06820g  ChrG_C_glabrata_CBS138 650668 649676 C 
CAGL0G06842g  ChrG_C_glabrata_CBS138 654152 651033 C 
CAGL0G06996g  ChrG_C_glabrata_CBS138 667930 667115 C 
CAGL0G07183g  ChrG_C_glabrata_CBS138 683243 678730 C 
CAGL0G07293g  ChrG_C_glabrata_CBS138 693448 690620 C 
CAGL0G07645g  ChrG_C_glabrata_CBS138 725540 725259 C 
CAGL0G07887g  ChrG_C_glabrata_CBS138 748964 748236 C 
CAGL0G08107g  ChrG_C_glabrata_CBS138 768772 770649 W 
CAGL0G08382g  ChrG_C_glabrata_CBS138 792588 793943 W 
CAGL0G08492g  ChrG_C_glabrata_CBS138 802604 804190 W 
CAGL0G08580g      
CAGL0G08602g  ChrG_C_glabrata_CBS138 808355 811147 W 
CAGL0G08866g  ChrG_C_glabrata_CBS138 850923 852752 W 
CAGL0G08954g  ChrG_C_glabrata_CBS138 858788 857016 C 
CAGL0G09064g  ChrG_C_glabrata_CBS138 865891 864422 C 
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CAGL0G09086g  ChrG_C_glabrata_CBS138 867382 867894 W 
CAGL0G09108g  ChrG_C_glabrata_CBS138 869367 868327 C 
CAGL0G09229g  ChrG_C_glabrata_CBS138 881783 881448 C 
CAGL0G09603g  ChrG_C_glabrata_CBS138 918130 917738 C 
CAGL0G09625g  ChrG_C_glabrata_CBS138 918731 919138 W 
CAGL0G09647g  ChrG_C_glabrata_CBS138 919676 919350 C 
CAGL0G09779g  ChrG_C_glabrata_CBS138 935346 935969 W 
CAGL0G10175g AWP6 ChrG_C_glabrata_CBS138 977483 979216 W 
CAGL0G10197g      
CAGL0G10219g  ChrG_C_glabrata_CBS138 988766 991744 W 
CAGL0H00110g  ChrH_C_glabrata_CBS138 3711 2611 C 
CAGL0H00352g  ChrH_C_glabrata_CBS138 33180 34292 W 
CAGL0H00638g VIK1 ChrH_C_glabrata_CBS138 62769 61015 C 
CAGL0H00704g  ChrH_C_glabrata_CBS138 69547 69155 C 
CAGL0H00715g      
CAGL0H00913g  ChrH_C_glabrata_CBS138 91592 90756 C 
CAGL0H01749g  ChrH_C_glabrata_CBS138 168634 168305 C 
CAGL0H01815g CBF1 ChrH_C_glabrata_CBS138 175972 174644 C 
CAGL0H02145g  ChrH_C_glabrata_CBS138 192690 190804 C 
CAGL0H02167g  ChrH_C_glabrata_CBS138 197907 196897 C 
CAGL0H02277g  ChrH_C_glabrata_CBS138 206023 206397 W 
CAGL0H02475g  ChrH_C_glabrata_CBS138 224077 226485 W 
CAGL0H02497g  ChrH_C_glabrata_CBS138 228775 228026 C 
CAGL0H02783g  ChrH_C_glabrata_CBS138 251169 256526 W 
CAGL0H02959g TOS8 ChrH_C_glabrata_CBS138 277540 278319 W 
CAGL0H03047g  ChrH_C_glabrata_CBS138 285868 288093 W 
CAGL0H03311g  ChrH_C_glabrata_CBS138 310699 311430 W 
CAGL0H03421g  ChrH_C_glabrata_CBS138 320386 319316 C 
CAGL0H03465g  ChrH_C_glabrata_CBS138 323129 323524 W 
CAGL0H03751g  ChrH_C_glabrata_CBS138 347169 344104 C 
CAGL0H03927g  ChrH_C_glabrata_CBS138 367018 365612 C 
CAGL0H04015g  ChrH_C_glabrata_CBS138 378264 377281 C 
CAGL0H04037g  ChrH_C_glabrata_CBS138 381916 379169 C 
CAGL0H04059g  ChrH_C_glabrata_CBS138 383690 383247 C 
CAGL0H04147g  ChrH_C_glabrata_CBS138 392825 393643 W 
CAGL0H04191g  ChrH_C_glabrata_CBS138 397001 396831 C 
CAGL0H04257g MT-II ChrH_C_glabrata_CBS138 405073 405231 W 
CAGL0H04279g MT-IIB ChrH_C_glabrata_CBS138 406327 406485 W 
CAGL0H04455g  ChrH_C_glabrata_CBS138 419033 421033 W 
CAGL0H04609g  ChrH_C_glabrata_CBS138 441790 433499 C 
CAGL0H04763g  ChrH_C_glabrata_CBS138 454589 455740 W 
CAGL0H05027g  ChrH_C_glabrata_CBS138 481654 483762 W 
CAGL0H05247g  ChrH_C_glabrata_CBS138 506947 507891 W 
CAGL0H05577g  ChrH_C_glabrata_CBS138 552456 545740 C 
CAGL0H05621g RLM1 ChrH_C_glabrata_CBS138 556498 558378 W 
CAGL0H05929g  ChrH_C_glabrata_CBS138 582132 584999 W 
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CAGL0H06215g GAL11A ChrH_C_glabrata_CBS138 609128 612415 W 
CAGL0H06413g SSR1 ChrH_C_glabrata_CBS138 632432 631794 C 
CAGL0H06765g BNR1 ChrH_C_glabrata_CBS138 676503 672619 C 
CAGL0H07337g  ChrH_C_glabrata_CBS138 718141 718590 W 
CAGL0H07557g  ChrH_C_glabrata_CBS138 738086 739516 W 
CAGL0H07645g  ChrH_C_glabrata_CBS138 747508 749538 W 
CAGL0H07843g HAP2 ChrH_C_glabrata_CBS138 766126 765236 C 
CAGL0H08107g  ChrH_C_glabrata_CBS138 792971 793987 W 
CAGL0H08151g      
CAGL0H08712g  ChrH_C_glabrata_CBS138 849446 848229 C 
CAGL0H08756g  ChrH_C_glabrata_CBS138 853968 853720 C 
CAGL0H08866g  ChrH_C_glabrata_CBS138 866293 864317 C 
CAGL0H08910g  ChrH_C_glabrata_CBS138 871136 870096 C 
CAGL0H08998g  ChrH_C_glabrata_CBS138 877952 879595 W 
CAGL0H09394g  ChrH_C_glabrata_CBS138 921373 920468 C 
CAGL0H09482g  ChrH_C_glabrata_CBS138 928788 928384 C 
CAGL0H09592g  ChrH_C_glabrata_CBS138 937859 938569 W 
CAGL0H09614g  ChrH_C_glabrata_CBS138 939996 939286 C 
CAGL0H09702g  ChrH_C_glabrata_CBS138 949553 948066 C 
CAGL0H09922g  ChrH_C_glabrata_CBS138 970713 967366 C 
CAGL0H09988g  ChrH_C_glabrata_CBS138 975811 973850 C 
CAGL0H10010g  ChrH_C_glabrata_CBS138 977299 976466 C 
CAGL0H10164g  ChrH_C_glabrata_CBS138 992579 991125 C 
CAGL0H10208g  ChrH_C_glabrata_CBS138 999936 996853 C 
CAGL0H10626g  ChrH_C_glabrata_CBS138 1043943 1047923 W 
CAGL0I00220g EPA23 ChrI_C_glabrata_CBS138 14903 12309 C 
CAGL0I00374g  ChrI_C_glabrata_CBS138 28154 27597 C 
CAGL0I00396g  ChrI_C_glabrata_CBS138 29592 29245 C 
CAGL0I00550g  ChrI_C_glabrata_CBS138 41775 41539 C 
CAGL0I00726g  ChrI_C_glabrata_CBS138 52931 52542 C 
CAGL0I00902g  ChrI_C_glabrata_CBS138 69090 67387 C 
CAGL0I00968g  ChrI_C_glabrata_CBS138 78375 81368 W 
CAGL0I01210g  ChrI_C_glabrata_CBS138 99925 101580 W 
CAGL0I01606g  ChrI_C_glabrata_CBS138 128683 132156 W 
CAGL0I01650g  ChrI_C_glabrata_CBS138 138286 134918 C 
CAGL0I01782g  ChrI_C_glabrata_CBS138 146481 149636 W 
CAGL0I01914g  ChrI_C_glabrata_CBS138 159798 160229 W 
CAGL0I01936g  ChrI_C_glabrata_CBS138 161109 160546 C 
CAGL0I01958g  ChrI_C_glabrata_CBS138 162266 165565 W 
CAGL0I02068g  ChrI_C_glabrata_CBS138 176743 177165 W 
CAGL0I02134g PEX21B ChrI_C_glabrata_CBS138 183860 183081 C 
CAGL0I02244g  ChrI_C_glabrata_CBS138 195726 195217 C 
CAGL0I02596g  ChrI_C_glabrata_CBS138 235250 234648 C 
CAGL0I02816g  ChrI_C_glabrata_CBS138 248692 247817 C 
CAGL0I02838g  ChrI_C_glabrata_CBS138 250671 248704 C 
CAGL0I03014g  ChrI_C_glabrata_CBS138 262731 262249 C 
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CAGL0I03212g  ChrI_C_glabrata_CBS138 275826 278717 W 
CAGL0I03982g      
CAGL0I04466g  ChrI_C_glabrata_CBS138 397172 399460 W 
CAGL0I05082g  ChrI_C_glabrata_CBS138 475276 473462 C 
CAGL0I05170g CST6 ChrI_C_glabrata_CBS138 490959 493064 W 
CAGL0I05610g  ChrI_C_glabrata_CBS138 530369 529962 C 
CAGL0I06226g  ChrI_C_glabrata_CBS138 597520 598887 W 
CAGL0I06314g  ChrI_C_glabrata_CBS138 605636 607507 W 
CAGL0I06446g  ChrI_C_glabrata_CBS138 624290 622713 C 
CAGL0I06644g  ChrI_C_glabrata_CBS138 644830 644156 C 
CAGL0I06919g  ChrI_C_glabrata_CBS138 669200 667962 C 
CAGL0I06941g  ChrI_C_glabrata_CBS138 670718 669657 C 
CAGL0I07183g  ChrI_C_glabrata_CBS138 692395 690080 C 
CAGL0I07293g  ChrI_C_glabrata_CBS138 708640 703325 C 
CAGL0I07425g  ChrI_C_glabrata_CBS138 715390 714551 C 
CAGL0I07491g  ChrI_C_glabrata_CBS138 720444 719539 C 
CAGL0I07711g  ChrI_C_glabrata_CBS138 740473 742197 W 
CAGL0I07887g  ChrI_C_glabrata_CBS138 762373 763521 W 
CAGL0I08151g  ChrI_C_glabrata_CBS138 793917 795065 W 
CAGL0I08415g  ChrI_C_glabrata_CBS138 820773 824699 W 
CAGL0I08437g  ChrI_C_glabrata_CBS138 825046 829038 W 
CAGL0I08591g  ChrI_C_glabrata_CBS138 839319 837766 C 
CAGL0I08613g DUR3 ChrI_C_glabrata_CBS138 841861 840182 C 
CAGL0I08811g  ChrI_C_glabrata_CBS138 858471 859535 W 
CAGL0I09196g  ChrI_C_glabrata_CBS138 889696 891537 W 
CAGL0I09636g  ChrI_C_glabrata_CBS138 923436 921232 C 
CAGL0I09768g  ChrI_C_glabrata_CBS138 934608 933082 C 
CAGL0I09834g  ChrI_C_glabrata_CBS138 939751 938648 C 
CAGL0I09856g  ChrI_C_glabrata_CBS138 942327 943151 W 
CAGL0I10098g PWP7 ChrI_C_glabrata_CBS138 964074 959218 C 
CAGL0I10246g PWP2 ChrI_C_glabrata_CBS138 1002627 1006349 W 
CAGL0I10252g      
CAGL0I10340g PWP5 ChrI_C_glabrata_CBS138 1013299 1016337 W 
CAGL0I10362g PWP4 ChrI_C_glabrata_CBS138 1020373 1025691 W 
CAGL0I10692g      
CAGL0I10725g  ChrI_C_glabrata_CBS138 1060071 1058860 C 
CAGL0I10769g  ChrI_C_glabrata_CBS138 1065957 1065199 C 
CAGL0I11011g  ChrI_C_glabrata_CBS138 1096813 1100349 W 
CAGL0J00253g  ChrJ_C_glabrata_CBS138 17376 15883 C 
CAGL0J00913g  ChrJ_C_glabrata_CBS138 94620 95756 W 
CAGL0J01177g  ChrJ_C_glabrata_CBS138 111185 112624 W 
CAGL0J01419g  ChrJ_C_glabrata_CBS138 133832 130812 C 
CAGL0J01573g      
CAGL0J01595g GLM6 ChrJ_C_glabrata_CBS138 151584 152618 W 
CAGL0J01683g      
CAGL0J01727g  ChrJ_C_glabrata_CBS138 160781 157842 C 
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CAGL0J01774g  ChrJ_C_glabrata_CBS138 172073 164808 C 
CAGL0J01958g  ChrJ_C_glabrata_CBS138 196501 194396 C 
CAGL0J02024g  ChrJ_C_glabrata_CBS138 204836 203412 C 
CAGL0J02046g  ChrJ_C_glabrata_CBS138 205632 205871 W 
CAGL0J02464g  ChrJ_C_glabrata_CBS138 238695 241445 W 
CAGL0J02508g AWP1 ChrJ_C_glabrata_CBS138 248822 246210 C 
CAGL0J02530g  ChrJ_C_glabrata_CBS138 252893 250629 C 
CAGL0J02552g  ChrJ_C_glabrata_CBS138 257549 254862 C 
CAGL0J02618g  ChrJ_C_glabrata_CBS138 261400 261843 W 
CAGL0J02706g  ChrJ_C_glabrata_CBS138 269104 267965 C 
CAGL0J03014g  ChrJ_C_glabrata_CBS138 291832 290111 C 
CAGL0J03388g  ChrJ_C_glabrata_CBS138 327822 329105 W 
CAGL0J03432g  ChrJ_C_glabrata_CBS138 330031 331899 W 
CAGL0J03564g  ChrJ_C_glabrata_CBS138 340647 343736 W 
CAGL0J03982g  ChrJ_C_glabrata_CBS138 377534 377881 W 
CAGL0J04708g  ChrJ_C_glabrata_CBS138 447836 449728 W 
CAGL0J04862g  ChrJ_C_glabrata_CBS138 462163 464562 W 
CAGL0J04884g  ChrJ_C_glabrata_CBS138 465532 466518 W 
CAGL0J04972g  ChrJ_C_glabrata_CBS138 475587 476606 W 
CAGL0J05192g      
CAGL0J05302g  ChrJ_C_glabrata_CBS138 510020 510943 W 
CAGL0J05390g  ChrJ_C_glabrata_CBS138 517202 516870 C 
CAGL0J05786g  ChrJ_C_glabrata_CBS138 553406 551562 C 
CAGL0J05808g  ChrJ_C_glabrata_CBS138 553745 554044 W 
CAGL0J05830g  ChrJ_C_glabrata_CBS138 556054 554231 C 
CAGL0J05852g  ChrJ_C_glabrata_CBS138 557558 556527 C 
CAGL0J05896g  ChrJ_C_glabrata_CBS138 559944 560519 W 
CAGL0J06160g  ChrJ_C_glabrata_CBS138 584111 585373 W 
CAGL0J06556g  ChrJ_C_glabrata_CBS138 630978 634214 W 
CAGL0J06622g  ChrJ_C_glabrata_CBS138 637316 638311 W 
CAGL0J06798g  ChrJ_C_glabrata_CBS138 654817 655521 W 
CAGL0J07348g  ChrJ_C_glabrata_CBS138 711496 713091 W 
CAGL0J07502g  ChrJ_C_glabrata_CBS138 727961 726663 C 
CAGL0J08327g      
CAGL0J08701g      
CAGL0J09130g  ChrJ_C_glabrata_CBS138 902880 904658 W 
CAGL0J09174g  ChrJ_C_glabrata_CBS138 906232 907293 W 
CAGL0J09548g  ChrJ_C_glabrata_CBS138 940777 936524 C 
CAGL0J10076g  ChrJ_C_glabrata_CBS138 989186 988050 C 
CAGL0J10142g      
CAGL0J10318g  ChrJ_C_glabrata_CBS138 1009995 1008835 C 
CAGL0J10582g  ChrJ_C_glabrata_CBS138 1035745 1037154 W 
CAGL0J10714g  ChrJ_C_glabrata_CBS138 1046800 1047771 W 
CAGL0J10956g  ChrJ_C_glabrata_CBS138 1068578 1070431 W 
CAGL0J11044g  ChrJ_C_glabrata_CBS138 1078322 1076112 C 
CAGL0J11088g  ChrJ_C_glabrata_CBS138 1081270 1081962 W 
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CAGL0J11176g  ChrJ_C_glabrata_CBS138 1088473 1090362 W 
CAGL0J11374g  ChrJ_C_glabrata_CBS138 1106466 1106215 C 
CAGL0J11418g  ChrJ_C_glabrata_CBS138 1108949 1107909 C 
CAGL0J11594g  ChrJ_C_glabrata_CBS138 1129709 1126896 C 
CAGL0J11616g  ChrJ_C_glabrata_CBS138 1130080 1130436 W 
CAGL0J11968g EPA15 ChrJ_C_glabrata_CBS138 1172919 1175795 W 
CAGL0K00110g AWP2 ChrK_C_glabrata_CBS138 5830 3332 C 
CAGL0K00341g  ChrK_C_glabrata_CBS138 37953 37531 C 
CAGL0K00385g  ChrK_C_glabrata_CBS138 42643 43347 W 
CAGL0K00495g  ChrK_C_glabrata_CBS138 53462 55564 W 
CAGL0K01221g PEX8 ChrK_C_glabrata_CBS138 114592 116427 W 
CAGL0K01507g  ChrK_C_glabrata_CBS138 134490 131704 C 
CAGL0K01639g  ChrK_C_glabrata_CBS138 147354 146143 C 
CAGL0K01727g RPN4 ChrK_C_glabrata_CBS138 154897 153398 C 
CAGL0K01903g  ChrK_C_glabrata_CBS138 169974 169669 C 
CAGL0K01947g  ChrK_C_glabrata_CBS138 172658 172341 C 
CAGL0K02013g  ChrK_C_glabrata_CBS138 176257 177375 W 
CAGL0K02101g  ChrK_C_glabrata_CBS138 182946 187847 W 
CAGL0K02145g  ChrK_C_glabrata_CBS138 190884 191837 W 
CAGL0K02519g  ChrK_C_glabrata_CBS138 228185 227541 C 
CAGL0K02585g YAP3 ChrK_C_glabrata_CBS138 235078 233972 C 
CAGL0K02695g  ChrK_C_glabrata_CBS138 245459 244992 C 
CAGL0K03003g  ChrK_C_glabrata_CBS138 277585 279528 W 
CAGL0K03245g  ChrK_C_glabrata_CBS138 299646 298216 C 
CAGL0K03663g  ChrK_C_glabrata_CBS138 339486 339752 W 
CAGL0K03905g  ChrK_C_glabrata_CBS138 363233 364318 W 
CAGL0K04191g  ChrK_C_glabrata_CBS138 386857 388446 W 
CAGL0K04257g  ChrK_C_glabrata_CBS138 393759 392116 C 
CAGL0K04631g  ChrK_C_glabrata_CBS138 444591 441550 C 
CAGL0K04653g  ChrK_C_glabrata_CBS138 448486 446732 C 
CAGL0K04675g  ChrK_C_glabrata_CBS138 455284 455718 W 
CAGL0K04697g  ChrK_C_glabrata_CBS138 459195 460742 W 
CAGL0K04719g  ChrK_C_glabrata_CBS138 462817 462359 C 
CAGL0K04763g      
CAGL0K04895g  ChrK_C_glabrata_CBS138 476625 475558 C 
CAGL0K05247g  ChrK_C_glabrata_CBS138 509508 513182 W 
CAGL0K05511g  ChrK_C_glabrata_CBS138 542127 539944 C 
CAGL0K05643g  ChrK_C_glabrata_CBS138 551022 552314 W 
CAGL0K05687g  ChrK_C_glabrata_CBS138 555370 556536 W 
CAGL0K06039g  ChrK_C_glabrata_CBS138 589631 592027 W 
CAGL0K06083g  ChrK_C_glabrata_CBS138 594349 593405 C 
CAGL0K06127g  ChrK_C_glabrata_CBS138 597610 598566 W 
CAGL0K06171g      
CAGL0K06325g  ChrK_C_glabrata_CBS138 623378 621549 C 
CAGL0K06435g  ChrK_C_glabrata_CBS138 630381 635204 W 
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CAGL0K06479g  ChrK_C_glabrata_CBS138 637125 640100 W 
CAGL0K06655g  ChrK_C_glabrata_CBS138 648911 651319 W 
CAGL0K06721g  ChrK_C_glabrata_CBS138 655617 656933 W 
CAGL0K07183g  ChrK_C_glabrata_CBS138 705897 706220 W 
CAGL0K07205g  ChrK_C_glabrata_CBS138 708222 707503 C 
CAGL0K07271g  ChrK_C_glabrata_CBS138 714624 712294 C 
CAGL0K07502g  ChrK_C_glabrata_CBS138 742349 742990 W 
CAGL0K07634g  ChrK_C_glabrata_CBS138 756054 754675 C 
CAGL0K07678g  ChrK_C_glabrata_CBS138 764843 764196 C 
CAGL0K07920g  ChrK_C_glabrata_CBS138 788342 786915 C 
CAGL0K08294g  ChrK_C_glabrata_CBS138 837573 825448 C 
CAGL0K08470g  ChrK_C_glabrata_CBS138 852119 851940 C 
CAGL0K08624g  ChrK_C_glabrata_CBS138 870380 869340 C 
CAGL0K08690g  ChrK_C_glabrata_CBS138 879137 877494 C 
CAGL0K09130g  ChrK_C_glabrata_CBS138 907965 907150 C 
CAGL0K09504g  ChrK_C_glabrata_CBS138 939088 938579 C 
CAGL0K09746g  ChrK_C_glabrata_CBS138 955125 952549 C 
CAGL0K09812g  ChrK_C_glabrata_CBS138 959122 960138 W 
CAGL0K09834g  ChrK_C_glabrata_CBS138 964855 960893 C 
CAGL0K10032g  ChrK_C_glabrata_CBS138 981372 980068 C 
CAGL0K10164g  ChrK_C_glabrata_CBS138 990940 990287 C 
CAGL0K10318g  ChrK_C_glabrata_CBS138 1004753 1007506 W 
CAGL0K10428g  ChrK_C_glabrata_CBS138 1019646 1020206 W 
CAGL0K10648g  ChrK_C_glabrata_CBS138 1039063 1036025 C 
CAGL0K11319g  ChrK_C_glabrata_CBS138 1098955 1097846 C 
CAGL0K11396g SIR4 ChrK_C_glabrata_CBS138 1108107 1103764 C 
CAGL0K11484g  ChrK_C_glabrata_CBS138 1114883 1115206 W 
CAGL0K11638g  ChrK_C_glabrata_CBS138 1125950 1124172 C 
CAGL0K11946g  ChrK_C_glabrata_CBS138 1153568 1153891 W 
CAGL0K11990g  ChrK_C_glabrata_CBS138 1159199 1156224 C 
CAGL0K12078g  ChrK_C_glabrata_CBS138 1171209 1169818 C 
CAGL0K12298g  ChrK_C_glabrata_CBS138 1201583 1200966 C 
CAGL0K12320g  ChrK_C_glabrata_CBS138 1201918 1204275 W 
CAGL0K12364g  ChrK_C_glabrata_CBS138 1206621 1207109 W 
CAGL0K12540g HAC1 ChrK_C_glabrata_CBS138 1225334 1224345 C 
CAGL0K12980g BMT7 ChrK_C_glabrata_CBS138 1286134 1283966 C 
CAGL0K13002g AED2 ChrK_C_glabrata_CBS138 1291683 1294496 W 
CAGL0K13024g AED1 ChrK_C_glabrata_CBS138 1297775 1301002 W 
CAGL0L00176g      
CAGL0L00473g  ChrL_C_glabrata_CBS138 53395 54774 W 
CAGL0L00583g  ChrL_C_glabrata_CBS138 71544 72710 W 
CAGL0L01023g  ChrL_C_glabrata_CBS138 119978 119691 C 
CAGL0L01045g  ChrL_C_glabrata_CBS138 120342 120109 C 
CAGL0L01507g  ChrL_C_glabrata_CBS138 167209 171099 W 
CAGL0L01573g  ChrL_C_glabrata_CBS138 176421 176894 W 
CAGL0L01771g  ChrL_C_glabrata_CBS138 198971 200278 W 
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CAGL0L02013g  ChrL_C_glabrata_CBS138 237127 235616 C 
CAGL0L02453g  ChrL_C_glabrata_CBS138 280524 278611 C 
CAGL0L02541g  ChrL_C_glabrata_CBS138 300308 300988 W 
CAGL0L02981g  ChrL_C_glabrata_CBS138 349506 348799 C 
CAGL0L03157g  ChrL_C_glabrata_CBS138 367003 367563 W 
CAGL0L03388g  ChrL_C_glabrata_CBS138 388777 389391 W 
CAGL0L03674g  ChrL_C_glabrata_CBS138 422571 424460 W 
CAGL0L03784g  ChrL_C_glabrata_CBS138 439813 437192 C 
CAGL0L03894g  ChrL_C_glabrata_CBS138 448634 448143 C 
CAGL0L03916g  ChrL_C_glabrata_CBS138 452880 450952 C 
CAGL0L04114g  ChrL_C_glabrata_CBS138 484447 482705 C 
CAGL0L04818g  ChrL_C_glabrata_CBS138 553653 552334 C 
CAGL0L05038g  ChrL_C_glabrata_CBS138 571776 573317 W 
CAGL0L05192g  ChrL_C_glabrata_CBS138 585066 585383 W 
CAGL0L05214g      
CAGL0L05324g  ChrL_C_glabrata_CBS138 592217 591903 C 
CAGL0L05786g  ChrL_C_glabrata_CBS138 639219 638173 C 
CAGL0L05830g  ChrL_C_glabrata_CBS138 651511 652161 W 
CAGL0L05940g  ChrL_C_glabrata_CBS138 662250 663698 W 
CAGL0L05984g  ChrL_C_glabrata_CBS138 669527 669150 C 
CAGL0L06072g  ChrL_C_glabrata_CBS138 682823 681921 C 
CAGL0L06226g  ChrL_C_glabrata_CBS138 707044 705599 C 
CAGL0L06424g  ChrL_C_glabrata_CBS138 728331 728999 W 
CAGL0L06512g  ChrL_C_glabrata_CBS138 736479 736255 C 
CAGL0L06644g  ChrL_C_glabrata_CBS138 750307 752793 W 
CAGL0L06688g  ChrL_C_glabrata_CBS138 758073 756016 C 
CAGL0L06776g  ChrL_C_glabrata_CBS138 763580 766066 W 
CAGL0L07194g  ChrL_C_glabrata_CBS138 800960 801430 W 
CAGL0L07480g  ChrL_C_glabrata_CBS138 825181 824237 C 
CAGL0L07502g  ChrL_C_glabrata_CBS138 829066 828380 C 
CAGL0L07524g      
CAGL0L07568g  ChrL_C_glabrata_CBS138 837713 837393 C 
CAGL0L07590g  ChrL_C_glabrata_CBS138 838499 838293 C 
CAGL0L08008g  ChrL_C_glabrata_CBS138 875742 875861 W 
CAGL0L08470g  ChrL_C_glabrata_CBS138 930917 930435 C 
CAGL0L08536g  ChrL_C_glabrata_CBS138 934441 934662 W 
CAGL0L08954g  ChrL_C_glabrata_CBS138 979515 980879 W 
CAGL0L09251g  ChrL_C_glabrata_CBS138 1004824 1003976 C 
CAGL0L09339g  ChrL_C_glabrata_CBS138 1014256 1016889 W 
CAGL0L09361g  ChrL_C_glabrata_CBS138 1018071 1018406 W 
CAGL0L09383g  ChrL_C_glabrata_CBS138 1020856 1021956 W 
CAGL0L09845g  ChrL_C_glabrata_CBS138 1056009 1054843 C 
CAGL0L09889g  ChrL_C_glabrata_CBS138 1057762 1059915 W 
CAGL0L09911g  ChrL_C_glabrata_CBS138 1064342 1068697 W 
CAGL0L10186g  ChrL_C_glabrata_CBS138 1097625 1097104 C 
CAGL0L10626g  ChrL_C_glabrata_CBS138 1136212 1137753 W 
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CAGL0L11484g  ChrL_C_glabrata_CBS138 1222937 1224250 W 
CAGL0L11880g  ChrL_C_glabrata_CBS138 1274920 1277862 W 
CAGL0L12122g  ChrL_C_glabrata_CBS138 1303778 1302987 C 
CAGL0L12298g  ChrL_C_glabrata_CBS138 1331972 1331112 C 
CAGL0L12320g  ChrL_C_glabrata_CBS138 1332269 1333105 W 
CAGL0L12496g  ChrL_C_glabrata_CBS138 1349053 1348769 C 
CAGL0L12518g  ChrL_C_glabrata_CBS138 1349621 1349271 C 
CAGL0L12782g  ChrL_C_glabrata_CBS138 1370285 1371082 W 
CAGL0L13090g  ChrL_C_glabrata_CBS138 1397800 1400046 W 
CAGL0L13332g EPA13 ChrL_C_glabrata_CBS138 1436026 1439133 W 
CAGL0M00132g EPA12 ChrM_C_glabrata_CBS138 14404 11636 C 
CAGL0M00308g  ChrM_C_glabrata_CBS138 39072 38758 C 
CAGL0M00440g  ChrM_C_glabrata_CBS138 56009 56707 W 
CAGL0M00638g  ChrM_C_glabrata_CBS138 78077 76881 C 
CAGL0M00704g  ChrM_C_glabrata_CBS138 81930 82796 W 
CAGL0M00726g  ChrM_C_glabrata_CBS138 83656 82968 C 
CAGL0M00770g SIR3 ChrM_C_glabrata_CBS138 86290 89556 W 
CAGL0M00792g  ChrM_C_glabrata_CBS138 91057 90755 C 
CAGL0M00968g  ChrM_C_glabrata_CBS138 107989 109311 W 
CAGL0M01254g STE12 ChrM_C_glabrata_CBS138 143315 141519 C 
CAGL0M01716g  ChrM_C_glabrata_CBS138 193696 192389 C 
CAGL0M01870g  ChrM_C_glabrata_CBS138 220760 219813 C 
CAGL0M01914g  ChrM_C_glabrata_CBS138 232780 234810 W 
CAGL0M02013g  ChrM_C_glabrata_CBS138 245581 244928 C 
CAGL0M02079g  ChrM_C_glabrata_CBS138 253472 251658 C 
CAGL0M02299g  ChrM_C_glabrata_CBS138 273725 276406 W 
CAGL0M02321g  ChrM_C_glabrata_CBS138 277990 276554 C 
CAGL0M02453g  ChrM_C_glabrata_CBS138 287732 288094 W 
CAGL0M02541g  ChrM_C_glabrata_CBS138 294479 294348 C 
CAGL0M02717g  ChrM_C_glabrata_CBS138 309656 310444 W 
CAGL0M02915g  ChrM_C_glabrata_CBS138 329923 329147 C 
CAGL0M03069g  ChrM_C_glabrata_CBS138 349230 347584 C 
CAGL0M03157g  ChrM_C_glabrata_CBS138 358599 361211 W 
CAGL0M03421g  ChrM_C_glabrata_CBS138 391586 390927 C 
CAGL0M03773g  ChrM_C_glabrata_CBS138 427099 426518 C 
CAGL0M04015g  ChrM_C_glabrata_CBS138 447889 447059 C 
CAGL0M04169g  ChrM_C_glabrata_CBS138 459618 460739 W 
CAGL0M04345g  ChrM_C_glabrata_CBS138 478693 477731 C 
CAGL0M04389g  ChrM_C_glabrata_CBS138 481522 483702 W 
CAGL0M04455g  ChrM_C_glabrata_CBS138 491183 489048 C 
CAGL0M04543g  ChrM_C_glabrata_CBS138 498691 499533 W 
CAGL0M04851g  ChrM_C_glabrata_CBS138 532127 532318 W 
CAGL0M04917g  ChrM_C_glabrata_CBS138 537760 539520 W 
CAGL0M05115g  ChrM_C_glabrata_CBS138 549946 551247 W 
CAGL0M05137g  ChrM_C_glabrata_CBS138 552160 556215 W 
CAGL0M05313g  ChrM_C_glabrata_CBS138 568646 567906 C 
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CAGL0M05401g  ChrM_C_glabrata_CBS138 575952 575740 C 
CAGL0M05819g  ChrM_C_glabrata_CBS138 615435 615635 W 
CAGL0M06149g  ChrM_C_glabrata_CBS138 642556 640964 C 
CAGL0M06325g  ChrM_C_glabrata_CBS138 659269 657290 C 
CAGL0M06479g  ChrM_C_glabrata_CBS138 671810 671472 C 
CAGL0M06831g CRZ1 ChrM_C_glabrata_CBS138 695162 697099 W 
CAGL0M07007g  ChrM_C_glabrata_CBS138 713125 712268 C 
CAGL0M07205g  ChrM_C_glabrata_CBS138 726724 727449 W 
CAGL0M07337g  ChrM_C_glabrata_CBS138 743961 743020 C 
CAGL0M07491g  ChrM_C_glabrata_CBS138 754350 753496 C 
CAGL0M07590g  ChrM_C_glabrata_CBS138 758940 760310 W 
CAGL0M07634g  ChrM_C_glabrata_CBS138 763929 764702 W 
CAGL0M07744g  ChrM_C_glabrata_CBS138 779985 779281 C 
CAGL0M07766g  ChrM_C_glabrata_CBS138 781830 782546 W 
CAGL0M07832g  ChrM_C_glabrata_CBS138 784724 783505 C 
CAGL0M08096g  ChrM_C_glabrata_CBS138 809185 809559 W 
CAGL0M08316g  ChrM_C_glabrata_CBS138 829069 831963 W 
CAGL0M08536g  ChrM_C_glabrata_CBS138 853376 852150 C 
CAGL0M08558g  ChrM_C_glabrata_CBS138 855342 855046 C 
CAGL0M08580g  ChrM_C_glabrata_CBS138 856036 855443 C 
CAGL0M08778g  ChrM_C_glabrata_CBS138 873232 873642 W 
CAGL0M08800g YAP6 ChrM_C_glabrata_CBS138 878328 879119 W 
CAGL0M09042g  ChrM_C_glabrata_CBS138 901459 902817 W 
CAGL0M09691g  ChrM_C_glabrata_CBS138 963159 961939 C 
CAGL0M09955g  ChrM_C_glabrata_CBS138 984334 982943 C 
CAGL0M10065g  ChrM_C_glabrata_CBS138 1002184 1002933 W 
CAGL0M10153g  ChrM_C_glabrata_CBS138 1013291 1010688 C 
CAGL0M10395g  ChrM_C_glabrata_CBS138 1038860 1043857 W 
CAGL0M10978g  ChrM_C_glabrata_CBS138 1090119 1088278 C 
CAGL0M11088g  ChrM_C_glabrata_CBS138 1095910 1095254 C 
CAGL0M11858g  ChrM_C_glabrata_CBS138 1178837 1179550 W 
CAGL0M12056g  ChrM_C_glabrata_CBS138 1207001 1206666 C 
CAGL0M12078g      
CAGL0M12100g  ChrM_C_glabrata_CBS138 1209814 1210788 W 
CAGL0M12254g  ChrM_C_glabrata_CBS138 1222321 1224765 W 
CAGL0M12342g  ChrM_C_glabrata_CBS138 1235565 1234192 C 
CAGL0M12364g  ChrM_C_glabrata_CBS138 1236300 1236064 C 
CAGL0M12452g  ChrM_C_glabrata_CBS138 1241018 1241242 W 
CAGL0M12474g  ChrM_C_glabrata_CBS138 1242276 1243610 W 
CAGL0M12507g      
CAGL0M12793g  ChrM_C_glabrata_CBS138 1262305 1263201 W 
CAGL0M12815g  ChrM_C_glabrata_CBS138 1263880 1266834 W 
CAGL0M12881g  ChrM_C_glabrata_CBS138 1273254 1274573 W 
CAGL0M13035g  ChrM_C_glabrata_CBS138 1286086 1284308 C 
CAGL0M13123g  ChrM_C_glabrata_CBS138 1291605 1289611 C 
CAGL0M13211g  ChrM_C_glabrata_CBS138 1299931 1300689 W 
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CAGL0M13233g  ChrM_C_glabrata_CBS138 1304297 1300974 C 
CAGL0M13365g  ChrM_C_glabrata_CBS138 1314673 1316544 W 
CAGL0M13387g  ChrM_C_glabrata_CBS138 1317526 1316747 C 
CAGL0M13607g  ChrM_C_glabrata_CBS138 1338688 1339728 W 
CAGL0M13695g  ChrM_C_glabrata_CBS138 1345104 1344157 C 
CAGL0M14069g PWP6 ChrM_C_glabrata_CBS138 1391579 1394179 W 
CAGL0M14091g  ChrM_C_glabrata_CBS138 1395548 1396189 W 
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Table 2: 294 C. glabrata ORFs with no S. cerevisiae orthologues based on the Yeast Gene 
Order Browser  (http://ygob.ucd.ie/). 
 
ORF name C. glabrata 
gene name 
Chromosome Start 
coordinate 
Stop 
coordinate 
Strand 
CAGL0A00165g  ChrA_C_glabrata_CBS138 18876 18037 C 
CAGL0A00583g  ChrA_C_glabrata_CBS138 65286 67226 W 
CAGL0A00649g  ChrA_C_glabrata_CBS138 70937 71320 W 
CAGL0A00715g  ChrA_C_glabrata_CBS138 73333 73623 W 
CAGL0A00737g  ChrA_C_glabrata_CBS138 74767 76416 W 
CAGL0A01221g  ChrA_C_glabrata_CBS138 125780 126661 W 
CAGL0A01243g GIT1 ChrA_C_glabrata_CBS138 129101 127506 C 
CAGL0A01284g EPA10 ChrA_C_glabrata_CBS138 131362 135567 W 
CAGL0A01325g PGD1 ChrA_C_glabrata_CBS138 136262 137695 W 
CAGL0A01366g EPA9 ChrA_C_glabrata_CBS138 140305 144693 W 
CAGL0A01870g  ChrA_C_glabrata_CBS138 193719 191335 C 
CAGL0A01892g  ChrA_C_glabrata_CBS138 194560 194826 W 
CAGL0A02255g  ChrA_C_glabrata_CBS138 244683 245501 W 
CAGL0A02299g  ChrA_C_glabrata_CBS138 250851 251690 W 
CAGL0A02343g  ChrA_C_glabrata_CBS138 254861 255127 W 
CAGL0A02882g  ChrA_C_glabrata_CBS138 302262 302576 W 
CAGL0A03410g  ChrA_C_glabrata_CBS138 348708 349451 W 
CAGL0A03608g  ChrA_C_glabrata_CBS138 366934 366290 C 
CAGL0B00220g  ChrB_C_glabrata_CBS138 10385 10615 W 
CAGL0B00440g  ChrB_C_glabrata_CBS138 31504 32313 W 
CAGL0B00572g  ChrB_C_glabrata_CBS138 49506 48898 C 
CAGL0B01595g  ChrB_C_glabrata_CBS138 146542 148740 W 
CAGL0B02882g BMT2 ChrB_C_glabrata_CBS138 281184 279334 C 
CAGL0B02904g BMT6 ChrB_C_glabrata_CBS138 283910 282093 C 
CAGL0B02926g BMT3 ChrB_C_glabrata_CBS138 286753 284897 C 
CAGL0B02948g BMT4 ChrB_C_glabrata_CBS138 289799 288006 C 
CAGL0B02970g BMT5 ChrB_C_glabrata_CBS138 293137 291248 C 
CAGL0B03223g  ChrB_C_glabrata_CBS138 314992 314690 C 
CAGL0B03611g  ChrB_C_glabrata_CBS138 360952 360764 C 
CAGL0B03883g  ChrB_C_glabrata_CBS138 383602 384522 W 
CAGL0B03949g  ChrB_C_glabrata_CBS138 389759 387861 C 
CAGL0B04235g SCP120 ChrB_C_glabrata_CBS138 416601 415660 C 
CAGL0C00110g EPA6 ChrC_C_glabrata_CBS138 4284 2137 C 
CAGL0C00209g AWP7 ChrC_C_glabrata_CBS138 12939 11626 C 
CAGL0C00231g  ChrC_C_glabrata_CBS138 15916 17538 W 
CAGL0C00253g  ChrC_C_glabrata_CBS138 23710 18884 C 
CAGL0C00781g  ChrC_C_glabrata_CBS138 81411 82193 W 
CAGL0C00847g EPA8 ChrC_C_glabrata_CBS138 86130 88502 W 
CAGL0C00968g  ChrC_C_glabrata_CBS138 96914 100018 W 
CAGL0C01133g  ChrC_C_glabrata_CBS138 114805 117915 W 
CAGL0C01617g  ChrC_C_glabrata_CBS138 174618 175334 W 
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CAGL0C01837g  ChrC_C_glabrata_CBS138 193387 191463 C 
CAGL0C01859g  ChrC_C_glabrata_CBS138 196167 193730 C 
CAGL0C01919g MFA2 ChrC_C_glabrata_CBS138 202488 202384 C 
CAGL0C02057g  ChrC_C_glabrata_CBS138 213539 213180 C 
CAGL0C02365g  ChrC_C_glabrata_CBS138 239122 238940 C 
CAGL0C03311g  ChrC_C_glabrata_CBS138 334443 333898 C 
CAGL0C03916g  ChrC_C_glabrata_CBS138 385875 383989 C 
CAGL0C03938g  ChrC_C_glabrata_CBS138 388586 386673 C 
CAGL0C03960g  ChrC_C_glabrata_CBS138 391121 389250 C 
CAGL0C03982g  ChrC_C_glabrata_CBS138 393798 391909 C 
CAGL0C04004g  ChrC_C_glabrata_CBS138 396512 394614 C 
CAGL0C04026g  ChrC_C_glabrata_CBS138 399213 397303 C 
CAGL0C04048g  ChrC_C_glabrata_CBS138 401596 399734 C 
CAGL0C04763g  ChrC_C_glabrata_CBS138 445881 444934 C 
CAGL0C05401g  ChrC_C_glabrata_CBS138 515623 515886 W 
CAGL0D00154g AQY1 ChrD_C_glabrata_CBS138 17914 17042 C 
CAGL0D00286g BMT1 ChrD_C_glabrata_CBS138 37583 39784 W 
CAGL0D00374g  ChrD_C_glabrata_CBS138 45775 46086 W 
CAGL0D00396g  ChrD_C_glabrata_CBS138 46558 46316 C 
CAGL0D01210g  ChrD_C_glabrata_CBS138 137954 138646 W 
CAGL0D01254g  ChrD_C_glabrata_CBS138 140355 141038 W 
CAGL0D01265g MT-I ChrD_C_glabrata_CBS138 142000 142191 W 
CAGL0D02486g  ChrD_C_glabrata_CBS138 253763 256399 W 
CAGL0D02640g  ChrD_C_glabrata_CBS138 274285 275979 W 
CAGL0D02662g  ChrD_C_glabrata_CBS138 279793 278099 C 
CAGL0D02750g  ChrD_C_glabrata_CBS138 288647 289021 W 
CAGL0D03608g  ChrD_C_glabrata_CBS138 364790 363465 C 
CAGL0D03872g  ChrD_C_glabrata_CBS138 387624 388433 W 
CAGL0D04840g  ChrD_C_glabrata_CBS138 471574 472164 W 
CAGL0D05434g  ChrD_C_glabrata_CBS138 518767 518042 C 
CAGL0D05456g  ChrD_C_glabrata_CBS138 521445 522071 W 
CAGL0D05654g  ChrD_C_glabrata_CBS138 538337 537378 C 
CAGL0D06226g  ChrD_C_glabrata_CBS138 588725 586395 C 
CAGL0D06380g  ChrD_C_glabrata_CBS138 601040 602083 W 
CAGL0D06534g  ChrD_C_glabrata_CBS138 622492 622178 C 
CAGL0D06666g  ChrD_C_glabrata_CBS138 638537 638737 W 
CAGL0D06710g  ChrD_C_glabrata_CBS138 643127 641982 C 
CAGL0E00187g  ChrE_C_glabrata_CBS138 13227 12511 C 
CAGL0E00275g EPA20 ChrE_C_glabrata_CBS138 25881 28523 W 
CAGL0E00363g  ChrE_C_glabrata_CBS138 30527 30336 C 
CAGL0E01661g  ChrE_C_glabrata_CBS138 160703 164950 W 
CAGL0E01727g YPS3 ChrE_C_glabrata_CBS138 171119 172738 W 
CAGL0E01749g YPS4 ChrE_C_glabrata_CBS138 174323 172875 C 
CAGL0E01771g YPS5 ChrE_C_glabrata_CBS138 177211 175652 C 
CAGL0E01793g YPS6 ChrE_C_glabrata_CBS138 179961 178411 C 
CAGL0E01815g YPS8 ChrE_C_glabrata_CBS138 182713 181154 C 
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CAGL0E01837g YPS9 ChrE_C_glabrata_CBS138 184802 183237 C 
CAGL0E01859g YPS10 ChrE_C_glabrata_CBS138 187387 185870 C 
CAGL0E01881g YPS11 ChrE_C_glabrata_CBS138 188277 189803 W 
CAGL0E02211g  ChrE_C_glabrata_CBS138 215568 215768 W 
CAGL0E03498g  ChrE_C_glabrata_CBS138 324961 324476 C 
CAGL0E04554g  ChrE_C_glabrata_CBS138 439395 440117 W 
CAGL0E05192g  ChrE_C_glabrata_CBS138 507868 506831 C 
CAGL0E05214g  ChrE_C_glabrata_CBS138 509315 508275 C 
CAGL0E05236g  ChrE_C_glabrata_CBS138 510749 509715 C 
CAGL0E05280g GRE2(B) ChrE_C_glabrata_CBS138 513263 512208 C 
CAGL0E06094g  ChrE_C_glabrata_CBS138 603704 603877 W 
CAGL0E06402g  ChrE_C_glabrata_CBS138 643478 643768 W 
CAGL0E06600g  ChrE_C_glabrata_CBS138 658435 661332 W 
CAGL0E06644g EPA1 ChrE_C_glabrata_CBS138 665110 668214 W 
CAGL0E06666g EPA2 ChrE_C_glabrata_CBS138 674692 670430 C 
CAGL0E06688g EPA3 ChrE_C_glabrata_CBS138 683331 680404 C 
CAGL0F00209g  ChrF_C_glabrata_CBS138 23731 22109 C 
CAGL0F01815g  ChrF_C_glabrata_CBS138 180414 179470 C 
CAGL0F02057g  ChrF_C_glabrata_CBS138 199689 197149 C 
CAGL0F03641g  ChrF_C_glabrata_CBS138 356059 354791 C 
CAGL0F04543g  ChrF_C_glabrata_CBS138 456591 456866 W 
CAGL0F06699g  ChrF_C_glabrata_CBS138 659539 658958 C 
CAGL0F07381g  ChrF_C_glabrata_CBS138 720934 719330 C 
CAGL0F08767g  ChrF_C_glabrata_CBS138 867394 867789 W 
CAGL0F09141g  ChrF_C_glabrata_CBS138 904448 904239 C 
CAGL0F09273g  ChrF_C_glabrata_CBS138 925942 926406 W 
CAGL0G00836g  ChrG_C_glabrata_CBS138 74216 74605 W 
CAGL0G01408g  ChrG_C_glabrata_CBS138 134524 134928 W 
CAGL0G02519g  ChrG_C_glabrata_CBS138 229958 228822 C 
CAGL0G02563g  ChrG_C_glabrata_CBS138 237393 235498 C 
CAGL0G02871g  ChrG_C_glabrata_CBS138 264266 263943 C 
CAGL0G03201g  ChrG_C_glabrata_CBS138 299668 299021 C 
CAGL0G03685g  ChrG_C_glabrata_CBS138 354696 354923 W 
CAGL0G03949g  ChrG_C_glabrata_CBS138 375421 375924 W 
CAGL0G03993g  ChrG_C_glabrata_CBS138 379229 378876 C 
CAGL0G04279g  ChrG_C_glabrata_CBS138 406126 404144 C 
CAGL0G04785g  ChrG_C_glabrata_CBS138 456307 456011 C 
CAGL0G04829g  ChrG_C_glabrata_CBS138 459677 462151 W 
CAGL0G05522g  ChrG_C_glabrata_CBS138 524170 524448 W 
CAGL0G06050g  ChrG_C_glabrata_CBS138 581306 581530 W 
CAGL0G06160g  ChrG_C_glabrata_CBS138 587971 588246 W 
CAGL0G06446g  ChrG_C_glabrata_CBS138 622068 622394 W 
CAGL0G06644g  ChrG_C_glabrata_CBS138 634825 634475 C 
CAGL0G06710g  ChrG_C_glabrata_CBS138 643070 642819 C 
CAGL0G06996g  ChrG_C_glabrata_CBS138 667930 667115 C 
CAGL0G07183g  ChrG_C_glabrata_CBS138 683243 678730 C 
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CAGL0G07645g  ChrG_C_glabrata_CBS138 725540 725259 C 
CAGL0G09086g  ChrG_C_glabrata_CBS138 867382 867894 W 
CAGL0G09625g  ChrG_C_glabrata_CBS138 918731 919138 W 
CAGL0G09647g  ChrG_C_glabrata_CBS138 919676 919350 C 
CAGL0G10175g AWP6 ChrG_C_glabrata_CBS138 977483 979216 W 
CAGL0G10219g  ChrG_C_glabrata_CBS138 988766 991744 W 
CAGL0H00110g  ChrH_C_glabrata_CBS138 3711 2611 C 
CAGL0H00418g  ChrH_C_glabrata_CBS138 42181 41327 C 
CAGL0H01749g  ChrH_C_glabrata_CBS138 168634 168305 C 
CAGL0H02277g  ChrH_C_glabrata_CBS138 206023 206397 W 
CAGL0H03465g  ChrH_C_glabrata_CBS138 323129 323524 W 
CAGL0H04015g  ChrH_C_glabrata_CBS138 378264 377281 C 
CAGL0H04059g  ChrH_C_glabrata_CBS138 383690 383247 C 
CAGL0H04147g  ChrH_C_glabrata_CBS138 392825 393643 W 
CAGL0H04257g MT-II ChrH_C_glabrata_CBS138 405073 405231 W 
CAGL0H04279g MT-IIB ChrH_C_glabrata_CBS138 406327 406485 W 
CAGL0H06017g FLR1 ChrH_C_glabrata_CBS138 590229 588556 C 
CAGL0H06039g  ChrH_C_glabrata_CBS138 594295 592526 C 
CAGL0H06853g ADH6 ChrH_C_glabrata_CBS138 681266 680184 C 
CAGL0H07337g  ChrH_C_glabrata_CBS138 718141 718590 W 
CAGL0H08712g  ChrH_C_glabrata_CBS138 849446 848229 C 
CAGL0H08756g  ChrH_C_glabrata_CBS138 853968 853720 C 
CAGL0H09240g  ChrH_C_glabrata_CBS138 907598 905670 C 
CAGL0H09262g  ChrH_C_glabrata_CBS138 910135 908258 C 
CAGL0H09394g  ChrH_C_glabrata_CBS138 921373 920468 C 
CAGL0H09482g  ChrH_C_glabrata_CBS138 928788 928384 C 
CAGL0H09592g  ChrH_C_glabrata_CBS138 937859 938569 W 
CAGL0H10010g  ChrH_C_glabrata_CBS138 977299 976466 C 
CAGL0H10626g  ChrH_C_glabrata_CBS138 1043943 1047923 W 
CAGL0I00220g EPA23 ChrI_C_glabrata_CBS138 14903 12309 C 
CAGL0I00242g  ChrI_C_glabrata_CBS138 18146 17649 C 
CAGL0I00286g  ChrI_C_glabrata_CBS138 22188 20521 C 
CAGL0I00396g  ChrI_C_glabrata_CBS138 29592 29245 C 
CAGL0I02024g OYE2 ChrI_C_glabrata_CBS138 173433 172231 C 
CAGL0I02046g  ChrI_C_glabrata_CBS138 176085 175036 C 
CAGL0I02244g  ChrI_C_glabrata_CBS138 195726 195217 C 
CAGL0I02596g  ChrI_C_glabrata_CBS138 235250 234648 C 
CAGL0I05874g  ChrI_C_glabrata_CBS138 558845 558102 C 
CAGL0I07293g  ChrI_C_glabrata_CBS138 708640 703325 C 
CAGL0I08151g  ChrI_C_glabrata_CBS138 793917 795065 W 
CAGL0I08437g  ChrI_C_glabrata_CBS138 825046 829038 W 
CAGL0I08613g DUR3 ChrI_C_glabrata_CBS138 841861 840182 C 
CAGL0I09108g  ChrI_C_glabrata_CBS138 884075 882180 C 
CAGL0I09724g  ChrI_C_glabrata_CBS138 929606 928113 C 
CAGL0I10147g PWP1 ChrI_C_glabrata_CBS138 983741 970731 C 
CAGL0I10200g PWP3 ChrI_C_glabrata_CBS138 992434 996555 W 
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CAGL0I10246g PWP2 ChrI_C_glabrata_CBS138 1002627 1006349 W 
CAGL0I10340g PWP5 ChrI_C_glabrata_CBS138 1013299 1016337 W 
CAGL0I10362g PWP4 ChrI_C_glabrata_CBS138 1020373 1025691 W 
CAGL0J00451g  ChrJ_C_glabrata_CBS138 37169 36171 C 
CAGL0J01727g  ChrJ_C_glabrata_CBS138 160781 157842 C 
CAGL0J01774g  ChrJ_C_glabrata_CBS138 172073 164808 C 
CAGL0J01800g  ChrJ_C_glabrata_CBS138 177152 173901 C 
CAGL0J02024g  ChrJ_C_glabrata_CBS138 204836 203412 C 
CAGL0J02046g  ChrJ_C_glabrata_CBS138 205632 205871 W 
CAGL0J02508g AWP1 ChrJ_C_glabrata_CBS138 248822 246210 C 
CAGL0J02530g  ChrJ_C_glabrata_CBS138 252893 250629 C 
CAGL0J02552g  ChrJ_C_glabrata_CBS138 257549 254862 C 
CAGL0J03982g  ChrJ_C_glabrata_CBS138 377534 377881 W 
CAGL0J04554g  ChrJ_C_glabrata_CBS138 434978 433719 C 
CAGL0J04972g  ChrJ_C_glabrata_CBS138 475587 476606 W 
CAGL0J05159g  ChrJ_C_glabrata_CBS138 494336 489747 C 
CAGL0J05390g  ChrJ_C_glabrata_CBS138 517202 516870 C 
CAGL0J05786g  ChrJ_C_glabrata_CBS138 553406 551562 C 
CAGL0J05852g  ChrJ_C_glabrata_CBS138 557558 556527 C 
CAGL0J10714g  ChrJ_C_glabrata_CBS138 1046800 1047771 W 
CAGL0J11000g  ChrJ_C_glabrata_CBS138 1073752 1074513 W 
CAGL0J11088g  ChrJ_C_glabrata_CBS138 1081270 1081962 W 
CAGL0J11374g  ChrJ_C_glabrata_CBS138 1106466 1106215 C 
CAGL0J11616g  ChrJ_C_glabrata_CBS138 1130080 1130436 W 
CAGL0J11891g AWP3 ChrJ_C_glabrata_CBS138 1165100 1161474 C 
CAGL0K00110g AWP2 ChrK_C_glabrata_CBS138 5830 3332 C 
CAGL0K00170g EPA22 ChrK_C_glabrata_CBS138 14140 18411 W 
CAGL0K00341g  ChrK_C_glabrata_CBS138 37953 37531 C 
CAGL0K02013g  ChrK_C_glabrata_CBS138 176257 177375 W 
CAGL0K02519g  ChrK_C_glabrata_CBS138 228185 227541 C 
CAGL0K03245g  ChrK_C_glabrata_CBS138 299646 298216 C 
CAGL0K04609g  ChrK_C_glabrata_CBS138 440457 438628 C 
CAGL0K04675g  ChrK_C_glabrata_CBS138 455284 455718 W 
CAGL0K05665g  ChrK_C_glabrata_CBS138 553943 552804 C 
CAGL0K05687g  ChrK_C_glabrata_CBS138 555370 556536 W 
CAGL0K07183g  ChrK_C_glabrata_CBS138 705897 706220 W 
CAGL0K07337g  ChrK_C_glabrata_CBS138 724973 725914 W 
CAGL0K07502g  ChrK_C_glabrata_CBS138 742349 742990 W 
CAGL0K07546g PMU2 ChrK_C_glabrata_CBS138 745201 746172 W 
CAGL0K07568g PMU3 ChrK_C_glabrata_CBS138 747658 748629 W 
CAGL0K07678g  ChrK_C_glabrata_CBS138 764843 764196 C 
CAGL0K08338g  ChrK_C_glabrata_CBS138 841389 840409 C 
CAGL0K08470g  ChrK_C_glabrata_CBS138 852119 851940 C 
CAGL0K10890g  ChrK_C_glabrata_CBS138 1063220 1064422 W 
CAGL0K11484g  ChrK_C_glabrata_CBS138 1114883 1115206 W 
CAGL0K11946g  ChrK_C_glabrata_CBS138 1153568 1153891 W 
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CAGL0K12364g  ChrK_C_glabrata_CBS138 1206621 1207109 W 
CAGL0K12980g BMT7 ChrK_C_glabrata_CBS138 1286134 1283966 C 
CAGL0K13002g AED2 ChrK_C_glabrata_CBS138 1291683 1294496 W 
CAGL0L00157g  ChrL_C_glabrata_CBS138 5931 736 C 
CAGL0L00227g  ChrL_C_glabrata_CBS138 27536 17811 C 
CAGL0L01023g  ChrL_C_glabrata_CBS138 119978 119691 C 
CAGL0L01045g  ChrL_C_glabrata_CBS138 120342 120109 C 
CAGL0L01831g  ChrL_C_glabrata_CBS138 212208 212366 W 
CAGL0L03388g  ChrL_C_glabrata_CBS138 388777 389391 W 
CAGL0L03894g  ChrL_C_glabrata_CBS138 448634 448143 C 
CAGL0L04832g  ChrL_C_glabrata_CBS138 554478 554284 C 
CAGL0L04836g  ChrL_C_glabrata_CBS138 554702 554508 C 
CAGL0L05192g  ChrL_C_glabrata_CBS138 585066 585383 W 
CAGL0L05324g  ChrL_C_glabrata_CBS138 592217 591903 C 
CAGL0L05984g  ChrL_C_glabrata_CBS138 669527 669150 C 
CAGL0L06688g  ChrL_C_glabrata_CBS138 758073 756016 C 
CAGL0L07194g  ChrL_C_glabrata_CBS138 800960 801430 W 
CAGL0L07568g  ChrL_C_glabrata_CBS138 837713 837393 C 
CAGL0L07590g  ChrL_C_glabrata_CBS138 838499 838293 C 
CAGL0L08470g  ChrL_C_glabrata_CBS138 930917 930435 C 
CAGL0L08536g  ChrL_C_glabrata_CBS138 934441 934662 W 
CAGL0L09361g  ChrL_C_glabrata_CBS138 1018071 1018406 W 
CAGL0L09537g  ChrL_C_glabrata_CBS138 1029031 1030233 W 
CAGL0L10092g  ChrL_C_glabrata_CBS138 1084445 1088695 W 
CAGL0L12496g  ChrL_C_glabrata_CBS138 1349053 1348769 C 
CAGL0L12518g  ChrL_C_glabrata_CBS138 1349621 1349271 C 
CAGL0L13266g  ChrL_C_glabrata_CBS138 1418408 1420147 W 
CAGL0L13299g EPA11 ChrL_C_glabrata_CBS138 1426694 1431586 W 
CAGL0L13332g EPA13 ChrL_C_glabrata_CBS138 1436026 1439133 W 
CAGL0L13354g TNR1 ChrL_C_glabrata_CBS138 1441319 1439574 C 
CAGL0L13365r RDN25-1 ChrL_C_glabrata_CBS138 1448197 1444790 C 
CAGL0L13387r RDN58-1 ChrL_C_glabrata_CBS138 1448584 1448427 C 
CAGL0L13398r RDN18-1 ChrL_C_glabrata_CBS138 1450786 1448987 C 
CAGL0L13409r RDN5-1 ChrL_C_glabrata_CBS138 1452956 1453076 W 
CAGL0M00154g CYN1 ChrM_C_glabrata_CBS138 22039 23691 W 
CAGL0M00308g  ChrM_C_glabrata_CBS138 39072 38758 C 
CAGL0M00704g  ChrM_C_glabrata_CBS138 81930 82796 W 
CAGL0M00792g  ChrM_C_glabrata_CBS138 91057 90755 C 
CAGL0M01760g CDR1 ChrM_C_glabrata_CBS138 203616 208115 W 
CAGL0M01870g  ChrM_C_glabrata_CBS138 220760 219813 C 
CAGL0M01914g  ChrM_C_glabrata_CBS138 232780 234810 W 
CAGL0M02321g  ChrM_C_glabrata_CBS138 277990 276554 C 
CAGL0M02541g  ChrM_C_glabrata_CBS138 294479 294348 C 
CAGL0M03421g  ChrM_C_glabrata_CBS138 391586 390927 C 
CAGL0M04543g  ChrM_C_glabrata_CBS138 498691 499533 W 
CAGL0M04851g  ChrM_C_glabrata_CBS138 532127 532318 W 
 245 | P a g e  
 
CAGL0M05115g  ChrM_C_glabrata_CBS138 549946 551247 W 
CAGL0M05137g  ChrM_C_glabrata_CBS138 552160 556215 W 
CAGL0M05819g  ChrM_C_glabrata_CBS138 615435 615635 W 
CAGL0M07744g  ChrM_C_glabrata_CBS138 779985 779281 C 
CAGL0M07766g  ChrM_C_glabrata_CBS138 781830 782546 W 
CAGL0M08096g  ChrM_C_glabrata_CBS138 809185 809559 W 
CAGL0M08558g  ChrM_C_glabrata_CBS138 855342 855046 C 
CAGL0M10065g  ChrM_C_glabrata_CBS138 1002184 1002933 W 
CAGL0M10263g  ChrM_C_glabrata_CBS138 1027902 1027450 C 
CAGL0M10395g  ChrM_C_glabrata_CBS138 1038860 1043857 W 
CAGL0M10978g  ChrM_C_glabrata_CBS138 1090119 1088278 C 
CAGL0M11088g  ChrM_C_glabrata_CBS138 1095910 1095254 C 
CAGL0M11660g  ChrM_C_glabrata_CBS138 1160862 1160116 C 
CAGL0M12056g  ChrM_C_glabrata_CBS138 1207001 1206666 C 
CAGL0M12364g  ChrM_C_glabrata_CBS138 1236300 1236064 C 
CAGL0M12452g  ChrM_C_glabrata_CBS138 1241018 1241242 W 
CAGL0M12881g  ChrM_C_glabrata_CBS138 1273254 1274573 W 
CAGL0M12947g PUP1 ChrM_C_glabrata_CBS138 1277761 1278396 W 
CAGL0M13123g  ChrM_C_glabrata_CBS138 1291605 1289611 C 
CAGL0M14069g PWP6 ChrM_C_glabrata_CBS138 1391579 1394179 W 
CAGL0M14091g  ChrM_C_glabrata_CBS138 1395548 1396189 W 
CAGL0M14113g TNR2 ChrM_C_glabrata_CBS138 1399152 1397407 C 
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Appendix 4: Functional information for targeted C. 
glabrata gene deletions 
 
Table 1: Deleted and verified C. glabrata ORFs. Coordinates of the deletion cassette are given as chromosomal location followed by 
position relative to the start of the coding sequence. Predicted domains encoded by each ORF (ebi.ac.uk/interpro/) and their associated 
GO terms are also listed. 
 
C. glabrata ORF S. 
cerevisiae 
orthologue 
(YGOB) 
Coordinates of 
deletion 
construct 
Interpro domains Interpro: GO 
Biological Process 
Interpro: GO 
Molecular Function 
Interpro: GO Cellular 
Compartment 
CAGL0A02299g None 250844 to 251762 
(-7 to +912) 
None None None None 
CAGL0A02343g None 254831 to 255132 
(-30 to +272) 
None None None None 
CAGL0A04565g SWI4 445874 to 449018 
(-9 to +3136) 
APSES-type DNA-
binding domain; 
Ankyrin repeat-
containing domain 
GO:0006355 regulatio
n of transcription, 
DNA-dependent  
GO:0003677 DNA 
binding 
GO:0003700 
sequence-specific 
DNA binding 
transcription factor 
activity 
None 
CAGL0B00726g GLK1 63877 to 65154 
(-26 to +1252) 
Hexokinase GO:0005975 carbohyd
rate metabolic process  
GO:0005524 ATP 
binding 
GO:0016773 
phosphotransferase 
activity, alcohol group 
as acceptor 
None 
CAGL0B02926g None 284892 to 286823 None None None None 
 247 | P a g e  
 
(-6 to +1927) 
CAGL0B02946g None 252227 to 254950 
(-33 to 2692) 
None None None None 
CAGL0B02948g None 287995 to 289873 
(-11 to +1868) 
None None None None 
CAGL0B02970g None 291235 to 293148 
(-14 to +1902) 
None None None None 
CAGL0B03223g None 314580 to 315021 
(-110 to +332) 
None None None None 
CAGL0B03883g None 383602 to 384523 
(+1 to +922) 
Mitochondrial 
carrier domain 
None None None 
CAGL0C00253g None 18868 to 23731 
(-16 to +4848) 
None None None None 
CAGL0C01837g None 191460 to 193408 
(-3 to +1945) 
None None None GO:0016021 integral 
to membrane 
CAGL0C04763g None 444889 to 445883 
(-35 to +950) 
None None None GO:0016021 integral 
to membrane 
CAGL0D00682g SFP1 89099 to 90871 
(-95 to +1677) 
Zinc finger C2H2-
type/integrase DNA 
binding domain; 
zinc finger, C2H2 
None GO:0003676 nucleic 
acid binding; 
GO:0046872 metal ion 
binding  
None 
CAGL0D01210g None 137908 to 138661 
(-46 to +708) 
Aspartate 
racemase 
GO:0006520 cellular 
amino acid metabolic 
process 
GO:0006807 nitrogen 
compound metabolic 
process 
GO:0008152 
metabolic process 
GO:0016855 racemas
e and epimerase 
activity, acting on 
amino acids and 
derivatives 
GO:0036361 
racemase activity, 
acting on amino acids 
and derivatives 
None 
CAGL0D03850g RSC30 384666 to 387223 
(-23 to +2535) 
Zn(2)-C6 fungal-
type DNA-binding 
domain 
GO:0006355 regulatio
n of transcription, 
DNA-dependent  
GO:0000981 sequenc
e-specific DNA binding 
RNA polymerase II 
transcription factor 
activity 
GO:0008270 zinc ion 
GO:0005634 nucleus  
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binding 
CAGL0D03872g None 387620 to 388433 
(-3 to +810) 
None None None None 
CAGL0D05170g PHO4 493835 to 495498 
(-44 to +1602) 
Myc-type, basic 
helix-loop-helix 
domain 
None GO:0046983 protein 
dimerization activity  
None 
CAGL0D05434g None 518011 to 518813 
(-31 to +772) 
Repressor Rox1, 
High mobility group 
box domain 
GO:0043618 regulatio
n of transcription from 
RNA polymerase II 
promoter in response 
to stress  
GO:0043565 sequenc
e-specific DNA binding  
GO:0000790 nuclear 
chromatin 
CAGL0D06226g None 586360 to 588754 
(-35 to +2342) 
None None None None 
CAGL0E00275g None 25857 to 28568 
(-5 to +2688) 
PA14; GLEYA 
adhesin domain 
None None None 
CAGL0E06600g None 658325 to 661393 
(-110 to 2959) 
Hyphally-regulated 
cell was protein; 
Flocculin 
GO:0000128 flocculati
on  
None None 
CAGL0E06644g None 665109 to 668298 
(-1 to +3171) 
PA14; GLEYA 
adhesin domain 
None None None 
CAGL0F01815g None 179369 to 180475 
(-101 to +988) 
RmlC-like cupin 
domain; Pirin 
None None None 
CAGL0F03905g SKY1 377984 to 380088 
(+22 to +2109) 
Protein kinase 
domain 
GO:0006468 protein 
phosphorylation  
GO:0004672 protein 
kinase activity 
GO:0004674 protein 
serine/threonine 
kinase activity  
GO:0005524 ATP 
binding; GO:0016772 
transferase activity, 
transferring 
phosphorus-containing 
groups 
None 
CAGL0F04081g TEC1 406040 to 408033 
(-110 to +1883) 
TEA/ATTS GO:0006355 regulatio
n of transcription, 
DNA-dependent  
GO:0003700 sequenc
e-specific DNA binding 
transcription factor 
GO:0005634 nucleus  
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activity  
CAGL0F05159g VPS72 525178 to 527640 
(-51 to +2411) 
YL1 Nuclear GO:0006355 regulatio
n of transcription, 
DNA-dependent  
None None 
CAGL0F05973g MIH1 595747 to 597393 
(-5 to +1642) 
M-phase inducer 
phosphatase; 
Rhodanese-like 
domain 
GO:0000087 M phase 
of mitotic cell cycle 
GO:0006470 protein 
dephosphorylation 
GO:0004725 protein 
tyrosine phosphatase 
activity 
GO:0005622 intracell
ular  
CAGL0F06237g MCM1 618975 to 619693 
(-1 to +718) 
Transcription factor; 
MADS-box 
None GO:0003677 DNA 
binding 
GO:0046983 protein 
dimerization activity 
KO 
CAGL0F08767g None 867393 to 867813 
(-1 to +420) 
None None None None 
CAGL0F09229g YER184c 908185 to 910715 
(-1 to 2530) 
Zn(2)-C6 fungal-
type DNA binding 
domain; 
Transcription factor 
domain, fungi 
GO:0006351 transcript
ion, DNA-dependent 
GO:0006355 
regulation of 
transcription, DNA-
dependent 
GO:0000981 sequenc
e-specific DNA binding 
RNA polymerase II 
transcription factor 
activity 
GO:0003677 DNA 
binding 
GO:0008270 zinc ion 
binding 
GO:0005634 nucleus  
CAGL0G02607g ARK1 240259 to 242297 
(+16 to 2054) 
Protein kinase-like 
domain; 
Serine/threonine-
protein kinase, 
active site 
GO:0006468 protein 
phosphorylation  
GO:0004672 protein 
kinase activity 
GO:0004674 protein 
serine/threonine 
kinase activity 
GO:0005524 ATP 
binding 
GO:0016772 
transferase activity, 
transferring 
phosphorus-containing 
groups 
None 
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CAGL0G03201g None 299019 to 299680 
(-2 to +660) 
FMN-binding split 
barrel; Flavin-
reductase-like, 
FMN-binding 
GO:0055114 oxidation
-reduction process  
GO:0010181 FMN 
binding 
GO:0016491 
oxidoreductase activity 
GO:0042602 riboflavin 
reductase (NADPH) 
activity  
KO 
CAGL0G04279g None 404052 to 406165 
(-74 to +2022) 
Alpha 
mannosyltransferas
e 
GO:0006486 protein 
glycosylation  
None None 
CAGL0G05522g None 524159 to 524473 
(-11 to 304) 
None None None None 
CAGL0G08866g FKH1 850934 to 852770 
(+12 to 1848) 
SMAO/FHA 
domain; Winged 
helix-turn-helix 
DNA-binding 
domain 
GO:0006355 regulatio
n of transcription, 
DNA-dependent  
GO:0003700 sequenc
e-specific DNA binding 
transcription factor 
activity 
GO:0005515 protein 
binding 
GO:0043565 
sequence-specific 
DNA binding 
None 
CAGL0G10175g None 977401 to 979260 
(-82 to +1778) 
None None None None 
CAGL0H01749g None 168264 to 168654 
(-43 to +333) 
None None None None 
CAGL0H06765g BNR1 672619 to 676510 
(-1 to +3892) 
Formin, GTP-ase-
binding and FH3 
domain; Formin, 
FH2 domain; 
Formin, diaphanous 
autoregulatory 
(DAD) domain 
GO:0007015 actin 
filament organization ; 
actin cytoskeleton 
organization 
GO:0045010 actin 
nucleation  
GO:0003779 actin 
binding 
GO:0005488 binding  
GO:0017048 Rho 
GTPase binding 
GO:0005884 actin 
filament  
CAGL0H08712g None 848226 to 849480 
(-3 to +1253) 
Src homology-3 
domain; Phox 
homology domain 
GO:0007154 cell 
communication  
GO:0005515 protein 
binding 
GO:0035091 
phosphatidylinositol 
None 
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binding 
CAGL0H09988g REB1 973838 to 975840 
(-12 to 1990) 
Homeodomain-like; 
SANT/Myb domain 
None GO:0003677 DNA 
binding 
GO:0003682 
chromatin binding 
None 
CAGL0H10208g AKL1 996857 to 999925 
(+5 to +3073) 
Protein kinase 
domain; 
Serine/threonine-
protein kinase, 
active site 
GO:0006468 protein 
phosphorylation  
GO:0004672 protein 
kinase activity 
GO:0004674 protein 
serine/threonine 
kinase activity 
GO:0005524 ATP 
binding 
GO:0016772 
transferase activity, 
transferring 
phosphorus-containing 
groups 
None 
CAGL0I02244g None 195216 to 195798 
(-1 to +582) 
no hit None None None 
CAGL0I08437g None 825005 to 829037 
(-41 to +3992) 
no hit None None None 
CAGL0I08613g None 839182 to 842886 
(+1 to +1705) 
Sodium/solute 
symporter 
GO:0006810 transport
GO:0055085 
transmembrane 
transport 
GO:0005215 transport
er activity  
GO:0016020 membra
ne  
CAGL0J05786g None 550495 to 554463 
(-67 to +1902) 
Zinc finger, B-box None GO:0008270 zinc ion 
binding  
GO:0005622 intracell
ular  
CAGL0J05852g None 556482 to 557601 
(-45 to +1075) 
NAD(P)-binding 
domain 
GO:0008152 metaboli
c process  
GO:0016491 oxidored
uctase activity 
None 
CAGL0K02145g YER130C 189978 to 191009 
(-28 to +955) 
Zinc finger C2H2-
type/integrase 
DNA-binding 
domain 
None GO:0003676 nucleic 
acid binding 
GO:0046872 metal ion 
binding  
None 
CAGL0K05687g None 554478 to 555693 
(-63 to +1153) 
Aldolase-type TIM 
barrel; NADH:flavin 
oxidoreductase/NA
None GO:0004842 ubiquitin-
protein ligase activity 
GO:0008270 zinc ion 
None 
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DH oxidase, N-
terminal 
binding  
CAGL0K07634g GAT1 753820 to 755228 
(-25 to +1384) 
Zinc finger, GATA-
type 
GO:0006355 regulatio
n of transcription, 
DNA-dependent  
GO:0003700 sequenc
e-specific DNA binding 
transcription factor 
activity 
GO:0008270 zinc ion 
binding 
GO:0043565 
sequence-specific 
DNA binding 
None 
CAGL0K10318g RGA1 1003916 to 
1006756 
(-8 to +2833) 
Zinc finger, LIM-
type; Rho GTPase 
activation protein 
domain 
GO:0007165 signal 
transduction  
GO:0008270 zinc ion 
binding  
GO:0005622 intracell
ular  
CAGL0K11066g None 1078268 to 
1078921 
(-32 to +605) 
Trimeric LpxA-like; 
Hexapeptide 
transferase, 
conserved site 
None GO:0016740 transfera
se activity 
None 
CAGL0L03674g GSM1 420554 to 422473 
(-20 to +1901) 
Zn(2)-C6 fungal-
type DNA-binding 
domain; PAS 
domain 
GO:0006355 regulatio
n of transcription, 
DNA-dependent 
GO:0007165 signal 
transduction  
GO:0000981 sequenc
e-specific DNA binding 
RNA polymerase II 
transcription factor 
activity 
GO:0004871 signal 
transducer activity 
GO:0004871 signal 
transducer activity  
GO:0005634 nucleus  
CAGL0L06776g GAT2 761565 to 764069 
(-18 to +2487) 
Zinc finger, GATA-
type 
GO:0006355 regulatio
n of transcription, 
DNA-dependent  
GO:0003700 sequenc
e-specific DNA binding 
transcription factor 
activity 
GO:0008270 zinc ion 
binding 
GO:0043565 
sequence-specific 
None 
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DNA binding  
CAGL0L07480g NRG2 822201 to 823243 
(-39 to +1004) 
Zinc finger, C2H2 None GO:0003676 nucleic 
acid binding 
GO:0046872 metal ion 
binding  
None 
CAGL0L09383g SUT2 1018870 - 
1019987 (+12 to 
+1129) 
Zn(2)-C6 fungal-
type DNA-binding 
domain 
None None None 
CAGL0M01716g TEC1 192371 to 193706 
(+1 to +1318) 
TEA/ATTS GO:0006355 regulatio
n of transcription, 
DNA-dependent  
GO:0003700 sequenc
e-specific DNA binding 
transcription factor 
activity 
None 
CAGL0M01870g None 219810 to 220787 
(-3 to +975) 
Zinc finger, C2H2 None GO:0003676 nucleic 
acid binding 
GO:0046872 metal ion 
binding  
None 
CAGL0M01914g None 232780 to 234877 
(+1 to +2098) 
Tetratricopeptide-
like helical 
None GO:0005515 protein 
binding  
None 
CAGL0M02299g YPL150W 273683 to 276535 
(-42 to +2811) 
Protein kinase 
domain; 
Serine/threonine-
/dual specificity 
protein kinase, 
catalytic domain 
GO:0006468 protein 
phosphorylation  
GO:0004672 protein 
kinase activity 
GO:0004674 protein 
serine/threonine 
kinase activity 
GO:0005524 ATP 
binding 
GO:0016772 
transferase activity, 
transferring 
phosphorus-containing 
groups  
None 
CAGL0M02321g None 276552 to 277991 
(-2 to +1438) 
None None None None 
CAGL0M05137g None 552098 to 556242 
(-62 to +4083) 
Regulator of 
chromosome 
condesation1/beta-
lactamase-inhibitor 
None GO:0005515 protein 
binding  
GO:0005634 nucleus  
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protein II; BTB/POZ 
fold 
CAGL0M10153g STE20 1010630 to 
1013383 
(-58 to +2696) 
PAK-box/P21-Rho-
binding; 
Serine/threonine-
/dual specificity 
protein kinase, 
catalytic domain 
GO:0006468 protein 
phosphorylation  
GO:0004672 protein 
kinase activity 
GO:0004674 protein 
serine/threonine 
kinase activity 
GO:0005515 protein 
binding 
GO:0005524 ATP 
binding 
GO:0016772 
transferase activity, 
transferring 
phosphorus-containing 
groups  
None 
CAGL0M10978g None 1098987 to 
10990393 
(-13 to +1842) 
no hit None None None 
 
  
 255 | P a g e  
 
Table 2: C. glabrata ORFs for which fusion constructs were generated but were not successfully transformed or verified into C. 
glabrata. Coordinates of the deletion cassette are given as chromosomal location followed by position relative to the start of the coding 
sequence. Predicted domains encoded by each ORF (ebi.ac.uk/interpro/) and their associated GO terms are also listed. 
C. glabrata  
ORF 
S. 
cerevisiae 
orthologue 
(YGOB) 
Coordinates of 
deletion construct 
Interpro domains Interpro: GO biological 
process 
Interpro: GO Molecular 
Function 
Interpro: GO Cellular 
Compartment 
CAGL0A01870g None 191328 to 193764 
(-7 to +2630) 
Sialidases; Collagen 
triple helix repeat 
None None GO:0016021 integral to 
membrane 
CAGL0A01892g None 194514 to 194873 
(-46 to +314) 
no hits None None None 
CAGL0A02255g None 244674 to 245446 
(-9 to +781) 
no hits None None None 
CAGL0A03608g None 366262 to 366991 
(-28 to +702) 
no hits None None None 
CAGL0A04257g TOD6 417613 to 419632 
(-31 to +1970) 
Myb domain; 
homeodomain-like 
None GO:0003677 DNA binding 
GO:0003682 chromatin 
binding  
None 
CAGL0B01287g BUD5 114798 to 118596 
(-33 to +3765) 
Ras guanine 
nucleotide exchange 
factor; Src homology-3 
domain 
GO:0007264 small GTPase 
mediated signal 
transduction 
GO:0051056 regulation of 
small GTPase mediated 
signal transduction  
GO:0005085 guanyl-
nucleotide exchange factor 
activity GO:0005515 
protein binding  
GO:0005622 intracellular  
CAGL0B02882g None 279334 to 281185 
(+1 to +1852) 
no hits None None None 
CAGL0C00110g None 2132 to 4352 (-6 to 
+2198) 
PA14; GLEYA adhesin 
domain 
None None None 
CAGL0C00847g None 86017 to 88562 (-
113 to +2433) 
PA14; GLEYA adhesin 
domain 
None None None 
CAGL0C02277g GLN3 230471 to 232986 
(-26 to +2491) 
Zinc finger; GATA-type GO:0006355 regulation of 
transcription, DNA-
dependent  
GO:0003700 sequence-
specific DNA binding 
transcription factor activity 
GO:0008270 zinc ion 
None 
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binding 
GO:0043565 sequence-
specific DNA binding 
CAGL0D02750g None 288623 to 289032 
(-24 to +386) 
no hits None None None 
CAGL0D06380g None 601021 to 602088 
(+1 to +1149) 
no hits None None None 
CAGL0F02057g None 197109 to 199697 
(-41 to +2549) 
Homeodomain-like None GO:0003677 DNA binding  None 
CAGL0F03069g CAD1 301624 to 303133 
(-28 to +1484) 
Basic-leucine zipper 
domain 
GO:0006355 regulation of 
transcription, DNA-
dependent;  
GO:0003700 sequence-
specific DNA binding 
transcription factor activity 
GO:0043565 sequence-
specific DNA binding 
None 
CAGL0F08195g MGA1 813027 to 814110 
(-2 to +1061) 
Heat shock factor 
(HSF)-type, DNA 
binding 
GO:0006355 regulation of 
transcription, DNA-
dependent  
GO:0003700 sequence-
specific DNA binding 
transcription factor activity 
GO:0043565 sequence-
specific DNA binding  
GO:0005634 nucleus  
CAGL0G03421g FLO8 327810 to 330923 
(-23 to +3091) 
Sequence-specific 
single-strand DNA-
binding; LisH 
dimerisation motif 
None GO:0003697 single-
stranded DNA binding 
GO:0005515 protein 
binding  
None 
CAGL0G04389g GZF3 413333 to 414803 
(-43 to +1431) 
Zinc finger, GATA-type GO:0006355 regulation of 
transcription, DNA-
dependent  
GO:0003700 sequence-
specific DNA binding 
transcription factor activity 
GO:0008270 zinc ion 
binding 
GO:0043565 sequence-
specific DNA binding  
None 
CAGL0H04037g GAC1 379158 to 381918 
(-12 to +2750) 
Putative phosphatase 
regulatory subunit 
None GO:0005515 protein 
binding  
None 
CAGL0H09592g None 937855 to 938662 
(-4 to +804) 
Yeast PIR protein 
repeat 
GO:0006950 response to 
stress  
GO:0005199 structural 
constituent of cell wall  
GO:0005618 cell wall  
CAGL0I08151g None 793860 to 795117 
(-57 to +1201) 
RmlC-like cupin 
domain; Pirin 
None None None 
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CAGL0I10362g None 1020342 to 
1025748 (-13 to 
+5376) 
PA14 None None None 
CAGL0J01177g ABF1 111179 to 112625 
(-6 to +1441) 
no hits GO:0006338 chromatin 
remodeling  
GO:0003677 DNA binding  GO:0005634 nucleus  
CAGL0J02530g None 250910 to 252989 
(-18 to +2362) 
no hits None None None 
CAGL0J04972g None 475550 to 476623 
(-37 to +1037) 
Protein kinase domain; 
serine/threonine-
protein kinase, active 
site 
GO:0006468 protein 
phosphorylation;  
GO:0004672 protein 
kinase activity 
GO:0004674 protein 
serine/threonine kinase 
activity 
GO:0005524 ATP binding 
GO:0016772 transferase 
activity, transferring 
phosphorus-containing 
groups  
None 
CAGL0K02013g None 175201 to 178434 
(-56 to +1178) 
Zinc finger, N-recognin None GO:0004842 ubiquitin-
protein ligase activity 
GO:0008270 zinc ion 
binding  
None 
CAGL0K02585g YAP3 233130 to 234278 
(-12 to +1136) 
Basic-leucine zipper 
domain 
GO:0006355 regulation of 
transcription, DNA-
dependent  
GO:0003700 sequence-
specific DNA binding 
transcription factor activity 
GO:0043565 sequence-
specific DNA binding 
None 
CAGL0K08294g DYN1 824611 to 836743 
(-13 to +12125) 
Dynein heavy chain, 
domain-1; Dynein 
heavy chain-domain-2; 
AAA+ ATPase domain; 
Dynein heavy chain, 
P-loop containing D4 
domain; Dynein heavy 
chain, coiled coil stalk 
GO:0007018 microtubule-
based movement ;  
GO:0000166 nucleotide 
binding 
GO:0003777 microtubule 
motor activity 
GO:0005524 ATP binding; 
GO:0016887 ATPase 
activity GO:0016887 
ATPase activity  
None 
CAGL0L03916g AZF1 448927 to 450883 
(-28 to +1929) 
Zing finger C2H2-
type/integrase DNA-
None GO:0003676 nucleic acid 
binding  
None 
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binding domain GO:0046872 metal ion 
binding  
CAGL0L05686g None   no hits None None 
CAGL0L06072g YER130C 679893 to 680866 
(-31 to +943) 
Zing finger, C2H2 None GO:0003676 nucleic acid 
binding GO:0046872 metal 
ion binding  
None 
CAGL0M00770g SIR3 86279 to 89665 (-
11 to +3376) 
Bromo adjacent 
homology (BAH) 
domain 
None GO:0003677 DNA binding  None 
CAGL0M04543g None 498649 to 499607 
(-42 to +917) 
no hits None None None 
CAGL0M10065g None 1002100 to 
1002963 (-83 to 
+780) 
Galactose-binding 
domain-like; PITH 
domain 
None None None 
CAGL0M12881g None 1273191 to 
1274626 (-63 to 
+1373) 
dihydroorotate 
dehydrogenase, class 
1/2; aldolase-type TIM 
barrel 
GO:0006207 'de novo' 
pyrimidine nucleobase 
biosynthetic process 
GO:0006222 UMP 
biosynthetic process 
GO:0055114 oxidation-
reduction process 
GO:0003824 catalytic 
activity 
GO:0004152 
dihydroorotate 
dehydrogenase activity 
GO:0004158 
dihydroorotate oxidase 
activity 
GO:0016020 membrane  
CAGL0F00627g SLF1 65464 to 67407 (-
52 to +1892) 
Winged helix-turn-helix 
DNA-binding domain; 
RNA-binding protein 
Lupus La 
None None None 
CAGL0F01265g YAP7 131674 to 133622 
(-32 to +1898) 
Basic-leucine zipper 
domain 
GO:0006355 regulation of 
transcription, DNA-
dependent  
GO:0003700 sequence-
specific DNA binding 
transcription factor activity 
GO:0043565 sequence-
specific DNA binding  
None 
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Appendix 5: Statistical Analysis of 
Fitness Profiles 
 
Table1: Average lag time, doubling time and final OD600 readings for S. 
cerevisiae SGA strains expressing C. glabrata CAGL0D05434g compared 
with empty vector controls. P-values correspond to two-sample T-test 
comparing data sets from the previous cells. 
Strain Lag time 
(minutes) 
T-test p 
value 
Doubling 
Time 
(minutes) 
T-test p-
value 
Final OD T-test p 
value 
KH02 480 0.089 248 9.17e-
13 
0.766 1.6e-8 
KH02-
D05434 
499 301 0.733 
KH03 546 4.94e-5 283 1.35e-
11 
0.768 1.98e-14 
KH03-
D05434 
603 451 0.674 
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Appendix 6: Genetic interactions with C. glabrata 
CAGL0D05434g 
 
Table 1: S. cerevisiae ORFs and SGD description (yeastgenome.org) which showed genetic interactions with C. glabrata 
CAGL0D05434g expressed from S. cerevisiae strain ΔIme1-D05434. Genes highlighted in blue are implicated in mating, meiosis or 
sporulation. Orange denotes genes which function in DNA replication, DNA damage stress or whose expression increases in abundance 
or re-localises in response to DNA damage stress. Red represents genes involved in metal ion homeostasis, transport or resistance. 
Gene 
Name 
ORF name SGD Description 
ADH5  YBR145W Alcohol dehydrogenase isoenzyme V; involved in ethanol production; ADH5 has a paralog, ADH1, that arose from the whole 
genome duplication 
ADY3 YDL239C Protein required for spore wall formation; thought to mediate assembly of a Don1p-containing structure at the leading edge of the 
prospore membrane via interaction with spindle pole body components; potentially phosphorylated by Cdc28p; ADY3 has a 
paralog, CNM67, that arose from the whole genome duplication 
AEP3  YPL005W Protein that may facilitate use of unformylated tRNA-Met in mitochondrial translation initiation; localized to the matrix face of the 
mitochondrial inner membrane; stabilizes the bicistronic AAP1-ATP6 mRNA 
APM3  YBR288C Mu3-like subunit of the clathrin associated protein complex (AP-3); functions in transport of alkaline phosphatase to the vacuole 
via the alternate pathway 
ARF2 YDL137W ADP-ribosylation factor; GTPase of the Ras superfamily involved in regulation of coated formation vesicles in intracellular 
trafficking within the Golgi; ARF2 has a paralog, ARF1, that arose from the whole genome duplication 
ATG29  YPL166W Autophagy-specific protein; required for recruiting other ATG proteins to the pre-autophagosomal structure (PAS); interacts with 
Atg17p and localizas to the PAS in a manner interdependent with Atg17p and Cis1p; not conserved; relocalizes from nucleus to 
cytoplasmic foci upon DNA replication stress 
BDF1 YLR399C Protein involved in transcription initiation at TATA-containing promoters; associates with the basal transcription factor TFIID; 
contains two bromodomains; corresponds to the C-terminal region of mammalian TAF1; redundant with Bdf2p 
BOP3 YNL042W Protein of unknown function, potential Cdc28p substrate; overproduction confers resistance to methylmercury 
CDC73 YLR418C Component of the Paf1p complex; binds to and modulates the activity of RNA polymerases I and II; required for expression of 
certain genes, modification of some histones, and telomere maintenance; involved in transcription elongation as demonstrated by 
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the G-less-based run-on (GLRO) assay; protein abundance increases in response to DNA replication stress 
CHA4 YLR098C DNA binding transcriptional activator, mediates serine/threonine activation of the catabolic L-serine (L-threonine) deaminase 
(CHA1); Zinc-finger protein with Zn[2]-Cys[6] fungal-type binuclear cluster domain 
CHS6  YJL099W Member of the ChAPs (Chs5p-Arf1p-binding proteins) family; part of the exomer complex that mediates export of specific cargo 
proteins, including Chs3p, from the Golgi to the plasma membrane; CHS6 has a paralog, BCH2, that arose from the whole 
genome duplication 
CRS5  YOR031W Copper-binding metallothionein, required for wild-type copper resistance 
CTK2  YJL006C Beta subunit of C-terminal domain kinase I (CTDK-I), which phosphorylates both RNA pol II subunit Rpo21p to affect transcription 
and pre-mRNA 3' end processing, and ribosomal protein Rps2p to increase translational fidelity  
DDC1 YPL194W DNA damage checkpoint protein; part of a PCNA-like complex required for DNA damage response, required for pachytene 
checkpoint to inhibit cell cycle in response to unrepaired recombination intermediates; potential Cdc28p substrate; forms nuclear 
foci upon DNA replication stress 
ESBP6  YNL125C Protein with similarity to monocarboxylate permeases, appears not to be involved in transport of monocarboxylates such as 
lactate, pyruvate or acetate across the plasma membrane 
FRA1  YLL029W Protein involved in negative regulation of transcription of iron regulon; forms an iron independent complex with Fra2p, Grx3p, and 
Grx4p; cytosolic; mutant fails to repress transcription of iron regulon and is defective in spore formation 
FYV5  YCL058C Protein involved in regulation of the mating pathway; binds with Matalpha2p to promoters of haploid-specific genes; required for 
survival upon exposure to K1 killer toxin; involved in ion homeostasis 
GCN20 YFR009W Positive regulator of the Gcn2p kinase activity, forms a complex with Gcn1p; proposed to stimulate Gcn2p activation by an 
uncharged tRNA 
HAM1 YJR069C Nucleoside triphosphate pyrophosphohydrolase; active against a wide range of substrates including ITP, dITP and XTP; mediates 
exclusion of noncanonical purines and pyrimadines from deoxyribonucleoside triphosphate pools; mutant is sensitive to the base 
analog 6-N-hydroxylaminopurine; protein abundance increases in response to DNA replication stress 
HEF3  YNL014W Translational elongation factor EF-3; member of the ABC superfamily; stimulates EF-1 alpha-dependent binding of aminoacyl-
tRNA by the ribosome; normally expressed in zinc deficient cells; HEF3 has a paralog, YEF3, that arose from the whole genome 
duplication 
HMS2  YJR147W Protein with similarity to heat shock transcription factors; overexpression suppresses the pseudohyphal filamentation defect of a 
diploid mep1 mep2 homozygous null mutant; HMS2 has a paralog, SKN7, that arose from the whole genome duplication 
HOR7 YMR251W-A Protein of unknown function; overexpression suppresses Ca2+ sensitivity of mutants lacking inositol phosphorylceramide 
mannosyltransferases Csg1p and Csh1p; transcription is induced under hyperosmotic stress and repressed by alpha factor; HOR7 
has a paralog, DDR2, that arose from the whole genome duplication 
HST1  YOL068C NAD(+)-dependent histone deacetylase; essential subunit of the Sum1p/Rfm1p/Hst1p complex required for ORC-dependent 
silencing and mitotic repression; non-essential subunit of the Set3C deacetylase complex; involved in telomere maintenance 
HST4  YDR191W Member of the Sir2 family of NAD(+)-dependent protein deacetylases; involved along with Hst3p in silencing at telomeres, cell 
cycle progression, radiation resistance, genomic stability and short-chain fatty acid metabolism 
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IME1 YJR094C Master regulator of meiosis that is active only during meiotic events, activates transcription of early meiotic genes through 
interaction with Ume6p, degraded by the 26S proteasome following phosphorylation by Ime2p 
IRC4  YDR540C Putative protein of unknown function; null mutant displays increased levels of spontaneous Rad52p foci; green fluorescent protein 
(GFP)-fusion protein localizes to the cytoplasm and nucleus 
ISF1  YMR081C Serine-rich, hydrophilic protein with similarity to Mbr1p; overexpression suppresses growth defects of hap2, hap3, and hap4 
mutants; expression is under glucose control; cotranscribed with NAM7 in a cyp1 mutant 
MDJ2  YNL328C Constituent of the mitochondrial import motor associated with the presequence translocase; function overlaps with that of Pam18p; 
stimulates the ATPase activity of Ssc1p to drive mitochondrial import; contains a J domain 
MDM31  YHR194W Mitochondrial protein that may have a role in phospholipid metabolism; inner membrane protein with similarity to Mdm32p; 
required for normal mitochondrial morphology and inheritance; interacts genetically with MMM1, MMM2, MDM10, MDM12, and 
MDM34  
MHT1  YLL062C S-methylmethionine-homocysteine methyltransferase, functions along with Sam4p in the conversion of S-adenosylmethionine 
(AdoMet) to methionine to control the methionine/AdoMet ratio 
MPP6 YNR024W Nuclear exosome-associated RNA binding protein; involved in surveillance of pre-rRNAs and pre-mRNAs, and the degradation of 
cryptic non-coding RNAs (ncRNA); copurifies with ribosomes 
MRF1 YGL143C Mitochondrial translation release factor, involved in stop codon recognition and hydrolysis of the peptidyl-tRNA bond during 
mitochondrial translation; lack of MRF1 causes mitochondrial genome instability 
MRS4 YKR052C Iron transporter of the mitochondrial carrier family; mediates Fe2+ transport across the inner mitochondrial membrane; active 
under low-iron conditions; may transport other cations; protein abundance increases in response to DNA replication stress; MRS4 
has a paralog, MRS3, that arose from the whole genome duplication 
MSH5 YDL154W Protein of the MutS family, forms a dimer with Msh4p that facilitates crossovers between homologs during meiosis; msh5-Y823H 
mutation confers tolerance to DNA alkylating agents; homologs present in C. elegans and humans  
NOT5  YPR072W Subunit of the CCR4-NOT complex, which is a global transcriptional regulator with roles in transcription initiation and elongation 
and in mRNA degradation 
NRP1  YDL167C Putative RNA binding protein of unknown function; localizes to stress granules induced by glucose deprivation; predicted to be 
involved in ribosome biogenesis 
NTH1  YDR001C Neutral trehalase, degrades trehalose; required for thermotolerance and may mediate resistance to other cellular stresses; may be 
phosphorylated by Cdc28p; NTH1 has a paralog, NTH2, that arose from the whole genome duplication. 
OAF1  YAL051W Oleate-activated transcription factor; acts alone and as a heterodimer with Pip2p; activates genes involved in beta-oxidation of 
fatty acids and peroxisome organization and biogenesis; OAF1 has a paralog, PIP2, that arose from the whole genome duplication 
OMA1  YKR087C Metalloendopeptidase of the mitochondrial inner membrane; involved in turnover of membrane-embedded proteins; mediates 
degradation of Cox1p in coa2 mutant cells; member of a family of predicted membrane-bound metallopeptidases in prokaryotes 
and higher eukaryotes 
PAN6  YIL145C Pantothenate synthase, also known as pantoate-beta-alanine ligase, required for pantothenic acid biosynthesis, deletion causes 
pantothenic acid auxotrophy, homologous to E. coli panC 
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PEX6 YNL329C AAA-peroxin that heterodimerizes with AAA-peroxin Pex1p and participates in the recycling of peroxisomal signal receptor Pex5p 
from the peroxisomal membrane to the cystosol 
PHM7 YOL084W Protein of unknown function; expression is regulated by phosphate levels; green fluorescent protein (GFP)-fusion protein localizes 
to the cell periphery and vacuole; protein abundance increases in response to DNA replication stress 
POM34 YLR018C Subunit of the transmembrane ring of the nuclear pore complex (NPC); contributes to nucleocytoplasmic transport, NPC 
biogenesis and spindle pole body duplication 
PYK2 YOR347C Pyruvate kinase; appears to be modulated by phosphorylation; transcription repressed by glucose, and Pyk2p may be active 
under low glycolytic flux; PYK2 has a paralog, CDC19, that arose from the whole genome duplication 
RCR1  YBR005W Protein of the ER membrane involved in cell wall chitin deposition; may function in the endosomal-vacuolar trafficking pathway, 
helping determine whether plasma membrane proteins are degraded or routed to the plasma membrane; RCR1 has a paralog, 
RCR2, that arose from the whole genome duplication  
RCR2 YDR003W Vacuolar protein; presumably functions within the endosomal-vacuolar trafficking pathway, affecting events that determine whether 
plasma membrane proteins are degraded or routed to the plasma membrane; RCR2 has a paralog, RCR1, that arose from the 
whole genome duplication 
RDH54  YBR073W DNA-dependent ATPase; stimulates strand exchange by modifying the topology of double-stranded DNA; involved in 
recombinational repair of DNA double-strand breaks during mitosis and meiosis; proposed to be involved in crossover 
interference; interacts with Dmc1p; stimulates Dmc1p and Rad51p 
RPS30B YOR182C Protein component of the small (40S) ribosomal subunit; homologous to mammalian ribosomal protein S30, no bacterial homolog; 
RPS30B has a paralog, RPS30A, that arose from the whole genome duplication; protein abundance increases in response to DNA 
replication stress 
RTG1 YOL067C Transcription factor (bHLH) involved in interorganelle communication between mitochondria, peroxisomes, and nucleus 
SCS3 YGL126W Protein required for inositol prototrophy; required for normal ER membrane biosynthesis; ortholog of the FIT family of proteins 
involved in triglyceride droplet biosynthesis and homologous to human FIT2; disputed role in the synthesis of inositol 
phospholipids from inositol 
SDT1 YGL224C Pyrimidine nucleotidase; overexpression suppresses the 6-AU sensitivity of transcription elongation factor S-II, as well as 
resistance to other pyrimidine derivatives 
SET6  YPL165C SET domain protein of unknown function; deletion heterozygote is sensitive to compounds that target ergosterol biosynthesis, may 
be involved in compound availability 
SFM1  YOR021C SPOUT methyltransferase; catalyzes omega-monomethylation of Rps3p on Arg-146; not an essential gene; predicted to be 
involved in rRNA processing and ribosome biogenesis and in biopolymer catabolism  
SHE2 YKL130C RNA-binding protein that binds specific mRNAs and interacts with She3p; part of the mRNA localization machinery that restricts 
accumulation of certain proteins to the bud  
SIP5 YMR140W Protein of unknown function; interacts with both the Reg1p/Glc7p phosphatase and the Snf1p kinase; forms cytoplasmic foci upon 
DNA replication stress 
SKG1 YKR100C Transmembrane protein with a role in cell wall polymer composition; localizes on the inner surface of the plasma membrane at the 
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bud and in the daughter cell 
SOM1 YEL059C-A Subunit of the mitochondrial inner membrane peptidase, which is required for maturation of mitochondrial proteins of the 
intermembrane space; Som1p facilitates cleavage of a subset of substrates; contains twin cysteine-x9-cysteine motifs  
SUC2  YIL162W Invertase, sucrose hydrolyzing enzyme; a secreted, glycosylated form is regulated by glucose repression, and an intracellular, 
nonglycosylated enzyme is produced constitutively 
TDA1 YMR291W Protein kinase of unknown cellular role; green fluorescent protein (GFP)-fusion protein localizes to the cytoplasm and nucleus; null 
mutant is sensitive to expression of the top1-T722A allele; not an essential gene; relocalizes from nucleus to cytoplasm upon DNA 
replication stress 
TDP1 YBR223C Tyrosyl-DNA phosphodiesterase I; hydrolyzes 3' and 5'-phosphotyrosyl bonds; involved in the repair of DNA lesions created by 
topoisomerase I and topoisomerase II; mutations in human homolog result in the neurodegenerative disease SCANI 
THR4 YCR053W Threonine synthase, conserved protein that catalyzes formation of threonine from O-phosphohomoserine; expression is regulated 
by the GCN4-mediated general amino acid control pathway 
TOM6 YOR045W Component of the TOM (translocase of outer membrane) complex responsible for recognition and initial import steps for all 
mitochondrially directed proteins; promotes assembly and stability of the TOM complex 
TPP1 TPP1 DNA 3'-phosphatase; functions in repair of endogenous damage of double-stranded DNA, activity is specific for removal of 3' 
phosphates at strand breaks; similar to the l-2-haloacid dehalogenase superfamily; homolog of human polynucleotide kinase/3′-
phosphatase 
TRS33 YOR115C One of 10 subunits of the transport protein particle (TRAPP) complex of the cis-Golgi which mediates vesicle docking and fusion; 
involved in endoplasmic reticulum (ER) to Golgi membrane traffic 
TVP38 YKR088C ntegral membrane protein localized to late Golgi vesicles along with the v-SNARE Tlg2p; required for asymmetric localization of 
Kar9p during mitosis; GFP-fusion protein localizes to the cytoplasm in a punctate pattern 
UGA2 YBR006W Succinate semialdehyde dehydrogenase involved in the utilization of gamma-aminobutyrate (GABA) as a nitrogen source; part of 
the 4-aminobutyrate and glutamate degradation pathways; localized to the cytoplasm 
VMA4  YOR332W Subunit E of the V1 domain of the vacuolar H+-ATPase (V-ATPase); V-ATPase is an electrogenic proton pump found throughout 
the endomembrane system; V1 domain has eight subunits; required for the V1 domain to assemble onto the vacuolar membrane; 
protein abundance increases in response to DNA replication stress 
WHI2 YOR043W Protein required, with binding partner Psr1p, for full activation of the general stress response, possibly through Msn2p 
dephosphorylation; regulates growth during the diauxic shift; negative regulator of G1 cyclin expression 
YBR238C YBR238C Mitochondrial membrane protein with similarity to Rmd9p; not required for respiratory growth but causes a synthetic respiratory 
defect in combination with rmd9 mutations; transcriptionally up-regulated by TOR; deletion increases life span 
YDL206W YDL206W Putative protein of unknown function; YDL206W is not an essential protein 
YDR186C YDR186C Putative protein of unknown function; may interact with ribosomes, based on co-purification experiments; green fluorescent protein 
(GFP)-fusion protein localizes to the cytoplasm  
YDR541C YDR541C Putative dihydrokaempferol 4-reductase 
 265 | P a g e  
 
YIA6  YIL006W Mitochondrial NAD+ transporter, involved in the transport of NAD+ into the mitochondria (see also YEA6); member of the 
mitochondrial carrier subfamily; disputed role as a pyruvate transporter; has putative mouse and human orthologs 
YML082W YML082W Putative protein predicted to have carbon-sulfur lyase activity; transcriptionally regulated by Upc2p via an upstream sterol 
response element; green fluorescent protein (GFP)-fusion protein localizes to the nucleus and the cytoplasm; YML082W is not an 
essential gene 
YOR019W YOR019W Protein of unknown function that may interact with ribosomes, based on co-purification experiments 
YPL014W YPL014W Putative protein of unknown function; green fluorescent protein (GFP)-fusion protein localizes to the cytoplasm and to the nucleus 
YPL150W YPL150W Protein kinase of unknown cellular role; binds phosphatidylinositols and cardiolipin in a large-scale study 
ZAP1 YJL056C Zinc-regulated transcription factor; binds to zinc-responsive promoters to induce transcription of certain genes in presence of zinc, 
represses other genes in low zinc; regulates its own transcription; contains seven zinc-finger domains 
ZRT1 YGL255W High-affinity zinc transporter of the plasma membrane, responsible for the majority of zinc uptake; transcription is induced under 
low-zinc conditions by the Zap1p transcription factor 
 
 
Table 2: S. cerevisiae ORFs and SGD description (yeastgenome.org) which showed genetic interactions with C. glabrata 
CAGL0D05434g expressed from S. cerevisiae strain ΔIme2-D05434. Genes highlighted in blue are implicated in mating, meiosis or 
sporulation. Orange denotes genes which function in DNA replication, DNA damage stress or whose expression increases in abundance 
or re-localises in response to DNA damage stress. Red represents genes involved in metal ion homeostasis, transport or resistance. 
Gene 
Name 
ORF name SGD Description 
ALT1 YLR089C Alanine transaminase (glutamic pyruvic transaminase); involved in alanine biosynthetic and catabolic processes; expression is 
induced in the presence of alanine; repression is mediated by Nrg1p; the authentic, non-tagged protein is detected in highly 
purified mitochondria in high-throughput studies; paralogous gene ALT2 is catalytically inactive 
ASH1 YKL185W Zinc-finger inhibitor of HO transcription; mRNA is localized and translated in the distal tip of anaphase cells, resulting in 
accumulation of Ash1p in daughter cell nuclei and inhibition of HO expression; potential Cdc28p substrate 
BLI1 YKL061W Putative protein of unknown function; likely member of BLOC complex involved in endosomal cargo sorting; green fluorescent 
protein (GFP)-fusion protein localizes to the endosome 
CKI1 YLR133W Choline kinase; catalyzes the first step in phosphatidylcholine synthesis via the CDP-choline (Kennedy pathway); exhibits some 
ethanolamine kinase activity contributing to phosphatidylethanolamine synthesis via the CDP-ethanolamine pathway; CKI1 has a 
paralog, EKI1, that arose from the whole genome duplication 
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COA6 YMR244C Protein involved in cytochrome c oxidase assembly; also required for efficient formation of respiratory supercomplexes 
comprised of Complexes III and IV; localizes to the mitochondrial intermembrane space; has a human homolog; transcription is 
induced in response to the DNA-damaging agent MMS; protein abundance increases in response to DNA replication stress 
CPA1  YOR303W Small subunit of carbamoyl phosphate synthetase, which catalyzes a step in the synthesis of citrulline, an arginine precursor; 
translationally regulated by an attenuator peptide encoded by YOR302W within the CPA1 mRNA 5'-leader 
CUP9  YPL177C Homeodomain-containing transcriptional repressor; regulates expression of PTR2, which encodes a major peptide transporter; 
imported peptides activate ubiquitin-dependent proteolysis, resulting in degradation of Cup9p and de-repression of PTR2 
transcription; CUP9 has a paralog, TOS8, that arose from the whole genome duplication; protein abundance increases in 
response to DNA replication stress 
DGA1 YOR245C Diacylglycerol acyltransferase, catalyzes the terminal step of triacylglycerol (TAG) formation, acylates diacylglycerol using acyl-
CoA as an acyl donor, localized to lipid particles  
EFT2  YDR385W Elongation factor 2 (EF-2), also encoded by EFT1; catalyzes ribosomal translocation during protein synthesis; contains 
diphthamide, the unique posttranslationally modified histidine residue specifically ADP-ribosylated by diphtheria toxin; EFT2 has 
a paralog, EFT1, that arose from the whole genome duplication 
FRE8 YLR047C Protein with sequence similarity to iron/copper reductases, involved in iron homeostasis; deletion mutant has iron 
deficiency/accumulation growth defects; expression increased in the absence of copper-responsive transcription factor Mac1p 
FUM1  YPL262W Fumarase, converts fumaric acid to L-malic acid in the TCA cycle; cytosolic and mitochondrial distribution determined by the N-
terminal targeting sequence, protein conformation, and status of glyoxylate shunt; phosphorylated in mitochondria 
GDB1 YPR184W Glycogen debranching enzyme; contains glucanotranferase and alpha-1,6-amyloglucosidase activities; required for glycogen 
degradation; phosphorylated in mitochondria; activity is inhibited by Igd1p; protein abundance increases in response to DNA 
replication stress 
KEL1 YHR158C Protein required for proper cell fusion and cell morphology; functions in a complex with Kel2p to negatively regulate mitotic exit, 
interacts with Tem1p and Lte1p; localizes to regions of polarized growth; potential Cdc28p substrate 
KES1  YPL145C One of seven members of the yeast oxysterol binding protein family; involved in negative regulation of Sec14p-dependent Golgi 
complex secretory functions, peripheral membrane protein that localizes to the Golgi complex; KES1 has a paralog, HES1, that 
arose from the whole genome duplication 
MGR2 YPL098C Subunit of the TIM23 translocase complex; acts to couple Tim21p with the core Tim23 translocase; absolutely required for 
mitochondrial import of presequence-containing proteins at elevated temperature; required for viability of cells lacking the 
mitochondrial genome (petite-negative phenotype) 
MRC1 YCL061C S-phase checkpoint protein required for DNA replication; interacts with and stabilizes Pol2p at stalled replication forks during 
stress, where it forms a pausing complex with Tof1p and is phosphorylated by Mec1p; protects uncapped telomeres 
MRP8 YKL142W Protein of unknown function; undergoes sumoylation; transcription induced under cell wall stress; protein levels are reduced 
under anaerobic conditions; protein abundance increases in response to DNA replication stress; originally thought to be a 
mitochondrial ribosomal protein based on sequence analysis 
NDL1 YLR254C Homolog of nuclear distribution factor NudE, NUDEL; interacts with Pac1p and regulates dynein targeting to microtubule plus 
ends 
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NYV1 YLR093C v-SNARE component of the vacuolar SNARE complex involved in vesicle fusion; inhibits ATP-dependent Ca(2+) transport 
activity of Pmc1p in the vacuolar membrane 
OAR1  YKL055C Mitochondrial 3-oxoacyl-[acyl-carrier-protein] reductase, may comprise a type II mitochondrial fatty acid synthase along with 
Mct1p 
OPI10 YOL032W Protein with a possible role in phospholipid biosynthesis; null mutant displays an inositol-excreting phenotype that is suppressed 
by exogenous choline; protein abundance increases in response to DNA replication stress 
OTU2 YHL013C Protein of unknown function; may interact with ribosomes, based on co-purification experiments; member of the ovarian tumor-
like (OTU) superfamily of predicted cysteine proteases; shows cytoplasmic localization; protein abundance increases in response 
to DNA replication stress 
PMT3 YOR321W Protein O-mannosyltransferase; transfers mannose residues from dolichyl phosphate-D-mannose to protein serine/threonine 
residues; acts in a complex with Pmt5p, can instead interact with Pmt1p in some conditions; antifungal drug target; PMT3 has a 
paralog, PMT2, that arose from the whole genome duplication 
PSH1 YOL054W E3 ubiquitin ligase that mediates poyubiquitination and degradation of centromere-binding protein Cse4p and prevents Cse4p 
from mislocalizing to euchromatin; ubiquitylation of Cse4p may be antagonized by Scm3p 
PUT4  YOR348C Proline permease, required for high-affinity transport of proline; also transports the toxic proline analog azetidine-2-carboxylate 
(AzC); PUT4 transcription is repressed in ammonia-grown cells 
QCR10 YHR001W Subunit of the ubiqunol-cytochrome c oxidoreductase complex which includes Cobp, Rip1p, Cyt1p, Cor1p, Qcr2p, Qcr6p, Qcr7p, 
Qcr8p, Qcr9p, and Qcr10p and comprises part of the mitochondrial respiratory chain 
RBD2 YPL246C Possible rhomboid protease, has similarity to eukaryotic rhomboid proteases including Pcp1p 
RMD6 YEL072W Required for Meiotic nuclear Division 
RPL7B  YPL198W Ribosomal 60S subunit protein L7B; contains a conserved C-terminal Nucleic acid Binding Domain (NDB2); homologous to 
mammalian ribosomal protein L7 and bacterial L30; RPL7B has a paralog, RPL7A, that arose from the whole genome duplication 
SAS4 YDR181C Subunit of the SAS complex (Sas2p, Sas4p, Sas5p), which acetylates free histones and nucleosomes and regulates 
transcriptional silencing; required for the HAT activity of Sas2p 
SBP1 YHL034C Protein that binds eIF4G and has a role in repression of translation; has an RGG motif; found in cytoplasmic P bodies; found 
associated with small nucleolar RNAs snR10 and snR11 
SCM4  YGR049W Mitochondrial outer membrane protein of unknown function; predicted to have 4 transmembrane segments; import is mediated by 
Tom70p and Mim1p; interacts genetically with a cdc4 mutation  
SEM1 YDR363W Component of lid subcomplex of the 26S proteasome regulatory subunit; involved in mRNA export mediated by the TREX-2 
complex (Sac3p-Thp1p); ortholog of human DSS1; protein abundance increases in response to DNA replication stress 
SHE9 YDR393W Mitochondrial inner membrane protein required for normal mitochondrial morphology, may be involved in fission of the inner 
membrane; forms a homo-oligomeric complex 
SOP4 YJL192C ER-membrane protein; suppressor of pma1-7, deletion of SOP4 slows down the export of wild-type Pma1p and Pma1-7 from the 
ER 
SPO75 YLL005C Meiosis-specific protein of unknown function, required for spore wall formation during sporulation; dispensable for both nuclear 
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divisions during meiosis 
STB5  YHR178W Transcription factor, involved in regulating multidrug resistance and oxidative stress response; forms a heterodimer with Pdr1p; 
contains a Zn(II)2Cys6 zinc finger domain that interacts with a pleiotropic drug resistance element in vitro 
TDA2 YER071C Protein of unknown function; green fluorescent protein (GFP)-fusion protein localizes to the cytoplasm in a punctate pattern; null 
mutant is sensitive to expression of the top1-T722A allele 
TIR2  YOR010C Putative cell wall mannoprotein of the Srp1p/Tip1p family of serine-alanine-rich proteins; transcription is induced by cold shock 
and anaerobiosis 
TMA19 YKL056C Protein that associates with ribosomes; homolog of translationally controlled tumor protein; green fluorescent protein (GFP)-
fusion protein localizes to the cytoplasm and relocates to the mitochondrial outer surface upon oxidative stress 
TPP1 YMR156C DNA 3'-phosphatase; functions in repair of endogenous damage of double-stranded DNA, activity is specific for removal of 3' 
phosphates at strand breaks; similar to the l-2-haloacid dehalogenase superfamily; homolog of human polynucleotide kinase/3′-
phosphatase 
UBI4 YLL039C Ubiquitin; becomes conjugated to proteins, marking them for selective degradation via the ubiquitin-26S proteasome system; 
essential for the cellular stress response; encoded as a polyubiquitin precursor comprised of 5 head-to-tail repeats; protein 
abundance increases in response to DNA replication stress 
VMA4  YOR332W Subunit E of the V1 domain of the vacuolar H+-ATPase (V-ATPase); V-ATPase is an electrogenic proton pump found throughout 
the endomembrane system; V1 domain has eight subunits; required for the V1 domain to assemble onto the vacuolar 
membrane; protein abundance increases in response to DNA replication stress 
VPS28  YPL065W Component of the ESCRT-I complex (Stp22p, Srn2p, Vps28p, and Mvb12p), which is involved in ubiquitin-dependent sorting of 
proteins into the endosome; conserved C-terminal domain interacts with ESCRT-III subunit Vps20p  
WHI2 YOR043W Protein required, with binding partner Psr1p, for full activation of the general stress response, possibly through Msn2p 
dephosphorylation; regulates growth during the diauxic shift; negative regulator of G1 cyclin expression 
YAT2  YER024W Carnitine acetyltransferase; has similarity to Yat1p, which is a carnitine acetyltransferase associated with the mitochondrial outer 
membrane 
YBP1 YBR216C Protein required for oxidation of specific cysteine residues of the transcription factor Yap1p, resulting in the nuclear localization of 
Yap1p in response to stress 
YBR220C YBR220C Putative protein of unknown function; YBR220C is not an essential gene 
YDR131C YDR131C F-box protein, substrate-specific adaptor subunit that recruits substrates to a core ubiquitination complex 
YDR179W YDR179W Putative protein of unknown function  
YEA6 YEL006W Putative mitochondrial NAD+ transporter, member of the mitochondrial carrier subfamily (see also YIA6); has putative human 
ortholog 
YER158C YER158C Protein of unknown function; potentially phosphorylated by Cdc28p; YER158C has a paralog, AFR1, that arose from the whole 
genome duplication 
YIG1 YPL201C Protein that interacts with glycerol 3-phosphatase and plays a role in anaerobic glycerol production; localizes to the nucleus and 
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cytosol 
YMR244W YMR244W Putative protein of unknown function 
YOR012W YOR012W Putative protein of unknown function 
YPS3  YLR121C Aspartic protease, member of the yapsin family of proteases involved in cell wall growth and maintenance; attached to the 
plasma membrane via a glycosylphosphatidylinositol (GPI) anchor 
YSP3  YOR003W Putative precursor to the subtilisin-like protease III 
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Appendix 7: Fitness Measures for 
C. glabrata Deletion Mutants 
Table 1: Summary of fitness measures for C. glabrata deletion mutants 
relative to the parental strain. Numbers represent either a positive or negative 
increase in the specified fitness measure compared with parental strain Cg2001 
Δhis3. Lag time was measured as time taken for cultures to reach OD600 0.2. 
Doubling time was calculated as described (see 2.6.3) taking measurements 
from cultures in exponential phase (approximately OD600 0.4 to 0.8). Maximum 
density was taken as the final OD600 of cultures at 24 hours of growth profiling. 
Strains with fitness significantly different from the parental strain are highlighted 
in yellow (Anova p<0.05; Dunnett’s critical value 3.37). 
C. glabrata strain Change in lag time 
(minutes) 
Change in doubling 
time (minutes) 
Change in maximum 
density (OD600) 
ΔCAGL0A02299g A -20.00 9.75 0.0027 
ΔCAGL0A02299g B -18.33 2.42 -0.0052 
ΔCAGL0A02343g A 0.00 5.91 -0.0071 
ΔCAGL0A02343g B 10.00 -6.58 -0.0369 
ΔCAGL0A04565g A 110.00 109.03 -0.3452 
ΔCAGL0B00726g A -13.33 12.29 0.0343 
ΔCAGL0B00726g B 2.00 -2.86 0.0105 
ΔCAGL0B02926g A 0.00 0.29 0.0160 
ΔCAGL0B02946g A -12.50 -8.18 1.1513 
ΔCAGL0B02946g B -6.67 0.56 1.1475 
ΔCAGL0B02948g A 22.50 115.19 0.0004 
ΔCAGL0B02948g B 10.00 114.76 0.0299 
ΔCAGL0B02970g A 31.67 5.03 0.0110 
ΔCAGL0B03223g A 13.33 -11.16 0.0270 
ΔCAGL0B03223g B 6.67 -3.39 0.0141 
ΔCAGL0B03883g A 30.00 1.45 -0.0478 
ΔCAGL0B03883g B 40.00 6.75 -0.0429 
ΔCAGL0C00253g A 20.00 19.49 -0.0185 
ΔCAGL0C00253g B 38.00 -7.20 0.0016 
ΔCAGL0C01837g A 12.50 3.06 -0.0039 
ΔCAGL0C01837g B 6.67 0.73 0.0159 
ΔCAGL0C04763g A 2.50 4.01 -0.0073 
ΔCAGL0C04763g B 8.00 4.83 -0.0086 
ΔCAGL0D00682g A -16.67 7.91 0.0191 
ΔCAGL0D00682g A 4.00 6.95 -0.0041 
ΔCAGL0D01210g A -3.33 -5.69 0.0312 
ΔCAGL0D01210g B -15.00 4.97 0.0187 
ΔCAGL0D03850g A 75.00 38.40 0.0136 
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ΔCAGL0D03850g B 42.50 24.89 0.0202 
ΔCAGL0D03872g A -21.67 8.14 -0.0021 
ΔCAGL0D03872g B -22.50 9.52 -0.0168 
ΔCAGL0D05170g A 8.33 1.63 0.0096 
ΔCAGL0D05170g B -16.67 4.97 0.0148 
ΔCAGL0D05434g A 55.00 15.58 0.0509 
ΔCAGL0D05434g B 50.00 2.23 0.0231 
ΔCAGL0D06226g A -2.00 0.45 0.0228 
ΔCAGL0D06226g B -20.00 1.68 0.0243 
ΔCAGL0E00275g A 63.33 11.80 -0.0670 
ΔCAGL0E06600g A 0.00 5.56 -0.0118 
ΔCAGL0E06600g B -1.67 -0.03 -0.0176 
ΔCAGL0E06644g A 1.67 -1.54 0.0091 
ΔCAGL0E06644g B -10.00 6.76 -0.0031 
ΔCAGL0F01815g A 11.67 2.51 -0.0363 
ΔCAGL0F01815g B 3.33 5.83 -0.0423 
ΔCAGL0F03905g A 0.00 11.55 0.0172 
ΔCAGL0F03905g B 1.67 12.31 0.0320 
ΔCAGL0F04081g A 8.00 2.15 0.0103 
ΔCAGL0F05159g A 28.00 21.94 -0.0648 
ΔCAGL0F05159g B 21.67 18.87 -0.1109 
ΔCAGL0F05973g A 11.67 -7.12 0.0385 
ΔCAGL0F06237g A 1.67 28.98 0.0008 
ΔCAGL0F06237g B 12.50 22.83 -0.0113 
ΔCAGL0F08767g A -20.00 23.50 0.0419 
ΔCAGL0F08767g B -22.50 15.34 0.0244 
ΔCAGL0F09229g A -1.67 -4.54 -0.1747 
ΔCAGL0F09229g B -20.00 4.07 -0.0069 
ΔCAGL0G02607g A 0.00 8.01 0.0200 
ΔCAGL0G03201g A -20.00 12.06 0.0115 
ΔCAGL0G04279g A -20.00 14.71 -0.0128 
ΔCAGL0G04279g B -16.67 17.28 -0.0003 
ΔCAGL0G05522g A 40.00 121.52 -0.0237 
ΔCAGL0G05522g B 44.00 109.38 -0.0026 
ΔCAGL0G08866g A -6.00 18.62 -0.0148 
ΔCAGL0G08866g B -4.00 16.21 -0.0079 
ΔCAGL0G10175g A -48.00 20.90 0.0253 
ΔCAGL0G10175g B -107.50 22.24 -0.0036 
ΔCAGL0H01749g A 8.00 -7.86 0.0212 
ΔCAGL0H01749g B -13.33 4.86 0.0157 
ΔCAGL0H06765g A 30.00 -0.91 -0.0044 
ΔCAGL0H06765g B 13.33 -5.19 -0.0126 
ΔCAGL0H08712g A 2.50 17.09 0.0151 
ΔCAGL0H08712g B 0.00 15.84 0.0495 
ΔCAGL0H09988g A 23.33 1.44 -0.0009 
ΔCAGL0H09988g B 4.00 5.02 -0.0376 
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ΔCAGL0H10208g A 18.00 3.56 -0.1050 
ΔCAGL0H10208g B -3.33 3.70 -0.1326 
ΔCAGL0H10208g C -8.33 -5.04 0.0242 
ΔCAGL0I02244g A 6.67 0.50 0.0113 
ΔCAGL0I08437g A 28.33 12.25 0.0011 
ΔCAGL0I08613g A 41.67 -3.72 -0.0515 
ΔCAGL0I08613g B 10.00 2.42 -0.0193 
ΔCAGL0J05786g A 23.33 7.74 -0.0301 
ΔCAGL0J05786g B 36.00 -4.96 -0.0467 
ΔCAGL0J05852g A 12.00 -6.42 0.0254 
ΔCAGL0J05852g B 6.67 5.55 0.0267 
ΔCAGL0K02145g A -12.50 -5.13 0.0359 
ΔCAGL0K02145g B -32.50 1.90 0.0176 
ΔCAGL0K05687g A 26.67 -1.19 -0.0178 
ΔCAGL0K05687g A 5.00 3.37 -0.0221 
ΔCAGL0K05687g B 34.00 -1.56 -0.0201 
ΔCAGL0K05687g B -1.67 3.40 -0.0281 
ΔCAGL0K07634g A 30.00 -12.59 -0.0064 
ΔCAGL0K07634g B -12.50 8.22 0.0594 
ΔCAGL0K10318g A 42.50 14.74 -0.0454 
ΔCAGL0K10318g B 60.00 9.81 -0.0639 
ΔCAGL0K11066g A 36.67 8.26 -0.0206 
ΔCAGL0L03674g A 14.00 -2.52 0.0290 
ΔCAGL0L03674g B 6.67 -0.37 0.0243 
ΔCAGL0L06776g A 6.67 2.60 0.0264 
ΔCAGL0L06776g B 5.00 -0.66 0.0416 
ΔCAGL0L07480g A 20.00 -3.31 0.0102 
ΔCAGL0L07480g B -23.33 7.90 0.0362 
ΔCAGL0L09383g A 16.67 4.92 0.0252 
ΔCAGL0L09383g B 30.00 -4.96 0.0152 
ΔCAGL0M01716g A -2.00 -1.76 -0.0090 
ΔCAGL0M01716g B -6.00 4.17 0.0234 
ΔCAGL0M01870g A -23.33 3.86 0.0436 
ΔCAGL0M01914g A 14.00 0.61 0.0612 
ΔCAGL0M02299g A 36.67 4.22 -0.0805 
ΔCAGL0M02321g A 0.00 16.37 -0.0068 
ΔCAGL0M02321g B 0.00 3.38 0.0291 
ΔCAGL0M04543g A 6.67 4.31 -0.0051 
ΔCAGL0M04543g B 12.50 4.31 0.0037 
ΔCAGL0M05137g A -2.50 29.04 -0.0032 
ΔCAGL0M05137g B 15.00 8.98 0.0166 
ΔCAGL0M10153g A -2.50 10.11 0.0110 
ΔCAGL0M10978g A -2.50 7.26 -0.0090 
ΔCAGL0M10978g B 30.00 -4.21 -0.0687 
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Appendix 8: Growth profiling of C. 
glabrata mutants 
 
Fitness of C. glabrata deletion mutants and parental strain Cg2001 Δhis3 was 
assessed by measuring growth in YPD broth at 30 °C (see 2.6.3). Growth 
profiles represent average optical density readings of C. glabrata cultures taken 
every ten minutes over a 24 hour period with continuous shaking between 
reads. Error bars represent standard deviation across replicates. 
 
Figure 1: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0A02299g isolates A and B. 
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Figure 2: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0A02343g isolates A and B. 
 
Figure 3: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0A04565g. 
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Figure 4: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0B00726g isolates A and B. 
 
 
Figure 5: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0B02926g. 
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Figure 6: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0B02946g isolates A and B. 
 
Figure 7: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0B02948g isolates A and B. 
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Figure 8: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0B02970g.  
 
Figure 9: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0B03223g isolates A and B.  
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Figure 10: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0B03883g isolates A and B.  
 
Figure 11: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0C00253g isolates A and B.  
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Figure 12: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0C01837g isolates A and B.  
 
Figure 13: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0C04763g isolates A and B.  
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Figure 14: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0D00682g isolates A and B.  
 
Figure 15: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0D01210g isolates A and B.  
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Figure 16: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0D03850g isolates A and B.  
 
 
Figure 17: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0D03872g isolates A and B. 
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Figure 18: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0D05170g isolates A and B. 
 
Figure 19: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0D05434g isolates A and B. 
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Figure 20: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0D06226g isolates A and B. 
 
Figure 21: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0E00275g. 
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Figure 22: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0E06600g isolates A and B. 
 
Figure 23: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0E06644g isolates A and B. 
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Figure 24: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0F01815g isolates A and B. 
 
Figure 25: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0F03905g isolates A and B. 
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Figure 26: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0F04081g. 
 
Figure 27: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0F05159g isolates A and B. 
  
 287 | P a g e  
 
Figure 28: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0F05973g. 
 
Figure 29: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0F06237g isolates A and B. 
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Figure 30: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0F08767g isolates A and B. 
 
Figure 31: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0F09229g isolates A and B. 
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Figure 32: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0G02607g. 
 
Figure 33: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0G03201g. 
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Figure 34: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0G04279g isolates A and B. 
 
Figure 35: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0G05522g isolates A and B. 
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Figure 36: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0G08866g isolates A and B. 
 
Figure 37: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0G10175g isolates A and B. 
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Figure 38: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0H01749g isolates A and B. 
 
Figure 39: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0H06765g isolates A and B. 
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Figure 40: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0H08712g isolates A and B. 
 
Figure 41: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0H09988g isolates A and B. 
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Figure 42: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0H10208g isolates A and B. 
 
Figure 43: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0I02244g. 
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Figure 44: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0I08437g. 
 
 
 
Figure 45: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0I08613g isolates A and B. 
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Figure 46: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0J05786g isolates A and B. 
 
 
Figure 47: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0J05852g isolates A and B. 
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Figure 48: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0K02145g isolates A and B. 
 
Figure 49: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0K05687g isolates A and B. 
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Figure 50: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0K07634g. 
 
 
Figure 51: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0K10318g isolates A and B. 
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Figure 52: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0K11066g. 
 
 
Figure 53: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0L03674g isolates A and B. 
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Figure 54: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0L06776g isolates A and B. 
 
Figure 55: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0L07480g isolates A and B. 
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Figure 56: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0L09383g isolates A and B. 
 
 
Figure 57: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0M01716g isolates A and B. 
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Figure 58: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0M01870g. 
 
 
Figure 59: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0M01914g. 
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Figure 60: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0M02299g. 
 
 
 
Figure 61: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0M02321g isolates A and B. 
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Figure 62: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0M05137g isolates A and B. 
 
 
Figure 63: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0M10153g. 
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Figure 64: Growth profile of C. glabrata parental strain Cg2001 Δhis3 and 
ΔCAGL0M10978g isolates A and B. 
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Appendix 9: C. glabrata deletion 
mutants from the Schwarzmüller 
et al., 2013 study with no S. 
cerevisiae orthologue used in 
phenotypic screens 
 
Table 1: List of 67 C. glabrata ORFs from the Scharzmüller et al., 2013 
study identified by RBH searches to have no orthologue in S. cerevisiae. 
ORFs with no coordinates have been disregarded by CGD during the course of 
this study (candidagenome.org).   
C. glabrata ORF Start 
coordinate 
Stop coordinate Strand S. cerevisiae 
best hit 
CAGL0A00143g    - 
CAGL0A01892g 194560 194826 W - 
CAGL0A02299g 250851 251690 W - 
CAGL0A03410g 348708 349451 W - 
CAGL0A03586g 365696 365127 C YLR040C 
CAGL0A04609g    - 
CAGL0A04763g    - 
CAGL0B00440g 31504 32313 W - 
CAGL0B00572g 49506 48898 C - 
CAGL0B03223g 314992 314690 C - 
CAGL0C00803g    - 
CAGL0C00869g    - 
CAGL0C01111g    - 
CAGL0C02365g 239122 238940 C - 
CAGL0C02915g    - 
CAGL0C03311g 334443 333898 C - 
CAGL0C05401g 515623 515886 W - 
CAGL0D01210g 137954 138646 W - 
CAGL0D02750g 288647 289021 W - 
CAGL0D04840g 471574 472164 W MSS18 
CAGL0D05104g    - 
CAGL0D05654g 538337 537378 C - 
CAGL0D06534g 622492 622178 C - 
CAGL0D06666g 638537 638737 W - 
CAGL0E00165g    - 
CAGL0E01375g    - 
CAGL0E01771g 177211 175652 C - 
CAGL0E02211g 215568 215768 W - 
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CAGL0E03135g    - 
CAGL0E03498g 324961 324476 C - 
CAGL0E04202g    - 
CAGL0E04620g 446284 447573 W PST1 
CAGL0E06094g 603704 603877 W - 
CAGL0E06578g    - 
CAGL0E06622g    - 
CAGL0F00341g 37817 38098 W - 
CAGL0F00781g    - 
CAGL0F01441g    - 
CAGL0F05995g 600612 598819 C - 
CAGL0F07601g 739068 738412 C CWP2 
CAGL0F07865g 770804 768270 C ECM22 
CAGL0G01386g 133878 132280 C SLM2 
CAGL0G09757g 930351 934622 W YLR278C 
CAGL0H02563g 232068 231892 C DDR2 
CAGL0H03861g 362520 361189 C HRB1 
CAGL0I04092g 358219 359889 W SHE10 
CAGL0J00253g 17376 15883 C MID2 
CAGL0K01507g 134490 131704 C GPR1 
CAGL0K03003g 277585 279528 W MOT3 
CAGL0K03245g 299646 298216 C - 
CAGL0K04037g 373375 379068 W - 
CAGL0K05841g 573144 577262 W HAP1 
CAGL0K06479g 637125 640100 W PKH3 
CAGL0K10164g 990940 990287 C SPI1 
CAGL0K12078g 1171209 1169818 C - 
CAGL0L00627g 77798 80341 W GPB1 
CAGL0L01771g 198971 200278 W - 
CAGL0L01903g 220700 224563 W RGT1 
CAGL0L03674g 422571 424460 W GSM1 
CAGL0L04400g 516722 513759 C YRR1 
CAGL0L12782g 1370285 1371082 W DIG1 
CAGL0M03773g 427099 426518 C TOS6 
CAGL0M04169g 459618 460739 W KRE1 
CAGL0M06831g 695162 697099 W CRZ1 
CAGL0M10791g    - 
CAGL0M11726g 1166748 1166308 C - 
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Appendix 10: Screening C. 
glabrata deletion mutants for 
virulence using a Drosophila 
melanogaster gastrointestinal 
infection model 
 
Table 1: D. melanogaster Toll pathway activation in response to infection 
by C. glabrata mutants. Pools of 50 5-day old Drs-GFP larvae were fed C. 
glabrata cell. Larval GFP expression was observed 48 hours post infection as a 
read-out of Toll-pathway activation. For each C. glabrata isolate four pools of 50 
D. melanogaster Drs-GFP larvae were infected. 
C. glabrata strain No. of GFP-expressing larvae Average 
Pool 1 Pool 2 Pool 3 Pool 4 
∆CAGL0A02299g A 48 48 50 50 49 
∆CAGL0A02299g B 44 48 45 44 45.25 
∆CAGL0A02343g A 44 42 47 47 45 
∆CAGL0A02343g B 45 48 49 47 47.25 
∆CAGL0A04565g A 48 50 47 46 47.75 
∆CAGL0B00726g A 48 45 47 41 45.25 
∆CAGL0B00726g B 50 48 48 45 47.75 
∆CAGL0B02926g A 50 48 48 50 49 
∆CAGL0B02946g A 41 42 42 48 43.25 
∆CAGL0B02946g B 42 47 49 50 47 
∆CAGL0B02948g A 44 45 49 49 46.75 
∆CAGL0B02948g B 45 48 44 50 46.75 
∆CAGL0B02970g A 48 49 47 45 47.25 
∆CAGL0B03223g A 47 47 43 48 46.25 
∆CAGL0B03223g B 40 42 41 47 42.5 
∆CAGL0B03883g A 50 48 50 48 49 
∆CAGL0B03883g B 48 48 47 46 47.25 
∆CAGL0C00253g A 48 48 42 43 45.25 
∆CAGL0C00253g B 50 47 45 47 47.25 
∆CAGL0C01837g A 48 46 45 46 46.25 
∆CAGL0C01837g B 43 41 40 44 42 
∆CAGL0C04763g A 50 50 47 42 47.25 
∆CAGL0C04763g B 45 49 41 44 44.75 
∆CAGL0D00682g A 44 47 42 45 44.5 
∆CAGL0D00682g B 50 48 47 50 48.75 
∆CAGL0D01210g A 45 47 42 46 45 
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∆CAGL0D01210g B 45 43 49 48 46.25 
∆CAGL0D03850g A 50 48 45 44 46.75 
∆CAGL0D03850g B 47 45 46 48 46.5 
∆CAGL0D03872g A 50 50 50 50 50 
∆CAGL0D03872g B 39 44 42 42 41.75 
∆CAGL0D05170g A 50 50 49 49 49.5 
∆CAGL0D05170g B 38 44 44 41 41.75 
∆CAGL0D05434g A 44 44 49 49 46.5 
∆CAGL0D05434g B 50 49 50 47 49 
∆CAGL0D06226g A 50 46 50 45 47.75 
∆CAGL0D06226g B 46 48 48 46 47 
∆CAGL0E00275g A 50 45 42 41 44.5 
∆CAGL0E06600g A 50 49 47 50 49 
∆CAGL0E06600g B 46 46 48 46 46.5 
∆CAGL0E06644g A 44 46 47 46 45.75 
∆CAGL0E06644g B 50 41 45 44 45 
∆CAGL0F01815g A 47 44 42 41 43.5 
∆CAGL0F01815g B 49 47 50 44 47.5 
∆CAGL0F03905g A 42 50 44 46 45.5 
∆CAGL0F03905g B 50 47 50 50 49.25 
∆CAGL0F04081g A 50 50 50 47 49.25 
∆CAGL0F05159g A 42 48 41 41 43 
∆CAGL0F05159g B 45 45 41 47 44.5 
∆CAGL0F05973g A 50 50 47 46 48.25 
∆CAGL0F06237g A 45 45 42 48 45 
∆CAGL0F06237g B 50 47 47 46 47.5 
∆CAGL0F08767g A 45 43 43 50 45.25 
∆CAGL0F08767g B 47 48 43 44 45.5 
∆CAGL0F09229g A 45 50 50 50 48.75 
∆CAGL0F09229g B 40 49 50 50 47.25 
∆CAGL0G02607g A 50 48 49 50 49.25 
∆CAGL0G03201g A 48 47 47 46 47 
∆CAGL0G04279g A 39 47 48 44 44.5 
∆CAGL0G04279g B 45 47 45 46 45.75 
∆CAGL0G05522g A 40 45 46 44 43.75 
∆CAGL0G05522g B 48 49 45 45 46.75 
∆CAGL0G08866g A 50 48 48 48 48.5 
∆CAGL0G08866g B 50 47 50 50 49.25 
∆CAGL0G10175g A 48 49 50 50 49.25 
∆CAGL0G10175g B 48 47 47 44 46.5 
∆CAGL0H01749g A 44 45 45 45 44.75 
∆CAGL0H01749g B 49 45 47 47 47 
∆CAGL0H06765g A 44 41 40 48 43.25 
∆CAGL0H06765g B 50 44 48 50 48 
∆CAGL0H08712g A 50 50 48 48 49 
∆CAGL0H08712g B 50 50 45 50 48.75 
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∆CAGL0H09988g A 45 50 45 48 47 
∆CAGL0H09988g B 50 50 48 47 48.75 
∆CAGL0H10208g A 48 50 48 48 48.5 
∆CAGL0H10208g B 50 47 46 44 46.75 
∆CAGL0I02244g A 44 48 49 42 45.75 
∆CAGL0I02244g B 45 50 47 44 46.5 
∆CAGL0I08437g A 45 45 42 48 45 
∆CAGL0I08613g A 50 47 44 47 47 
∆CAGL0I08613g B 46 49 47 45 46.75 
∆CAGL0J05786g A 44 42 41 47 43.5 
∆CAGL0J05786g B 44 41 38 43 41.5 
∆CAGL0J05852g A 50 49 48 47 48.5 
∆CAGL0J05852g B 45 48 49 48 47.5 
∆CAGL0K02145g A 50 50 48 48 49 
∆CAGL0K02145g B 50 48 48 49 48.75 
∆CAGL0K05687g A 41 42 47 41 42.75 
∆CAGL0K05687g B 48 50 50 50 49.5 
∆CAGL0K05687g B 41 45 48 46 45 
∆CAGL0K07634g A 50 50 48 50 49.5 
∆CAGL0K10318g A 50 48 47 48 48.25 
∆CAGL0K10318g B 48 45 44 44 45.25 
∆CAGL0L03674g A 50 47 46 46 47.25 
∆CAGL0L03674g B 43 44 41 48 44 
∆CAGL0L06776g A 48 48 42 44 45.5 
∆CAGL0L06776g B 50 48 47 47 48 
∆CAGL0L07480g A 50 46 47 44 46.75 
∆CAGL0L07480g B 45 50 48 47 47.5 
∆CAGL0L09383g A 50 48 48 46 48 
∆CAGL0L09383g B 47 45 46 45 45.75 
∆CAGL0M01716g A 46 50 47 47 47.5 
∆CAGL0M01716g B 44 45 47 47 45.75 
∆CAGL0M01870g A 50 50 48 42 47.5 
∆CAGL0M01914g A 50 42 47 41 45 
∆CAGL0M02299g A 50 43 44 47 46 
∆CAGL0M02321g A 47 47 48 48 47.5 
∆CAGL0M02321g B 45 41 48 45 44.75 
∆CAGL0M04543g A 50 47 48 49 48.5 
∆CAGL0M04543g B 43 41 47 47 44.5 
∆CAGL0M05137g A 47 44 46 43 45 
∆CAGL0M05137g B 46 48 42 47 45.75 
∆CAGL0M10153g A 50 48 48 50 49 
∆CAGL0M10978g A 46 42 50 50 47 
∆CAGL0M10978g B 47 48 49 50 48.5 
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Table 2: Survival of immunocompromised dif/key D. melanogaster larvae 
in response to infection by C. glabrata mutants. Pools of 50 5-day old 
dif/key larvae were fed C. glabrata cells. Survival of larvae was observed 48 
hours post infection. For each C. glabrata isolate four pools of 50 D. 
melanogaster dif/key larvae were infected. 
C. glabrata strain No. of surviving dif/key larvae Average 
Pool 1 Pool 2 Pool 3 Pool 4 
∆CAGL0A02299g A 2 8 4 4 4.5 
∆CAGL0A02299g B 4 5 0 4 3.25 
∆CAGL0A02343g A 2 7 7 3 4.75 
∆CAGL0A02343g B 1 4 4 2 2.75 
∆CAGL0A04565g A 1 3 1 4 2.25 
∆CAGL0B00726g A 44 40 41 38 40.75 
∆CAGL0B00726g B 32 35 33 33 33.25 
∆CAGL0B02926g A 0 7 4 2 3.25 
∆CAGL0B02946g A 6 8 7 6 6.75 
∆CAGL0B02946g B 4 1 1 7 3.25 
∆CAGL0B02948g A 3 3 5 1 3 
∆CAGL0B02948g B 2 0 3 0 1.25 
∆CAGL0B02970g A 9 11 5 8 8.25 
∆CAGL0B03223g A 5 6 6 2 4.75 
∆CAGL0B03223g B 3 9 4 0 4 
∆CAGL0B03883g A 4 2 0 0 1.5 
∆CAGL0B03883g B 10 14 18 26 17 
∆CAGL0C00253g A 10 12 9 3 8.5 
∆CAGL0C00253g B 11 4 8 8 7.75 
∆CAGL0C01837g A 9 4 6 1 5 
∆CAGL0C01837g B 7 3 5 4 4.75 
∆CAGL0C04763g A 5 6 6 1 4.5 
∆CAGL0C04763g B 3 2 2 3 2.5 
∆CAGL0D00682g A 3 2 3 2 2.5 
∆CAGL0D00682g B 0 4 2 1 1.75 
∆CAGL0D01210g A 4 8 8 2 5.5 
∆CAGL0D01210g B 2 5 2 0 2.25 
∆CAGL0D03850g A 38 41 42 44 41.25 
∆CAGL0D03850g B 39 38 41 41 39.75 
∆CAGL0D03872g A 0 8 0 4 3 
∆CAGL0D03872g B 0 3 0 4 1.75 
∆CAGL0D05170g A 0 8 5 5 4.5 
∆CAGL0D05170g B 7 4 1 1 3.25 
∆CAGL0D05434g A 4 4 0 0 2 
∆CAGL0D05434g B 5 5 6 4 5 
∆CAGL0D06226g A 6 7 2 2 4.25 
∆CAGL0D06226g B 4 8 2 8 5.5 
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∆CAGL0E00275g A 4 4 1 1 2.5 
∆CAGL0E06600g A 5 5 4 4 4.5 
∆CAGL0E06600g B 1 0 5 0 1.5 
∆CAGL0E06644g A 4 4 1 5 3.5 
∆CAGL0E06644g B 2 6 0 4 3 
∆CAGL0F01815g A 0 3 2 0 1.25 
∆CAGL0F01815g B 3 4 7 8 5.5 
∆CAGL0F03905g A 3 8 4 4 4.75 
∆CAGL0F03905g B 12 7 6 6 7.75 
∆CAGL0F04081g A 8 8 4 2 5.5 
∆CAGL0F05159g A 0 0 2 0 0.5 
∆CAGL0F05159g B 0 0 1 1 0.5 
∆CAGL0F05973g A 3 5 4 1 3.25 
∆CAGL0F06237g A 4 3 2 2 2.75 
∆CAGL0F06237g B 2 1 1 2 1.5 
∆CAGL0F08767g A 1 4 0 0 1.25 
∆CAGL0F08767g B 0 2 1 1 1 
∆CAGL0F09229g A 5 5 4 4 4.5 
∆CAGL0F09229g B 6 5 5 6 5.5 
∆CAGL0G02607g A 9 6 3 4 5.5 
∆CAGL0G03201g A 0 4 4 1 2.25 
∆CAGL0G04279g A 6 6 3 3 4.5 
∆CAGL0G04279g B 5 1 2 4 3 
∆CAGL0G05522g A 1 2 3 1 1.75 
∆CAGL0G05522g B 1 1 1 0 0.75 
∆CAGL0G08866g A 2 2 3 4 2.75 
∆CAGL0G08866g B 3 2 5 5 3.75 
∆CAGL0G10175g A 0 0 0 0 0 
∆CAGL0G10175g B 1 1 0 1 0.75 
∆CAGL0H01749g A 36 33 40 41 37.5 
∆CAGL0H01749g B 39 41 41 38 39.75 
∆CAGL0H06765g A 5 8 7 7 6.75 
∆CAGL0H06765g B 5 2 2 0 2.25 
∆CAGL0H08712g A 4 4 8 7 5.75 
∆CAGL0H08712g B 3 1 4 3 2.75 
∆CAGL0H09988g A 10 8 7 7 8 
∆CAGL0H09988g B 4 4 4 1 3.25 
∆CAGL0H10208g A 9 2 0 1 3 
∆CAGL0H10208g B 2 4 5 6 4.25 
∆CAGL0I02244g A 8 8 4 7 6.75 
∆CAGL0I02244g B 4 7 2 4 4.25 
∆CAGL0I08437g A 0 0 0 1 0.25 
∆CAGL0I08613g A 2 2 0 4 2 
∆CAGL0I08613g B 1 0 0 2 0.75 
∆CAGL0J05786g A 4 0 7 6 4.25 
∆CAGL0J05786g B 1 4 1 4 2.5 
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∆CAGL0J05852g A 2 8 4 3 4.25 
∆CAGL0J05852g B 4 3 4 8 4.75 
∆CAGL0K02145g A 2 2 0 1 1.25 
∆CAGL0K02145g B 8 4 4 2 4.5 
∆CAGL0K05687g A 39 42 42 38 40.25 
∆CAGL0K05687g B 38 38 35 33 36 
∆CAGL0K05687g B 40 40 36 33 37.25 
∆CAGL0K07634g A 0 0 0 1 0.25 
∆CAGL0K10318g A 2 4 6 0 3 
∆CAGL0K10318g B 5 0 2 4 2.75 
∆CAGL0L03674g A 41 38 42 42 40.75 
∆CAGL0L03674g B 42 40 41 42 41.25 
∆CAGL0L06776g A 8 7 7 2 6 
∆CAGL0L06776g B 8 7 5 7 6.75 
∆CAGL0L07480g A 35 34 32 39 35 
∆CAGL0L07480g B 33 32 30 30 31.25 
∆CAGL0L09383g A 2 2 0 1 1.25 
∆CAGL0L09383g B 6 4 4 5 4.75 
∆CAGL0M01716g A 0 5 5 8 4.5 
∆CAGL0M01716g B 0 4 4 0 2 
∆CAGL0M01870g A 6 5 6 4 5.25 
∆CAGL0M01914g A 0 1 0 4 1.25 
∆CAGL0M02299g A 4 4 2 1 2.75 
∆CAGL0M02321g A 11 8 6 4 7.25 
∆CAGL0M02321g B 1 3 2 1 1.75 
∆CAGL0M04543g A 2 7 1 1 2.75 
∆CAGL0M04543g B 2 5 4 6 4.25 
∆CAGL0M05137g A 3 3 7 4 4.25 
∆CAGL0M05137g B 6 4 5 10 6.25 
∆CAGL0M10153g A 4 7 2 5 4.5 
∆CAGL0M10978g A 4 2 2 1 2.25 
∆CAGL0M10978g B 0 1 4 1 1.5 
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Appendix 11: Screening C. 
glabrata deletion mutants for 
Biofilm Formation 
 
Table 1: Quantification of biofilm formation for 117 C. glabrata isolates 
corresponding to 65 C. glabrata ORF deletions. Values indicate the average 
OD492 of XTT solution incubated with C. glabrata biofilms for 1 hour at 37 °C as 
well as that of the parental strain control Cg2001 ∆his3. Where available, two 
independent isolates of each C. glabrata deletion mutant were tested for biofilm 
formation. C. glabrata isolates for which biofilm formation was significantly 
increased or decreased compared with the parental strain are highlighted in 
yellow (Anova p<1.45E-05, Dunnett’s critical value 3.37). 
C. glabrata isolate Average XTT reduction 
(OD492) 
Average Cg2001 ∆his3 
control XXT reduction 
(OD492) 
∆CAGL0A02299g A 0.4793 0.3740 
∆CAGL0A02299g B 0.4402 0.3740 
∆CAGL0A02343g A 0.4623 0.3740 
∆CAGL0A02343g B 0.4437 0.3740 
∆CAGL0A03608g A 0.7953 0.8035 
∆CAGL0A03608g B 0.8133 0.8035 
∆CAGL0B00726g A 0.7512 0.8247 
∆CAGL0B00726g B 0.7558 0.8247 
∆CAGL0B02926g A 0.4247 0.4150 
∆CAGL0B02946g B 0.4027 0.3038 
∆CAGL0B02948g A 0.8056 0.8035 
∆CAGL0B02948g B 0.8156 0.8035 
∆CAGL0B02970g A 0.6341 0.6341 
∆CAGL0B03223g A 0.6943 0.8035 
∆CAGL0B03223g B 0.6746 0.8035 
∆CAGL0B03883g A 0.3508 0.4150 
∆CAGL0B03883g B 0.3655 0.4150 
∆CAGL0C00253g A 0.8133 0.8035 
∆CAGL0C00253g B 0.8086 0.8035 
∆CAGL0C01837g A 0.7983 0.8035 
∆CAGL0C01837g B 0.7806 0.8035 
∆CAGL0C04763g A 0.4015 0.3038 
∆CAGL0C04763g B 0.4352 0.3038 
∆CAGL0D00682g A 0.2808 0.3038 
∆CAGL0D00682g B 0.3757 0.3038 
 315 | P a g e  
 
∆CAGL0D01210g A 0.8156 0.8035 
∆CAGL0D01210g B 0.8056 0.8035 
∆CAGL0D03850g A 0.3987 0.5490 
∆CAGL0D03850g B 0.3372 0.5490 
∆CAGL0D03872g A 0.7550 0.8035 
∆CAGL0D05170g A 0.5133 0.5490 
∆CAGL0D05170g B 0.5238 0.5490 
∆CAGL0D05434g A 0.5452 0.5490 
∆CAGL0D05434g B 0.5383 0.5490 
∆CAGL0D06226g A 0.8533 0.8035 
∆CAGL0E00275g A 0.3786 0.8035 
∆CAGL0E06600g A 0.4518 0.3740 
∆CAGL0E06600g B 0.4028 0.3740 
∆CAGL0E06644g A 0.3305 0.3038 
∆CAGL0E06644g B 0.2907 0.3038 
∆CAGL0F01815g A 0.3965 0.4150 
∆CAGL0F01815g B 0.3757 0.4150 
∆CAGL0F03905g A 0.6948 0.8247 
∆CAGL0F03905g B 0.7097 0.8247 
∆CAGL0F04081g A 0.5572 0.5382 
∆CAGL0F05159g A 0.6300 0.8247 
∆CAGL0F05159g B 0.6718 0.8247 
∆CAGL0F05973g A 0.5718 0.5382 
∆CAGL0F06237g A 0.5165 0.5490 
∆CAGL0F06237g B 0.5147 0.5490 
∆CAGL0F08767g A 0.7423 0.8035 
∆CAGL0F08767g B 0.7265 0.8035 
∆CAGL0F09229g A 0.7348 0.8247 
∆CAGL0F09229g B 0.7738 0.8247 
∆CAGL0G02607g A 0.6863 0.5382 
∆CAGL0G02607g B 0.4992 0.5725 
∆CAGL0G03201g A 0.4775 0.3740 
∆CAGL0G04279g A 0.6233 0.8035 
∆CAGL0G04279g B 0.5921 0.8035 
∆CAGL0G05522g A 0.8150 0.8035 
∆CAGL0G05522g B 0.8518 0.8035 
∆CAGL0G08866g A 0.5525 0.5490 
∆CAGL0G08866g B 0.5552 0.5490 
∆CAGL0G10175g A 0.8353 0.8035 
∆CAGL0G10175g B 0.8213 0.8035 
∆CAGL0H01749g A 0.4668 0.4268 
∆CAGL0H01749g B 0.4158 0.4268 
∆CAGL0H06765g A 0.5893 0.5725 
∆CAGL0H06765g B 0.6737 0.5725 
∆CAGL0H08712g A 0.4495 0.4268 
∆CAGL0H08712g B 0.3323 0.4268 
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∆CAGL0H09988g A 0.5015 0.5490 
∆CAGL0H09988g B 0.5087 0.5490 
∆CAGL0H10208g A 0.4992 0.5725 
∆CAGL0H10208g B 0.6195 0.5382 
∆CAGL0I02244g A 0.4378 0.4268 
∆CAGL0I02244g B 0.4302 0.4268 
∆CAGL0I08437g A 0.8183 0.8035 
∆CAGL0I08613g A 0.4422 0.3740 
∆CAGL0I08613g B 0.3905 0.3740 
∆CAGL0J05786g A 0.4563 0.4268 
∆CAGL0J05786g B 0.4730 0.4268 
∆CAGL0J05852g A 0.8260 0.8035 
∆CAGL0J05852g B 0.7993 0.8035 
∆CAGL0K02145g A 0.4172 0.4150 
∆CAGL0K02145g B 0.3547 0.4150 
∆CAGL0K05687g A 0.7322 0.5725 
∆CAGL0K05687g A 0.5028 0.4268 
∆CAGL0K05687g B 0.7068 0.5725 
∆CAGL0K07634g A 0.6883 0.5382 
∆CAGL0K10318g A 0.6403 0.5725 
∆CAGL0K10318g B 0.8353 0.8035 
∆CAGL0K11066g A 0.8740 0.8035 
∆CAGL0L03674g A 0.7520 0.8247 
∆CAGL0L03674g B 0.7583 0.8247 
∆CAGL0L06776g A 0.8480 0.8247 
∆CAGL0L06776g B 0.7787 0.8247 
∆CAGL0L07480g A 0.6498 0.8247 
∆CAGL0L07480g B 0.5578 0.8247 
∆CAGL0L09383g A 0.5018 0.5490 
∆CAGL0L09383g B 0.4840 0.5490 
∆CAGL0M01716g A 0.3927 0.4150 
∆CAGL0M01716g B 0.3588 0.4150 
∆CAGL0M01870g A 0.6615 0.5382 
∆CAGL0M01914g A 0.7176 0.8035 
∆CAGL0M02299g A 0.3093 0.5725 
∆CAGL0M02321g A 0.4727 0.4268 
∆CAGL0M02321g B 0.4308 0.4268 
∆CAGL0M04543g A 0.8583 0.8035 
∆CAGL0M04543g B 0.8643 0.8035 
∆CAGL0M05137g A 0.8583 0.8035 
∆CAGL0M05137g B 0.8643 0.8035 
∆CAGL0M10153g A 0.7008 0.5382 
∆CAGL0M10978g A 0.4728 0.3740 
∆CAGL0M10978g B 0.3765 0.3740 
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Appendix 12: CAGL0K05687g genetic interactions 
Table 1: S. cerevisiae ORFs and SGD description (yeastgenome.org) which showed genetic interactions with C. glabrata 
CAGL0K05687g expressed from S. cerevisiae strain KH03-K05687. Genes highlighted in orange highlight S. cerevisiae membrane 
proteins and transporters. S. cerevisiae genes involved in transcriptional regulation are highlighted in blue. ORFs highlighted green are 
associated with the vesicle. 
ORF name Gene name SGD Description 
YAL002W VPS8 Membrane-binding component of the CORVET complex; involved in endosomal vesicle tethering and fusion in the 
endosome to vacuole protein targeting pathway; interacts with Vps21p; contains RING finger motif  
YAL004W YAL004W Dubious open reading frame; unlikely to encode a functional protein, based on available experimental and comparative 
sequence data; completely overlaps verified gene SSA1/YAL005C 
YAL005C SSA1 ATPase involved in protein folding and NLS-directed nuclear transport; member of HSP70 family; forms chaperone complex 
with Ydj1p; localized to nucleus, cytoplasm, and cell wall; 98% identical with paralogue Ssa2p, but subtle differences 
between the two proteins provide functional specificity with respect to propagation of yeast [URE3] prions and vacuolar-
mediated degradations of gluconeogenesis enzymes; general targeting factor of Hsp104p to prion fibrils 
YAL010C MDM10 Subunit of both the ERMES complex and the SAM complex; the ERMES complex links the ER to mitochondria; the SAM 
complex is mitochondrial sorting and assembly machinery that functions in import and assembly of outer membrane beta-
barrel proteins 
YAL011W SWC3 Protein of unknown function; component of the SWR1 complex, which exchanges histone variant H2AZ (Htz1p) for 
chromatin-bound histone H2A; required for formation of nuclear-associated array of smooth endoplasmic reticulum known 
as karmellae 
YAL014C SYN8 Endosomal SNARE related to mammalian syntaxin 8 
YAL015C NTG1 DNA N-glycosylase and apurinic/apyrimidinic (AP) lyase; involved in base excision repair; acts in both nucleus and 
mitochondrion; creates a double-strand break at mtDNA origins that stimulates replication in response to oxidative stress; 
required for maintaining mitochondrial genome integrity; NTG1 has a paralog, NTG2, that arose from the whole genome 
duplication  
YAL017W PSK1 PAS domain-containing serine/threonine protein kinase; coordinately regulates protein synthesis and carbohydrate 
metabolism and storage in response to a unknown metabolite that reflects nutritional status; PSK1 has a paralog, PSK2, that 
arose from the whole genome duplication 
YAL018C YAL018C Protein Involved in spore wall assembly; localizes to lipid droplets found on or outside of the prospore membrane; shares 
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similarity with Lds2p and Rrt8p, and a strain mutant for all 3 genes exhibits reduced dityrosine fluorescence relative to the 
single mutants 
YAL019W FUN30 Snf2p family member with ATP-dependent chromatin remodeling activity; has a role in silencing at the mating type locus, 
telomeres and centromeres; enriched at centromeres and is required for correct chromatin structure around centromeres, as 
well as at the boundary element of the silent HMR; recruited to DNA double-strand breaks (DSBs) where it promotes 5' 
strand resection of DSBs; potential Cdc28p substrate 
YAL020C ATS1 Protein required for modification of wobble nucleosides in tRNA; acts with Elongator complex, Kti11p, and Kti12p; has a 
potential role in regulatory interactions between microtubules and the cell cycle 
YAL027W SAW1 5'- and 3'-flap DNA binding protein; recruits Rad1p-Rad10p to single-strand annealing intermediates with 3' non-homologous 
tails for removal during double-strand break repair; complexes with Rad1p-Rad10p and stimulates its endonuclease activity; 
green fluorescent protein (GFP)-fusion protein localizes to the nucleus  
YAL028W FRT2 Tail-anchored ER membrane protein of unknown function; interacts with homolog Frt1p; promotes growth in conditions of 
high Na+, alkaline pH, or cell wall stress, possibly via a role in posttranslational translocation; potential Cdc28p substrate; 
FRT2 has a paralog, FRT1, that arose from the whole genome duplication 
YAL030W SNC1 Vesicle membrane receptor protein (v-SNARE); involved in the fusion between Golgi-derived secretory vesicles with the 
plasma membrane; proposed to be involved in endocytosis; member of the synaptobrevin/VAMP family of R-type v-SNARE 
proteins; SNC1 has a paralog, SNC2, that arose from the whole genome duplication 
YAL031C GIP4 Cytoplasmic Glc7-interacting protein whose overexpression relocalizes Glc7p from the nucleus and prevents chromosome 
segregation; potential Cdc28p substrate  
YAL034C FUN19 Non-essential protein of unknown function; expression induced in response to heat stress; FUN19 has a paralog, 
YOR338W, that arose from the whole genome duplication 
YAL036C RBG1 Member of the DRG family of GTP-binding proteins; associates with translating ribosomes; interacts with Tma46p, 
Ygr250cp, Gir2p and Yap1p via two-hybrid 
YAL037W YAL037W Putative protein of unknown function; YAL037W has a paralog, YOR342C, that arose from the whole genome duplication 
YAL040C CLN3 G1 cyclin involved in cell cycle progression; activates Cdc28p kinase to promote the G1 to S phase transition; plays a role in 
regulating transcription of the other G1 cyclins, CLN1 and CLN2; regulated by phosphorylation and proteolysis; acetly-CoA 
induces CLN3 transcription in response to nutrient repletion to promote cell-cycle entry 
YAL042W ERV46 Protein localized to COPII-coated vesicles; forms a complex with Erv41p; involved in the membrane fusion stage of transport 
YAL043C-a YAL042C-A Dubious open reading frame; unlikely to encode a functional protein, based on available experimental and comparative 
sequence data; partially overlaps verified ORF ERV46/YAL042W; YAL042C-A is a non-essential gene 
YAL044C GCV3 H subunit of the mitochondrial glycine decarboxylase complex; glycine decarboxylase is required for the catabolism of 
glycine to 5,10-methylene-THF; also required for all protein lipoylation; expression is regulated by levels of 5,10-methylene-
THF 
YAL045C YAL045C Dubious open reading frame; unlikely to encode a functional protein, based on available experimental and comparative 
sequence data; almost completely overlaps YAL044W-A 
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YAL049C AIM2 Cytoplasmic protein involved in mitochondrial function or organization; null mutant displays reduced frequency of 
mitochondrial genome loss; potential Hsp82p interactor 
YAL053W FLC2 Putative FAD transporter; required for uptake of FAD into endoplasmic reticulum; involved in cell wall maintenance; FLC2 
has a paralog, YOR365C, that arose from the whole genome duplication 
YAL055W PEX22 Putative peroxisomal membrane protein required for import of peroxisomal proteins, functionally complements a Pichia 
pastoris pex22 mutation 
YAL056W GPB2 Multistep regulator of cAMP-PKA signaling; inhibits PKA downstream of Gpa2p and Cyr1p, thereby increasing cAMP 
dependency; inhibits Ras activity through direct interactions with Ira1p/2p; regulated by G-alpha protein Gpa2p; GPB2 has a 
paralog, GPB1, that arose from the whole genome duplication 
YAL058W CNE1 Calnexin; integral membrane ER chaperone involved in folding and quality control of glycoproteins; chaperone activity is 
inhibited by Mpd1p, with which Cne1p interacts; 24% identical to mammalian calnexin; Ca+ binding not yet shown in yeast 
YAL062W GDH3 NADP(+)-dependent glutamate dehydrogenase; synthesizes glutamate from ammonia and alpha-ketoglutarate; rate of 
alpha-ketoglutarate utilization differs from Gdh1p; expression regulated by nitrogen and carbon sources; GDH3 has a 
paralog, GDH1, that arose from the whole genome duplication 
YAL065C YAL065C Putative protein of unknown function; has homology to FLO1; possible pseudogene 
YAL066W YAL066W Dubious open reading frame; unlikely to encode a functional protein, based on available experimental and comparative 
sequence data 
YAL067C SEO1 Putative permease; member of the allantoate transporter subfamily of the major facilitator superfamily; mutation confers 
resistance to ethionine sulfoxide 
YAR002W NUP60 FG-nucleoporin component of central core of the nuclear pore complex (NPC); contributes directly to nucleocytoplasmic 
transport and maintenance of the NPC permeability barrier and is involved in gene tethering at the nuclear periphery; 
relocalizes to the cytosol in response to hypoxia; both NUP1 and NUP60 are homologous to human NUP153  
YAR003W SWD1 Subunit of the COMPASS (Set1C) complex; COMPASS methylates histone H3 on lysine 4 and is required in transcriptional 
silencing near telomeres; WD40 beta propeller superfamily member with similarity to mammalian Rbbp7 
YAR014C BUD14 Protein involved in bud-site selection; Bud14p-Glc7p complex is a cortical regulator of dynein; inhibitor of the actin assembly 
factor Bnr1p (formin); diploid mutants display a random budding pattern instead of the wild-type bipolar pattern; relative 
distribution to the nucleus increases upon DNA replication stress 
YAR015W ADE1 N-succinyl-5-aminoimidazole-4-carboxamide ribotide synthetase; required for 'de novo' purine nucleotide biosynthesis; red 
pigment accumulates in mutant cells deprived of adenine; protein abundance increases in response to DNA replication 
stress 
YAR018C KIN3 Nonessential serine/threonine protein kinase; possible role in DNA damage response; influences tolerance to high levels of 
ethanol 
YAR020C PAU7 Member of the seripauperin multigene family; active during alcoholic fermentation, regulated by anaerobiosis, inhibited by 
oxygen, repressed by heme 
YAR023C YAR023C Putative integral membrane protein; member of DUP240 gene family 
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YAR027W UIP3 Putative integral membrane protein of unknown function; interacts with Ulp1p at the nuclear periphery; member of DUP240 
gene family 
YAR028W YAR028W Putative integral membrane protein; member of DUP240 gene family; GFP-fusion protein is induced in response to the DNA-
damaging agent MMS 
YAR031W PRM9 Pheromone-regulated protein; contains 3 predicted transmembrane segments and an FF sequence, a motif involved in 
COPII binding; member of DUP240 gene family; PRM9 has a paralog, PRM8, that arose from a segmental duplication  
YAR035W YAT1 Outer mitochondrial carnitine acetyltransferase; minor ethanol-inducible enzyme involved in transport of activated acyl 
groups from the cytoplasm into the mitochondrial matrix; phosphorylated 
YAR037W None None  
YAR040C None None 
YAR042W SWH1 Protein similar to mammalian oxysterol-binding protein; contains ankyrin repeats; localizes to the Golgi and the nucleus-
vacuole junction; SWH1 has a paralog, OSH2, that arose from the whole genome duplication 
YAR043C-a None None 
YAR044W YAR044W Protein similar to mammalian oxysterol-binding protein; contains ankyrin repeats; localizes to the Golgi and the nucleus-
vacuole junction; SWH1 has a paralog, OSH2, that arose from the whole genome duplication 
YAR047C YAR047C Dubious open reading frame; unlikely to encode a functional protein, based on available experimental and comparative 
sequence data 
YBL042C FUI1 High affinity uridine permease, localizes to the plasma membrane; also mediates low but significant transport of the cytotoxic 
nucleoside analog 5-fluorouridine; not involved in uracil transport; relative distribution to the vacuole increases upon DNA 
replication stress  
YBR266C SLM6 Protein with a potential role in actin cytoskeleton organization; gene exhibits synthetic genetic interaction with MSS4 
encoding phosphatidylinositol 4-phosphate kinase 
YDL158C YDL158C Dubious open reading frame; unlikely to encode a functional protein, based on available experimental and comparative 
sequence data 
YDL169C UGX2 Protein of unknown function; transcript accumulates in response to any combination of stress conditions 
YDR120C TRM1 tRNA methyltransferase; two forms of the protein are made by alternative translation starts; localizes to both the nucleus and 
mitochondrion to produce the modified base N2,N2-dimethylguanosine in tRNAs in both compartments 
YDR158W HOM2 Aspartic beta semi-aldehyde dehydrogenase; catalyzes the second step in the common pathway for methionine and 
threonine biosynthesis; expression regulated by Gcn4p and the general control of amino acid synthesis 
YDR226W ADK1 Adenylate kinase, required for purine metabolism; localized to the cytoplasm and the mitochondria; lacks cleavable signal 
sequence; protein abundance increases in response to DNA replication stress  
YER060W-A FCY22 Putative purine-cytosine permease; very similar to Fcy2p but cannot substitute for its function 
YGL016W KAP122 Karyopherin beta; responsible for import of the Toa1p-Toa2p complex into the nucleus; binds to nucleoporins Nup1p and 
Nup2p; may play a role in regulation of pleiotropic drug resistance 
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YGL031C RPL24A Ribosomal 60S subunit protein L24A; not essential for translation but may be required for normal translation rate; 
homologous to mammalian ribosomal protein L24, no bacterial homolog; RPL24A has a paralog, RPL24B, that arose from 
the whole genome duplication 
YGL072C YGL072C Dubious open reading frame; unlikely to encode a functional protein, based on available experimental and comparative 
sequence data; partially overlaps the verified gene HSF1; null mutant displays increased resistance to antifungal agents 
gliotoxin, cycloheximide and H2O2  
YGR159C NSR1 Nucleolar protein that binds nuclear localization sequences; required for pre-rRNA processing and ribosome biogenesis 
YGR182C YGR182C Dubious open reading frame; unlikely to encode a functional protein, based on available experimental and comparative 
sequence data; partially overlaps the verified ORF TIM13/YGR181W 
YGR188C BUB1 Protein kinase involved in the cell cycle checkpoint into anaphase; forms complex with Mad1p and Bub3p crucial to 
preventing cell cycle progression into anaphase in presence of spindle damage; CDC28-mediated phosphorylation at 
Bub1p-T566 is important for degradation in anaphase and adaptation of checkpoint to prolonged mitotic arrest; associates 
with centromere DNA via Skp1p; BUB1 has a paralog, MAD3, that arose from the whole genome duplication 
YHL011C PRS3 5-phospho-ribosyl-1(alpha)-pyrophosphate synthetase; synthesizes PRPP, which is required for nucleotide, histidine, and 
tryptophan biosynthesis; one of five related enzymes, which are active as heteromultimeric complexes 
YHL031C GOS1 v-SNARE protein involved in Golgi transport; homolog of the mammalian protein GOS-28/GS28 
YHR041C SRB2 Subunit of the RNA polymerase II mediator complex; associates with core polymerase subunits to form the RNA polymerase 
II holoenzyme; general transcription factor involved in telomere maintenance 
YHR060W VMA22 Peripheral membrane protein that is required for vacuolar H+-ATPase (V-ATPase) function, although not an actual 
component of the V-ATPase complex; functions in the assembly of the V-ATPase; localized to the yeast endoplasmic 
reticulum (ER) 
YJL115W ASF1 Nucleosome assembly factor; involved in chromatin assembly and disassembly, anti-silencing protein that causes 
derepression of silent loci when overexpressed; plays a role in regulating Ty1 transposition; relocalizes to the cytosol in 
response to hypoxia 
YJL129C TRK1 Component of the Trk1p-Trk2p potassium transport system; 180 kDa high affinity potassium transporter; phosphorylated in 
vivo and interacts physically with the phosphatase Ppz1p, suggesting Trk1p acitivy is regulated by phosphorylation; TRK1 
has a paralog, TRK2, that arose from the whole genome duplication  
YJL183W MNN11 Subunit of a Golgi mannosyltransferase complex; this complex also contains Anp1p, Mnn9p, Mnn10p, and Hoc1p, and 
mediates elongation of the polysaccharide mannan backbone; has homology to Mnn10p 
YKL206C ADD66 Protein involved in 20S proteasome assembly; forms a heterodimer with Pba1p that binds to proteasome precursors; 
interaction with Pba1p-Add66p may affect function of the mature proteasome and its role in maintaining respiratory 
metabolism; similar to human PAC2 constituent of the PAC1-PAC2 complex involved in proteasome assembly 
YKR067W GPT2 Glycerol-3-phosphate/dihydroxyacetone phosphate sn-1 acyltransferase; located in lipid particles and the ER; involved in the 
stepwise acylation of glycerol-3-phosphate and dihydroxyacetone in lipid biosynthesis; the most conserved motifs and 
functionally relevant residues are oriented towards the ER lumen 
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YKR072C SIS2 Negative regulatory subunit of protein phosphatase 1 (Ppz1p); involved in coenzyme A biosynthesis; subunit of 
phosphopantothenoylcysteine decarboxylase (PPCDC: Cab3p, Sis2p, Vhs3p) complex and the CoA-Synthesizing Protein 
Complex (CoA-SPC: Cab2p, Cab3p, Cab4p, Cab5p, Sis2p and Vhs3p); SIS2 has a paralog, VHS3, that arose from the 
whole genome duplication 
YLR303W MET17 Methionine and cysteine synthase (O-acetyl homoserine-O-acetyl serine sulfhydrylase), required for sulfur amino acid 
synthesis  
YLR315W NKP2 Central kinetochore protein and subunit of the Ctf19 complex; mutants have elevated rates of chromosome loss; orthologous 
to fission yeast kinetochore protein cnl2 
YML088W UFO1 F-box receptor protein; subunit of the Skp1-Cdc53-F-box receptor (SCF) E3 ubiquitin ligase complex; binds to 
phosphorylated Ho endonuclease, allowing its ubiquitylation by SCF and subsequent degradation 
YML107C PML39 Protein required for nuclear retention of unspliced pre-mRNAs along with Mlp1p and Pml1p; anchored to nuclear pore 
complex via Mlp1p and Mlp2p; found with the subset of nuclear pores farthest from the nucleolus; may interact with 
ribosomes 
YMR014W BUD22 Protein required for 18S rRNA maturation and small ribosomal subunit biogenesis; cosediments with pre-ribosomal particles; 
mutation decreases efficiency of +1 Ty1 frameshifting and transposition, and affects budding pattern 
YMR188C MRPS17 Mitochondrial ribosomal protein of the small subunit 
YMR267W PPA2 Mitochondrial inorganic pyrophosphatase; required for mitochondrial function and possibly involved in energy generation 
from inorganic pyrophosphate 
YNL248C RPA49 RNA polymerase I subunit A49 
YOR369C RPS12 Protein component of the small (40S) ribosomal subunit; homologous to mammalian ribosomal protein S12, no bacterial 
homolog 
YPL086C ELP3 Subunit of Elongator complex; Elongator is required for modification of wobble nucleosides in tRNA; exhibits histone 
acetyltransferase activity that is directed to histones H3 and H4; disruption confers resistance to K. lactis zymotoxin 
YPL244C HUT1 Protein with a role in UDP-galactose transport to the Golgi lumen; has similarity to human UDP-galactose transporter 
UGTrel1, exhibits a genetic interaction with S. cerevisiae ERO1 
YPL269W KAR9 Karyogamy protein required for correct positioning of the mitotic spindle and for orienting cytoplasmic microtubules, localizes 
at the shmoo tip in mating cells and at the tip of the growing bud in small-budded cells through anaphase 
YPR023C EAF3 Component of the Rpd3S histone deacetylase complex; Esa1p-associated factor, nonessential component of the NuA4 
acetyltransferase complex, homologous to Drosophila dosage compensation protein MSL3; plays a role in regulating Ty1 
transposition 
YPR124W CTR1 High-affinity copper transporter of the plasma membrane; mediates nearly all copper uptake under low copper conditions; 
transcriptionally induced at low copper levels and degraded at high copper levels; protein increases in abundance and 
relocalizes from nucleus to plasma membrane upon DNA replication stress 
YPR139C LOA1 Lysophosphatidic acid acyltransferase; involved in triacelglyceride homeostasis and lipid droplet formation; localized to lipid 
droplets and the ER; specificity for oleoyl-CoA 
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Abstract 
 
The opportunistic fungal pathogen Candida glabrata is a frequent cause of candidiasis, 
causing infections ranging from superficial to life-threatening disseminated disease. The 
inherent tolerance of C. glabrata to azole drugs makes this pathogen a serious clinical threat. 
To identify genes implicated in drug resistance, we have constructed a genome-scale C. 
glabrata deletion library consisting of 619 unique individually bar-coded mutant strains, each 
lacking one specific gene. Functional analysis of this library in a series of phenotypic and 
fitness assays identified numerous genes required for growth of C. glabrata under normal or 
specific stress conditions, as well as a number of novel genes involved in tolerance to 
clinically important antifungal drugs such as azoles and echinocandins. We identified 39 
deletions displaying increased susceptibility to caspofungin, 28 of which are novel, encoding 
functions that have not previously been linked to echinocandin tolerance. Our results 
demonstrate the potential of the C. glabrata mutant collection as a valuable resource in 
functional genomics studies of this important fungal pathogen of humans, and to facilitate the 
identification of putative novel antifungal drug target and virulence genes. 
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Author Summary 
Clinical infections by the yeast-like pathogen Candida glabrata have been ever-increasing 
over the past years. Importantly, C. glabrata is one of the most prevalent causes of drug-
refractory fungal infections in humans. We have generated a novel genome-scale collection 
of some 619 bar-coded C. glabrata mutants, each lacking a single gene. Extensive profiling 
of phenotypes reveals a number of novel genes implicated in tolerance to antifungal drugs 
that interfere with proper cell wall function, as well as genes affecting fitness of C. glabrata 
both during normal growth and under environmental stress. This fungal deletion collection 
will be an valuable resource for the community to study mechanisms of virulence and 
antifungal drug tolerance in C. glabrata, which is particularly relevant in view of the 
increasing prevalence of infections caused by this important human fungal pathogen. 
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Introduction 
Candida glabrata, a small, asexual, haploid yeast, is the second most frequent cause 
of candidiasis after Candida albicans, accounting for approximately 15%-25% of clinical 
cases [1-4]. C. glabrata forms part of the normal microbial flora in humans, but can 
cause serious infections in immunocompromised and hospitalized patients; antibiotic 
exposure and presence of central venous catheter devices, being additional important 
risk factors for disease development [2]. In contrast to the pleomorphic diploid C. 
albicans [5], C. glabrata is found clinically, exclusively as monomorphic yeast cells. It 
also lacks several attributes considered key mediators of fungal pathogenicity in other 
Candida spp, such as secretion of proteases and lipases [6,7]. Despite the apparent 
absence of these well-known fungal virulence traits, C. glabrata remains highly 
pathogenic to humans. Hence, C. glabrata may rely upon distinct strategies and other 
virulence attributes to initiate infection, as well as to persist in infected patients.  
Some traits that have been linked to the clinical importance and virulence of C. 
glabrata include an inherently elevated tolerance to azole antifungals [8-11]; the 
presence of a large repertoire of telomere-associated adhesins [12-18]; melanin-like 
pigment production [19]; adaptation to the acidic phagosomal environment and intra-
phagosomal survival [20-22]; and Ace2-dependent components of the cell wall [23]. 
However, it is clear that the molecular basis of C. glabrata virulence is far from being 
completely understood. 
C. glabrata clinical isolates generally exhibit a high inherent tolerance level to 
azole drugs [9]. While this trait has been extensively studied, the underlying 
mechanisms remain incompletely explained. Azole resistance can be acquired through 
increased expression of genes encoding ABC transporters (Cdr1, Pdh1, Snq2) or 
changes in their transcriptional regulatory system (Pdr1, Gal11) [24-28]. Mitochondrial 
dysfunction [29] and serum utilization via the putative sterol transporter Aus1 [30,31] 
also impact the ability of C. glabrata to tolerate high azole levels. It remains unclear if 
these are the only mechanisms driving azole resistance in C. glabrata. However, the 
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clinical implications of this resistance demand alternative antifungals for effective 
treatment C. glabrata infections in patients, especially since C. glabrata infections are 
globally rising, sometimes accounting for more than 30% of clinical cases [32]. 
Echinocandins such as caspofungin (CF), anidulafungin and micafungin are a 
relatively new class of effective yet high-cost antifungal drugs targeting fungal 1,3-β-D-
glucan synthases and thereby impairing cell wall integrity [33]. Mutations in subunits of 
glucan synthases can render fungi resistant to echinocandin [33-36]. Surprisingly, even 
ectopic overexpression of the C. albicans Cdr2 efflux ABC transporter gene in both 
laboratory strains and clinical isolates markedly increases CF tolerance [37]. However, 
a better understanding of molecular mechanisms modulating echinocandin 
susceptibility is necessary, since it may facilitate targeted drug discovery, especially in 
the case of emerging resistant strains [38]. 
Reverse genetics coupled with global functional profiling has proven a powerful 
approach to identify genes required for specific phenotypes. Functional genomics 
studies in the non-pathogenic yeast S. cerevisiae have provided the starting point to 
decipher genotype-phenotype relations as it enabled answers about fundamentally 
important questions concerning complex genetic interactions and the genetic 
landscape of yeast. These approaches also unraveled stress response mechanisms 
and provided new insights into drug susceptibility and morphogenesis [39-46]. Heroic 
efforts by a few groups have recently resulted in highly useful genome-scale deletion 
collections of the major pathogen C. albicans [47-49] and Cryptococcus neoformans 
[50], enabling the identification of novel virulence genes and further demonstrating the 
power of a functional genomics approach.  
Here, we have adapted a semi-automated approach [48] for constructing gene 
deletions to generate a collection of individually bar-coded strains in the sequenced C. 
glabrata strain ATCC 2001 [51], each lacking one defined open reading frame. We took 
advantage of this library to undertake the first systematic functional genomic analysis of 
C. glabrata, in particular examining the response to traits putatively implicated in 
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virulence and antifungal resistance. We performed a series of growth assays in distinct 
media to determine the impact of gene deletion on fitness. We then determined the 
susceptibility of the collection to major antifungal compounds (including azoles and 
caspofungin) and various other cell wall-damaging compounds. Finally, we investigated 
the effect on cellular morphology on fitness in vitro, and the ability to form biofilms. This 
enabled us to generate the first large-scale chemogenetic and phenotypic profile of C. 
glabrata. Our analysis revealed numerous novel genes implicated in stress response, 
cell wall homeostasis, growth morphology and fitness. Most importantly, we discover 
numerous novel genes implicated in susceptibility to echinocandins, demonstrating the 
usefulness of this deletion collection for the functional analysis of virulence-related, as 
well as clinically relevant traits, including the discovery of novel antifungal target genes. 
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Results 
Gene selection. Using a large-scale phylogenetic approach across many fungal 
species [52], we identified 1047 putatively non-essential candidate genes in C. glabrata 
representing functional GO categories such as environmental stress sensing and 
signaling (MAPK pathways, TOR, RIM, PKA); transcriptional regulation; antifungal drug 
resistance (PDR network, membrane permeases); cell wall structure and homeostasis 
(glucan, mannan, chitin synthesis, glycosylation, adhesins, glycosylphosphatidylinositol 
(GPI)-anchor); chromatin and histone modification; iron metabolism and metal 
sensitivity; peroxisome biogenesis. We also selected genes lacking obvious 
orthologues in S. cerevisiae (Supplemental Table S1). 
 
Parental recipient strains. To enable the rescue of deletion phenotypes and to 
facilitate double- or triple mutant construction, we engineered a triple-auxotrophic 
recipient strain in the sequenced type strain C. glabrata ATCC 2001 [51]. We used the 
dominant recyclable nourseothricin resistance marker SAT1 [53] to replace the coding 
sequences of HIS3, LEU2 and TRP1 (Supplemental Figure S1-A). The repeated use of 
this marker cassette resulted in the new C. glabrata background recipient strain for 
deletions referred to as HTL (his3∆::FRT leu2∆::FRT trp1∆::FRT), as well as all 
possible isogenic single deletions and all combinations of double deletion strains 
(Supplemental Table S2). We also constructed a bar-coded version of the HTL strain, 
C. glabrata HTL reference, by inserting 20bp barcodes flanking the trp1 locus 
(Supplemental Table S2).  The transcription factor (TF) mutants were made in a his3 
derivative of ATCC 2001, the majority using a codon-optimized version of the NAT1 
marker [54]. We avoided the use of the URA3 marker in C. glabrata, since it is known 
to alter virulence properties of C. albicans [55,56]. The HTL strain displayed similar 
growth properties and rates as the parental strain, on both minimal and full media 
(Supplemental Figure S1C). Importantly, the auxotrophic markers did not significantly 
influence growth in vitro, or the survival in immunocompetent mice when compared to 
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the parental wild type strain [57]. While the growth behaviour of C. glabrata HTL was 
largely unchanged, these cells reached a slightly lower maximal cell density when 
growing in minimal media when compared to wild type cells (Supplemental Figure 1C). 
 
Gene deletion strategy. Targeted gene disruption with short-homology flanking 
regions, as was done to construct the S. cerevisiae knock-out library, is inefficient in C. 
glabrata. Higher targeting efficiency requires the use of ≥500 base pair (bp) flanking 
regions [58]. Therefore, to maximise efficiency of gene replacement, we adapted and 
automated the fusion PCR technique [48] to generate gene deletion constructs 
containing ~500bp homologous flanking regions for every gene, fused to the dominant 
marker NAT1 and flanked by unique barcode identifiers (Figure 1A). We employed a 
limited set of barcode sequences selected from those successfully used in the S. 
cerevisiae genome deletion project [40,46]. These barcodes enable quantification and 
tracking of single mutants in pool experiments. A complete list of all barcode 
sequences corresponding to each deleted ORF in the collection is given in 
Supplemental Table S3.  
C. glabrata recipient strains were transformed with these deletion cassettes 
using a modified 96-well format electroporation protocol. All resulting nourseothricin-
resistant transformants were tested for correct genomic integration by colony PCR to 
verify both 5’ and 3’ junctions (Figure 1B). Single colonies of up to six verified 
transformants for each gene were isolated; the absence of the corresponding gene 
from the genome was confirmed using another PCR-based step and confirmed gene 
deletion strains were cryo-preserved (Figure 1C). A total of 24 PCR-verified gene 
deletion strains were randomly selected and subjected to Southern blot analysis to 
confirm correct genomic replacements (data not shown).  
In all, we successfully deleted 619 of the 1047 genes initially selected for 
inactivation, yielding a total of 1601 independent unique deletion strains (Supplemental 
Table S3; http://funpath.cdl.univie.ac.at), representing 53% of the selected genes and 
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about 13% of the entire C. glabrata genome. Notably, for 77 genes only one deletion 
was obtained, while the majority of deletions result from two (246) or three (224) 
independent transformation and thus genomic removal events (Supplemental Table 
S2). We assume that a large fraction of the genes that we failed to inactivate is a 
consequence of inefficient homologous targeting, rather than a true representation of 
the frequency of essential genes.  
 
Phenotypic screening and mutant characterization. We then carried out a 
preliminary pilot screen using a small set of selected deletion mutants displaying known 
phenotypes. Mutants lacking genes of the high osmolarity glycerol (HOG) pathway, the 
cell integrity protein kinase C (PKC) pathway and the pleiotropic drug resistance (PDR) 
network were tested for growth under conditions known to affect the corresponding 
mutants in S. cerevisiae. As expected, lack of PBS2, encoding the central MAPK 
(mitogen-activated protein kinase) of the HOG pathway [59], resulted in severe 
osmosensitivity (Supplemental Figure S2-A). Likewise, azole hypersensitivity was 
observed in cdr1 and pdr1 strains (Supplemental Figure S2-B) [24-26,28,60,61]. 
Finally, as previously shown, cells lacking the SLT2 kinase of PKC pathway [62,63] 
displayed drastic hypersensitivities to CF (Supplemental Figure S2-C). Following these 
initial experiments, which served to establish and validate screening parameters, the 
collection of 1601 gene deletion mutants was subjected to extensive phenotypic 
profiling in four independent laboratories using the same conditions, including a variety 
of assays to monitor growth properties, fitness, stress and antifungal susceptibility, 
biofilm formation, as well as obvious colony or cellular morphology alterations.  
 
Growth and fitness defects. Changes in the pathogenic potential of a fungus may be 
associated with a gain or loss of in vitro or in vivo growth, influencing the ability to 
efficiently replicate in the host or to withstand antifungal treatment [64]. Thus, we 
measured the growth rates of individual mutants in the deletion collection in YPD at 
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30°C. For each deletion strain, a relative fitness index [65] was calculated using the 
doubling times from at least two independent cultures of 1-6 independent mutants, and 
compared to the doubling time of all other strains. Notably, we identified 57 deletion 
mutants showing strong variations in relative fitness between independent cultures 
(Supplemental Table S4), all of which were omitted from further analysis along with 
deletions that were present in duplicate. Hence, reproducible fitness data could be 
obtained for 504 unique mutants (representing 1125 deletions). Out of these gene 
knock-outs, 399 had a relative fitness index within two standard deviations (SD) of the 
average relative fitness (Figure 2A, Supplemental Table S5). These data suggested 
that the corresponding genes are not necessary for efficient planktonic growth of C. 
glabrata in YPD at 30°C. However, some 71 strains showed a significant fitness defect 
(doubling time of ≥2 SD below the average fitness). Interestingly, another 34 deletions 
showed a gain in fitness (doubling time of ≥2 SD above the average fitness) under 
these growth conditions (Figure 2A, Supplemental Table S6).  
 Notably, many deletion strains exhibiting fitness defects in vitro also displayed 
obvious alterations to colony and cellular morphology (Figure 2B). Most morphology 
mutants grew as small or large wrinkled or smooth colonies. Microscopic inspection of 
deletion mutants then allowed for further classification of mutant morphologies into 
small round cells (dse2, tos6, ace2, chs3, bni4, cwh41), giant cells with obvious 
structural defects (cdc21, cbk1, kre6), cells with pseudohyphal-like elongated 
morphologies (gin4), and as pearl-string-like cells connected to each other as for dse2 
mutants (Figure 2B). Notably, except for pseudohyphal morphologies [66,67] or small 
round cells for ace2 [23], many of these morphological alterations have not been 
described in C. glabrata to date. 
 
Phenotypic profiling. Fungal pathogens need to adapt to diverse host environments 
and environmental stresses. Relevant stresses include perturbation of cell wall 
integrity, pH and osmostress during phagolysosome maturation, iron or nutrient 
 334 | P a g e  
 
depletion, growth at elevated temperature and exposure to antifungal drugs. An 
efficient adaptation to particular stress conditions may also include formation of 
biofilms. We therefore phenotypically profiled the mutant collection to identify genes 
implicated in the response to host-mimicking adverse conditions such as osmostress. 
Interestingly, we identified remarkably strong osmosensitivity phenotypes caused by 
genes that have not been linked to osmostress in other fungi before, including atm1, 
arb1, kre1, anp1, mps3 and ptr3 (Supplemental Figure S3). Moreover, we scored for 
susceptibilities to the major antifungal drugs fluconazole, voriconazole, amphotericin B 
(AmB) and CF, as well as to the cell wall stressors Congo Red (CR) and Calcofluor 
White (CW). Finally, we also assessed the ability to form biofilms and to grow at 
elevated temperatures. 
 
Biofilm and temperature sensitivity. Biofilm formation on medical devices represents 
a significant risk for invasive infections by Candida spp [68-70]. Hence, mutants in the 
deletion in the collection were scored for their ability to form biofilms. Strains were 
induced to form biofilms in 96-well polystyrene plates in minimal medium at 37°C; the 
biofilm biomass was quantified using a fluorescein diacetate (FDA) accumulation assay 
[71,72]. For each strain, a relative biofilm-forming index was calculated using FDA 
hydrolysis data from at least two independent cultures of the independent deletion 
mutants for each gene  (see Materials and Methods; Supplemental Table S7, S8, S9). 
Independent deletions of the same gene including duplicates showing strong variations 
in relative biofilm formation between independent assays or independent cultures 
(Supplemental Table S7) were omitted from further analysis, leaving 420 deletions for 
which biofilm production was analyzed in detail (Figure 3; Supplemental Table S8). Out 
of these, 341 gene deletions resulted in a relative biofilm forming index within two 
standard deviations (SD) of the average relative biofilm-forming capacity (Figure 3; 
Supplemental Table S9), suggesting that the corresponding genes do not contribute to 
biofilm formation in minimal medium at 37°C. Isolates for the 46 gene deletions that 
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resulted in an alteration in biofilm formation (i.e. a biofilm fitness score 2 SD below or 
above the average relative biofilm-forming index) but not of planktonic growth at 30°C 
were retested in quadruplicate for their ability to form biofilms. Moreover, the planktonic 
growth rate of these strains in minimal medium at 37°C was monitored to assess 
possible effects of the higher incubation temperature on biofilm formation. Notably, a 
number of the corresponding deletions also displayed temperature-sensitive 
phenotypes and may therefore not be solely biofilm-specific. Yet, this analysis identified 
14 gene deletions that resulted in significant defects in biofilm formation and no defect 
in planktonic growth (AVO2, BCY1, CCW12, CCH1, CNB1, DCW1, GAS1, MHP1, 
PKH2, SLM1, SUB1, UTP14, YNL300W, YOR1; Supplemental Table S8). Remarkably, 
we identified 11 gene knock-outs resulting in a gain in biofilm formation without an 
increase in planktonic growth (BPH1, GAL11, GPB2, MIG1, PEX2, SSN2, SSN8, 
STE20, YAP6, YDR134C, YVC1; Supplemental Table S8). Notably, the heat stress 
profiling on plates identified several genes implicated in cell wall biogenesis and 
organization, including CWH41, ALG5, OST3, ALG6, KTR2, BIG1, CBK1, ALG3. 
Interestingly, this gene set showed some overlap with the CF, CR or CW gene clusters 
(Figure 4), suggesting that heat stress triggers a distinct set of partially overlapping 
signaling response pathways, ranging from stress and cell integrity signaling to cell wall 
homeostasis and lipid membrane perturbation. 
 
Susceptibility to azole and AmB antifungals. Azoles and AmB remain the most 
common drugs for treating fungal infections. The reduced azole susceptibility of the 
majority of C. glabrata clinical isolates is considered a major contributor to its clinical 
prevalence [73]. While this is mainly the consequence of transcriptional upregulation of 
the CDR1 and PDH1 (CDR2) encoding membrane efflux pumps or gain-of-function 
mutations in the PDR1 regulator [28], additional mechanisms may play a role. The 
polyene AmB is thought to impair membrane function by binding to ergosterol, resulting 
in cellular leakage of cytoplasm [74]. While C. glabrata can develop AmB tolerance 
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[75,76], the underlying molecular mechanisms remain obscure. We have thus used the 
C. glabrata deletion collection to identify genes modulating azole as well as AmB 
susceptibility. A total of 14 deletions displayed marked hypersensitivities to azoles such 
as fluconazole and voriconazole albeit to a different extent (Supplemental Figure S5-
A,C; Figure 4B). Moreover, 13 deletions were hypersusceptible AmB (Supplemental 
Figure S6-A, Figure 4B). The corresponding mutants were retested using microdilution 
assays to quantify their IC50 values (Supplemental Figure S5-C,D; Supplemental Figure 
S6-B). The majority of the 14 azole-sensitive strains were sensitive to both fluconazole 
and voriconazole (Supplemental Figure S5-C,D), while 6 strains (ktr2, cwh41, ssd1, 
ktr6, hap1 and slt2) appeared more sensitive to voriconazole. Notably, the strain 
lacking the KTR2 gene encoding a mannosyltransferase [77] displayed the most 
significant voriconazole-specific hypersensitivity (Supplemental Figure S5-C,D). As 
expected, deletion of either the PDR1 transcription factor or its target CDR1 efflux 
pump resulted in marked azole hypersensitivity. Interestingly, calcineurin pathway 
mutants such as cna1 and cnb1 also displayed pronounced azole hypersensitivities. 
Several additional signaling mutants (slt2, wsc1, ypk1, cka2), as well as cell wall 
mutants (ktr2, cwh41, ssd1, ktr6) displayed slight to intermediate azole 
hypersensitivities (Supplemental Figure S5-A,B; Figure 4B). Among the 13 AmB-
sensitive strains, the five genes displaying the most pronounced susceptibilities play 
diverse roles in phospho- and sphingolipid signaling, including YPK1, CKA2, DEP1, 
SNF6 and VPS15. 
 
Cell wall stress and CF sensitivity. The fungicidal echinocandins stand out as the 
most efficient clinically used drugs that block cell wall glucan biogenesis. Thus, we 
subjected the deletion collection to profiling for susceptibilities to caspofungin (CF), as 
well as other cell wall stressors such as CR and CW (Figure 4, Figure 5, Supplemental 
Figure 7). A total of 12 mutants were strongly hypersensitive to CR, and six to CW 
(Figure 4A; Supplemental Figure S7-BC). Unsurprisingly, deletion of genes encoding 
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functions implicated in cell wall integrity or polarity (PSA1, KRE1, CWH41, OST3, 
KTR2, MNN10, ANP1, CBK1) conferred hypersensitivity to CR and/or CW. Strikingly, 
we identified 48 mutants with altered CF susceptibilities (Figure 4A,B), 38 of which 
were strongly hypersensitive, while another 9 were mildly CF-sensitive, including 
MET31, RTG3, OST3, KTR1, YFH1, TNA1, ATM1, SNF6, CRZ1 (Figure 4, 
Supplemental Figure 9).  
To identify the functionally overlapping mutants, we used hierarchical clustering 
of stress-induced phenotypes, including heat, CF, CR and CW, identifying some 106 
putative chemical-genetic interactions (Figure 5). The clustering approach identified 
three subsets of deletion mutants displaying distinct but partially overlapping 
hypersensitivities to high temperature, CR, CW and CF (Figure 5). Remarkably, the 
profiling analysis revealed some 28 novel CF tolerance genes, none of which had 
previously been associated with echinocandin hypersensitivities in S. cerevisiae, C. 
albicans or in other fungal pathogens (Figure 4, Figure 5). Notably, the group of genes 
affecting CF sensitivity was highly enriched in genes operating in the PKC cell integrity 
signaling pathway (WSC1, SLT2, BCK1, MKK1), in calcium / calcineurin signaling 
(CNA1, CNB1, MID1, CCH1), general cell wall homeostasis, including mannosylation 
and glycosylation (MNN10, ANP1, MNS1, MNT3, PMT2, PSA1, KRE2), as well as 
transcriptional regulators (RLM1, DEP1, POP2, SPT3, MCM1, SIP3, SNF1). 
Interestingly, deletion of several genes encoding components of the chromatin and 
histone modification machinery (RPD3, HEK2, MPS3, SDS3, SIN3, ASF1) also 
modulated CF susceptibility, suggesting an important regulatory role for chromatin in 
controlling surface homeostasis and CF susceptibility, as recently demonstrated for the 
C. albicans Hat1 acetyltransferase [78]. The removal of only three genes (WSC1, 
CNB1 and CNA1) resulted in sensitivity to all three cell wall stressors (Figure 4A), 
confirming the pivotal roles PKC and calcineurin signaling pathways play in sensing 
and maintaining cell wall homeostasis in fungal pathogens [35,79,80].  
 338 | P a g e  
 
Discussion 
C. glabrata is an important human fungal pathogen, and after C. albicans, the second-
most frequent cause of candidiasis, causing 15-30% of infections in humans [1-4]. 
Although C. glabrata appears similar to S. cerevisiae concerning gene synteny and 
conservation it is an obligate haploid, and the lack of a sexual cycle and elevated rates 
of non-homologous recombination have prevented a systematic genetic analysis. 
Importantly, the decreased sensitivity of C. glabrata clinical isolates to azoles 
antifungals is at least in part responsible for its clinical significance [32]. To address 
these issues, as well as to better understand virulence properties, we have generated a 
genome-scale deletion collection of C. glabrata. This deletion mutant collection 
comprising 619 unique strains each lacking a single gene has several advantages over 
known transposon-based mutant collections [81], since each ORF is completely 
removed. Thus, gene dosage effects or dominant phenotypes from truncated protein 
variants are excluded. Likewise, aberrantly expressed proteins due to insertion in 
promoters, which may result in partial loss or gain-of-function for the corresponding 
gene product, are precluded. The deletion collection was subjected to extensive 
phenotypic profiling, with a particular emphasis on susceptibility to major antifungal 
drugs, growth and morphology phenotypes, stress response pathways, cell wall 
biogenesis as well as biofilm formation, which has been associated with the initiation 
and development of candidiasis [82]. Importantly, we show here the feasibility to 
generate a genome-scale bar-coded gene deletion library in C. glabrata, revealing 
novel genes contributing to fitness, biofilm formation, antifungal drug resistance and 
several genes implicated in general cell wall homeostasis. We found a large number of 
mutants sensitive to at least one of the tested conditions. About 21% of the mutants 
display altered fitness and about 19% show alterations in biofilm formation, while only 
2% exhibit abnormal cell and colony morphology. Approximately 15% of the mutants 
show severe stress-related phenotypes, including hypersensitivity to several antifungal 
drugs, heat and osmostress conditions.  
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General fitness defects and biofilm formation. C. glabrata and S. cerevisiae are 
phylogenetically related [51]. Hence, many orthologous gene functions may have been 
conserved between the two species. Remarkably however, several mutants with 
reduced or increased fitness in rich media corresponded to genes whose inactivation in 
S. cerevisiae resulted in entirely different or opposing phenotypes. These include 
homologous genes from the RAS-PKA pathway (RAS2, GPA2 and GPR1) and genes 
involved in N-glycosylation and outer chain elongation (ALG5, KTR2 and MNN4). 
Moreover, several genes known to be essential in S. cerevisiae were non-essential in 
C. glabrata, although their inactivation often confers reduced fitness or morphology 
defects. These include MEC1, encoding a master DNA damage checkpoint kinase [83], 
and CBK1, although the latter is only essential in the yeast background S288c [84]. 
CBK1 encodes a RAM network kinase that is central to the establishment of cell 
polarity and involved in septum formation and cell separation and morphogenesis [85-
88]. Notably, inactivation of the orthologous genes in C. albicans is not lethal [88-90]. 
Hence, Mec1- and Cbk1-dependent regulatory networks may operate differently 
between S. cerevisiae and C. glabrata and, possibly, other hemiascomycetous yeasts. 
Many biological processes and regulatory networks in fungi have evolved under distinct 
evolutionary pressures [91,92]. Because Candida spp have evolved as opportunistic 
pathogens of mammals, including humans, it is fair to propose that adaptation to the 
host environment and immunity surveillance may have been driving the evolution of 
functionally rewired genetic regulatory networks [93]. Finally, and as expected, mutants 
with altered abilities to form biofilms are enriched for cell wall-related genes. Notably, 
the biofilm mutant lacking the putative kinase gene PKH2/CAGL0I07513g, whose 
orthologue in S. cerevisiae encodes a component of the alternative cell wall integrity 
pathway, has two additional paralogues in C. glabrata, namely CAGL0G04609g and 
CAGL0K06479g. While pkh2 mutants are defective in both biofilm formation and 
growth on solid media, lack of the other two paralogues leaves biofilm formation or 
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growth on solid media unaffected (data not shown). Thus, these data suggest that 
apparent PKH kinase homologues in C. glabrata have acquired some specialization 
concerning their roles in the sensing of cell integrity. 
 
Antifungal drug sensitivity. We generated the first chemical-genetic profile of C. 
glabrata relevant to the understanding of drug susceptibilities in vitro. In addition to 
known genes implicated in azole resistance (PDR1, CDR1, PDH1), the profiling for 
azoles revealed only small number of novel genes (YPK1, KTR2) mediating azole 
tolerance, with KTR2 even showing a significant a azole-specificity for voriconazole. 
These data imply that C. glabrata utilizes a limited set of mechanisms to mount azole 
resistance, with ABC transporter-mediated efflux by Cdr1 and Pdh1 being the most 
important one in vitro and in vivo [64].  
The results from our screen showed some overlap with phenotypic screens in 
S. cerevisiae [94] and C. albicans [95] regarding sensitivity to CF, which belongs to the 
family of the fungicidal echinocandin drugs that inhibit the fungal 1,3-β-D-glucan 
synthase. Out of 38 mutants showing strong alterations in echinocandin sensitivities, 
16 correspond to genes whose orthologues in baker’s yeast and in Candida spp (at 
least for FKS1) have been linked to CF tolerance [35,94-96]. Hyperresistance to 
echinocandins can result from mutations in the glucan synthase genes FKS1 or FKS2 
[34], as well as through the PKC pathway that mediates CF tolerance in S. cerevisiae 
[63] and C. albicans [97]. Accordingly, wsc1, slt2, mkk1, bck1, rlm1 and fks1 mutant 
cells, all lacking key genes of this central pathway, are also hypersensitive to CF in our 
assays. Despite the apparent differences between species, this overlap validates the 
phenotypic profiling to identify genes relevant for echinocandin susceptibility. 
Intriguingly, 23 genes whose deletion resulted in marked hypersensitivity to CF in C. 
glabrata have not previously been associated with CF susceptibility in yeast or any 
other fungal pathogens or heterozygous mutant collections from C. albicans [95]. While 
determining CF hypersensitivity phenotypes can be challenging, because many mutant 
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strains with aberrant cell morphologies (cdc12, ace2, fkh2, cbk1) or strong growth 
fitness defects (kre6) interfere with CF spot assays, our data clearly identify novel 
genes implicated in CF tolerance.  
Interestingly, cells lacking chitin synthesis genes such as CHS1 were also 
hypersensitive to the glucan synthase inhibitor, which is in line with reports from yeast 
[95], and recent data from C. albicans showing a role for chitin in regulating cell wall 
susceptibility to CF [98,99]. Likewise, the absence of calcineurin subunit genes CNA1 
or CNB1 leads to CF hypersensitivity, indicating that calcineurin signaling is necessary 
for buffering or compensating cell wall stress, perhaps by affecting FKS1 transcript 
levels through the transcription factor Crz1 [34]. In the mould Aspergillus fumigatus, a 
mutation or inhibition of calcineurin enhances the antifungal potency of CF [100]. Thus, 
calcineurin inhibitors may exert synergistic effects on cell wall mutants in other fungal 
species. The impact of CF on calcium signaling in C. glabrata is further confirmed by 
the hypersensitivity of mutants lacking CCH1 and MID1, both of which encode stress-
induced calcium channel proteins.  
In S. cerevisiae, the Ypk1-mediated signaling pathway, which is activated by 
lipid-sensing [101], constitutes an alternative cell integrity signaling pathway connected 
to the classical PKC pathway [102,103]. Remarkably, C. glabrata cells lacking YPK1 
and PKH2 are CF-hypersensitive, suggesting that the Ypk1-mediated signaling plays a 
major role in regulating CF tolerance or cell wall homeostasis in C. glabrata (Figure S4, 
Supplemental Figure S9). Taken together, these results indicate that C. glabrata 
employs several signaling pathways to respond to CF-induced cell wall damage and 
the required subsequent cell wall remodeling. It is therefore not unexpected that 
mutants displaying CF hypersensitivities include genes that affect trafficking of proteins 
or surface carbohydrate homeostasis, including chitin deposition and biogenesis. 
Genes implicated in the susceptibility to both CF and azoles include those 
encoding the calcineurin subunits Cna1 and Cnb1 and the PKC pathway components 
Wsc1 and Slt2. These results confirm that both pathways are necessary for a response 
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to both drug classes and are consistent with data showing the synergistic action of 
calcineurin inhibitors and azoles or CF [35,80,104-106]. Comparison of azole-sensitive, 
AmB-sensitive and CF-sensitive mutants show that only a small number of gene 
deletion strains are susceptible to all three or to at least two compounds, which is 
consistent with their distinct mechanism of action. Notably, deletions that confer 
sensitivity to all three drugs occur in genes that may encode general stress sensing 
kinases such as Ypk1 and the mRNA-binding protein Ssd1, which is thought to control 
expression of surface genes in concert with Cbk1 [107-111]. Interestingly, the function 
of Ypk1, a mammalian SGK kinase homologue [112], remains unclear in C. glabrata. It 
is tempting to speculate though that Ypk1 is part of a distinctly wired kinase network 
implicated in regulating membrane perturbations, drug sensitivity and lipid-mediated 
stress signalling [92,113]. 
 AmB is thought to interfere with normal membrane bilayer function by forming 
complexes with ergosterol [114]. Indeed, cells deficient in membrane biogenesis or 
organelle dynamics may show a synthetic fitness loss upon perturbation of the lipid 
composition, potentially explaining the AmB hypersensitivity of snf7, vps15 and sla1 
mutants. A similar reason may explain the sensitivity of cells lacking DEP1, which, in S. 
cerevisiae, regulates transcription of structural phospholipid biosynthesis genes [115]. 
Notably, the profiling analysis reveals a strong genetic interaction between AmB action 
and genes implicated in cell wall function. AmB-sensitive strains include mutants 
lacking KRE1 and SAC7, which encode proteins implicated in glucan homeostasis, as 
well as KTR6, KTR2, CWH41, whose products affect surface protein glycosylation. 
Remarkably, the latter three mutants show pronounced azole hypersensitivity, 
demonstrating a direct link between membrane lipid perturbation, cell wall function and 
antifungal sensitivity. 
The hierarchical clustering of stress-induced phenotypes caused by heat, CF, 
CR and CW, identifies some 106 putative chemical-genetic interactions (Figure 5). We 
expected to discover distinct patterns for each compound, since CR and CW mainly 
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affect cell wall structure and composition, whereas CF targets Fks1. Remarkably 
though, all compounds strongly activate cell integrity signaling, which together drives 
cell wall remodeling and regulates surface homeostasis. Accordingly, the CF profile 
was enriched for genes involved in cell wall organization, signaling and transcriptional 
regulators, reflecting the activity of CF as an inhibitor of fungal cell wall biosynthesis 
(Figure 4). Only a few genes in the CF cluster overlap with genes associated with CR 
and CW sensitivity (Figure 4A), most of which are involved in stress and cell wall 
signaling (CNA1, CNB1, WSC1) or cell wall biogenesis (KRE1, PSA1, ANP1, MNN10), 
indicating that several distinct signaling pathways must cooperate to ensure 
maintenance of a functional cell wall under various adverse conditions.  
Importantly, we identify numerous novel genes, whose function may have C. 
glabrata-specific roles in drug susceptibility and cell wall integrity signaling. Because 
the phenotypes are in general hypersensitivities, these data suggest that at least some 
of these genes may turn out as feasible targets for drug discovery. The discovery of a 
large number of deletion mutants affecting CF tolerance expands our knowledge about 
plausible mechanisms regulating CF sensitivity. For example, the fact that several CF-
sensitive mutants are implicated in exocytic delivery of cell wall components such as 
chitin, glucan or mannan, implies a constant cross-talk of distinct signaling pathways to 
control proper cell wall remodeling upon CF-induced surface damage. As the number 
of chemical-genetic and genomic data in baker’s yeast [42,43] is steadily increasing, 
our data add novel information concerning the function of related genes in an important 
human fungal pathogen. Hence, these data represent an important contribution 
towards a better understanding of drug resistance mechanisms, as well as species-
specific differences.  
These large-scale phenotypic profiling data also demonstrate the power of the 
C. glabrata knock-out collection, which is, in addition to the C. albicans and C. 
neoformans collections [47,50], to the best of our knowledge, among the three largest 
academic deletion collections for a human fungal pathogen. This library will facilitate 
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studies on novel virulence factors and other aspects of C. glabrata pathogenicity. The 
use of unique sequence tags, which were adopted from the S. cerevisiae gene deletion 
collection [40], allows for the functional analysis of single gene functions in vitro and in 
vivo [47,50]. The use of auxotrophic marker genes [57] do not affect in vivo 
dissemination of strains in standard mouse models of fungal virulence. The design of 
recipient strains will even enable to study genetic interactions and pathway epistasis 
through double and triple mutants. Moreover, in vivo organ-tropism and colonization, as 
well as virulence can be assessed in different infection models. Notably, screens of the 
collection in animal models and the understanding of virulence phenotypes (or lack 
thereof) can be challenging and laborious requiring a very large number of animals, 
due to the potential impact of fitness defects on growth in vivo or possible genetic 
redundancy. We suggest that interpretation of virulence phenotypes will be aided by 
the in vitro phenotypic analysis presented here, permitting correlation of in vitro 
phenotypes and in vivo fitness effects for C. glabarata. 
Similar to existing C. albicans [47] or C. neoformans [50] collections, the C. 
glabrata mutant library constitutes a valuable tool for the fungal research community to 
study the function of virulence and drug resistance genes in C. glabrata. In view of 
rapid changes in the epidemiology of fungal infections, with C. glabrata infections 
showing ever-increasing clinical importance reaching up to 30% prevalence in some 
countries [32,116], this work is the first large-scale contribution to the systematic 
analysis of mechanisms implicated in antifungal drug resistance and C. glabrata 
pathogenicity. Notably, much of the previous work aimed at unraveling the molecular 
basis of drug resistance mechanisms in C. glabrata have been based on what is known 
from baker’s yeast [94,117] or other Candida pathogens [95]. Although gene synteny 
has been largely conserved between pathogenic an non-pathogenic yeasts such as C. 
glabrata and S. cerevisiae, extensive rewiring of signaling pathways generated distinct 
and species-specific functions for seemingly orthologous genes. Indeed, our work 
clearly demonstrates that comparing and predicting drug resistance or virulence 
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phenotypes for C. glabrata based on data from even related yeasts requires extensive 
experimental verification and the use of loss-of-function approaches. This fungal 
pathogen deletion collection will pave the way for these future efforts. 
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Materials & Methods 
Ethics Statement - The use of clinical C. glabrata isolates was approved through 
respective ethics committees according to national regulations. 
 
Media and growth conditions. YPD (1% yeast extract, 2% peptone, 2% dextrose) 
media were prepared as described elsewhere [118]. Synthetic complete (SC) medium 
contained 0,67% YNB, 2% glucose supplemented with 1xCSM (ForMedium; complete 
synthetic mixture) containing histidine, tryptophane and leucine, which are required for 
growth of the deletion strains. Plates contained 2% agar.  
 
Bioinformatic analysis and gene selection. Genes of different functional categories 
were manually selected based on potential function in virulence and drug resistance. 
The categories involved genes of signalling pathways, kinases, ABC transporters and 
permeases, GPI-anchored proteins, cell wall associated genes, genes involved in 
glycosylation, phospholipid biosynthesis, histone modification, iron metabolism, and 
several genes with no obvious homologue in S. cerevisiae. The genes were selected 
by their homology to S. cerevisiae based on these functional categories (SGD 
annotations; http://www.yeastgenome.org/). C. glabrata orthologues of the selected 
genes were first identified using a BLAST approach. The three best-aligned hits for 
each gene were saved and the C. glabrata homologue with the highest P-value was 
arbitrarily defined as the C. glabrata orthologue of a given gene in baker’s yeast and 
named accordingly.  In addition, a complete catalogue of orthology and paralogy 
relationships between C. glabrata genes and their homologues in 16 other fully-
sequenced fungi was derived using a phylogenetic approach [119]. For this a complete 
collection of Maximum Likelihood phylogenetic trees for all C. glabrata genes, the so-
called phylome, was generated using the automated pipeline described elsewhere 
[120]. Gene phylogenies, alignments and orthology and paralogy predictions are 
publicly available through PhylomeDB (www.phylomedb.org).  
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Primer design and generation. Oligonucleotide sequences for generation of the 
deletion cassettes and strain verification were automatically designed, using a custom-
written Perl script called PrimerList (W. Glaser, unpublished data). PrimerList utilizes 
Bioperl to read and process nucleotide sequences and uses the EMBOSS [121] 
programs eprimer 3 and stssearch to find suitable primersets. Details on parameters 
used by PrimerList for primer design are found in Supplemental Table 1. For PCR-
based generation of knock-out constructs, upstream and downstream fragments for 
genomic recombination were chosen to have a size between 450 and 550 nucleotides. 
5’5’ (forward) and 3’3’ (reverse) primers were chosen to have a length of 20 to 30 bp, a 
GC content between 30 and 60% and a melting temperature of 50°C ± 4°C with a GC 
clamp. 5’3’, 3’5’ primers were chosen to have a length of 20 to 30 bp plus the 20 bp 
constant overlap sequence (Fig. 1, Supplementary Table S2, ‘barcode sequence 
sheet’), a GC content between 30 and 60% and a melting temperature of 50°C ± 4°C. 
5’3’ (reverse), 3’5’ (forward) primers were chosen to bind exactly adjacent to the coding 
sequence, including the start codon ATG or the stop codon, respectively. 5c and 3c 
control primers have a length of 20 to 25 bp, a GC content between 40 and 60% and a 
melting temperature between 50°C to 60°C. The product size of the control PCR is 
between 750 and 900 bp. Internal control primers (5i and 3i) were designed to bind 
inside the coding sequence and to give a product of 400 to 500 bp in size. The primers 
have a length of 20 to 25 bp, a GC content between 40 and 60% and a melting 
temperature between 55°C to 60°C. Oligonucleotides were commercially purchased in 
96-well plate format (Eurogentec, Belgium). Six plates were needed for each set. Each 
of the six plates (5’5’, 5’3’, 3’5’, 3’3’, 5c, 3c) contained the primers for a specific gene at 
the exact same well position. 
 
Generation of gene deletion cassettes by fusion PCR. The dominant marker NAT1 
was amplified from plasmid pJK863 [54] using the primers fp_NAT1-U2 and rp_NAT1-
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D2 to add the constant 20 bp sequences U2 and D2. The PCR product was ligated into 
a pGEM-T vector (Promega), generating plasmid pTS50. For the fusion PCR step, 
deletion cassettes were generated using a modified fusion PCR protocol [48]. Briefly, 
500bp long flanking homology regions were amplified from ATCC2001 genomic DNA 
with primer pairs 5’5’/5’3’ and 3’5’/3’3’ adding the constant overlap sequence (U1/D1) 
of 20 bp and purified by ethanol precipitation. The conditions for a 50 µl reaction were 
as follows: 1x Taq buffer (50 mM KCl, 10 mM Tris-HCl (pH 9.0, 25°C), 0.1% TritionX-
100, 1.5 mM MgCl2), 0.2 µM dNTPs, 0.5 µM each primer, 1 µl Taq-Polymerase and 
genomic wild type DNA from strain ATCC2001; 93°C for 5 minutes, 35 cycles 93°C for 
30s, 45°C for 30s, 72°C for 90s, finally 10 minutes at 72°C.  
The dominant marker NAT1 was amplified from plasmid pTS50 in a separate 
PCR reaction using primers 5M and 3M, adding unique barcode tags and constant 
complementary U1 and D1 sequences. Marker fragments wer gel-purified in 0.7% 
agarose gels. The conditions for a 50 µl reaction were as follows: 1 x Taq buffer, 0.2 
µM dNTPs, 0,5 µM each primer, 1 µl Taq-Polymerase and plasmid TS50; 93°C for 3 
minutes, 32 cycles 93°C for 30s, 49°C for 30s, 72°C for 2,5 minutes, finally 10 minutes 
at 72°C. Fusion PCR was carried out in a 50 µl volume with the same conditions as 
above: 1x ExTaq buffer, 0.2 µM dNTPs, 0.5 µM each primer, 0.5 µl ExTaq-Polymerase 
(TaKaRa) and 3 µl marker fragment, 1.25 µl each flanking homology fragment; 93°C for 
3 minutes, 35 cycles 93°C for 30s, 45°C for 30s, 72°C for 3 minutes, finally 10 minutes 
at 72°C. The final deletion construct was purified by ethanol precipitation. 
 
Transformation of C. glabrata by electroporation. For transformation of the 
background strain HTL, we used a modified electroporation protocol [53]. Aliquots of 50 
ml of a C. glabrata culture in YPD at an optical density of 600nm (OD600) of 1.3 were 
harvested, washed with H2O, resuspended in 1x TE buffer, 100mM LiAc and incubated 
at 30°C for 30 minutes with slow shaking (130xrpm). After addition of 250 µl 1M DTT 
and further incubation at 30°C for 60 minutes (130xrpm), 40 ml of H2O were added and 
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the cells were harvested at 1000g for 5 minutes at 4°C. The cells were washed with 25 
ml H2O, subsequently with 5 ml 1 M cold sorbitol, finally resuspended in 550 µl 1 M 
sorbitol and kept on ice until use. Sterile electroporation cuvettes were precooled on ice 
and loaded with a mix of 40 - 45 µl electrocompetent cells and 5 - 10 µl linear DNA 
deletion construct (app. 2 - 3 µg DNA). Cells were left on ice for 10 minutes and 
electroporation was carried out with a BioRad GenePulser (200Ω, 1.5kV, 25µF). For 
recovery, 950 µl YPD was added and cells incubated for 4 h shaking at 30°C, before 
plating on YPD supplemented with 200 µg/ml Nourseothricin (Werner Bioagents, Jena). 
The plates were incubated for 48 hours at 30°C.  For auxotrophic marker constructs the 
cells were recovered for 1 h at 30°C before plating on selective SC medium. 
Transformants were patched on YPD/Nourseothricin plates for colony PCR. For 96-well 
parallel electroporation, 300 ml of culture were grown to OD600 of 1.3, split into 50 ml 
aliquots and treated as described above. For electroporation, we used a BTX Harvard 
Apparatus ECM630 electroporation device with a HT-100 plate handler. 
 
Verification by yeast colony PCR. Strains were verified by colony PCR and “loss-of-
gene” PCR according to the following protocol (Figure 1B). Transformants were 
patched on selective plates and incubated at 30°C for 24h. Cells were resuspended in 
40 µl PCR mix 1 (0.2µM dNTPs, 0.5 µM of each gene specific primer 5c/3c up-
/downstream of the homology region and marker specific primer 5M/3M) and heated for 
10 minutes at 93°C. After cooling on ice, 10 µl polymerase mix (5 µl 10 x PCR buffer 
and 1 µl Taq-Pol.) were added per reaction and a regular PCR was performed (93°C 
for 5 min, 25 cycles 93°C for 30s, 45°C for 30s, 72°C for 90s, final 10 min 72°C). To 
verify the loss of the coding sequence (CDS), colony PCR was essentially performed 
the same way. Oligonucleotides used to screen for CDS loss bind inside the CDS to 
generate a product of 500 bp. All internal primers were also checked for functionality in 
a separate PCR reaction, amplifying the fragment from genomic wild type DNA. 
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Phenotypic profiling. For phenotypic analysis of the deletion collection, mutant cells 
were re-streaked from frozen stocks and grown for 48 h at 30°C on fresh YPD plates. 
Each of the three plates containing independent transformants of the same set of 
genes was arrayed into a 384-spot format serving as source plates. Phenotypic 
profiling of the deletion collection was performed using a robot on YPD plates (RoToR 
HDA, Singer Ltd., Roadwater, UK) or by manually spotting (two 1:10 dilutions from 24h 
culture in SC) on SC plates supplemented with the compounds to be tested. Plates 
were routinely incubated at 30°C for up to 3 days and scanned photographed with S&P 
Imaging system (S&P Imaging, Canada), after 24, 48 and 72h for documentation. 
Primary hits were manually rescreened for confirmation in 1:10 serial dilutions. 
Exponentially growing cells were adjusted to an OD600 of 0.1. Equal volumes of serial 
dilutions (1:10, 1:100 and 1:1000) were spotted on YPD plates containing drugs and 
incubated as described above.  Hypersensitive mutants identified as primary hits by 
robotic screening were independently re-screened manually in 96-well format, to verify 
growth phenotypes on agar plates containing various concentrations of xenobiotics. All 
manual re-screening assays were carried out independently at least in biological 
triplicates in four different laboratories, including the confirmation of hits by serial-
dilution spot assays on agar plates or as appropriate by microdilution assays in liquid 
cultures.  
 
Azole and drug susceptibility screenings. Azole susceptibility screenings were 
carried out by a modified endpoint method [122] in liquid culture in microtiter plates, 
using the following drug concentrations: 4 µg/ml Fluconazole, 0.1 µg/ml Voriconazole, 
0.1 µg/ml Ketoconazole, 0.1 µg/ml Itraconazole (all azoles from Discovery Fine 
Chemicals), 3 µg/ml AmB (Discovery Fine Chemicals), 5 µg/ml 5-Flucytosine (Sigma-
Aldrich). Cells were grown overnight in deep well plates to stationary phase, diluted 
100-fold in sterile water and 100 µl suspension mixed with 100 µl of 2 x YPD containing 
a 2 x drug concentration (app. 105 cells/well). After incubation at 30°C for 24 h and 48 
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h, cells were resuspended and the OD600 was measured with a Victor plate reader 
(Perkin Elmer, USA). Finally, we added 120 ng/ml CF, 50 μg/ml CW (Sigma-Aldrich) or 
250 μg/ml CR (Sigma-Aldrich) as supplements to media from sterile stock solutions 
after autoclaving. Plates were routinely incubated at 30°C for up to 3 days and 
documented every 24h. 
 
Microbroth dilution assay for IC50 determination. To determine the IC50 of 
antifungal drugs a modified protocol of the microbroth dilution assay was used [123]. 
Briefly, an overnight culture was diluted 1:100 in YPD, regrown to an OD600 of 1 and an 
inoculum of 2.5 x 104 cells/ml was prepared. Antifungal stock solutions were prepared 
in DMSO. Two fold serial dilutions of the drugs were then prepared in water in a deep 
well plate and stored at -20°C until use. 100 µl of two fold serial drug dilutions were 
distributed in triplicates into a flat bottom microtiter plate. The last wells free of 
antifungal drugs served as a growth control. After adding 100 µl of the inoculum (200 µl 
total volume), plates were incubated at 30°C for 24h and 48h in a humid environment 
to avoid evaporation. OD600 was determined with a plate reader. Endpoint readings 
were set as the antifungal concentrations, causing at least 90% growth inhibition after 
24 h of growth when compared to the control. The IC50 was determined by linear 
regression using Graph Pad Prism software. 
 
Fitness analysis. Growth curves were performed in 96-well plates in a Tecan Infinite 
M200 microplate reader or a Tecan Sunrise microplate reader. C. glabrata strains were 
grown in YPD at 30°C. For each 96-well plate, the doubling times of each of the 96 
tested strains were calculated based on the time necessary for a given strain to go 
from OD 0.15 to OD 0.6. The relative fitness of a strain was then calculated as the ratio 
of the average doubling time of all strains within the third to eighth deciles to the 
doubling time of the strain of interest [65]. Means and standard deviations are 
presented for fitness values determined for one or two independent knock-out mutants 
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in two biological replicates. Strains with standard deviation above 0.1 or an absolute 
difference between the relative fitness of two independent knock-out mutants above 0.1 
were not considered further. In order to identify among the remaining strains those that 
showed significantly increased or decreased fitness, the average and standard 
deviation of the fitness for strains within the second to ninth deciles were calculated. 
Strains were classified based on the number of standard deviation between their 
fitness and the average fitness. Strains with decreased fitness had a fitness at least 
two standard deviations below the average fitness. Strains with increased fitness had a 
fitness at least two standard deviations above the average fitness. 
 
Biofilm formation assays. Biofilms were produced in 96-well plates as previously 
described [72]. Briefly, saturated cultures in YPD were pin-inoculated diluted in 100 µl 
SD 0.4% glucose medium in 96-well polystyrene plates and incubated at 37°C for 24 h. 
The 96-well plates were then washed with PBS using a HydroFlex platform (Tecan) 
and 100 µl of a 1X FDA solution (50X stock: fluorescein diacetate, 2 g l-1 in acetone; 
diluted to 1X in PBS) was added per well [71]. Plates were wrapped in aluminium foil 
and incubated for 1 h at 37°C before measuring fluorescence in a Tecan Infinite M200 
microplate reader using an excitation filter of 486±9 nm and an emission filter of 
535±20 nm. The relative biofilm fitness of a strain was then calculated as the ratio of 
the OD535nm recording for the strain of interest to the average of the OD535nm recordings 
obtained for strains within the third to eighth deciles of all OD535nm recordings obtained 
within the 96-well plate to which the strain of interest belonged. Means and standard 
deviations are presented for fitness values determined for one or two independent 
knock-out mutants in two biological replicates. Strains with standard deviation above 
0.3 or an absolute difference between the 2-4 relative biofilm fitness values above 0.5 
were not considered further. In order to identify among the remaining strains those that 
showed significantly increased or decreased ability to form biofilm, the average and 
standard deviation of the relative biofilm fitness for strains within the second to ninth 
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deciles were calculated. Strains were classified based on the number of standard 
deviation between their biofilm fitness and the average biofilm fitness. Strains with 
decreased biofilm fitness had a relative biofilm fitness at least two standard deviations 
below the average relative biofilm fitness. Strains with increased biofilm fitness had a 
relative biofilm fitness at least two standard deviations above the average fitness. 
Strains with decreased or increased biofilm fitness were further evaluated by 
performing a biofilm assay in quadruplicate for each of two independent isolates. Data 
obtained for the 58 candidate strains were compared to those obtained for wild type 
isolates (96 independent values) using the Wilcoxon test. A p value below 0.01 was 
considered as indicative of a significant difference with the wild type strain. In this 
assay, a yak1∆ mutant was found significantly impaired in biofilm formation while a 
sir3∆ mutant showed significantly elevated biofilm production as previously shown [72].
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Figure Legends 
 
Figure 1. Generation of C. glabrata mutants and systematic phenotypic analysis. 
(a) Generation of gene deletion constructs by fusion PCR using the dominant 
selectable marker NAT1. A set of two times 96 unique barcode sequences was 
integrated in oligonucleotides to amplify the marker fragment and to add overlap 
sequences. (b) Transformants were verified by colony PCR for correct integration on 
the 5’ and 3’ junction and checked for absence of the target ORF. (c) Overview of the 
construction of the gene deletion strain library. Primer design and deletion fragment 
construction. For PCR-based generation of knock-out constructs, upstream and 
downstream fragments for genomic recombination were chosen to have a size 
between 450 and 550 nucleotides. 5’5’ (forward) and 3’3’ (reverse) primers were 
chosen to have a length of 20 to 30 bp, a GC content between 30 and 60% and a 
melting temperature of 50°C ± 4°C with a GC clamp. 5’3’, 3’5’ primers were chosen to 
have a length of 20 to 30 bp plus the 20 bp constant overlap sequence (Figure 1, 
Supplemental Table S2, ‘barcode sequence sheet’), a GC content between 30 and 
60% and a melting temperature of 50°C ± 4°C. 5’3’ (reverse), 3’5’ (forward) primers 
were chosen to bind exactly adjacent to the coding sequence, including the start codon 
ATG or the stop codon, respectively. 5c and 3c control primers have a length of 20 to 
25 bp, a GC content between 40 and 60% and a melting temperature between 50°C to 
60°C. The product size of the control PCR is between 750 and 900 bp. Internal control 
primers (5i and 3i) were designed to bind inside the coding sequence and to give a 
product of 400 to 500 bp in size. The primers have a length of 20 to 25 bp, a GC 
content between 40 and 60% and a melting temperature between 55°C to 60°C. 
Oligonucleotides were commercially purchased in 96-well plate format (Eurogentec, 
Belgium). Six plates were needed per set. Each of the six plates (5’5’, 5’3’, 3’5’, 3’3’, 
5c, 3c) contained the primers for a specific gene at the exact same well position. 
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Figure 2. Relative fitness distribution and morphology of C. glabrata gene 
deletion strains. (a) Wild type and mutant strains were grown in rich medium at 30°C 
and doubling times were recorded. The median doubling time of the wild type C. 
glabrata ATCC2001 strain under these conditions was 63.9 min while the median for 
mutant strains was 68.1 min. For each strain, the relative fitness was calculated using 
doubling times from at least two independent cultures of 1-6 independent mutants. 
Strains that showed strong variations in relative fitness between independent mutants 
or independent cultures were omitted from further analysis (Supplemental Table 6). 
Data were obtained for 551 knock-out mutants (Supplemental Table 5). (b) Colony and 
cell morphologies of C. glabrata deletion strains. Different types of distinct cell and 
colony morphologies were found. Cell morphology classes: ellipsoid (a), chains (b, f, g, 
i, k, l), elongated (c, d), large clumps (d, j, m, n), round (e), large and round (h); colony 
morphologies: smooth (a, b, c, e, f, g, i), small (h), slightly wrinkled (k, l), wrinkled (d, j, 
m, n). WT = HTL background strain; white bars correspond to 10 µm.  
 
Figure 3. Relative biofilm fitness distribution. Wild type and mutant strains were 
induced to form biofilms in 96-well polystyrene plates in minimal medium at 37°C and 
the biofilm biomass was quantified using fluorescein diacetate (FDA). For each strain, a 
relative biofilm fitness was calculated based on FDA hydrolysis data from at least two 
independent cultures. Data were obtained for 420 knock-out mutants (Supplemental 
Table S8). Strains that showed strong variations in relative fitness between 
independent mutants or independent cultures were omitted from further analysis 
(Supplemental Table 8).  
 
Figure 4. Classification of C. glabrata chemogenetic profiles. (A) Overlap between 
the chemical-genetic profile of CF (38 genes), CR (12 genes) and CW (6 genes). 28 
genes (labeled in bold letters) were novel CF tolerance genes, since they have not 
been previously associated with echinocandin hypersensitivity in S. cerevisiae or C. 
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albicans. (B) Overlap between the chemical-genetic profile of CF, azoles and AmB. 61 
genes displayed an increased sensitivity to CF (39 genes plus 9 genes with weak 
sensitivity), azoles (14 genes; fluconazole and voriconazole) and AmB (13 genes). The 
mutant strain collection was screened in a 96 well microplate format using an endpoint 
assay and medium was supplemented with 5 µg/ml fluconazole, 100 ng/ml 
voriconazole and 1,5 µg/ml AmB. The OD600 was determined after 24 and 48 hours of 
incubation at 30°C. Grey-colored genes only display a weak sensitivity phenotype or 
were excluded from further analysis due to strong variations in the screening. Nodes 
represent compounds or genes and edges indicate chemical-genetic interactions. 
Gene nodes are color-coded according to GO annotation. Venn diagrams summarize 
distribution of genes affecting resistance to one of the three compounds. 
 
Figure 5. Clustering of susceptibility data of the C. glabrata gene deletion 
collection. The set of mutants was screened on plates for hypersensitivity to four 
distinct stress conditions (CF, CR, CW and 42°C heat stress) using serial dilution 
assays on agar plates. (A) Two-dimensional hierarchical cluster plot of chemical-
genetic profiles. On the horizontal axis genes are listed and stress conditions on the 
vertical axis. Interactions are shown in yellow depending on the degree of growth 
sensitivity (yellow = no growth, black = WT growth). Stress conditions and genes are 
clustered by the similarity of their interactions. (B) The clusters of genes are enlarged 
to highlight the chemical-genetic interaction profile of Caspofungin (blue bar in ‘a’ 
labeled ‘b’). (C) A section of the cluster (orange bar labeled ‘C’) involved in heat stress 
(42°C) is enlarged. (D) Genes implicated in sensitivity to the cell wall-perturbing agents 
CR and CW (red and green bar labeled ‘D’). 
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Supplemental Figures 
 
Figure S1. Generation of the new triple auxotrophic strain HTL. (A) Cloning 
strategy using the SAT1 flipper for recyclable deletion cassettes of C. glabrata TRP1, 
LEU2 and HIS3 genes. 500bp homology flanking regions were ligated into ApaI/XhoI 
and SacII/SacI restriction sites in pSFS2a, the deletion cassette excised with ApaI/SacI 
and the resulting fragment used to transform C. glabrata ATCC2001. (B) Growth of 
ATCC2001 wild type strain, HTL and HTL reference strain on YPD, supplemented with 
200 μg/ml Nourseothricin and SC plates lacking histidine, leucine or tryptophan. (C) 
Growth of ATCC 2001 wild type, HTL and HTL reference strains at 30°C and 37°C on 
solid YPD and minimal medium (YNB, ammonium sulfate, glucose, histidine, leucine or 
tryptophan), as well as in liquid YPD at 30°C and 37°C. 
 
Figure S2. Verification of C. glabrata sensitivities to antifungals and 
hyperosmoloratity. Deletions were tested for (A) osmostress (NaCl), (B) fluconazole 
(Flc) and (C) CF susceptibility. Serial dilutions of C. glabrata ATCC 2001, HTL and 
selected deletion strains were spotted onto YPD plates supplemented with the 
indicated compounds. Plates were incubated for two days at 30°C. 
 
Figure S3. Sensitivity of C. glabrata strains to NaCl treatment. Confirmation of 
NaCl sensitivities of osmosensitivity mutants on agar plates. Deletions strains were 
spotted in serial dilutions on synthetic medium supplemented with 1M NaCl and growth 
was monitored over 3 days at 30°C. 
 
Figure S4. Deletions with altered fitness under planktonic or biofilm growth 
conditions. VENN diagrams showing the overlap between planktonic and biofilm 
growth. (A) 36 strains showed a decrease in fitness in biofilm conditions, while 55 
strains show a fitness decrease in planktonic conditions. 13 strains showed a decrease 
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in fitness under both conditions. (B) 36 mutants displayed a fitness gain under biofilm 
conditions, while 35 mutants showed increased fitness under planktonic conditions. 8 
strains showed an increase in both growth conditions. SD (standard deviation), Fb 
(fitness biofilm growth), F (fitness planktonic growth). 
 
Figure S5. Susceptibilities of C. glabrata mutants to azoles Susceptible strains 
identified in the primary screenings were subjected to IC50 determination. Overnight 
cultures were grown to an OD600 of 1.0 and a microdilution assay was carried out in 
YPD to determine IC50 values as described in Materials and Methods. The OD600 was 
determined in a microplate reader after 24 h and 48 h of incubation at 30°C. Each 
strain was tested in triplicates and mean values normalized to the untreated control 
were plotted against the antifungal concentration of fluconazole (A). The IC50 was 
calculated by nonlinear regression (curve fit), using GraphPadPrism (B). Shown are 
data of 24 h measurements. Bars denote standard deviations. 
 
Figure S6. Susceptibilities of C. glabrata mutants to AmB. AmB-susceptible strains 
identified in the primary robotic screening were subjected to IC50 determination. 
Overnight cultures were grown to an OD600 of 1.0 and a microdilution assay carried out 
in YPD to determine IC50 for AmB (A) as described in Materials and Methods. The 
OD600 was determined in a microplate reader after 24 h and 48 h of incubation at 30°C. 
Each strain was tested in triplicates and mean values normalized to the untreated 
control were plotted against the antifungal concentration. The IC50 were calculated for 
each mutant by nonlinear regression (curve fit), using GraphPadPrism (B). Shown are 
data of 24 h measurement. Bars indicate standard deviations. 
 
Figure S7. Sensitivity of C. glabrata deletion strains to cell integrity stressors.  
Deletion strain sensitivities were tested against CF, CW, CR, and 42°C in liquid culture 
and on plates. (A) Growth susceptibilities of C. glabrata strains to CF. Susceptible 
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strains identified in the primary robotic screenings were subjected to IC50 
determination. Overnight cultures were grown to OD600 of 1.0 and a microdilution assay 
was carried out in YPD to determine IC50 as described in Materials & Methods. The 
optical density (OD) of each well was determined at 600 nm on a microplate reader 
after 24h and 48h of incubation at 30°C. Each strain was tested in triplicates and mean 
values normalized to the untreated control were plotted against the antifungal 
concentration. The IC50 was calculated by nonlinear regression (curve fit), using 
GraphPadPrism. Shown are data of 48h measurement. Bars denote standard 
deviations. (B) Confirmation of CF sensitivity on plates. Strains were spotted in serial 
dilutions on synthetic medium supplemented with 120ng/ml caspofungin (CF) and 
growth was monitored over 3 days at 30°C. (C) Congo Red (CR), heat and Calcofluor 
White (CW) sensitivity on plates. Strains were spotted in serial dilutions on synthetic 
medium supplemented with 250µg/ml Congo Red (CR) or 50µg/ml CW and growth was 
monitored over 3 days at 30°C.  For heat stress assay cells were grown at 42°C over 
three days. 
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Supplemental Tables  
 
Table S1. Classification of functional gene categories. Genes were selected by 
their homology to S. cerevisiae based on SGD gene ontology annotations 
(www.yeastgenome.org). C. glabrata orthologues were identified using a BLAST 
approach. The three best-aligned hits for each gene were saved. The orthologues have 
been remapped using a tree-based approach applying the algorithm described in 
[47,50]. 
 
Table S2. Isogenic C. glabrata background strains used in this study. The triple 
auxotrophic strain HTL and isogenic single and double deletion strains were generated 
in the sequenced reference strain ATCC2001. Strain HTL was used as recipient strain 
for the generation of the deletion mutants in the strain library. 
 
Table S3. Summary of auxotrophic C. glabrata deletion strains generated in the 
HTL background derived from the clinical isolate strain ATCC2001. Sheet 1: 
deletion strains + corresponding barcodes. Independent transformants of all generated 
gene deletion strains are listed with corresponding UP and DOWN tags, position in 
storage plates, number corresponding to the individual biological replicate (IBR#) for a 
targeted gene (e.g. the second of three independent replicates for CAGL0A01133g has 
IBR #2) and the nourseothricin marker used. All data can be searched online under: 
http://funpath.cdl.univie.ac.at. (Sheet 2: barcode sequences only). Bar-codes used as 
unique genomic tags in C. glabrata deletion strains. 2 x 96 upstream and downstream 
barcodes were used for every set of 96 gene deletion strains. These can be amplified 
from constant regions (U1 + U2; D1 + D2) identical in every deletion strain. Strains 
labeled with BM or BG carry individual barcodes and were made in the histidine 
auxotrophic strain derived from ATCC2001. The reference strain in the HTL 
background carries a unique barcode not used for any other strain. Barcode sequences 
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were adopted from the systematic S. cerevisiae gene deletion project (http://www-
sequence.stanford.edu/group/yeast_deletion_project/deletions3.html;) 
 
Table S4. Fitness raw data of C. glabrata deletion with strong variations in 
relative fitness. Deletions displaying strong variations between independent mutants 
in the same gene or independent cultures, identifying 57 strains that were excluded 
from fitness analysis due to a standard deviation of more than 0.1, or an absolute 
difference in fitness of more than 0.1 between two biological replicates. 
 
Table S5. Fitness raw data of C. glabrata deletion mutants. The table shows the 
raw data for fitness analysis, including fitness and standard deviation (SD). The orange 
and red color-coding (> 3 SD) and red (>2<3 SD) indicates genes with deviations 
below and above the average fitness indices. 
 
Table S6. Fitness distribution of C. glabrata knock-out mutants. The Table shows 
the distribution of fitness phenotypes. Strains with a standard deviation (SD) above 0.1 
or an absolute difference in fitness of more than 0.1 between two biological replicates 
were excluded from detailed analysis. Classification was based on the number of 
standard deviations between the fitness of a single strain and the average fitness. 
 
Table S7. Biofilm raw data - strains with strong variations in relative biofilm 
fitness. Some 158 deletions strains were excluded from biofilm analysis due to a 
standard deviation (SD) of more than 0.3 or an absolute difference of more than 0.5 
between replicates. 
 
Table S8. Biomass quantification using fluorescein diacetate assay. The table 
shows the raw data for biofilm analysis, including fitness and standard deviation (SD). 
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Table S9. Biofilm fitness distribution of C. glabrata knock-out mutants. Summary 
of biofilm fitness phenotypes. Strains with a standard deviation (SD) above 0.3, or an 
absolute difference in biofilm fitness of more than 0.5 between replicates were 
excluded. Classification was based on the number of standard deviations between the 
fitness of a single strain and the average fitness. 
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Appendix 14: Verification of 
fusion constructs and C. glabrata 
deletion mutants. 
Verification of fusion constructs. ORF-specific -500-F and +500-R primers 
(Appendix 1 Table 2) were added to a PCR reaction permitting the fusion of the 
NATR  cassette with homologous regions of ORF-specific 5’ and 3’ ends. 
Correct fusion produced a 2.3-2.4 kb amplification product, although several 
minor bands were also produced. 
 
Figure 1: Verification of fusion constructs. 
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Verification of C. glabrata deletion mutants. Transformants (labelled 
numerically) were checked for the presence of the target ORF (“internal”) using 
ORF-specific primers int-F and int-R (Appendix 1 Table 3), yielding an 
amplification product in the parental strain (labelled C) and no product in correct 
transformants. Junction PCR checks were performed on transformants which 
passed the internal PCR check. For PCR amplification of the 5’ junction, 
primers -600-F (Appendix 1 Table 3) and NAT-5’-R (Appendix 1 Table 1) were 
used, yielding an amplification product of 1-1.3 kb in transformants where the 
fusion construct had integrated at the correct locus. For the 3’ junction, primers 
+600-R (Appendix 1 Table 3) and NAT-3’-F (Appendix 1 Table 1) were used, 
yielding a 0.9-1.2 kb amplification product in correct transformants.  
 
Figure 2: Verification of C. glabrata ΔCAGL0A02299g. Three independent 
isolates (3, 7 and 14) were stored as glycerol stocks. 
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Figure 3: Verification of C. glabrata ΔCAGL0A02343g. Two independent 
isolates (3 and 13) were stored as glycerol stocks. 
 
 
 
Figure 4: Verification of C. glabrata ΔCAGL0A04565g. One independent 
isolates (1) was stored as glycerol stocks. 
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Figure 5: Verification of C. glabrata ΔCAGL0B00726g. Three independent 
isolates (1, 2 and 3) were stored as glycerol stocks. 
 
 
 
Figure 6: Verification of C. glabrata ΔCAGL0B02926g. One independent 
isolate (1) was stored as glycerol stocks. 
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Figure 7: Verification of C. glabrata ΔCAGL0B02946g. Three independent 
isolates (4, 5 and 7) were stored as glycerol stocks. 
 
 
 
 
Figure 8: Verification of C. glabrata ΔCAGL0B02948g. Three independent 
isolates (1, 2 and 4) were stored as glycerol stocks. 
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Figure 9: Verification of C. glabrata ΔCAGL0B02970g. One independent 
isolate (1) was stored as glycerol stocks. 
 
 
 
 
Figure 10: Verification of C. glabrata ΔCAGL0B03223g. Three independent 
isolates (7, 9 and 10) were stored as glycerol stocks. 
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Figure 11: Verification of C. glabrata ΔCAGL0B03883g. Three independent 
isolates (2,7 and 13) were stored as glycerol stocks. 
 
 
 
 
Figure 12: Verification of C. glabrata ΔCAGL0C00253g. Three independent 
isolates (1, 2 and 3) were stored as glycerol stocks. 
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Figure 13: Verification of C. glabrata ΔCAGL0C01837g. Three independent 
isolates (1, 2 and 5) were stored as glycerol stocks. 
 
 
 
Figure 14: Verification of C. glabrata ΔCAGL0C04763g. Three independent 
isolates (1, 3 and 4) were stored as glycerol stocks. 
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Figure 15: Verification of C. glabrata ΔCAGL0D00682g. Two independent 
isolates (1 and 3) were stored as glycerol stocks. 
 
 
 
Figure 16: Verification of C. glabrata ΔCAGL0D01210g. Three independent 
isolates (2, 3 and 5) were stored as glycerol stocks. 
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Figure 17: Verification of C. glabrata ΔCAGL0D03850g. Two independent 
isolates (3 and 4) were stored as glycerol stocks. 
 
 
 
Figure 18: Verification of C. glabrata ΔCAGL0D03872g. Three independent 
isolates (6, 9 and 11) were stored as glycerol stocks. 
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Figure 19: Verification of C. glabrata ΔCAGL0D05170g. Two independent 
isolates (1 and 4) were stored as glycerol stocks. 
 
 
Figure 20: Verification of C. glabrata ΔCAGL0D05434g. Two independent 
isolates (1 and 4) were stored as glycerol stocks. 
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Figure 21: Verification of C. glabrata ΔCAGL0D06226g. Three independent 
isolates (3, 9 and 11) were stored as glycerol stocks. 
 
 
 
Figure 22: Verification of C. glabrata ΔCAGL0E00275g. One independent 
isolates (13) was stored as glycerol stocks. 
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Figure 23: Verification of C. glabrata ΔCAGL0E06600g. Three independent 
isolates (1, 2 and 3) were stored as glycerol stocks. 
 
 
 
Figure 24: Verification of C. glabrata ΔCAGL0E06600g. Three independent 
isolates (2, 3 and 5) were stored as glycerol stocks. 
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Figure 25: Verification of C. glabrata ΔCAGL0F01815g. Three independent 
isolates (4, 6 and 7) were stored as glycerol stocks. 
 
 
 
Figure 26: Verification of C. glabrata ΔCAGL0F03905g. Three independent 
isolates (1, 2 and 3) were stored as glycerol stocks. 
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Figure 27: Verification of C. glabrata ΔCAGL0F04081g. One independent 
isolate (4) was stored as glycerol stocks. 
 
 
 
Figure 28: Verification of C. glabrata ΔCAGL0F05159g. Three independent 
isolates (5, 6 and 8) were stored as glycerol stocks. 
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Figure 29: Verification of C. glabrata ΔCAGL0F05973g. One independent 
isolate (7) was stored as glycerol stocks. 
 
 
 
Figure 30: Verification of C. glabrata ΔCAGL0F06237g. Two independent 
isolates (13 and 15) were stored as glycerol stocks. 
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Figure 31: Verification of C. glabrata ΔCAGL0F08767g. Three independent 
isolates (1, 2 and 3) were stored as glycerol stocks. 
 
 
 
Figure 32: Verification of C. glabrata ΔCAGL0F09229g. Two independent 
isolates (2 and 3) were stored as glycerol stocks. 
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Figure 33: Verification of C. glabrata ΔCAGL0G02607g. One independent 
isolate (2) was stored as glycerol stocks. 
 
 
 
Figure 34: Verification of C. glabrata ΔCAGL0G03201g. Three independent 
isolates (2, 3 and 6) were stored as glycerol stocks. 
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Figure 35: Verification of C. glabrata ΔCAGL0G04279g. Two independent 
isolates (1 and 2) were stored as glycerol stocks. 
 
 
 
Figure 36: Verification of C. glabrata ΔCAGL0G05522g. Two independent 
isolates (1 and 2) were stored as glycerol stocks. 
 400 | P a g e  
 
Figure 37: Verification of C. glabrata ΔCAGL0G08866g. Two independent 
isolates (4 and 8) were stored as glycerol stocks. 
 
 
Figure 38: Verification of C. glabrata ΔCAGL0G10175g. Three independent 
isolates (1, 2 and 3) were stored as glycerol stocks. 
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Figure 39: Verification of C. glabrata ΔCAGL0H01749g. Three independent 
isolates (2, 3 and 6) were stored as glycerol stocks. 
 
 
 
Figure 40: Verification of C. glabrata ΔCAGL0H06765g. Three independent 
isolates (1, 4 and 9) were stored as glycerol stocks. 
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Figure 41: Verification of C. glabrata ΔCAGL0H08712g. Three independent 
isolates (3, 5 and 14) were stored as glycerol stocks. 
 
 
 
Figure 42: Verification of C. glabrata ΔCAGL0H09988g. Two independent 
isolates (1 and 6) were stored as glycerol stocks. 
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Figure 43: Verification of C. glabrata ΔCAGL0H10208g. Three independent 
isolates (1, 2 and 3) were stored as glycerol stocks. 
 
 
Figure 44: Verification of C. glabrata ΔCAGL0I02244g. Three independent 
isolates (2, 3 and 4) were stored as glycerol stocks. 
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Figure 45: Verification of C. glabrata ΔCAGL0I08437g. One independent 
isolate (5) was stored as glycerol stocks. 
 
 
Figure 46: Verification of C. glabrata ΔCAGL0I08613g. Three independent 
isolates (1, 2 and 4) were stored as glycerol stocks. 
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Figure 47: Verification of C. glabrata ΔCAGL0J05786g. Three independent 
isolates (1, 3 and 7) were stored as glycerol stocks. 
 
 
Figure 48: Verification of C. glabrata ΔCAGL0J05852g. Three independent 
isolates (1, 3 and 4) were stored as glycerol stocks. 
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Figure 49: Verification of C. glabrata ΔCAGL0K02145g. Two independent 
isolates (1 and 13) were stored as glycerol stocks. 
 
 
 
Figure 50: Verification of C. glabrata ΔCAGL0K05687g. Two independent 
isolates (2 and 9) were stored as glycerol stocks. 
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Figure 51: Verification of C. glabrata ΔCAGL0K07634g. One independent 
isolate (2) were stored as glycerol stocks. 
 
 
 
Figure 52: Verification of C. glabrata ΔCAGL0K10318g. Two independent 
isolates (3 and 11) were stored as glycerol stocks. 
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Figure 53: Verification of C. glabrata ΔCAGL0K11066g. Two independent 
isolates (5 and 9) were stored as glycerol stocks. 
 
 
Figure 54: Verification of C. glabrata ΔCAGL0L03674g. Two independent 
isolates (2 and 4) were stored as glycerol stocks. 
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Figure 55: Verification of C. glabrata ΔCAGL0L06776g. Three independent 
isolates (2, 5 and 7) were stored as glycerol stocks. 
 
 
Figure 56: Verification of C. glabrata ΔCAGL0L07480g. Three independent 
isolates (2, 4 and 6) were stored as glycerol stocks. 
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Figure 57: Verification of C. glabrata ΔCAGL0L09383g. Two independent 
isolates (1 and 3) were stored as glycerol stocks. 
 
 
Figure 58: Verification of C. glabrata ΔCAGL0M01716g. Three independent 
isolates (3, 4 and 6) were stored as glycerol stocks. 
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Figure 59: Verification of C. glabrata ΔCAGL0M01870g. One independent 
isolate (1) was stored as glycerol stocks. 
 
 
 
Figure 60: Verification of C. glabrata ΔCAGL0M01914g. One independent 
isolate (10) was stored as glycerol stocks. 
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Figure 61: Verification of C. glabrata ΔCAGL0M02299g. One independent 
isolate (8) was stored as glycerol stocks. 
 
 
 
Figure 62: Verification of C. glabrata ΔCAGL0M02321g. Three independent 
isolates (2, 3 and 6) were stored as glycerol stocks. 
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Figure 63: Verification of C. glabrata ΔCAGL0M05137g. Two independent 
isolates (2 and 5) were stored as glycerol stocks. 
 
 
Figure 64: Verification of C. glabrata ΔCAGL0M10153g. One independent 
isolate (9) was stored as glycerol stocks. 
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Figure 65: Verification of C. glabrata ΔCAGL0M10153g. One independent 
isolate (9) was stored as glycerol stocks. 
 
 
Figure 66: Verification of C. glabrata ΔCAGL0M04543g. Three independent 
isolates (3, 4 and 7) was stored as glycerol stocks. 
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Appendix 15: Plasmid maps of 
Gateway® vectors. 
Figure 1: Plasmid map and features of ENTRY vector pENTR™221 (Life 
Technologies™). 
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Figure 2: Plasmid map and features of destination vector pAG413GPD-
ccdB (Addgene). 
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Figure 3: Plasmid map and features of destination vector pAG423GPD-
ccdB (Addgene). 
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Figure 4: Plasmid map and features of destination vector pAG416GPD-
ccdB (Addgene). 
 
 
 
 
 
 
 
 
 
 
 420 | P a g e  
 
Figure 5: Plasmid map and features of destination vector pAG426GPD-
ccdB (Addgene). 
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